Genome ID,Genome Name,Organism Name,NCBI Taxon ID,Genome Status,Strain,Serovar,Biovar,Pathovar,MLST,Other Typing,Culture Collection,Type Strain,Completion Date,Publication,BioProject Accession,BioSample Accession,Assembly Accession,GenBank Accessions,RefSeq Accessions,Sequencing Centers,Sequencing Status,Sequencing Platform,Sequencing Depth,Assembly Method,Chromosomes,Plasmids,Contigs,Sequences,Genome Length,GC Content,PATRIC CDS,BRC1 CDS,RefSeq CDS,Isolation Site,Isolation Source,Isolation Comments,Collection Date,Isolation Country,Geographic Location,Latitude,Longitude,Altitude,Depth,Other Environmental,Host Name,Host Gender,Host Age,Host Health,Body Sample Site,Body Sample Subsite,Other Clinical,AntiMicrobial Resistance,AntiMicrobial Resistance Evidence,Gram Stain,Cell Shape,Motility,Sporulation,Temperature Range,Optimal Temperature,Salinity,Oxygen Requirement,Habitat,Disease,Comments,Additional Metadata,Date Inserted,Date Modified
1010834_3,Mycobacterium tuberculosis HKBS1,Mycobacterium tuberculosis HKBS1,1010834.0,Complete,BS1,,,,,, ,,2014-02-18T00:00:00Z,,PRJNA66061,SAMN03081429,GCA_000572125.1,CP002871.1,NZ_CP002871.1,"'School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong'",complete,,,,1.0,,,1.0,4407929.0,65.6,4352.0,,4151.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,2014-12-08T22:12:10.356Z,2015-03-16T03:17:09.594Z
1010835_3,Mycobacterium tuberculosis BT2,Mycobacterium tuberculosis BT2,1010835.0,Complete,BT2,,,,,, ,,2014-02-18T00:00:00Z,,PRJNA66063,SAMN03081430,GCA_000572155.1,CP002882.1,NZ_CP002882.1,"'School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong'",complete,,,,1.0,,,1.0,4401899.0,65.6,4364.0,,4149.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,2014-12-08T22:12:08.517Z,2015-03-16T03:17:09.594Z
1010836_3,Mycobacterium tuberculosis BT1,Mycobacterium tuberculosis BT1,1010836.0,Complete,BT1,,,,,, ,,2014-02-18T00:00:00Z,,PRJNA66065,SAMN03081431,GCA_000572175.1,CP002883.1,NZ_CP002883.1,"'School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong'",complete,,,,1.0,,,1.0,4399405.0,65.6,4363.0,,4139.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mycobacterium tuberculosis BT1.This strain will be used for comparative genome analysis.,,2014-12-08T22:12:08.507Z,2015-03-16T03:17:09.594Z
1078763_3,Mycobacterium tuberculosis NCGM2209,Mycobacterium tuberculosis NCGM2209,1078763.0,WGS,,,,,,,,,2011-09-23T00:00:00Z,,PRJDA72517,-,GCA_000291765.1,BADQ00000000,,,,,,,,,228.0,317.0,4233842.0,65.34,4215.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,2014-12-08T22:12:14.221Z,2015-03-16T03:17:09.594Z
1126682_4,Mycobacterium tuberculosis OSDD071,Mycobacterium tuberculosis OSDD071,1126682.0,WGS,,,,,,,,,2011-12-28T00:00:00Z,,PRJNA78807,SAMN02469671,GCA_000240245.2,AHHX00000000,,,,,,,,,491.0,660.0,4163620.0,65.48,4202.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,2014-12-08T22:12:14.820Z,2015-03-16T03:17:09.594Z
1126683_4,Mycobacterium tuberculosis OSDD504,Mycobacterium tuberculosis OSDD504,1126683.0,WGS,,,,,,,,,2011-12-28T00:00:00Z,,PRJNA78959,SAMN02469672,GCA_000240265.2,AHHY00000000,,,,,,,,,793.0,1040.0,4065959.0,65.37,4122.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,2014-12-08T22:12:14.848Z,2015-03-16T03:17:09.594Z
1126684_4,Mycobacterium tuberculosis OSDD518,Mycobacterium tuberculosis OSDD518,1126684.0,WGS,,,,,,,,,2011-12-28T00:00:00Z,,PRJNA78961,SAMN02469670,GCA_000240285.2,AHHZ00000000,,,,,,,,,513.0,684.0,4127456.0,65.45,4167.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,-,,2014-12-08T22:12:14.857Z,2015-03-16T03:17:09.594Z
1138877_3,Mycobacterium tuberculosis 7199-99,Mycobacterium tuberculosis,1138877.0,Complete,7199-99,,,,,, ,,2013-01-07T00:00:00Z,,PRJNA82273,SAMEA2272730,GCA_000331445.1,HE663067.1,NC_020089.1,"Center for Biotechnology, Bielefeld University",complete,,,1,1.0,,,1.0,4421197.0,65.62,4354.0,,3994.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Mycobacterium tuberculosis Genome sequencing,,2014-12-08T22:12:08.491Z,2015-03-16T03:17:09.594Z
1151113_3,Mycobacterium tuberculosis XDR1219,Mycobacterium tuberculosis XDR1219,1151113.0,WGS,XDR1219,,,,,, ,,2014-01-07T00:00:00Z,23801408,PRJNA85129,SAMN02597361,GCA_000516395.1,AJGO00000000,-,"'State Key Lab of Genetic Engineering, College of Life Sciences, Fudan University, Shanghai 200433, P.R.China'",WGS,Illumina HiSeq2000,183x,SOAPdenovo v. 1.05,,,128.0,170.0,4282846.0,65.5,4298.0,,,,,,,China,China,,,,,,,,,,,,,,,Positive,,,,,,,,,,An extensively drug resistant strain of Beijing genotype used for comparative analysis with other M. tuberculosis strains.,,2014-12-08T22:12:22.042Z,2015-03-16T03:17:09.594Z
1160714_3,Mycobacterium tuberculosis XDR1221,Mycobacterium tuberculosis XDR1221,1160714.0,WGS,XDR1221,,,,,, ,,2014-01-07T00:00:00Z,23801408,PRJNA88523,SAMN02597360,GCA_000516435.1,AJGN00000000,-,Fudan University,WGS,454,22.2x,Newbler v. 2.3,,,183.0,214.0,4275719.0,65.5,4305.0,,,,,,,China,China,,,,,,,,,,,,,,,Positive,,,,,,,,,,This strain will be used for comparative genome analysis.,,2014-12-08T22:12:22.051Z,2015-03-16T03:17:09.594Z
1160715_3,Mycobacterium tuberculosis WX1,Mycobacterium tuberculosis WX1,1160715.0,WGS,WX1,,,,,, ,,2014-01-07T00:00:00Z,23801408,PRJNA88525,SAMN02597359,GCA_000516455.1,AJGM00000000,-,Fudan University,WGS,454,28.4x,Newbler v. 2.3,,,145.0,182.0,4245714.0,65.5,4260.0,,,,,,,China,China,,,,,,,,,,,,,,,Positive,,,,,,,,,,This strain will be used for comparative genome analysis.,,2014-12-08T22:12:22.004Z,2015-03-16T03:17:09.594Z
1160716_3,Mycobacterium tuberculosis WX3,Mycobacterium tuberculosis WX3,1160716.0,WGS,WX3,,,,,, ,,2014-01-07T00:00:00Z,23801408,PRJNA88527,SAMN02597358,GCA_000516415.1,AJGL00000000,-,Fudan University,WGS,454,28.5x,Newbler v. 2.3,,,129.0,160.0,4280311.0,65.5,4286.0,,,,,,,China,China,,,,,,,,,,,,,,,Positive,,,,,,,,,,This strain will be used for comparative genome analysis.,,2014-12-08T22:12:22.014Z,2015-03-16T03:17:09.594Z
1200347_3,Mycobacterium tuberculosis NA-A0008,Mycobacterium tuberculosis NA-A0008,1200347.0,WGS,NA-A0008,,,,,,,,2012-09-11T00:00:00Z,,PRJNA168604,SAMN02471802,GCA_000296175.1,ALYG00000000,-,University of Hyderabad,WGS,IonTorrent,89.0x,MIRA v. 2,,,239.0,280.0,4344894.0,65.4,4639.0,,,,sputum from a patient infected with tuberculosis,,2008,India,India: Orissa,,,,,,"Human, Homo sapiens",,,,,,,,,,,,,,,,,,,Genome sequencing of Mycobacterium tuberculosis NA-A0008,,2014-12-08T22:12:14.190Z,2015-03-16T03:17:09.594Z
1200348_3,Mycobacterium tuberculosis NA-A0009,Mycobacterium tuberculosis NA-A0009,1200348.0,WGS,NA-A0009,,,,,,,,2012-09-11T00:00:00Z,,PRJNA168605,SAMN02471797,GCA_000296155.1,ALYH00000000,-,University of Hyderabad,WGS,IonTorrent,93.0x,MIRA v. 2,,,266.0,310.0,4342522.0,65.4,4666.0,,,,sputum from a patient infected with tuberculosis,,2008,India,India: Orissa,,,,,,"Human, Homo sapiens",,,,,,,,,,,,,,,,,,,Genome sequencing of Mycobacterium tuberculosis NA-A0009,,2014-12-08T22:12:14.210Z,2015-03-16T03:17:09.594Z
1240677_3,Mycobacterium tuberculosis UM 1072388579,Mycobacterium tuberculosis UM 1072388579,1240677.0,WGS,UM 1072388579,,,,,, ,,2012-11-09T00:00:00Z,23405310,PRJNA176960,SAMN02471862,GCA_000313215.2,AMXW00000000,-,UNIVERSITY OF MALAYA,WGS,Illumina HiSeq,100.0x,Velvet v. 1.1.07,,,145.0,158.0,4249773.0,65.4,4248.0,,,,sputum,isolated XDR-TB strain in Malaysia,2011,Malaysia,Malaysia: University Malaya Medical Center,,,,,,"Human, Homo sapiens",,,,,,,,,,,,,,,,,,,"Mycobacterium tuberculosis UM 1072388579 is a clinical isolate of extensively drug-resistant strain, obtained from a patient of University Malaya Medical Centre. It is the first isolated XDR-TB strain in Malaysia. It is resistant to amikacin, capromycin, ciprofloxacin, ethionamide, isoniazid, kanamycin, ofloxacin, rifampicin, and streptomycin but sensitive to ethambutol and para salicylic acid.",,2014-12-08T22:12:21.831Z,2015-03-16T03:17:09.594Z
1245275_3,Mycobacterium tuberculosis FJ05194,Mycobacterium tuberculosis FJ05194,1245275.0,WGS,FJ05194,,,,,,,,2013-08-23T00:00:00Z,,PRJNA177778,SAMN02469373,GCA_000454325.1,ANBL00000000,-,BGI-Shenzhen,WGS,Illumina HiSeq,110x,SOAPdenovo v. 1.05,,,212.0,287.0,4298328.0,65.5,4297.0,,4165.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,To understand the mechanism of the drug resistance of XDR-TB.,,2014-12-08T22:12:10.039Z,2015-03-16T03:17:09.594Z
1245787_3,Mycobacterium tuberculosis GuangZ0019,Mycobacterium tuberculosis GuangZ0019,1245787.0,WGS,GuangZ0019,,,,,,,,2013-08-23T00:00:00Z,,PRJNA177783,SAMN02469376,GCA_000454345.1,ANFI00000000,-,BGI-Shenzhen,WGS,Illumina HiSeq,110x,SOAPdenovo v. 1.05,,,140.0,194.0,4324585.0,65.6,4318.0,,4198.0,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,To provide insight into the resistance mechanism of the super XDR-TB.,,2014-12-08T22:12:10.056Z,2015-03-16T03:17:09.594Z
1249615_4,Mycobacterium tuberculosis K,,1249615.0,Complete,K,,,,,,,,2014-06-05T00:00:00Z,-,PRJNA178919,SAMN02803802,GCA_000698475.1,CP007803.1,NZ_CP007803.1,Seoul National University,,Santer; Illumina MiSeq,570.51x,Phred/Phrap/Consed; CLC Genomics Workbench,1.0,,1.0,1.0,4385520.0,65.6,4298.0,,4145.0,,human-associated habitat,,1998,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,,,,Bacilli,No,No,,,,,,,Mycobacterium tuberculosis K. Sequencing of clinical isolate in Korea. This strain is sequenced for comparative genomic studies.,,2014-12-09T00:45:13.826Z,2015-03-16T03:17:09.594Z
1262525_3,Mycobacterium tuberculosis PanR0201,Mycobacterium tuberculosis PanR0201,1262525.0,Complete,PanR0201,,,,,,,,2013-08-02T00:00:00Z,,PRJNA182109,SAMN02471069,GCA_000442945.1,CM002049.1,-,Texas A&M University,WGS,Illumina GAIIx,68.0x,in-house software v. 11/13/2012,1.0,,,1.0,4402571.0,65.5,4352.0,,,,clinical isolate,isolate from Panama,,Panama,Panama,,,,,,"Human, Homo sapiens",,,,,,,,,,,,,,,,,,,MDR isolate from Panama.,,2014-12-08T22:12:14.876Z,2015-03-16T03:17:09.594Z
1262526_3,Mycobacterium tuberculosis PanR0802,Mycobacterium tuberculosis PanR0802,1262526.0,Complete,PanR0802,,,,,,,,2013-08-02T00:00:00Z,,PRJNA182111,SAMN02471108,GCA_000442965.1,CM002050.1,-,Texas A&M University,WGS,Illumina GAIIx,72.0x,in-house software v. 11/13/2012,1.0,,,1.0,4408178.0,65.6,4339.0,,,,clinical isolate,isolate from Panama,,Panama,Panama,,,,,,"Human, Homo sapiens",,,,,,,,,,,,,,,,,,,MDR isolate from Panama.,,2014-12-08T22:12:15.347Z,2015-03-16T03:17:09.594Z
1262529_3,Mycobacterium tuberculosis PanR1005,Mycobacterium tuberculosis PanR1005,1262529.0,Complete,PanR1005,,,,,,,,2013-08-01T00:00:00Z,,PRJNA182112,SAMN02471042,GCA_000443005.1,CM002051.1,-,Texas A&M University,WGS,Illumina GAIIx,73.0x,in-house software v. 11/13/2012,1.0,,,1.0,4408147.0,65.6,4322.0,,,,clinical isolate,isolate from Panama,,Panama,Panama,,,,,,"Human, Homo sapiens",,,,,,,,,,,,,,,,,,,MDR isolate from Panama.,,2014-12-08T22:12:15.449Z,2015-03-16T03:17:09.594Z
1266446_3,Mycobacterium tuberculosis PanR0704,Mycobacterium tuberculosis PanR0704,1266446.0,Complete,PanR0704,,,,,,,,2013-08-02T00:00:00Z,,PRJNA181126,SAMN02471068,GCA_000442795.1,CM002048.1,-,Texas A&M University,WGS,Illumina GAIIx,85.1x,in-house software v. 11/13/2012,1.0,,,1.0,4398504.0,65.6,4332.0,,,,clinical isolate,isolate from Panama,,Panama,Panama,,,,,,"Human, Homo sapiens",,,,,,,,,,,,,,,,,,,MDR isolate from Panama.,,2014-12-08T22:12:15.310Z,2015-03-16T03:17:09.594Z
1267355_3,Mycobacterium tuberculosis TKK-01-0008,Mycobacterium tuberculosis TKK-01-0008,1267355.0,WGS,TKK-01-0008,,,,,,,,2014-04-29T00:00:00Z,,PRJNA183514,SAMN01828242,GCA_000659025.1,JLZN00000000,-,Broad Institute,WGS,Illumina,238.0x,allpaths v. R46586,,,43.0,43.0,4383615.0,65.6,4365.0,,3996.0,,sputum,,2008,,,,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:PMH1363;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Beijing lineage,2014-12-08T22:12:17.509Z,2015-03-16T03:17:09.594Z
1267356_3,Mycobacterium tuberculosis TKK-01-0017,Mycobacterium tuberculosis TKK-01-0017,1267356.0,WGS,TKK-01-0017,,,,,,,,2014-04-29T00:00:00Z,,PRJNA183515,SAMN01828243,GCA_000659045.1,JLZE00000000,-,Broad Institute,WGS,Illumina,140.0x,allpaths v. R46513,,,9.0,9.0,4391906.0,65.6,4345.0,,4002.0,,sputum,,2008,,,,,,,,"Human, Homo sapiens",Female,56,,,,host_subject_id:SMH1034;co-morbidity:Unknown;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB not isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:KZN lineage,2014-12-08T22:12:17.593Z,2015-03-16T03:17:09.594Z
1267357_3,Mycobacterium tuberculosis TKK-01-0020,,1267357.0,WGS,TKK-01-0020,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA183516,SAMN01828244,GCA_000706545.1,JLZB00000000,-,Broad Institute,,Illumina,104.0x,allpaths v. R46513,,,9.0,22.0,4411620.0,65.6,4298.0,,4013.0,,sputum,,2008,,,,,,,,"Human, Homo sapiens",Female,61,,,,host_subject_id:STA2049;co-morbidity:HIV Negative;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Mycobacterium tuberculosis;TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:35:36.244Z,2015-03-16T03:17:09.594Z
1267358_3,Mycobacterium tuberculosis TKK-01-0021,Mycobacterium tuberculosis TKK-01-0021,1267358.0,WGS,TKK-01-0021,,,,,,,,2014-04-29T00:00:00Z,,PRJNA183517,SAMN01828245,GCA_000659065.1,JLZA00000000,-,Broad Institute,WGS,Illumina,135.0x,allpaths v. R46513,,,33.0,36.0,4380783.0,65.6,4358.0,,3991.0,,sputum,,2008,,,,,,,,"Human, Homo sapiens",Male,39,,,,host_subject_id:STA2041;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.613Z,2015-03-16T03:17:09.594Z
1267359_3,Mycobacterium tuberculosis TKK-01-0023,Mycobacterium tuberculosis TKK-01-0023,1267359.0,WGS,TKK-01-0023,,,,,,,,2014-04-29T00:00:00Z,,PRJNA183518,SAMN01828246,GCA_000659085.1,JLYY00000000,-,Broad Institute,WGS,Illumina,138.0x,allpaths v. R46813,,,35.0,35.0,4368700.0,65.6,4331.0,,3967.0,,sputum,,2008,,,,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:EST1013;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.632Z,2015-03-16T03:17:09.594Z
1267360_3,Mycobacterium tuberculosis TKK-01-0026,Mycobacterium tuberculosis TKK-01-0026,1267360.0,WGS,TKK-01-0026,,,,,,,,2014-04-29T00:00:00Z,,PRJNA183519,SAMN01828247,GCA_000659105.1,JLYV00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R46513,,,18.0,18.0,4398303.0,65.6,4348.0,,4010.0,,sputum,,2008,,,,,,,,"Human, Homo sapiens",Female,45,,,,host_subject_id:LSH2008;co-morbidity:HIV Positive;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.660Z,2015-03-16T03:17:09.594Z
1267361_3,Mycobacterium tuberculosis TKK-01-0032,Mycobacterium tuberculosis TKK-01-0032,1267361.0,WGS,TKK-01-0032,,,,,,,,2014-04-29T00:00:00Z,,PRJNA183520,SAMN01828248,GCA_000659125.1,JLYP00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R46513,,,13.0,15.0,4394599.0,65.6,4359.0,,4013.0,,sputum,,2008,,,,,,,,"Human, Homo sapiens",Female,32,,,,host_subject_id:GTH1028;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.717Z,2015-03-16T03:17:09.594Z
1267362_3,Mycobacterium tuberculosis TKK-01-0069,Mycobacterium tuberculosis TKK-01-0069,1267362.0,WGS,TKK-01-0069,,,,,,,,2014-04-29T00:00:00Z,,PRJNA183521,SAMN01828249,GCA_000659145.1,JLXE00000000,-,Broad Institute,WGS,Illumina,139.0x,allpaths v. R46513,,,6.0,6.0,4401766.0,65.6,4350.0,,4022.0,,sputum,,2010,,,,,,,,"Human, Homo sapiens",Male,53,,,,host_subject_id:NGW1284;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Pre-XDR;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:18.059Z,2015-03-16T03:17:09.594Z
1267363_3,Mycobacterium tuberculosis TKK-01-0072,Mycobacterium tuberculosis TKK-01-0072,1267363.0,WGS,TKK-01-0072,,,,,,,,2014-04-29T00:00:00Z,,PRJNA183522,SAMN01828250,GCA_000659165.1,JLXB00000000,-,Broad Institute,WGS,Illumina,239.0x,allpaths v. R46813,,,26.0,27.0,4395067.0,65.6,4353.0,,4021.0,,sputum,,2010,,,,,,,,"Human, Homo sapiens",Female,48,,,,host_subject_id:NGW1367;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:18.087Z,2015-03-16T03:17:09.594Z
1267364_3,Mycobacterium tuberculosis TKK-01-0080,Mycobacterium tuberculosis TKK-01-0080,1267364.0,WGS,TKK-01-0080,,,,,,,,2014-04-29T00:00:00Z,,PRJNA183523,SAMN01828251,GCA_000659185.1,JLWT00000000,-,Broad Institute,WGS,Illumina,184.0x,allpaths v. R46586,,,16.0,18.0,4402947.0,65.6,4355.0,,3974.0,,sputum,,2010,,,,,,,,"Human, Homo sapiens",Male,33,,,,host_subject_id:NGW1488;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:18.164Z,2015-03-16T03:17:09.594Z
1274431_3,Mycobacterium tuberculosis SP21,Mycobacterium tuberculosis SP21,1274431.0,WGS,SP21,,,,,,,,2013-04-15T00:00:00Z,,PRJNA181180,SAMN02470832,GCA_000364945.1,AOUF00000000,-,"Research Institute of Physical-Chemical Medicine, Moscow, Russia",WGS,454; IonTorrent,7.0x,GS De Novo Assembler v. 2.8; sspace v.,,,370.0,411.0,4212157.0,65.3,4297.0,,,,sputum,,2010,Russia,Russia: Saint Petersburg,,,,,,"Human, Homo sapiens",,,,,,,,,,,,,,,,,,,"38 M. tuberculosis clinical isolates were sequenced to study the genomic organization for Russia endemic M. tuberculosis strains. Project participants are Research Institute of Physical-Chemical Medicine, Moscow;Scientific and Clinical Antituberculosis Center of Moscow Government Health Department, Moscow; Research Institute of Phthisiopulmonology, St. Petersburg; St. Petersburg Pasteur Institute, St. Petersburg; Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow,Russia. All isolates were sequenced using the GS FLX+ System (Roche) and belong to three different genetic families (Beijing, Ural and LAM). This work is supported by 16.522.11.2003 grant of the Ministry of Education and Science of the Russian Federation for ¿¿¿¿¿¿¿Development and production of operative embodiments of diagnostic kit based on feature of the genomic organization for Russia endemic M. tuberculosis strains and suitable for the detection of drug-resistant tuberculosis¿¿¿¿¿¿¿",,2014-12-08T22:12:15.553Z,2015-03-16T03:17:09.594Z
1279011_3,Mycobacterium tuberculosis PR05,Mycobacterium tuberculosis PR05,1279011.0,WGS,PR05,,,,,,,,2013-04-19T00:00:00Z,,PRJNA185398,SAMN02471435,GCA_000372545.2,AOMG00000000,-,Universiti Teknologi MARA,WGS,Illumina GAIIx,205.0x,CLCBio Genomic Workbench v. 5.5.1,,,155.0,225.0,4278335.0,65.4,4379.0,,,,cerebrospinal fluid sample from tuberculosis patient,,2012,Malaysia,Malaysia: Selangor,,,,,,"Human, Homo sapiens",,,,,,,,,Positive,Bacilli,No,No,Mesophilic,37C,Mesophilic,Aerobic,HostAssociated,Tuberculosis,Whole genome sequence of a Malaysian Mycobacterium tuberculosis isolate.,,2014-12-08T22:12:14.866Z,2015-03-16T03:17:09.594Z
1279039_3,Mycobacterium tuberculosis 1034,Mycobacterium tuberculosis 1034,1279039.0,WGS,1034,,,,,, ,,2014-02-11T00:00:00Z,,PRJNA185382,SAMN02951936,GCA_000568275.1,APHO00000000,-,Lanzhou University,WGS,Illumina HiSeq,100.0x,SOAPdenovo v. 1.05,,,267.0,339.0,4239443.0,65.6,4242.0,,,,,"'isolated and sequenced belongs to the most prevalent Beijing genotype M. tuberculosis in Russia, China and the rest of Asia, and was not only resistant to but its growth was enhanced by rifampicin'",,China,China,,,,,,"Human, Homo sapiens",,,,,,,,,,,,,,,,,,,"'Mycobacterium tuberculosis is one of the world¿¿¿s most ancient and successful pathogens. Strain 1034 which we isolated and sequenced belongs to the most prevalent Beijing genotype M. tuberculosis in Russia, China and the rest of Asia, and was not only resistant to but its growth was enhanced by rifampicin.'",,2014-12-08T22:12:08.152Z,2015-03-16T03:17:09.594Z
1295720_3,Mycobacterium tuberculosis TKK_02_0004,Mycobacterium tuberculosis TKK_02_0004,1295720.0,WGS,TKK_02_0004,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190927,SAMN01925614,GCA_000659205.1,JMBG00000000,-,Broad Institute,WGS,Illumina,189.0x,allpaths v. R47129,,,5.0,6.0,4403697.0,65.6,4351.0,,4007.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,44,,,,host_subject_id:37;treatment course:adm;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.339Z,2015-03-16T03:17:09.594Z
1295721_3,Mycobacterium tuberculosis TKK_02_0005,Mycobacterium tuberculosis TKK_02_0005,1295721.0,WGS,TKK_02_0005,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190928,SAMN01925615,GCA_000659225.1,JMBF00000000,-,Broad Institute,WGS,Illumina,139.0x,allpaths v. R46813,,,6.0,6.0,4405404.0,65.6,4350.0,,4008.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,28,,,,host_subject_id:38;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.349Z,2015-03-16T03:17:09.594Z
1295723_3,Mycobacterium tuberculosis TKK_02_0007,Mycobacterium tuberculosis TKK_02_0007,1295723.0,WGS,TKK_02_0007,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190930,SAMN01925617,GCA_000659245.1,JMBE00000000,-,Broad Institute,WGS,Illumina,142.0x,allpaths v. R46813,,,4.0,4.0,4398890.0,65.6,4350.0,,4003.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,36,,,,host_subject_id:40;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.368Z,2015-03-16T03:17:09.594Z
1295724_3,Mycobacterium tuberculosis TKK_02_0008,Mycobacterium tuberculosis TKK_02_0008,1295724.0,WGS,TKK_02_0008,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190931,SAMN01925618,GCA_000659265.1,JMBD00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R46813,,,5.0,6.0,4403834.0,65.6,4349.0,,4015.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,31,,,,host_subject_id:41;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:2+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.377Z,2015-03-16T03:17:09.594Z
1295725_3,Mycobacterium tuberculosis TKK_02_0009,Mycobacterium tuberculosis TKK_02_0009,1295725.0,WGS,TKK_02_0009,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190932,SAMN01925619,GCA_000659285.1,JLWE00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R47738,,,2.0,2.0,4399818.0,65.6,4340.0,,4001.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,31,,,,host_subject_id:41;treatment course:8w;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.386Z,2015-03-16T03:17:09.594Z
1295726_3,Mycobacterium tuberculosis TKK_02_0010,Mycobacterium tuberculosis TKK_02_0010,1295726.0,WGS,TKK_02_0010,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190933,SAMN01925620,GCA_000659305.1,JMBC00000000,-,Broad Institute,WGS,Illumina,145.0x,allpaths v. R46813,,,15.0,15.0,4399341.0,65.6,4349.0,,3993.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,30,,,,host_subject_id:42;treatment course:adm;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.395Z,2015-03-16T03:17:09.594Z
1295727_3,Mycobacterium tuberculosis TKK_02_0011,Mycobacterium tuberculosis TKK_02_0011,1295727.0,WGS,TKK_02_0011,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190934,SAMN01925621,GCA_000659325.1,JMBB00000000,-,Broad Institute,WGS,Illumina,179.0x,allpaths v. R47129,,,27.0,28.0,4388932.0,65.6,4343.0,,3984.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,30,,,,host_subject_id:42;treatment course:8w;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:scanty;microscopy auramine:1+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.403Z,2015-03-16T03:17:09.594Z
1295739_3,Mycobacterium tuberculosis TKK_02_0023,Mycobacterium tuberculosis TKK_02_0023,1295739.0,WGS,TKK_02_0023,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190947,SAMN01925633,GCA_000659345.1,JMBA00000000,-,Broad Institute,WGS,Illumina,142.0x,allpaths v. R46813,,,3.0,4.0,4399446.0,65.6,4334.0,,4004.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,23,,,,host_subject_id:50;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:2+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.515Z,2015-03-16T03:17:09.594Z
1295740_3,Mycobacterium tuberculosis TKK_02_0024,Mycobacterium tuberculosis TKK_02_0024,1295740.0,WGS,TKK_02_0024,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190948,SAMN01925634,GCA_000659365.1,JLWD00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R47738,,,2.0,2.0,4398846.0,65.6,4345.0,,4001.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,30,,,,host_subject_id:51;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.525Z,2015-03-16T03:17:09.594Z
1295742_3,Mycobacterium tuberculosis TKK_02_0026,Mycobacterium tuberculosis TKK_02_0026,1295742.0,WGS,TKK_02_0026,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190950,SAMN01925636,GCA_000659385.1,JMAZ00000000,-,Broad Institute,WGS,Illumina,144.0x,allpaths v. R46813,,,3.0,3.0,4400491.0,65.6,4346.0,,4005.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:52;treatment course:8w;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.544Z,2015-03-16T03:17:09.594Z
1295744_3,Mycobacterium tuberculosis TKK_02_0028,Mycobacterium tuberculosis TKK_02_0028,1295744.0,WGS,TKK_02_0028,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190952,SAMN01925638,GCA_000659405.1,JMAY00000000,-,Broad Institute,WGS,Illumina,144.0x,allpaths v. R46813,,,5.0,5.0,4399975.0,65.6,4341.0,,4003.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,30,,,,host_subject_id:54;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:NG;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.563Z,2015-03-16T03:17:09.594Z
1295745_3,Mycobacterium tuberculosis TKK_02_0029,Mycobacterium tuberculosis TKK_02_0029,1295745.0,WGS,TKK_02_0029,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190953,SAMN01925639,GCA_000659425.1,JMAX00000000,-,Broad Institute,WGS,Illumina,140.0x,allpaths v. R46813,,,3.0,3.0,4401435.0,65.6,4343.0,,4003.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,30,,,,host_subject_id:54;treatment course:8w;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.572Z,2015-03-16T03:17:09.594Z
1295746_3,Mycobacterium tuberculosis TKK_02_0030,Mycobacterium tuberculosis TKK_02_0030,1295746.0,WGS,TKK_02_0030,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190954,SAMN01925640,GCA_000659445.1,JMAW00000000,-,Broad Institute,WGS,Illumina,141.0x,allpaths v. R46813,,,5.0,5.0,4400659.0,65.6,4331.0,,4000.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,20,,,,host_subject_id:57;treatment course:adm;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:scanty;microscopy smear status:Positive 5;lineage:Not tested,2014-12-08T22:12:18.582Z,2015-03-16T03:17:09.594Z
1295747_3,Mycobacterium tuberculosis TKK_02_0031,Mycobacterium tuberculosis TKK_02_0031,1295747.0,WGS,TKK_02_0031,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190955,SAMN01925641,GCA_000659465.1,JMAV00000000,-,Broad Institute,WGS,Illumina,140.0x,allpaths v. R46813,,,5.0,5.0,4397854.0,65.6,4337.0,,4001.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,40,,,,host_subject_id:60;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:NEG;tb culture 7h11:2 col;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.591Z,2015-03-16T03:17:09.594Z
1295751_3,Mycobacterium tuberculosis TKK_02_0035,Mycobacterium tuberculosis TKK_02_0035,1295751.0,WGS,TKK_02_0035,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190959,SAMN01925645,GCA_000659485.1,JMAU00000000,-,Broad Institute,WGS,Illumina,140.0x,allpaths v. R46813,,,9.0,9.0,4397166.0,65.6,4333.0,,3989.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,41,,,,host_subject_id:62;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:2+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.620Z,2015-03-16T03:17:09.594Z
1295753_3,Mycobacterium tuberculosis TKK_02_0037,Mycobacterium tuberculosis TKK_02_0037,1295753.0,WGS,TKK_02_0037,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190961,SAMN01925647,GCA_000659505.1,JMAT00000000,-,Broad Institute,WGS,Illumina,141.0x,allpaths v. R46813,,,10.0,12.0,4384101.0,65.6,4326.0,,3981.0,,sputum,,2010,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,26,,,,host_subject_id:65;treatment course:adm;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:2+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.643Z,2015-03-16T03:17:09.594Z
1295756_3,Mycobacterium tuberculosis TKK_02_0040,Mycobacterium tuberculosis TKK_02_0040,1295756.0,WGS,TKK_02_0040,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190964,SAMN01925650,GCA_000659525.1,JMAS00000000,-,Broad Institute,WGS,Illumina,143.0x,allpaths v. R46813,,,5.0,5.0,4398950.0,65.6,4339.0,,3999.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,25,,,,host_subject_id:69;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:1+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.670Z,2015-03-16T03:17:09.594Z
1295757_3,Mycobacterium tuberculosis TKK_02_0041,Mycobacterium tuberculosis TKK_02_0041,1295757.0,WGS,TKK_02_0041,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190965,SAMN01925651,GCA_000659545.1,JMAR00000000,-,Broad Institute,WGS,Illumina,144.0x,allpaths v. R46813,,,4.0,4.0,4403851.0,65.6,4335.0,,4003.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,45,,,,host_subject_id:71;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.679Z,2015-03-16T03:17:09.594Z
1295758_3,Mycobacterium tuberculosis TKK_02_0042,Mycobacterium tuberculosis TKK_02_0042,1295758.0,WGS,TKK_02_0042,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190966,SAMN01925652,GCA_000659565.1,JMAQ00000000,-,Broad Institute,WGS,Illumina,139.0x,allpaths v. R46813,,,12.0,15.0,4391432.0,65.6,4340.0,,4004.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,45,,,,host_subject_id:73;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:2+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.688Z,2015-03-16T03:17:09.594Z
1295759_3,Mycobacterium tuberculosis TKK_02_0043,Mycobacterium tuberculosis TKK_02_0043,1295759.0,WGS,TKK_02_0043,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190967,SAMN01925653,GCA_000659585.1,JMAP00000000,-,Broad Institute,WGS,Illumina,183.0x,allpaths v. R47129,,,9.0,9.0,4411213.0,65.6,4370.0,,4016.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,32,,,,host_subject_id:74;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.697Z,2015-03-16T03:17:09.594Z
1295760_3,Mycobacterium tuberculosis TKK_02_0044,Mycobacterium tuberculosis TKK_02_0044,1295760.0,WGS,TKK_02_0044,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190968,SAMN01925654,GCA_000659605.1,JMAO00000000,-,Broad Institute,WGS,Illumina,141.0x,allpaths v. R46813,,,2.0,2.0,4397493.0,65.6,4346.0,,4000.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,56,,,,host_subject_id:75;treatment course:adm;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.706Z,2015-03-16T03:17:09.594Z
1295763_3,Mycobacterium tuberculosis TKK_02_0047,Mycobacterium tuberculosis TKK_02_0047,1295763.0,WGS,TKK_02_0047,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190971,SAMN01925657,GCA_000659625.1,JMAN00000000,-,Broad Institute,WGS,Illumina,143.0x,allpaths v. R46813,,,4.0,4.0,4394582.0,65.6,4338.0,,3994.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,50,,,,host_subject_id:78;treatment course:adm;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:1+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.734Z,2015-03-16T03:17:09.594Z
1295764_3,Mycobacterium tuberculosis TKK_02_0048,Mycobacterium tuberculosis TKK_02_0048,1295764.0,WGS,TKK_02_0048,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190972,SAMN01925658,GCA_000659645.1,JMAM00000000,-,Broad Institute,WGS,Illumina,136.0x,allpaths v. R46813,,,5.0,5.0,4398781.0,65.6,4345.0,,4001.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:80;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.744Z,2015-03-16T03:17:09.594Z
1295766_3,Mycobacterium tuberculosis TKK_02_0050,Mycobacterium tuberculosis TKK_02_0050,1295766.0,WGS,TKK_02_0050,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190974,SAMN01925660,GCA_000659685.1,JMAK00000000,-,Broad Institute,WGS,Illumina,142.0x,allpaths v. R46813,,,6.0,6.0,4400516.0,65.6,4351.0,,4003.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,42,,,,host_subject_id:82;treatment course:6m;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.754Z,2015-03-16T03:17:09.594Z
1295767_3,Mycobacterium tuberculosis TKK_02_0051,Mycobacterium tuberculosis TKK_02_0051,1295767.0,WGS,TKK_02_0051,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190975,SAMN01925661,GCA_000659705.1,JMAJ00000000,-,Broad Institute,WGS,Illumina,142.0x,allpaths v. R46813,,,5.0,6.0,4402282.0,65.6,4342.0,,4008.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,37,,,,host_subject_id:87;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:1+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.764Z,2015-03-16T03:17:09.594Z
1295769_3,Mycobacterium tuberculosis TKK_02_0053,Mycobacterium tuberculosis TKK_02_0053,1295769.0,WGS,TKK_02_0053,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190977,SAMN01925663,GCA_000659725.1,JMAI00000000,-,Broad Institute,WGS,Illumina,96.0x,allpaths v. R46652,,,4.0,4.0,4400023.0,65.6,4346.0,,4002.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,21,,,,host_subject_id:91;treatment course:8w;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.783Z,2015-03-16T03:17:09.594Z
1295771_3,Mycobacterium tuberculosis TKK_02_0055,Mycobacterium tuberculosis TKK_02_0055,1295771.0,WGS,TKK_02_0055,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190979,SAMN01925665,GCA_000659745.1,JMAH00000000,-,Broad Institute,WGS,Illumina,143.0x,allpaths v. R46813,,,18.0,20.0,4389117.0,65.6,4336.0,,3986.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:94;treatment course:adm;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:C;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:1+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.792Z,2015-03-16T03:17:09.594Z
1295772_3,Mycobacterium tuberculosis TKK_02_0056,Mycobacterium tuberculosis TKK_02_0056,1295772.0,WGS,TKK_02_0056,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190980,SAMN01925666,GCA_000659765.1,JMAG00000000,-,Broad Institute,WGS,Illumina,142.0x,allpaths v. R46813,,,6.0,7.0,4394759.0,65.6,4352.0,,4003.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,43,,,,host_subject_id:95;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:scanty;microscopy auramine:scanty;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.800Z,2015-03-16T03:17:09.594Z
1295773_3,Mycobacterium tuberculosis TKK_02_0057,Mycobacterium tuberculosis TKK_02_0057,1295773.0,WGS,TKK_02_0057,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190981,SAMN01925667,GCA_000659785.1,JMAF00000000,-,Broad Institute,WGS,Illumina,142.0x,allpaths v. R46813,,,10.0,10.0,4406101.0,65.6,4378.0,,4010.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,43,,,,host_subject_id:95;treatment course:3m;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:NG;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.809Z,2015-03-16T03:17:09.594Z
1295774_3,Mycobacterium tuberculosis TKK_02_0058,Mycobacterium tuberculosis TKK_02_0058,1295774.0,WGS,TKK_02_0058,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190982,SAMN01925668,GCA_000659805.1,JMAE00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R46813,,,9.0,9.0,4403549.0,65.6,4370.0,,4011.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:96;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:scanty;microscopy auramine:scanty;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.818Z,2015-03-16T03:17:09.594Z
1295775_3,Mycobacterium tuberculosis TKK_02_0059,Mycobacterium tuberculosis TKK_02_0059,1295775.0,WGS,TKK_02_0059,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190983,SAMN01925669,GCA_000659825.1,JMAD00000000,-,Broad Institute,WGS,Illumina,141.0x,allpaths v. R46813,,,8.0,8.0,4400255.0,65.6,4333.0,,4004.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:96;treatment course:3m;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.827Z,2015-03-16T03:17:09.594Z
1295776_3,Mycobacterium tuberculosis TKK_02_0060,Mycobacterium tuberculosis TKK_02_0060,1295776.0,WGS,TKK_02_0060,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190984,SAMN01925670,GCA_000659845.1,JMAC00000000,-,Broad Institute,WGS,Illumina,143.0x,allpaths v. R46813,,,8.0,8.0,4405460.0,65.6,4341.0,,4007.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,31,,,,host_subject_id:97;treatment course:4wk;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.836Z,2015-03-16T03:17:09.594Z
1295781_3,Mycobacterium tuberculosis TKK_02_0065,Mycobacterium tuberculosis TKK_02_0065,1295781.0,WGS,TKK_02_0065,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190989,SAMN01925675,GCA_000659865.1,JMAB00000000,-,Broad Institute,WGS,Illumina,185.0x,allpaths v. R47141,,,7.0,7.0,4397479.0,65.6,4350.0,,3999.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,33,,,,host_subject_id:100;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:2+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.884Z,2015-03-16T03:17:09.594Z
1295782_3,Mycobacterium tuberculosis TKK_02_0066,Mycobacterium tuberculosis TKK_02_0066,1295782.0,WGS,TKK_02_0066,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190990,SAMN01925676,GCA_000659885.1,JMAA00000000,-,Broad Institute,WGS,Illumina,135.0x,allpaths v. R46813,,,17.0,18.0,4405889.0,65.6,4358.0,,4018.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,38,,,,host_subject_id:102;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.895Z,2015-03-16T03:17:09.594Z
1295790_3,Mycobacterium tuberculosis TKK_02_0074,Mycobacterium tuberculosis TKK_02_0074,1295790.0,WGS,TKK_02_0074,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190998,SAMN01925684,GCA_000659905.1,JLZZ00000000,-,Broad Institute,WGS,Illumina,136.0x,allpaths v. R46813,,,14.0,15.0,4404573.0,65.6,4355.0,,4018.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,34,,,,host_subject_id:107;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.963Z,2015-03-16T03:17:09.594Z
1295791_3,Mycobacterium tuberculosis TKK_02_0075,Mycobacterium tuberculosis TKK_02_0075,1295791.0,WGS,TKK_02_0075,,,,,,,,2014-04-29T00:00:00Z,,PRJNA190999,SAMN01925685,GCA_000659925.1,JLZY00000000,-,Broad Institute,WGS,Illumina,138.0x,allpaths v. R46813,,,13.0,13.0,4402999.0,65.6,4365.0,,3998.0,,sputum,,2012,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,34,,,,host_subject_id:107;treatment course:8w;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.972Z,2015-03-16T03:17:09.594Z
1295792_3,Mycobacterium tuberculosis TKK_02_0076,Mycobacterium tuberculosis TKK_02_0076,1295792.0,WGS,TKK_02_0076,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191000,SAMN01925686,GCA_000659945.1,JLZX00000000,-,Broad Institute,WGS,Illumina,107.0x,allpaths v. R46652,,,11.0,11.0,4399957.0,65.6,4341.0,,4007.0,,sputum,,2011,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,40,,,,host_subject_id:108;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:1+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.980Z,2015-03-16T03:17:09.594Z
1295795_3,Mycobacterium tuberculosis TKK_02_0079,Mycobacterium tuberculosis TKK_02_0079,1295795.0,WGS,TKK_02_0079,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191003,SAMN01925689,GCA_000659965.1,JLZW00000000,-,Broad Institute,WGS,Illumina,139.0x,allpaths v. R46813,,,14.0,14.0,4353583.0,65.6,4310.0,,3972.0,,sputum,,2012,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Female,24,,,,host_subject_id:112;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19Z,2015-03-16T03:17:09.594Z
1295796_3,Mycobacterium tuberculosis TKK_02_0080,Mycobacterium tuberculosis TKK_02_0080,1295796.0,WGS,TKK_02_0080,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191004,SAMN01925690,GCA_000659985.1,JLZV00000000,-,Broad Institute,WGS,Illumina,138.0x,allpaths v. R46813,,,22.0,22.0,4393760.0,65.6,4363.0,,3995.0,,sputum,,2012,South Africa,"South Africa: King George V Hospital, Durban",,,,,,"Human, Homo sapiens",Male,58,,,,host_subject_id:116;treatment course:adm;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.009Z,2015-03-16T03:17:09.594Z
1295797_3,Mycobacterium tuberculosis OFXR-2,Mycobacterium tuberculosis OFXR-2,1295797.0,WGS,OFXR-2,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191009,SAMN01925691,GCA_000660005.1,JLCM00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47687,,,13.0,13.0,4399228.0,65.6,4363.0,,3988.0,,Bodily fluid,,2005,,,,,,,,"Human, Homo sapiens",Female,30,TB,,,comorbidity:HIV negative;host_subject_id:4477239;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:94001843;phenotype:Mono DR,2014-12-08T22:12:14.617Z,2015-03-16T03:17:09.594Z
1295798_3,Mycobacterium tuberculosis OFXR-3,Mycobacterium tuberculosis OFXR-3,1295798.0,WGS,OFXR-3,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191010,SAMN01925692,GCA_000660025.1,JLCL00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R47687,,,17.0,19.0,4405046.0,65.6,4356.0,,4020.0,,Bodily fluid,,2006,,,,,,,,"Human, Homo sapiens",Female,37,MDR-TB,,,comorbidity:HIV negative;host_subject_id:3811782;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:95001704;phenotype:MDR,2014-12-08T22:12:14.707Z,2015-03-16T03:17:09.594Z
1295799_3,Mycobacterium tuberculosis OFXR-4,Mycobacterium tuberculosis OFXR-4,1295799.0,WGS,OFXR-4,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191011,SAMN01925693,GCA_000660045.1,JLCK00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47687,,,15.0,16.0,4409657.0,65.6,4383.0,,4016.0,,Bodily fluid,,2010,,,,,,,,"Human, Homo sapiens",Male,37,MDR-TB,,,comorbidity:HIV negative;host_subject_id:2363526;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:9900486;phenotype:MDR,2014-12-08T22:12:14.755Z,2015-03-16T03:17:09.594Z
1295800_3,Mycobacterium tuberculosis OFXR-5,Mycobacterium tuberculosis OFXR-5,1295800.0,WGS,OFXR-5,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191012,SAMN01925694,GCA_000660065.1,JLCJ00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R47687,,,15.0,16.0,4412844.0,65.6,4366.0,,4027.0,,Bodily fluid,,2007,,,,,,,,"Human, Homo sapiens",Male,48,TB,,,comorbidity:HIV negative;host_subject_id:5031353;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:96002133;phenotype:DR,2014-12-08T22:12:14.764Z,2015-03-16T03:17:09.594Z
1295801_3,Mycobacterium tuberculosis OFXR-7,Mycobacterium tuberculosis OFXR-7,1295801.0,WGS,OFXR-7,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191013,SAMN01925695,GCA_000660085.1,JLCH00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R47687,,,12.0,12.0,4411055.0,65.6,4354.0,,4016.0,,Bodily fluid,,2007,,,,,,,,"Human, Homo sapiens",Female,42,MDR-TB,,,comorbidity:HIV negative;host_subject_id:2422752;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:96000921;phenotype:MDR,2014-12-08T22:12:14.783Z,2015-03-16T03:17:09.594Z
1295802_3,Mycobacterium tuberculosis OFXR-10,Mycobacterium tuberculosis OFXR-10,1295802.0,WGS,OFXR-10,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191014,SAMN01925696,GCA_000660105.1,JLCE00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R47687,,,11.0,11.0,4404703.0,65.6,4352.0,,3996.0,,Bodily fluid,,2007,,,,,,,,"Human, Homo sapiens",Male,62,TB,,,comorbidity:HIV negative;host_subject_id:5146187;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:96000614;phenotype:Mono DR,2014-12-08T22:12:14.525Z,2015-03-16T03:17:09.594Z
1295803_3,Mycobacterium tuberculosis OFXR-11,Mycobacterium tuberculosis OFXR-11,1295803.0,WGS,OFXR-11,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191015,SAMN01925697,GCA_000660125.1,JLCD00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47687,,,15.0,15.0,4396228.0,65.6,4351.0,,3989.0,,Bodily fluid,,2007,,,,,,,,"Human, Homo sapiens",Male,74,TB,,,comorbidity:HIV negative;host_subject_id:3223861;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:96000793;phenotype:DR,2014-12-08T22:12:14.533Z,2015-03-16T03:17:09.594Z
1295804_3,Mycobacterium tuberculosis OFXR-12,Mycobacterium tuberculosis OFXR-12,1295804.0,WGS,OFXR-12,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191016,SAMN01925698,GCA_000660145.1,JLCC00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47687,,,17.0,18.0,4386597.0,65.6,4342.0,,3988.0,,Bodily fluid,,2007,,,,,,,,"Human, Homo sapiens",Male,30,TB,,,comorbidity:HIV negative;host_subject_id:5158559;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:96000697;phenotype:DR,2014-12-08T22:12:14.543Z,2015-03-16T03:17:09.594Z
1295805_3,Mycobacterium tuberculosis OFXR-13,Mycobacterium tuberculosis OFXR-13,1295805.0,WGS,OFXR-13,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191017,SAMN01925699,GCA_000660165.1,JLCB00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47687,,,13.0,15.0,4376462.0,65.6,4328.0,,3976.0,,Bodily fluid,,2009,,,,,,,,"Human, Homo sapiens",Male,37,MDR-TB,,,comorbidity:HIV negative;host_subject_id:5507933;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:980003031;phenotype:MDR,2014-12-08T22:12:14.553Z,2015-03-16T03:17:09.594Z
1295806_3,Mycobacterium tuberculosis OFXR-14,Mycobacterium tuberculosis OFXR-14,1295806.0,WGS,OFXR-14,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191018,SAMN01925700,GCA_000660185.1,JLCA00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47687,,,10.0,11.0,4394991.0,65.6,4342.0,,3995.0,,Bodily fluid,,2009,,,,,,,,"Human, Homo sapiens",Male,61,TB,,,comorbidity:HIV negative;host_subject_id:5501011;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:980002785;phenotype:DR,2014-12-08T22:12:14.562Z,2015-03-16T03:17:09.594Z
1295807_3,Mycobacterium tuberculosis OFXR-15,Mycobacterium tuberculosis OFXR-15,1295807.0,WGS,OFXR-15,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191019,SAMN01925701,GCA_000660205.1,JLBZ00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47687,,,19.0,19.0,4398958.0,65.6,4356.0,,3996.0,,Bodily fluid,,2009,,,,,,,,"Human, Homo sapiens",Male,54,TB,,,comorbidity:HIV negative;host_subject_id:5398926;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:980001546;phenotype:Mono DR,2014-12-08T22:12:14.571Z,2015-03-16T03:17:09.594Z
1295808_3,Mycobacterium tuberculosis OFXR-16,Mycobacterium tuberculosis OFXR-16,1295808.0,WGS,OFXR-16,,,,,,,,2014-04-29T00:00:00Z,,PRJNA191020,SAMN01925702,GCA_000660225.1,JLBY00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R47687,,,37.0,40.0,4378948.0,65.6,4345.0,,3986.0,,Bodily fluid,,2009,,,,,,,,"Human, Homo sapiens",Male,54,TB,,,comorbidity:HIV negative;host_subject_id:5398926;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:980000608;phenotype:Mono DR,2014-12-08T22:12:14.580Z,2015-03-16T03:17:09.594Z
1306400_3,Mycobacterium tuberculosis str. Beijing/NITR203,Mycobacterium tuberculosis str. Beijing/NITR203,1306400.0,Complete,Beijing/NITR203,,,,,,,,2013-04-15T00:00:00Z,,PRJNA193385,SAMN02603651,GCA_000364825.1,CP005082.1,NC_021054.1,"National Institute of Tuberculosis Research, Chennai, India",complete,Illumina,70x,CLC bio Genomicworkbench v. 6.01,1.0,,,1.0,4411128.0,65.6,4461.0,,4110.0,,"Tamilnadu, India was performed using paired read sequencing on Illumina Hiseq 2000","isolate from Tamilnadu, India was performed using paired read sequencing on Illumina Hiseq 2000",,,,,,,,,,,,,,,,,,,,,,,,,,,,"Whole genome sequencing of Bejing strain of Mycobacterium tuberculosis clinical isolate from Tamilnadu, India was performed using paired read sequencing on Illumina Hiseq 2000. A reference assembly has been generated by mapping reads to the genome of the reference strain of M. tuberculosis H37Rv.",,2014-12-08T22:12:23.443Z,2015-03-16T03:17:09.594Z
1306414_3,Mycobacterium tuberculosis EAI5,Mycobacterium tuberculosis EAI5,1306414.0,Complete,EAI5,,,,,,,,2013-07-11T00:00:00Z,,PRJNA210717,SAMN02603180,GCA_000422125.1,CP006578.1,NC_021740.1,"Department of Life Sciences, Mumbai University, Mumbai, India",complete,Illumina,45,CLC bio Genomic Workbench v. ver 6.0.4,1.0,,,1.0,4391174.0,65.6,4341.0,,3902.0,,Mumbai was isolated and whole genome was sequenced using Illumina Sequencing,is from Mumbai was isolated and whole genome was sequenced using Illumina Sequencing,,India,India: Mumbai,,,,,,,,,,,,,,,,,,,,,,,,,A clinical isolate of M. tuberculosis from Mumbai was isolated and whole genome was sequenced using Illumina Sequencing. Reference assembly was generated by mapping reads to the genome of reference sequence of M. tuberculosis h37Rv.,,2014-12-08T22:12:10.009Z,2015-03-16T03:17:09.594Z
1310115_3,Mycobacterium tuberculosis EAI5/NITR206,Mycobacterium tuberculosis EAI5/NITR206,1310115.0,Complete,EAI5/NITR206,,,,,,,,2013-05-08T00:00:00Z,,PRJNA193387,SAMN02603653,GCA_000389945.1,CP005387.1,NC_021194.1,"National Institute of Tuberculosis Research, Chennai, India",complete,Illumina,60X,CLC bio Genomic Workbench v. 6.0,1.0,,,1.0,4390306.0,65.6,4433.0,,4019.0,,"Tamilnadu, India was performed using paired read sequencing on Illumina Hiseq 2000","isolate from Tamilnadu, India was performed using paired read sequencing on Illumina Hiseq 2000",,,,,,,,,,,,,,,,,,,,,,,,,,,,"Whole genome sequencing of EAI3 strain of Mycobacterium tuberculosis clinical isolate from Tamilnadu, India was performed using paired read sequencing on Illumina Hiseq 2000. A reference assembly has been generated by mapping reads to the genome of the reference strain of M. tuberculosis H37Rv.",,2014-12-08T22:12:10.018Z,2015-03-16T03:17:09.594Z
1322343_3,Mycobacterium tuberculosis EAI/OSDD271,Mycobacterium tuberculosis EAI/OSDD271,1322343.0,WGS,EAI/OSDD271,,,,,,,,2013-06-17T00:00:00Z,,PRJNA196573,SAMN02045564,GCA_000411895.1,AQQC00000000,-,Open Source Drug Discovery,WGS,454 Flx; Ion Torrent PGM,74.35x,CLC genomic workbench v. 6,,,179.0,182.0,4160382.0,65.3,4530.0,,,,sputum sample from patient with tuberculosis,,,India,India,,,,,,"Human, Homo sapiens",,,,,,,,,,,,,,,,,,,Sequencing of clinical isolates from the OSDD Open Repsoitory.,,2014-12-08T22:12:10Z,2015-03-16T03:17:09.594Z
1324218_3,Mycobacterium tuberculosis TKK-01-0001,Mycobacterium tuberculosis TKK-01-0001,1324218.0,WGS,TKK-01-0001,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198103,SAMN02053741,GCA_000660245.1,JLZU00000000,-,Broad Institute,WGS,Illumina,140.0x,allpaths v. R46513,,,8.0,8.0,4410122.0,65.6,4350.0,,4012.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Female,28,,,,host_subject_id:PMH1670;co-morbidity:HIV Positive;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:KZN lineage,2014-12-08T22:12:17.441Z,2015-03-16T03:17:09.594Z
1324219_3,Mycobacterium tuberculosis TKK-01-0002,Mycobacterium tuberculosis TKK-01-0002,1324219.0,WGS,TKK-01-0002,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198104,SAMN02053742,GCA_000660265.1,JLZT00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R45633,,,26.0,26.0,4391877.0,65.6,4367.0,,3999.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Female,23,,,,host_subject_id:PMH1722;co-morbidity:Unknown;previous tb treatment:Unknown;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.452Z,2015-03-16T03:17:09.594Z
1324220_3,Mycobacterium tuberculosis TKK-01-0003,Mycobacterium tuberculosis TKK-01-0003,1324220.0,WGS,TKK-01-0003,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198105,SAMN02053743,GCA_000660285.1,JLZS00000000,-,Broad Institute,WGS,Illumina,267.0x,allpaths v. R46586,,,36.0,37.0,4390059.0,65.6,4354.0,,3995.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Female,38,,,,host_subject_id:PMH1780;co-morbidity:Unknown;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB not isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Beijing lineage,2014-12-08T22:12:17.461Z,2015-03-16T03:17:09.594Z
1324221_3,Mycobacterium tuberculosis TKK-01-0004,Mycobacterium tuberculosis TKK-01-0004,1324221.0,WGS,TKK-01-0004,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198106,SAMN02053744,GCA_000660305.1,JLZR00000000,-,Broad Institute,WGS,Illumina,138.0x,allpaths v. R47129,,,5.0,5.0,4405491.0,65.6,4344.0,,4008.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Female,30,,,,host_subject_id:PMH1264;co-morbidity:Unknown;previous tb treatment:Unknown;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:KZN lineage,2014-12-08T22:12:17.471Z,2015-03-16T03:17:09.594Z
1324222_3,Mycobacterium tuberculosis TKK-01-0005,Mycobacterium tuberculosis TKK-01-0005,1324222.0,WGS,TKK-01-0005,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198107,SAMN02053745,GCA_000660325.1,JLZQ00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R46513,,,29.0,30.0,4373809.0,65.6,4323.0,,3984.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Female,14,,,,host_subject_id:PMH1304;co-morbidity:Unknown;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Beijing lineage,2014-12-08T22:12:17.481Z,2015-03-16T03:17:09.594Z
1324223_3,Mycobacterium tuberculosis TKK-01-0006,Mycobacterium tuberculosis TKK-01-0006,1324223.0,WGS,TKK-01-0006,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198108,SAMN02053746,GCA_000660345.1,JLZP00000000,-,Broad Institute,WGS,Illumina,141.0x,allpaths v. R46513,,,11.0,11.0,4403557.0,65.6,4361.0,,4008.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Male,70,,,,host_subject_id:PMH1348;co-morbidity:HIV Negative;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:KZN lineage,2014-12-08T22:12:17.490Z,2015-03-16T03:17:09.594Z
1324224_3,Mycobacterium tuberculosis TKK-01-0007,Mycobacterium tuberculosis TKK-01-0007,1324224.0,WGS,TKK-01-0007,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198109,SAMN02053747,GCA_000660365.1,JLZO00000000,-,Broad Institute,WGS,Illumina,285.0x,allpaths v. R46586,,,31.0,35.0,4398007.0,65.6,4351.0,,4008.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Female,28,,,,host_subject_id:PMH1632;co-morbidity:HIV Positive;previous tb treatment:No,Resistant;Susceptible;Intermediate,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB not isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:17.499Z,2015-03-16T03:17:09.594Z
1324225_3,Mycobacterium tuberculosis TKK-01-0009,Mycobacterium tuberculosis TKK-01-0009,1324225.0,WGS,TKK-01-0009,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198110,SAMN02053748,GCA_000660385.1,JLZM00000000,-,Broad Institute,WGS,Illumina,139.0x,allpaths v. R47141,,,26.0,27.0,4400918.0,65.6,4357.0,,4029.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:PMH1382;co-morbidity:Unknown;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.518Z,2015-03-16T03:17:09.594Z
1324226_3,Mycobacterium tuberculosis TKK-01-0010,Mycobacterium tuberculosis TKK-01-0010,1324226.0,WGS,TKK-01-0010,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198111,SAMN02053749,GCA_000660405.1,JLZL00000000,-,Broad Institute,WGS,Illumina,254.0x,allpaths v. R46586,,,29.0,32.0,4410934.0,65.6,4375.0,,4029.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Male,57,,,,host_subject_id:PMH1383;co-morbidity:Unknown;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.528Z,2015-03-16T03:17:09.594Z
1324227_3,Mycobacterium tuberculosis TKK-01-0011,Mycobacterium tuberculosis TKK-01-0011,1324227.0,WGS,TKK-01-0011,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198112,SAMN02053750,GCA_000660425.1,JLZK00000000,-,Broad Institute,WGS,Illumina,136.0x,allpaths v. R46513,,,19.0,19.0,4352226.0,65.6,4322.0,,3978.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Male,32,,,,host_subject_id:PMH1398;co-morbidity:Unknown;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB not isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.537Z,2015-03-16T03:17:09.594Z
1324228_3,Mycobacterium tuberculosis TKK-01-0012,Mycobacterium tuberculosis TKK-01-0012,1324228.0,WGS,TKK-01-0012,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198113,SAMN02053751,GCA_000660445.1,JLZJ00000000,-,Broad Institute,WGS,Illumina,136.0x,allpaths v. R46513,,,8.0,8.0,4405907.0,65.6,4345.0,,4008.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Female,23,,,,host_subject_id:PMH1423;co-morbidity:HIV Negative;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:KZN lineage,2014-12-08T22:12:17.547Z,2015-03-16T03:17:09.594Z
1324229_3,Mycobacterium tuberculosis TKK-01-0013,Mycobacterium tuberculosis TKK-01-0013,1324229.0,WGS,TKK-01-0013,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198114,SAMN02053752,GCA_000660465.1,JLZI00000000,-,Broad Institute,WGS,Illumina,139.0x,allpaths v. R46513,,,34.0,35.0,4376603.0,65.6,4337.0,,3986.0,,sputum,,2008,South Africa,South Africa: Nkandla,,,,,,"Human, Homo sapiens",Male,40,,,,host_subject_id:NKA2017;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.557Z,2015-03-16T03:17:09.594Z
1324230_3,Mycobacterium tuberculosis TKK-01-0014,Mycobacterium tuberculosis TKK-01-0014,1324230.0,WGS,TKK-01-0014,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198115,SAMN02053753,GCA_000660485.1,JLZH00000000,-,Broad Institute,WGS,Illumina,250.0x,allpaths v. R46586,,,28.0,30.0,4407006.0,65.6,4354.0,,4006.0,,sputum,,2008,South Africa,South Africa: Nkandla,,,,,,"Human, Homo sapiens",Male,35,,,,host_subject_id:NKA2024;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.566Z,2015-03-16T03:17:09.594Z
1324231_3,Mycobacterium tuberculosis TKK-01-0015,Mycobacterium tuberculosis TKK-01-0015,1324231.0,WGS,TKK-01-0015,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198116,SAMN02053754,GCA_000660505.1,JLZG00000000,-,Broad Institute,WGS,Illumina,223.0x,allpaths v. R46586,,,30.0,33.0,4375063.0,65.6,4329.0,,4003.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Male,48,,,,host_subject_id:PMH1401;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Pre-XDR;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.575Z,2015-03-16T03:17:09.594Z
1324232_3,Mycobacterium tuberculosis TKK-01-0016,Mycobacterium tuberculosis TKK-01-0016,1324232.0,WGS,TKK-01-0016,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198117,SAMN02053755,GCA_000660525.1,JLZF00000000,-,Broad Institute,WGS,Illumina,179.0x,allpaths v. R46586,,,23.0,24.0,4385562.0,65.6,4341.0,,4011.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Male,27,,,,host_subject_id:PMH1405;co-morbidity:HIV Negative;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.584Z,2015-03-16T03:17:09.594Z
1324233_3,Mycobacterium tuberculosis TKK-01-0018,Mycobacterium tuberculosis TKK-01-0018,1324233.0,WGS,TKK-01-0018,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198118,SAMN02053756,GCA_000660545.1,JLZD00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R46513,,,27.0,28.0,4416666.0,65.6,4382.0,,4014.0,,sputum,,2008,South Africa,South Africa: Rietvlei,,,,,,"Human, Homo sapiens",Male,35,,,,host_subject_id:RIH1061;co-morbidity:Unknown;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.603Z,2015-03-16T03:17:09.594Z
1324235_3,Mycobacterium tuberculosis TKK-01-0022,Mycobacterium tuberculosis TKK-01-0022,1324235.0,WGS,TKK-01-0022,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198120,SAMN02053758,GCA_000660585.1,JLYZ00000000,-,Broad Institute,WGS,Illumina,139.0x,allpaths v. R46513,,,14.0,14.0,4406360.0,65.6,4352.0,,4018.0,,sputum,,2008,South Africa,South Africa: Escourt,,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:EST1002;co-morbidity:unk/ref;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.623Z,2015-03-16T03:17:09.594Z
1324236_3,Mycobacterium tuberculosis TKK-01-0024,Mycobacterium tuberculosis TKK-01-0024,1324236.0,WGS,TKK-01-0024,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198121,SAMN02053759,GCA_000660605.1,JLYX00000000,-,Broad Institute,WGS,Illumina,273.0x,allpaths v. R46586,,,27.0,27.0,4366072.0,65.6,4326.0,,3961.0,,sputum,,2008,South Africa,South Africa: Escourt,,,,,,"Human, Homo sapiens",Female,69,,,,host_subject_id:EST1018;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Beijing lineage,2014-12-08T22:12:17.641Z,2015-03-16T03:17:09.594Z
1324237_3,Mycobacterium tuberculosis TKK-01-0025,Mycobacterium tuberculosis TKK-01-0025,1324237.0,WGS,TKK-01-0025,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198122,SAMN02053760,GCA_000660625.1,JLYW00000000,-,Broad Institute,WGS,Illumina,137.0x,allpaths v. R46513,,,11.0,11.0,4401142.0,65.6,4365.0,,4011.0,,sputum,,2008,South Africa,South Africa: Ladysmith,,,,,,"Human, Homo sapiens",Female,35,,,,host_subject_id:LSH2006;co-morbidity:HIV Negative;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:KZN lineage,2014-12-08T22:12:17.651Z,2015-03-16T03:17:09.594Z
1324238_3,Mycobacterium tuberculosis TKK-01-0027,Mycobacterium tuberculosis TKK-01-0027,1324238.0,WGS,TKK-01-0027,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198123,SAMN02053761,GCA_000660645.1,JLYU00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R46513,,,31.0,34.0,4372234.0,65.6,4341.0,,3981.0,,sputum,,2008,South Africa,South Africa: Rietvlei,,,,,,"Human, Homo sapiens",Female,22,,,,host_subject_id:RIH1136;co-morbidity:Unknown;previous tb treatment:Unknown;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Beijing lineage,2014-12-08T22:12:17.669Z,2015-03-16T03:17:09.594Z
1324239_3,Mycobacterium tuberculosis TKK-01-0028,Mycobacterium tuberculosis TKK-01-0028,1324239.0,WGS,TKK-01-0028,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198124,SAMN02053762,GCA_000660665.1,JLYT00000000,-,Broad Institute,WGS,Illumina,96.0x,allpaths v. R46813,,,12.0,12.0,4409779.0,65.6,4361.0,,4009.0,,sputum,,2008,South Africa,South Africa: Charles Johnson Memorial,,,,,,"Human, Homo sapiens",Female,19,,,,host_subject_id:CJM1607;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB not isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.679Z,2015-03-16T03:17:09.594Z
1324240_3,Mycobacterium tuberculosis TKK-01-0029,Mycobacterium tuberculosis TKK-01-0029,1324240.0,WGS,TKK-01-0029,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198125,SAMN02053763,GCA_000660685.1,JLYS00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R46606,,,21.0,22.0,4394740.0,65.6,4346.0,,4007.0,,sputum,,2008,South Africa,South Africa: Charles Johnson Memorial,,,,,,"Human, Homo sapiens",Male,41,,,,host_subject_id:CJM1620;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB not isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:17.688Z,2015-03-16T03:17:09.594Z
1324241_3,Mycobacterium tuberculosis TKK-01-0030,Mycobacterium tuberculosis TKK-01-0030,1324241.0,WGS,TKK-01-0030,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198126,SAMN02053764,GCA_000660705.1,JLYR00000000,-,Broad Institute,WGS,Illumina,115.0x,allpaths v. R46513,,,24.0,24.0,4394660.0,65.6,4345.0,,4017.0,,sputum,,2008,South Africa,South Africa: Charles Johnson Memorial,,,,,,"Human, Homo sapiens",Female,42,,,,host_subject_id:CJM1631;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.698Z,2015-03-16T03:17:09.594Z
1324242_3,Mycobacterium tuberculosis TKK-01-0031,Mycobacterium tuberculosis TKK-01-0031,1324242.0,WGS,TKK-01-0031,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198127,SAMN02053765,GCA_000660725.1,JLYQ00000000,-,Broad Institute,WGS,Illumina,142.0x,allpaths v. R46513,,,12.0,12.0,4395266.0,65.6,4334.0,,3989.0,,sputum,,2008,South Africa,South Africa: Charles Johnson Memorial,,,,,,"Human, Homo sapiens",Female,33,,,,host_subject_id:CJM1641;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.708Z,2015-03-16T03:17:09.594Z
1324243_3,Mycobacterium tuberculosis TKK-01-0033,Mycobacterium tuberculosis TKK-01-0033,1324243.0,WGS,TKK-01-0033,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198128,SAMN02053766,GCA_000660745.1,JLYO00000000,-,Broad Institute,WGS,Illumina,140.0x,allpaths v. R47129,,,15.0,16.0,4395450.0,65.6,4355.0,,4009.0,,sputum,,2008,South Africa,South Africa: Greytown,,,,,,"Human, Homo sapiens",Male,27,,,,host_subject_id:GTH1034;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:KZN lineage,2014-12-08T22:12:17.727Z,2015-03-16T03:17:09.594Z
1324244_3,Mycobacterium tuberculosis TKK-01-0034,Mycobacterium tuberculosis TKK-01-0034,1324244.0,WGS,TKK-01-0034,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198129,SAMN02053767,GCA_000660765.1,JLYN00000000,-,Broad Institute,WGS,Illumina,140.0x,allpaths v. R46513,,,10.0,10.0,4394427.0,65.6,4325.0,,3992.0,,sputum,,2008,South Africa,South Africa: Rietvlei,,,,,,"Human, Homo sapiens",Male,35,,,,host_subject_id:RIH1171;co-morbidity:Unknown;previous tb treatment:Unknown;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.736Z,2015-03-16T03:17:09.594Z
1324245_3,Mycobacterium tuberculosis TKK-01-0035,Mycobacterium tuberculosis TKK-01-0035,1324245.0,WGS,TKK-01-0035,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198130,SAMN02053768,GCA_000660785.1,JLYM00000000,-,Broad Institute,WGS,Illumina,137.0x,allpaths v. R46513,,,7.0,7.0,4411474.0,65.6,4369.0,,4025.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Male,50,,,,host_subject_id:PMH2022;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:KZN lineage,2014-12-08T22:12:17.745Z,2015-03-16T03:17:09.594Z
1324246_3,Mycobacterium tuberculosis TKK-01-0036,Mycobacterium tuberculosis TKK-01-0036,1324246.0,WGS,TKK-01-0036,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198131,SAMN02053769,GCA_000657835.1,JLYL00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R46513,,,2.0,2.0,4398586.0,65.61,4348.0,,4009.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Female,22,,,,host_subject_id:PMH2068;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.755Z,2015-03-16T03:17:09.594Z
1324247_3,Mycobacterium tuberculosis TKK-01-0037,Mycobacterium tuberculosis TKK-01-0037,1324247.0,WGS,TKK-01-0037,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198132,SAMN02053770,GCA_000660805.1,JLYK00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R46606,,,27.0,27.0,4378105.0,65.6,4341.0,,3995.0,,sputum,,2008,South Africa,South Africa: Mahatma Gandhi,,,,,,"Human, Homo sapiens",Female,39,,,,host_subject_id:MGH2007;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB not isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:17.765Z,2015-03-16T03:17:09.594Z
1324248_3,Mycobacterium tuberculosis TKK-01-0038,Mycobacterium tuberculosis TKK-01-0038,1324248.0,WGS,TKK-01-0038,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198133,SAMN02053771,GCA_000660825.1,JLYJ00000000,-,Broad Institute,WGS,Illumina,137.0x,allpaths v. R46513,,,23.0,24.0,4393815.0,65.6,4355.0,,4018.0,,sputum,,2008,South Africa,South Africa: Madadeni,,,,,,"Human, Homo sapiens",Male,28,,,,host_subject_id:MAD2929;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Unknown;lineage:Unclassified,2014-12-08T22:12:17.774Z,2015-03-16T03:17:09.594Z
1324249_3,Mycobacterium tuberculosis TKK-01-0039,Mycobacterium tuberculosis TKK-01-0039,1324249.0,WGS,TKK-01-0039,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198134,SAMN02053772,GCA_000660845.1,JLYI00000000,-,Broad Institute,WGS,Illumina,243.0x,allpaths v. R46586,,,45.0,46.0,4385606.0,65.6,4364.0,,3991.0,,sputum,,2008,South Africa,South Africa: Madadeni,,,,,,"Human, Homo sapiens",Female,18,,,,host_subject_id:MAD2949;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Beijing lineage,2014-12-08T22:12:17.783Z,2015-03-16T03:17:09.594Z
1324250_3,Mycobacterium tuberculosis TKK-01-0040,Mycobacterium tuberculosis TKK-01-0040,1324250.0,WGS,TKK-01-0040,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198135,SAMN02053773,GCA_000660865.1,JLYH00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R46513,,,6.0,6.0,4412612.0,65.6,4358.0,,4023.0,,sputum,,2008,South Africa,South Africa: Madadeni,,,,,,"Human, Homo sapiens",Female,32,,,,host_subject_id:MAD2955;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:KZN lineage,2014-12-08T22:12:17.792Z,2015-03-16T03:17:09.594Z
1324251_3,Mycobacterium tuberculosis TKK-01-0041,Mycobacterium tuberculosis TKK-01-0041,1324251.0,WGS,TKK-01-0041,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198136,SAMN02053774,GCA_000660885.1,JLYG00000000,-,Broad Institute,WGS,Illumina,236.0x,allpaths v. R46586,,,26.0,28.0,4379898.0,65.6,4355.0,,4003.0,,sputum,,,South Africa,South Africa: Madadeni,,,,,,"Human, Homo sapiens",Male,28,,,,host_subject_id:MAD2929;co-morbidity:Unknown;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:Unknown;tb culture 7h11:Unknown;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Unknown;lineage:Unclassified,2014-12-08T22:12:17.801Z,2015-03-16T03:17:09.594Z
1324252_3,Mycobacterium tuberculosis TKK-01-0042,Mycobacterium tuberculosis TKK-01-0042,1324252.0,WGS,TKK-01-0042,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198137,SAMN02053775,GCA_000660905.1,JLYF00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R46586,,,29.0,30.0,4385502.0,65.6,4342.0,,4012.0,,sputum,,2008,South Africa,South Africa: Eshowe,,,,,,"Human, Homo sapiens",Male,22,,,,host_subject_id:ESH1411;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.811Z,2015-03-16T03:17:09.594Z
1324253_3,Mycobacterium tuberculosis TKK-01-0043,Mycobacterium tuberculosis TKK-01-0043,1324253.0,WGS,TKK-01-0043,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198138,SAMN02053776,GCA_000660925.1,JLYE00000000,-,Broad Institute,WGS,Illumina,140.0x,allpaths v. R46513,,,23.0,23.0,4384369.0,65.6,4365.0,,3986.0,,sputum,,2008,South Africa,South Africa: Eshowe,,,,,,"Human, Homo sapiens",Male,32,,,,host_subject_id:ESH1414;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Beijing lineage,2014-12-08T22:12:17.821Z,2015-03-16T03:17:09.594Z
1324254_3,Mycobacterium tuberculosis TKK-01-0044,Mycobacterium tuberculosis TKK-01-0044,1324254.0,WGS,TKK-01-0044,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198139,SAMN02053777,GCA_000660945.1,JLYD00000000,-,Broad Institute,WGS,Illumina,242.0x,allpaths v. R46606,,,49.0,51.0,4406326.0,65.6,4368.0,,4009.0,,sputum,,2008,South Africa,South Africa: Eshowe,,,,,,"Human, Homo sapiens",Male,26,,,,host_subject_id:ESH1418;co-morbidity:unk/ref;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.830Z,2015-03-16T03:17:09.594Z
1324255_3,Mycobacterium tuberculosis TKK-01-0045,Mycobacterium tuberculosis TKK-01-0045,1324255.0,WGS,TKK-01-0045,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198140,SAMN02053778,GCA_000660965.1,JLYC00000000,-,Broad Institute,WGS,Illumina,142.0x,allpaths v. R46513,,,17.0,19.0,4382808.0,65.6,4326.0,,3991.0,,sputum,,2008,South Africa,South Africa: Eshowe,,,,,,"Human, Homo sapiens",Female,25,,,,host_subject_id:ESH1424;co-morbidity:HIV Positive;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.840Z,2015-03-16T03:17:09.594Z
1324256_3,Mycobacterium tuberculosis TKK-01-0046,Mycobacterium tuberculosis TKK-01-0046,1324256.0,WGS,TKK-01-0046,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198141,SAMN02053779,GCA_000660985.1,JLYB00000000,-,Broad Institute,WGS,Illumina,247.0x,allpaths v. R46586,,,39.0,40.0,4377759.0,65.6,4343.0,,3987.0,,sputum,,2008,South Africa,South Africa: Rietvlei,,,,,,"Human, Homo sapiens",Male,31,,,,host_subject_id:RIH1362;co-morbidity:HIV Positive;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.849Z,2015-03-16T03:17:09.594Z
1324257_3,Mycobacterium tuberculosis TKK-01-0047,Mycobacterium tuberculosis TKK-01-0047,1324257.0,WGS,TKK-01-0047,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198142,SAMN02053780,GCA_000661005.1,JLYA00000000,-,Broad Institute,WGS,Illumina,181.0x,allpaths v. R46586,,,38.0,39.0,4374154.0,65.6,4337.0,,3989.0,,sputum,,2008,South Africa,South Africa: Rietvlei,,,,,,"Human, Homo sapiens",Male,33,,,,host_subject_id:RIH1364;co-morbidity:HIV Positive;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:17.858Z,2015-03-16T03:17:09.594Z
1324258_3,Mycobacterium tuberculosis TKK-01-0048,Mycobacterium tuberculosis TKK-01-0048,1324258.0,WGS,TKK-01-0048,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198143,SAMN02053781,GCA_000661025.1,JLXZ00000000,-,Broad Institute,WGS,Illumina,136.0x,allpaths v. R46513,,,7.0,7.0,4411660.0,65.6,4385.0,,4030.0,,sputum,,2009,South Africa,South Africa: Hlabisa,,,,,,"Human, Homo sapiens",Female,29,,,,host_subject_id:HLA2198;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.868Z,2015-03-16T03:17:09.594Z
1324259_3,Mycobacterium tuberculosis TKK-01-0049,Mycobacterium tuberculosis TKK-01-0049,1324259.0,WGS,TKK-01-0049,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198144,SAMN02053782,GCA_000661045.1,JLXY00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R46513,,,25.0,25.0,4404408.0,65.6,4369.0,,4014.0,,sputum,,2009,South Africa,South Africa: Hlabisa,,,,,,"Human, Homo sapiens",Male,34,,,,host_subject_id:HLA2366;co-morbidity:HIV Negative;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB not isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:17.879Z,2015-03-16T03:17:09.594Z
1324260_3,Mycobacterium tuberculosis TKK-01-0050,Mycobacterium tuberculosis TKK-01-0050,1324260.0,WGS,TKK-01-0050,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198145,SAMN02053783,GCA_000661065.1,JLXX00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R46513,,,24.0,26.0,4413899.0,65.6,4369.0,,4013.0,,sputum,,2009,South Africa,South Africa: Hlabisa,,,,,,"Human, Homo sapiens",Female,32,,,,host_subject_id:HLA2441;co-morbidity:HIV Positive;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:17.888Z,2015-03-16T03:17:09.594Z
1324262_3,Mycobacterium tuberculosis TKK-01-0052,Mycobacterium tuberculosis TKK-01-0052,1324262.0,WGS,TKK-01-0052,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198147,SAMN02053785,GCA_000661105.1,JLXV00000000,-,Broad Institute,WGS,Illumina,141.0x,allpaths v. R47142,,,16.0,16.0,4390641.0,65.6,4347.0,,3996.0,,sputum,,2009,South Africa,South Africa: Edendale,,,,,,"Human, Homo sapiens",Female,52,,,,host_subject_id:EDEN1392;co-morbidity:HIV Positive;previous tb treatment:Unknown;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:Culture contaminated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.909Z,2015-03-16T03:17:09.594Z
1324263_3,Mycobacterium tuberculosis TKK-01-0053,Mycobacterium tuberculosis TKK-01-0053,1324263.0,WGS,TKK-01-0053,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198148,SAMN02053786,GCA_000661125.1,JLXU00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R46513,,,22.0,22.0,4384784.0,65.6,4330.0,,3987.0,,sputum,,2009,South Africa,South Africa: Edendale,,,,,,"Human, Homo sapiens",Male,26,,,,host_subject_id:EDEN1432;co-morbidity:HIV Positive;previous tb treatment:Unknown;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:17.918Z,2015-03-16T03:17:09.594Z
1324264_3,Mycobacterium tuberculosis TKK-01-0054,Mycobacterium tuberculosis TKK-01-0054,1324264.0,WGS,TKK-01-0054,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198149,SAMN02053787,GCA_000661145.1,JLXT00000000,-,Broad Institute,WGS,Illumina,139.0x,allpaths v. R46513,,,16.0,16.0,4399378.0,65.6,4333.0,,3994.0,,sputum,,2009,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Male,52,,,,host_subject_id:NGW1071;co-morbidity:Unknown;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.928Z,2015-03-16T03:17:09.594Z
1324265_3,Mycobacterium tuberculosis TKK-01-0055,Mycobacterium tuberculosis TKK-01-0055,1324265.0,WGS,TKK-01-0055,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198150,SAMN02053788,GCA_000661165.1,JLXS00000000,-,Broad Institute,WGS,Illumina,136.0x,allpaths v. R46513,,,27.0,27.0,4377094.0,65.6,4335.0,,3981.0,,sputum,,2009,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Male,49,,,,host_subject_id:NGW1087;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:17.937Z,2015-03-16T03:17:09.594Z
1324266_3,Mycobacterium tuberculosis TKK-01-0056,Mycobacterium tuberculosis TKK-01-0056,1324266.0,WGS,TKK-01-0056,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198151,SAMN02053789,GCA_000661185.1,JLXR00000000,-,Broad Institute,WGS,Illumina,175.0x,allpaths v. R46586,,,36.0,36.0,4378592.0,65.6,4322.0,,3978.0,,sputum,,2009,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Male,44,,,,host_subject_id:NGW1088;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Pre-XDR;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:17.947Z,2015-03-16T03:17:09.594Z
1324267_3,Mycobacterium tuberculosis TKK-01-0057,Mycobacterium tuberculosis TKK-01-0057,1324267.0,WGS,TKK-01-0057,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198152,SAMN02053790,GCA_000661205.1,JLXQ00000000,-,Broad Institute,WGS,Illumina,174.0x,allpaths v. R46606,,,31.0,31.0,4395874.0,65.6,4356.0,,4014.0,,sputum,,2009,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,24,,,,host_subject_id:NGW1090;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:17.956Z,2015-03-16T03:17:09.594Z
1324268_3,Mycobacterium tuberculosis TKK-01-0058,Mycobacterium tuberculosis TKK-01-0058,1324268.0,WGS,TKK-01-0058,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198153,SAMN02053791,GCA_000661225.1,JLXP00000000,-,Broad Institute,WGS,Illumina,175.0x,allpaths v. R46606,,,23.0,24.0,4409324.0,65.6,4378.0,,4036.0,,sputum,,2009,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:NGW1096;co-morbidity:HIV Positive;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:17.966Z,2015-03-16T03:17:09.594Z
1324270_3,Mycobacterium tuberculosis TKK-01-0060,Mycobacterium tuberculosis TKK-01-0060,1324270.0,WGS,TKK-01-0060,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198155,SAMN02053793,GCA_000661245.1,JLXN00000000,-,Broad Institute,WGS,Illumina,138.0x,allpaths v. R46513,,,16.0,16.0,4400055.0,65.6,4354.0,,4006.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,24,,,,host_subject_id:NGW1193;co-morbidity:Unknown;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB not isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:17.976Z,2015-03-16T03:17:09.594Z
1324271_3,Mycobacterium tuberculosis TKK-01-0061,Mycobacterium tuberculosis TKK-01-0061,1324271.0,WGS,TKK-01-0061,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198156,SAMN02053794,GCA_000661265.1,JLXM00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R46513,,,27.0,28.0,4395909.0,65.6,4351.0,,4015.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,50,,,,host_subject_id:NGW1207;co-morbidity:Unknown;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:17.985Z,2015-03-16T03:17:09.594Z
1324272_3,Mycobacterium tuberculosis TKK-01-0062,Mycobacterium tuberculosis TKK-01-0062,1324272.0,WGS,TKK-01-0062,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198157,SAMN02053795,GCA_000661285.1,JLXL00000000,-,Broad Institute,WGS,Illumina,141.0x,allpaths v. R46513,,,25.0,25.0,4384365.0,65.6,4350.0,,3985.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,18,,,,host_subject_id:NGW1233;co-morbidity:Unknown;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:17.995Z,2015-03-16T03:17:09.594Z
1324273_3,Mycobacterium tuberculosis TKK-01-0063,Mycobacterium tuberculosis TKK-01-0063,1324273.0,WGS,TKK-01-0063,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198158,SAMN02053796,GCA_000661305.1,JLXK00000000,-,Broad Institute,WGS,Illumina,186.0x,allpaths v. R46586,,,27.0,28.0,4393571.0,65.6,4352.0,,4007.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,29,,,,host_subject_id:NGW1236;co-morbidity:HIV Positive;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Pre-XDR;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:18.005Z,2015-03-16T03:17:09.594Z
1324274_3,Mycobacterium tuberculosis TKK-01-0064,Mycobacterium tuberculosis TKK-01-0064,1324274.0,WGS,TKK-01-0064,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198159,SAMN02053797,GCA_000661325.1,JLXJ00000000,-,Broad Institute,WGS,Illumina,136.0x,allpaths v. R45374,,,27.0,28.0,4388445.0,65.6,4352.0,,4015.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Male,32,,,,host_subject_id:BEN1788;co-morbidity:Unknown;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:Unknown;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:18.014Z,2015-03-16T03:17:09.594Z
1324275_3,Mycobacterium tuberculosis TKK-01-0065,Mycobacterium tuberculosis TKK-01-0065,1324275.0,WGS,TKK-01-0065,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198160,SAMN02053798,GCA_000661345.1,JLXI00000000,-,Broad Institute,WGS,Illumina,235.0x,allpaths v. R46586,,,40.0,40.0,4380445.0,65.6,4331.0,,3987.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,37,,,,host_subject_id:NGW1245;co-morbidity:Unknown;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:18.023Z,2015-03-16T03:17:09.594Z
1324276_3,Mycobacterium tuberculosis TKK-01-0066,Mycobacterium tuberculosis TKK-01-0066,1324276.0,WGS,TKK-01-0066,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198161,SAMN02053799,GCA_000661365.1,JLXH00000000,-,Broad Institute,WGS,Illumina,117.0x,allpaths v. R46606,,,10.0,10.0,4413048.0,65.6,4354.0,,4039.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,28,,,,host_subject_id:NGW1254;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:18.032Z,2015-03-16T03:17:09.594Z
1324277_3,Mycobacterium tuberculosis TKK-01-0067,Mycobacterium tuberculosis TKK-01-0067,1324277.0,WGS,TKK-01-0067,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198162,SAMN02053800,GCA_000661385.1,JLXG00000000,-,Broad Institute,WGS,Illumina,240.0x,allpaths v. R46606,,,39.0,41.0,4386429.0,65.6,4360.0,,3994.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,35,,,,host_subject_id:NGW1259;co-morbidity:Unknown;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:18.041Z,2015-03-16T03:17:09.594Z
1324278_3,Mycobacterium tuberculosis TKK-01-0068,Mycobacterium tuberculosis TKK-01-0068,1324278.0,WGS,TKK-01-0068,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198163,SAMN02053801,GCA_000661405.1,JLXF00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R46513,,,6.0,6.0,4396502.0,65.6,4347.0,,4002.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,30,,,,host_subject_id:NGW1260;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:18.050Z,2015-03-16T03:17:09.594Z
1324279_3,Mycobacterium tuberculosis TKK-01-0070,Mycobacterium tuberculosis TKK-01-0070,1324279.0,WGS,TKK-01-0070,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198164,SAMN02053802,GCA_000661425.1,JLXD00000000,-,Broad Institute,WGS,Illumina,257.0x,allpaths v. R46586,,,30.0,32.0,4416731.0,65.6,4375.0,,4005.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:BEN1841;co-morbidity:HIV Positive;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:Unknown;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:18.068Z,2015-03-16T03:17:09.594Z
1324280_3,Mycobacterium tuberculosis TKK-01-0071,Mycobacterium tuberculosis TKK-01-0071,1324280.0,WGS,TKK-01-0071,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198167,SAMN02053803,GCA_000661445.1,JLXC00000000,-,Broad Institute,WGS,Illumina,136.0x,allpaths v. R46513,,,6.0,6.0,4399278.0,65.6,4337.0,,4003.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,28,,,,host_subject_id:NGW1325;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:18.077Z,2015-03-16T03:17:09.594Z
1324281_3,Mycobacterium tuberculosis TKK-01-0073,Mycobacterium tuberculosis TKK-01-0073,1324281.0,WGS,TKK-01-0073,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198168,SAMN02053804,GCA_000661465.1,JLXA00000000,-,Broad Institute,WGS,Illumina,140.0x,allpaths v. R46513,,,10.0,10.0,4404194.0,65.6,4345.0,,4010.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,52,,,,host_subject_id:NGW1394;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:18.097Z,2015-03-16T03:17:09.594Z
1324282_3,Mycobacterium tuberculosis TKK-01-0074,Mycobacterium tuberculosis TKK-01-0074,1324282.0,WGS,TKK-01-0074,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198169,SAMN02053805,GCA_000661485.1,JLWZ00000000,-,Broad Institute,WGS,Illumina,181.0x,allpaths v. R46586,,,7.0,7.0,4395035.0,65.6,4346.0,,4001.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Male,34,,,,host_subject_id:NGW1406;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:18.106Z,2015-03-16T03:17:09.594Z
1324283_3,Mycobacterium tuberculosis TKK-01-0075,Mycobacterium tuberculosis TKK-01-0075,1324283.0,WGS,TKK-01-0075,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198170,SAMN02053806,GCA_000661505.1,JLWY00000000,-,Broad Institute,WGS,Illumina,179.0x,allpaths v. R46586,,,9.0,9.0,4399414.0,65.6,4358.0,,4017.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,34,,,,host_subject_id:NGW1412;co-morbidity:Unknown;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:18.116Z,2015-03-16T03:17:09.594Z
1324284_3,Mycobacterium tuberculosis TKK-01-0076,Mycobacterium tuberculosis TKK-01-0076,1324284.0,WGS,TKK-01-0076,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198172,SAMN02053807,GCA_000661525.1,JLWX00000000,-,Broad Institute,WGS,Illumina,135.0x,allpaths v. R47129,,,6.0,6.0,4397855.0,65.6,4345.0,,4003.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Male,18,,,,host_subject_id:NGW1415;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB not isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:18.125Z,2015-03-16T03:17:09.594Z
1324285_3,Mycobacterium tuberculosis TKK-01-0077,Mycobacterium tuberculosis TKK-01-0077,1324285.0,WGS,TKK-01-0077,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198173,SAMN02053808,GCA_000662355.1,JLWW00000000,-,Broad Institute,WGS,Illumina,174.0x,allpaths v. R46586,,,28.0,31.0,4399433.0,65.6,4354.0,,4011.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Male,20,,,,host_subject_id:NGW1443;co-morbidity:Unknown;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:18.135Z,2015-03-16T03:17:09.594Z
1324286_3,Mycobacterium tuberculosis TKK-01-0078,Mycobacterium tuberculosis TKK-01-0078,1324286.0,WGS,TKK-01-0078,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198174,SAMN02053809,GCA_000661555.1,JLWV00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R46513,,,23.0,23.0,4387160.0,65.6,4371.0,,3994.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Male,30,,,,host_subject_id:NGW1461;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:18.144Z,2015-03-16T03:17:09.594Z
1324287_3,Mycobacterium tuberculosis TKK-01-0079,Mycobacterium tuberculosis TKK-01-0079,1324287.0,WGS,TKK-01-0079,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198175,SAMN02053810,GCA_000661575.1,JLWU00000000,-,Broad Institute,WGS,Illumina,239.0x,allpaths v. R46586,,,45.0,45.0,4388396.0,65.6,4356.0,,3992.0,,sputum,,2010,South Africa,South Africa: Ngwelezane,,,,,,"Human, Homo sapiens",Female,30,,,,host_subject_id:NGW1475;co-morbidity:HIV Positive;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:18.153Z,2015-03-16T03:17:09.594Z
1324288_3,Mycobacterium tuberculosis TKK-01-0081,Mycobacterium tuberculosis TKK-01-0081,1324288.0,WGS,TKK-01-0081,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198176,SAMN02053811,GCA_000661595.1,JLWS00000000,-,Broad Institute,WGS,Illumina,137.0x,allpaths v. R46513,,,19.0,19.0,4404231.0,65.6,4343.0,,4020.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Male,47,,,,host_subject_id:PMH1733;co-morbidity:Unknown;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:KZN lineage,2014-12-08T22:12:18.174Z,2015-03-16T03:17:09.594Z
1324289_3,Mycobacterium tuberculosis TKK-01-0082,Mycobacterium tuberculosis TKK-01-0082,1324289.0,WGS,TKK-01-0082,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198177,SAMN02053812,GCA_000661615.1,JLWR00000000,-,Broad Institute,WGS,Illumina,139.0x,allpaths v. R47129,,,18.0,19.0,4391228.0,65.6,4364.0,,3989.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Female,21,,,,host_subject_id:PMH1611;co-morbidity:HIV Positive;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Beijing lineage,2014-12-08T22:12:18.183Z,2015-03-16T03:17:09.594Z
1324290_3,Mycobacterium tuberculosis TKK-01-0083,Mycobacterium tuberculosis TKK-01-0083,1324290.0,WGS,TKK-01-0083,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198178,SAMN02053813,GCA_000661635.1,JLWQ00000000,-,Broad Institute,WGS,Illumina,142.0x,allpaths v. R47129,,,18.0,20.0,4403293.0,65.6,4357.0,,4015.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Female,24,,,,host_subject_id:PMH1649;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:18.192Z,2015-03-16T03:17:09.594Z
1324291_3,Mycobacterium tuberculosis TKK-01-0084,Mycobacterium tuberculosis TKK-01-0084,1324291.0,WGS,TKK-01-0084,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198179,SAMN02053814,GCA_000661655.1,JLWP00000000,-,Broad Institute,WGS,Illumina,186.0x,allpaths v. R47129,,,15.0,15.0,4410130.0,65.6,4355.0,,4027.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Male,35,,,,host_subject_id:PMH1740;co-morbidity:Unknown;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:KZN lineage,2014-12-08T22:12:18.200Z,2015-03-16T03:17:09.594Z
1324292_3,Mycobacterium tuberculosis TKK-01-0085,Mycobacterium tuberculosis TKK-01-0085,1324292.0,WGS,TKK-01-0085,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198180,SAMN02053815,GCA_000661675.1,JLWO00000000,-,Broad Institute,WGS,Illumina,142.0x,allpaths v. R47129,,,16.0,18.0,4349069.0,65.6,4304.0,,3980.0,,sputum,,2008,South Africa,South Africa: Prince Msheyeni,,,,,,"Human, Homo sapiens",Male,25,,,,host_subject_id:PMH1237;co-morbidity:HIV Positive;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Unclassified,2014-12-08T22:12:18.210Z,2015-03-16T03:17:09.594Z
1324293_3,Mycobacterium tuberculosis TKK-01-0086,Mycobacterium tuberculosis TKK-01-0086,1324293.0,WGS,TKK-01-0086,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198181,SAMN02053816,GCA_000661695.1,JLWN00000000,-,Broad Institute,WGS,Illumina,140.0x,allpaths v. R47129,,,16.0,18.0,4397705.0,65.6,4354.0,,4001.0,,sputum,,2008,South Africa,South Africa: Saint Margaret,,,,,,"Human, Homo sapiens",Male,50,,,,host_subject_id:SMH1035;co-morbidity:Unknown;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:18.220Z,2015-03-16T03:17:09.594Z
1324294_3,Mycobacterium tuberculosis TKK-01-0087,Mycobacterium tuberculosis TKK-01-0087,1324294.0,WGS,TKK-01-0087,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198182,SAMN02053817,GCA_000661715.1,JLWM00000000,-,Broad Institute,WGS,Illumina,140.0x,allpaths v. R47129,,,25.0,26.0,4415120.0,65.6,4356.0,,4019.0,,sputum,,2008,South Africa,South Africa: Rietvlei,,,,,,"Human, Homo sapiens",Male,56,,,,host_subject_id:RIH1057;co-morbidity:Unknown;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:Culture contaminated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:18.236Z,2015-03-16T03:17:09.594Z
1324295_3,Mycobacterium tuberculosis TKK-01-0088,Mycobacterium tuberculosis TKK-01-0088,1324295.0,WGS,TKK-01-0088,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198183,SAMN02053818,GCA_000661735.1,JLWL00000000,-,Broad Institute,WGS,Illumina,179.0x,allpaths v. R47129,,,30.0,32.0,4376830.0,65.6,4334.0,,3984.0,,sputum,,2008,South Africa,South Africa: Rietvlei,,,,,,"Human, Homo sapiens",Female,21,,,,host_subject_id:RIH1043;co-morbidity:Unknown;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Beijing lineage,2014-12-08T22:12:18.245Z,2015-03-16T03:17:09.594Z
1324296_3,Mycobacterium tuberculosis TKK-01-0089,Mycobacterium tuberculosis TKK-01-0089,1324296.0,WGS,TKK-01-0089,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198184,SAMN02053819,GCA_000661755.1,JLWK00000000,-,Broad Institute,WGS,Illumina,141.0x,allpaths v. R47129,,,34.0,36.0,4392890.0,65.6,4347.0,,4008.0,,sputum,,2008,South Africa,South Africa: Rietvlei,,,,,,"Human, Homo sapiens",Male,38,,,,host_subject_id:RIH1044;co-morbidity:Unknown;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:18.253Z,2015-03-16T03:17:09.594Z
1324297_3,Mycobacterium tuberculosis TKK-01-0090,Mycobacterium tuberculosis TKK-01-0090,1324297.0,WGS,TKK-01-0090,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198185,SAMN02053820,GCA_000661775.1,JLWJ00000000,-,Broad Institute,WGS,Illumina,142.0x,allpaths v. R47129,,,30.0,34.0,4398513.0,65.6,4378.0,,4019.0,,sputum,,2008,South Africa,South Africa: Rietvlei,,,,,,"Human, Homo sapiens",Male,61,,,,host_subject_id:RIH1053;co-morbidity:Unknown;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Unclassified,2014-12-08T22:12:18.263Z,2015-03-16T03:17:09.594Z
1324298_3,Mycobacterium tuberculosis TKK-01-0091,Mycobacterium tuberculosis TKK-01-0091,1324298.0,WGS,TKK-01-0091,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198186,SAMN02053821,GCA_000661795.1,JLWI00000000,-,Broad Institute,WGS,Illumina,139.0x,allpaths v. R47129,,,15.0,15.0,4391619.0,65.6,4335.0,,4003.0,,sputum,,2008,South Africa,South Africa: Rietvlei,,,,,,"Human, Homo sapiens",Male,37,,,,host_subject_id:RIH1071;co-morbidity:Unknown;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB not isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:KZN lineage,2014-12-08T22:12:18.273Z,2015-03-16T03:17:09.594Z
1324299_3,Mycobacterium tuberculosis TKK-01-0092,Mycobacterium tuberculosis TKK-01-0092,1324299.0,WGS,TKK-01-0092,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198187,SAMN02053822,GCA_000661815.1,JLWH00000000,-,Broad Institute,WGS,Illumina,141.0x,allpaths v. R47129,,,23.0,25.0,4394782.0,65.6,4348.0,,3991.0,,sputum,,,South Africa,South Africa: Rietvlei,,,,,,"Human, Homo sapiens",Unknown,Unknown,,,,host_subject_id:RIH1185;co-morbidity:Unknown;previous tb treatment:Unknown;previous mdr-tx:Unknown;previous drug susceptible tb tx:Unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Negative;lineage:Beijing lineage,2014-12-08T22:12:18.282Z,2015-03-16T03:17:09.594Z
1324300_3,Mycobacterium tuberculosis TKK-01-0093,Mycobacterium tuberculosis TKK-01-0093,1324300.0,WGS,TKK-01-0093,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198188,SAMN02053823,GCA_000661835.1,JLWG00000000,-,Broad Institute,WGS,Illumina,139.0x,allpaths v. R47129,,,39.0,40.0,4382621.0,65.6,4369.0,,3995.0,,sputum,,2008,South Africa,South Africa: Rietvlei,,,,,,"Human, Homo sapiens",Female,24,,,,host_subject_id:RIH1082;co-morbidity:HIV Negative;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:Culture contaminated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Beijing lineage,2014-12-08T22:12:18.291Z,2015-03-16T03:17:09.594Z
1324301_3,Mycobacterium tuberculosis TKK-01-0094,Mycobacterium tuberculosis TKK-01-0094,1324301.0,WGS,TKK-01-0094,,,,,,,,2014-04-29T00:00:00Z,,PRJNA198189,SAMN02053824,GCA_000661855.1,JLWF00000000,-,Broad Institute,WGS,Illumina,140.0x,allpaths v. R47129,,,28.0,29.0,4390633.0,65.6,4351.0,,3989.0,,sputum,,2008,South Africa,South Africa: Saint Margaret,,,,,,"Human, Homo sapiens",Male,18,,,,host_subject_id:SMH1108;co-morbidity:Unknown;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:Positive;lineage:Beijing lineage,2014-12-08T22:12:18.300Z,2015-03-16T03:17:09.594Z
1354101_3,Mycobacterium tuberculosis MAL020186,Mycobacterium tuberculosis MAL020186,1354101.0,WGS,MAL020186,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211708,SAMN02231175,GCA_000667465.1,JKYK00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,21.0,22.0,4415954.0,65.6,4369.0,,4010.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Female,25,TB,,,comorbidity:HIV negative;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,"genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:streptomycin, isoniazid resistant",2014-12-08T22:12:13.221Z,2015-03-16T03:17:09.594Z
1354102_3,Mycobacterium tuberculosis MAL020187,Mycobacterium tuberculosis MAL020187,1354102.0,WGS,MAL020187,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211709,SAMN02231176,GCA_000667485.1,JKYJ00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48476,,,31.0,33.0,4409064.0,65.6,4362.0,,4012.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,46,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.230Z,2015-03-16T03:17:09.594Z
1354103_3,Mycobacterium tuberculosis MAL020192,Mycobacterium tuberculosis MAL020192,1354103.0,WGS,MAL020192,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211710,SAMN02231177,GCA_000667505.1,JKYI00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48177,,,28.0,28.0,4371340.0,65.6,4342.0,,4013.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,46,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb Lam10;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.239Z,2015-03-16T03:17:09.594Z
1354105_3,Mycobacterium tuberculosis MAL020194,Mycobacterium tuberculosis MAL020194,1354105.0,WGS,MAL020194,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211712,SAMN02231179,GCA_000667545.1,JKYG00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R47573,,,26.0,29.0,4394547.0,65.6,4359.0,,4006.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,36,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.260Z,2015-03-16T03:17:09.594Z
1354106_3,Mycobacterium tuberculosis MAL020195,Mycobacterium tuberculosis MAL020195,1354106.0,WGS,MAL020195,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211713,SAMN02231180,GCA_000667565.1,JKYF00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R47573,,,19.0,20.0,4395338.0,65.6,4347.0,,3997.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,19,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.268Z,2015-03-16T03:17:09.594Z
1354107_3,Mycobacterium tuberculosis MAL020196,Mycobacterium tuberculosis MAL020196,1354107.0,WGS,MAL020196,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211714,SAMN02231181,GCA_000667585.1,JKYE00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,24.0,25.0,4425701.0,65.6,4372.0,,4019.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,57,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb H37Rv;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.277Z,2015-03-16T03:17:09.594Z
1354108_3,Mycobacterium tuberculosis MAL020197,Mycobacterium tuberculosis MAL020197,1354108.0,WGS,MAL020197,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211715,SAMN02231182,GCA_000667605.1,JKYD00000000,-,Broad Institute,WGS,Illumina,112.0x,allpaths v. R48177,,,11.0,12.0,4394605.0,65.6,4353.0,,3995.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,20,TB,,,comorbidity:HIV negative;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb Lam 8;organism detection method:MGIT and 7H11;phenotype:isoniazid resistant,2014-12-08T22:12:13.286Z,2015-03-16T03:17:09.594Z
1354109_3,Mycobacterium tuberculosis MAL020199,Mycobacterium tuberculosis MAL020199,1354109.0,WGS,MAL020199,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211716,SAMN02231183,GCA_000667625.1,JKYC00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48177,,,14.0,16.0,4404860.0,65.6,4349.0,,4005.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,39,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.295Z,2015-03-16T03:17:09.594Z
1354110_3,Mycobacterium tuberculosis MAL020200,Mycobacterium tuberculosis MAL020200,1354110.0,WGS,MAL020200,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211717,SAMN02231184,GCA_000667645.1,JKYB00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48177,,,21.0,22.0,4378601.0,65.6,4322.0,,3996.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,37,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb Lam10;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.305Z,2015-03-16T03:17:09.594Z
1354111_3,Mycobacterium tuberculosis MAL020201,Mycobacterium tuberculosis MAL020201,1354111.0,WGS,MAL020201,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211718,SAMN02231185,GCA_000667665.1,JKYA00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48476,,,26.0,27.0,4428421.0,65.6,4360.0,,4018.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,23,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.314Z,2015-03-16T03:17:09.594Z
1354112_3,Mycobacterium tuberculosis MAL020202,Mycobacterium tuberculosis MAL020202,1354112.0,WGS,MAL020202,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211719,SAMN02231186,GCA_000667685.1,JKXZ00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48177,,,16.0,18.0,4396768.0,65.6,4328.0,,3998.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,26,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.324Z,2015-03-16T03:17:09.594Z
1354113_3,Mycobacterium tuberculosis MAL020205,,1354113.0,WGS,MAL020205,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA211720,SAMN02231187,GCA_000706185.1,JKXY00000000,-,Broad Institute,,Illumina,127.0x,allpaths v. R47573,,,36.0,43.0,4435670.0,65.6,4315.0,,4004.0,Sputum,bodily fluid,,,Mali,Mali: Point G Hospital,,,,,,"Human, Homo sapiens",Male,24,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:39:56.234Z,2015-03-16T03:17:09.594Z
1354114_3,Mycobacterium tuberculosis MAL020206,Mycobacterium tuberculosis MAL020206,1354114.0,WGS,MAL020206,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211721,SAMN02231188,GCA_000667705.1,JKXX00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R47573,,,15.0,16.0,4401958.0,65.6,4341.0,,3999.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,40,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.333Z,2015-03-16T03:17:09.594Z
1354115_3,Mycobacterium tuberculosis MAL020208,Mycobacterium tuberculosis MAL020208,1354115.0,WGS,MAL020208,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211722,SAMN02231189,GCA_000667725.1,JKXW00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48177,,,21.0,21.0,4415967.0,65.6,4369.0,,4007.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,57,MDR-TB,,,"comorbidity:MDR-TB, HIV positive;treatment course:adm",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.343Z,2015-03-16T03:17:09.594Z
1354116_3,Mycobacterium tuberculosis MAL020209,Mycobacterium tuberculosis MAL020209,1354116.0,WGS,MAL020209,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211723,SAMN02231190,GCA_000667745.1,JKXV00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,12.0,14.0,4410515.0,65.6,4361.0,,4006.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Female,52,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.352Z,2015-03-16T03:17:09.594Z
1354117_3,Mycobacterium tuberculosis MAL020211,Mycobacterium tuberculosis MAL020211,1354117.0,WGS,MAL020211,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211724,SAMN02231191,GCA_000667765.1,JKXU00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R47573,,,19.0,19.0,4405817.0,65.6,4348.0,,3999.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,31,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.361Z,2015-03-16T03:17:09.594Z
1354119_3,Mycobacterium tuberculosis MAL020179,Mycobacterium tuberculosis MAL020179,1354119.0,WGS,MAL020179,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211704,SAMN02231171,GCA_000667385.1,JKYO00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,12.0,15.0,4410098.0,65.6,4380.0,,4026.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,27,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb X1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.194Z,2015-03-16T03:17:09.594Z
1354120_3,Mycobacterium tuberculosis MAL020181,Mycobacterium tuberculosis MAL020181,1354120.0,WGS,MAL020181,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211705,SAMN02231172,GCA_000667405.1,JKYN00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48177,,,22.0,22.0,4404685.0,65.6,4341.0,,4000.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,33,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.203Z,2015-03-16T03:17:09.594Z
1354121_3,Mycobacterium tuberculosis MAL020182,Mycobacterium tuberculosis MAL020182,1354121.0,WGS,MAL020182,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211706,SAMN02231173,GCA_000667425.1,JKYM00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48177,,,19.0,21.0,4396662.0,65.6,4328.0,,3998.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,35,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.212Z,2015-03-16T03:17:09.594Z
1354122_3,Mycobacterium tuberculosis MAL020138,Mycobacterium tuberculosis MAL020138,1354122.0,WGS,MAL020138,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211685,SAMN02231152,GCA_000667025.1,JKZG00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48177,,,23.0,24.0,4404719.0,65.6,4344.0,,4004.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Female,34,TB,,,comorbidity:HIV negative;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,"genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:streptomycin, isoniazid, ethambutol resistant",2014-12-08T22:12:13.052Z,2015-03-16T03:17:09.594Z
1354123_3,Mycobacterium tuberculosis MAL020141,Mycobacterium tuberculosis MAL020141,1354123.0,WGS,MAL020141,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211686,SAMN02231153,GCA_000667045.1,JKZF00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48177,,,13.0,14.0,4408797.0,65.6,4354.0,,4005.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,31,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.060Z,2015-03-16T03:17:09.594Z
1354124_3,Mycobacterium tuberculosis MAL020142,Mycobacterium tuberculosis MAL020142,1354124.0,WGS,MAL020142,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211687,SAMN02231154,GCA_000667065.1,JKZE00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,15.0,15.0,4411163.0,65.6,4363.0,,4003.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,48,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.069Z,2015-03-16T03:17:09.594Z
1354125_3,Mycobacterium tuberculosis MAL020144,Mycobacterium tuberculosis MAL020144,1354125.0,WGS,MAL020144,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211688,SAMN02231155,GCA_000667085.1,JKZD00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47573,,,22.0,22.0,4408460.0,65.6,4339.0,,4005.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,56,MDR-TB,,,"comorbidity:MDR_TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.078Z,2015-03-16T03:17:09.594Z
1354126_3,Mycobacterium tuberculosis MAL020145,Mycobacterium tuberculosis MAL020145,1354126.0,WGS,MAL020145,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211689,SAMN02231156,GCA_000667105.1,JKZC00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48177,,,16.0,16.0,4406906.0,65.6,4349.0,,3997.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,20,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.087Z,2015-03-16T03:17:09.594Z
1354127_3,Mycobacterium tuberculosis MAL020146,Mycobacterium tuberculosis MAL020146,1354127.0,WGS,MAL020146,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211690,SAMN02231157,GCA_000667125.1,JKZB00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48177,,,15.0,16.0,4405183.0,65.6,4355.0,,4006.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,40,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb Lam9;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.095Z,2015-03-16T03:17:09.594Z
1354128_3,Mycobacterium tuberculosis MAL020147,Mycobacterium tuberculosis MAL020147,1354128.0,WGS,MAL020147,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211691,SAMN02231158,GCA_000667145.1,JKZA00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,16.0,17.0,4406082.0,65.6,4360.0,,4008.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,32,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb Harlem3;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.104Z,2015-03-16T03:17:09.594Z
1354129_3,Mycobacterium tuberculosis MAL020150,Mycobacterium tuberculosis MAL020150,1354129.0,WGS,MAL020150,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211692,SAMN02231159,GCA_000667165.1,JKYZ00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47573,,,19.0,20.0,4406077.0,65.6,4354.0,,4004.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Female,21,TB,,,comorbidity:HIV negative;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,"genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:streptomycin, isoniazid resistant",2014-12-08T22:12:13.112Z,2015-03-16T03:17:09.594Z
1354130_3,Mycobacterium tuberculosis MAL020152,Mycobacterium tuberculosis MAL020152,1354130.0,WGS,MAL020152,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211693,SAMN02231160,GCA_000667185.1,JKYY00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R47573,,,21.0,22.0,4404024.0,65.6,4343.0,,4002.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,39,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.121Z,2015-03-16T03:17:09.594Z
1354131_3,Mycobacterium tuberculosis MAL020156,Mycobacterium tuberculosis MAL020156,1354131.0,WGS,MAL020156,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211694,SAMN02231161,GCA_000667205.1,JKYX00000000,-,Broad Institute,WGS,Illumina,117.0x,allpaths v. R48177,,,39.0,42.0,4405244.0,65.6,4355.0,,4007.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,43,TB,,,comorbidity:HIV negative;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,"genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:isoniazid, ethambutol resistant",2014-12-08T22:12:13.130Z,2015-03-16T03:17:09.594Z
1354132_3,Mycobacterium tuberculosis MAL020157,Mycobacterium tuberculosis MAL020157,1354132.0,WGS,MAL020157,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211695,SAMN02231162,GCA_000667225.1,JKYW00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48177,,,15.0,15.0,4404599.0,65.6,4365.0,,4003.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,78,TB,,,comorbidity:HIV negative;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:13.139Z,2015-03-16T03:17:09.594Z
1354133_3,Mycobacterium tuberculosis MAL020160,Mycobacterium tuberculosis MAL020160,1354133.0,WGS,MAL020160,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211696,SAMN02231163,GCA_000667245.1,JKYV00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R47573,,,20.0,20.0,4384675.0,65.6,4373.0,,4021.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,31,TB,,,comorbidity:HIV negative;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb Lam10;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:13.148Z,2015-03-16T03:17:09.594Z
1354134_3,Mycobacterium tuberculosis MAL020162,Mycobacterium tuberculosis MAL020162,1354134.0,WGS,MAL020162,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211697,SAMN02231164,GCA_000667265.1,JKYU00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R47573,,,16.0,16.0,4408563.0,65.6,4356.0,,4003.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,31,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.157Z,2015-03-16T03:17:09.594Z
1354135_3,Mycobacterium tuberculosis MAL020167,Mycobacterium tuberculosis MAL020167,1354135.0,WGS,MAL020167,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211698,SAMN02231165,GCA_000667285.1,JKYT00000000,-,Broad Institute,WGS,Illumina,115.0x,allpaths v. R48177,,,53.0,54.0,4356526.0,65.6,4306.0,,3976.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,32,TB,,,comorbidity:HIV negative;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,"genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:streptomycin, isoniazid resistant",2014-12-08T22:12:13.167Z,2015-03-16T03:17:09.594Z
1354136_3,Mycobacterium tuberculosis MAL020172,Mycobacterium tuberculosis MAL020172,1354136.0,WGS,MAL020172,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211699,SAMN02231166,GCA_000667305.1,JKYS00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,16.0,17.0,4403973.0,65.6,4339.0,,3996.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,49,MDR-TB,,,"comorbidity:MDR-TB, HIV negative;treatment course:adm",Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:13.176Z,2015-03-16T03:17:09.594Z
1354137_3,Mycobacterium tuberculosis MAL020110,Mycobacterium tuberculosis MAL020110,1354137.0,WGS,MAL020110,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211677,SAMN02231144,GCA_000666885.1,JKZN00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,15.0,15.0,4399188.0,65.6,4361.0,,4003.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",,Adult,TB,,,comorbidity:HIV negative;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb Lam 9;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:13.006Z,2015-03-16T03:17:09.594Z
1354138_3,Mycobacterium tuberculosis MAL020120,Mycobacterium tuberculosis MAL020120,1354138.0,WGS,MAL020120,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211678,SAMN02231145,GCA_000666905.1,JKZM00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48476,,,27.0,29.0,4401079.0,65.6,4355.0,,4006.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",,Adult,TB,,,comorbidity:HIV negative;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:13.015Z,2015-03-16T03:17:09.594Z
1354139_3,Mycobacterium tuberculosis MAL020131,Mycobacterium tuberculosis MAL020131,1354139.0,WGS,MAL020131,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211680,SAMN02231147,GCA_000666945.1,JKZK00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48177,,,20.0,23.0,4399647.0,65.6,4347.0,,3996.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",,Adult,TB,,,comorbidity:HIV negative;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:13.024Z,2015-03-16T03:17:09.594Z
1354140_3,Mycobacterium tuberculosis MAL020132,Mycobacterium tuberculosis MAL020132,1354140.0,WGS,MAL020132,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211681,SAMN02231148,GCA_000666965.1,JKZJ00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48177,,,14.0,14.0,4400529.0,65.6,4334.0,,3996.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",,Adult,TB,,,comorbidity:HIV negative;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:13.033Z,2015-03-16T03:17:09.594Z
1354142_3,Mycobacterium tuberculosis MAL020174,Mycobacterium tuberculosis MAL020174,1354142.0,WGS,MAL020174,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211701,SAMN02231168,GCA_000667345.1,JKYQ00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,17.0,19.0,4411591.0,65.6,4340.0,,4013.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Female,48,TB,,,comorbidity:HIV negative;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,"genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:streptomycin, isoniazid resistant",2014-12-08T22:12:13.185Z,2015-03-16T03:17:09.594Z
1354143_3,Mycobacterium tuberculosis MAL010078,Mycobacterium tuberculosis MAL010078,1354143.0,WGS,MAL010078,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211634,SAMN02231103,GCA_000666245.1,JLAW00000000,-,Broad Institute,WGS,Illumina,102.0x,allpaths v. R48123,,,21.0,21.0,4407091.0,65.6,4347.0,,3998.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Female,43,TB,,,comorbidity:HIV negative;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:12.883Z,2015-03-16T03:17:09.594Z
1354144_3,Mycobacterium tuberculosis MAL010080,Mycobacterium tuberculosis MAL010080,1354144.0,WGS,MAL010080,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211636,SAMN02231105,GCA_000666285.1,JLAU00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47573,,,18.0,19.0,4401900.0,65.6,4359.0,,4002.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,34,TB,,,comorbidity:HIV negative;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:12.892Z,2015-03-16T03:17:09.594Z
1354145_3,Mycobacterium tuberculosis MAL010086,Mycobacterium tuberculosis MAL010086,1354145.0,WGS,MAL010086,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211638,SAMN02231107,GCA_000666325.1,JLAS00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48177,,,20.0,22.0,4405941.0,65.6,4339.0,,4001.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,49,TB,,,comorbidity:HIV negative;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:12.900Z,2015-03-16T03:17:09.594Z
1354146_3,Mycobacterium tuberculosis MAL010087,Mycobacterium tuberculosis MAL010087,1354146.0,WGS,MAL010087,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211639,SAMN02231108,GCA_000666345.1,JLAR00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48177,,,20.0,20.0,4407682.0,65.6,4325.0,,4011.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Female,18,TB,,,comorbidity:HIV positive;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb X3;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:12.908Z,2015-03-16T03:17:09.594Z
1354147_3,Mycobacterium tuberculosis MAL010088,Mycobacterium tuberculosis MAL010088,1354147.0,WGS,MAL010088,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211640,SAMN02231109,GCA_000666365.1,JLAQ00000000,-,Broad Institute,WGS,Illumina,116.0x,allpaths v. R48123,,,37.0,37.0,4400483.0,65.6,4365.0,,4008.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,20,TB,,,comorbidity:HIV negative;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:rifampicin resistant,2014-12-08T22:12:12.917Z,2015-03-16T03:17:09.594Z
1354148_3,Mycobacterium tuberculosis MAL010103,Mycobacterium tuberculosis MAL010103,1354148.0,WGS,MAL010103,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211651,SAMN02231118,GCA_000666465.1,JLAL00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R47573,,,16.0,17.0,4402331.0,65.6,4329.0,,4013.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,30,TB,,,comorbidity:HIV negative;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:12.925Z,2015-03-16T03:17:09.594Z
1354149_3,Mycobacterium tuberculosis MAL010105,Mycobacterium tuberculosis MAL010105,1354149.0,WGS,MAL010105,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211652,SAMN02231119,GCA_000666485.1,JLAK00000000,-,Broad Institute,WGS,Illumina,101.0x,allpaths v. R47573,,,18.0,18.0,4411065.0,65.6,4352.0,,4008.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,40,MDR-TB,,,"comorbidity:MDR-TB, HIV positive;treatment course:adm",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb EAI;organism detection method:MGIT and 7H11;phenotype:MDR,2014-12-08T22:12:12.934Z,2015-03-16T03:17:09.594Z
1354150_3,Mycobacterium tuberculosis MAL010106,Mycobacterium tuberculosis MAL010106,1354150.0,WGS,MAL010106,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211653,SAMN02231120,GCA_000666505.1,JLAJ00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48177,,,18.0,18.0,4418376.0,65.6,4368.0,,4015.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,45,TB,,,comorbidity:HIV positive;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:12.942Z,2015-03-16T03:17:09.594Z
1354151_3,Mycobacterium tuberculosis MAL010108,Mycobacterium tuberculosis MAL010108,1354151.0,WGS,MAL010108,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211654,SAMN02231121,GCA_000666525.1,JLAI00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48177,,,14.0,14.0,4413519.0,65.6,4371.0,,4007.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,29,TB,,,comorbidity:HIV negative;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,"genotyping method:spoligotyping;lineage:Mtb Harlem 3;organism detection method:MGIT and 7H11;phenotype:streptomycin, isoniazid resistant",2014-12-08T22:12:12.950Z,2015-03-16T03:17:09.594Z
1354152_3,Mycobacterium tuberculosis MAL010109,Mycobacterium tuberculosis MAL010109,1354152.0,WGS,MAL010109,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211655,SAMN02231122,GCA_000666545.1,JLAH00000000,-,Broad Institute,WGS,Illumina,117.0x,allpaths v. R47573,,,29.0,33.0,4357891.0,65.6,4329.0,,3991.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Female,25,TB,,,comorbidity:HIV positive;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:12.960Z,2015-03-16T03:17:09.594Z
1354153_3,Mycobacterium tuberculosis MAL010110,Mycobacterium tuberculosis MAL010110,1354153.0,WGS,MAL010110,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211656,SAMN02231123,GCA_000666565.1,JLAG00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R47573,,,10.0,10.0,4409264.0,65.6,4368.0,,4003.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Female,34,TB,,,comorbidity:HIV positive;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:12.969Z,2015-03-16T03:17:09.594Z
1354154_3,Mycobacterium tuberculosis MAL010133,Mycobacterium tuberculosis MAL010133,1354154.0,WGS,MAL010133,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211669,SAMN02231136,GCA_000666785.1,JKZT00000000,-,Broad Institute,WGS,Illumina,117.0x,allpaths v. R48177,,,26.0,26.0,4387580.0,65.6,4326.0,,3986.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,21,TB,,,comorbidity:HIV positive;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:12.989Z,2015-03-16T03:17:09.594Z
1354155_3,Mycobacterium tuberculosis MAL010134,Mycobacterium tuberculosis MAL010134,1354155.0,WGS,MAL010134,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211670,SAMN02231137,GCA_000666805.1,JKZS00000000,-,Broad Institute,WGS,Illumina,69.0x,allpaths v. R48207,,,112.0,128.0,4365234.0,65.6,4361.0,,3970.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,41,TB,,,comorbidity:HIV positive;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb EAI;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:12.998Z,2015-03-16T03:17:09.594Z
1354156_3,Mycobacterium tuberculosis MAL020102,,1354156.0,WGS,MAL020102,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA211673,SAMN02231140,GCA_000706205.1,JKZP00000000,-,Broad Institute,,Illumina,127.0x,allpaths v. R48177,,,4.0,27.0,4410220.0,65.6,4323.0,,4007.0,Sputum,bodily fluid,,,Mali,Mali: Point G Hospital,,,,,,"Human, Homo sapiens",,Adult,TB,,,comorbidity:HIV negative;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:39:56.786Z,2015-03-16T03:17:09.594Z
1354157_3,Mycobacterium tuberculosis MAL010117,,1354157.0,WGS,MAL010117,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA211659,SAMN02231126,GCA_000706245.1,JLAD00000000,-,Broad Institute,,Illumina,130.0x,allpaths v. R48177,,,4.0,17.0,4419020.0,65.6,4290.0,,4004.0,Sputum,bodily fluid,,,Mali,Mali: Point G Hospital,,,,,,"Human, Homo sapiens",Male,25,TB,,,comorbidity:HIV negative;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:39:57.590Z,2015-03-16T03:17:09.594Z
1354158_3,Mycobacterium tuberculosis MAL010121,Mycobacterium tuberculosis MAL010121,1354158.0,WGS,MAL010121,,,,,,,,2014-04-29T00:00:00Z,,PRJNA211662,SAMN02231129,GCA_000666665.1,JLAA00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47573,,,22.0,22.0,4397814.0,65.6,4348.0,,1225.0,Sputum,Bodily fluid,,,Mali,"Mali: Point G Hospital, Bamako",,,,,,"Human, Homo sapiens",Male,40,TB,,,comorbidity:HIV negative;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb Harlem 3;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:12:12.980Z,2015-03-16T03:17:09.594Z
1354159_3,Mycobacterium tuberculosis MAL010124,,1354159.0,WGS,MAL010124,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA211664,SAMN02231131,GCA_000706225.1,JKZY00000000,-,Broad Institute,,Illumina,129.0x,allpaths v. R48559,,,9.0,18.0,4412060.0,65.6,4306.0,,4003.0,Sputum,bodily fluid,,,Mali,Mali: Point G Hospital,,,,,,"Human, Homo sapiens",Male,36,TB,,,comorbidity:HIV positive;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Mali,genotyping method:spoligotyping;lineage:Mtb T1;organism detection method:MGIT and 7H11;phenotype:susceptible,2014-12-08T22:39:58.163Z,2015-03-16T03:17:09.594Z
1397853_3,Mycobacterium tuberculosis TKK_02_0001,Mycobacterium tuberculosis TKK_02_0001,1397853.0,WGS,TKK_02_0001,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218225,SAMN02350408,GCA_000671775.1,JLWC00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48294,,,20.0,20.0,4399758.0,65.6,4357.0,,3987.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,37,,,,host_subject_id:35;treatment course:adm;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.310Z,2015-03-16T03:17:09.594Z
1397854_3,Mycobacterium tuberculosis TKK_02_0002,Mycobacterium tuberculosis TKK_02_0002,1397854.0,WGS,TKK_02_0002,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218226,SAMN02350409,GCA_000671795.1,JLWB00000000,-,Broad Institute,WGS,Illumina,58.0x,allpaths v. R48294,,,33.0,33.0,4388408.0,65.6,4365.0,,3993.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,33,,,,host_subject_id:36;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.320Z,2015-03-16T03:17:09.594Z
1397855_3,Mycobacterium tuberculosis TKK_02_0003,Mycobacterium tuberculosis TKK_02_0003,1397855.0,WGS,TKK_02_0003,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218227,SAMN02350410,GCA_000671815.1,JLWA00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48294,,,17.0,19.0,4393037.0,65.6,4376.0,,3995.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,33,,,,host_subject_id:36;treatment course:8w;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.329Z,2015-03-16T03:17:09.594Z
1397856_3,Mycobacterium tuberculosis TKK_02_0006,Mycobacterium tuberculosis TKK_02_0006,1397856.0,WGS,TKK_02_0006,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218228,SAMN02350411,GCA_000671835.1,JLVZ00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48294,,,6.0,6.0,4402343.0,65.6,4357.0,,4003.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,27,,,,host_subject_id:39;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.358Z,2015-03-16T03:17:09.594Z
1397857_3,Mycobacterium tuberculosis TKK_02_0012,Mycobacterium tuberculosis TKK_02_0012,1397857.0,WGS,TKK_02_0012,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218229,SAMN02350412,GCA_000671855.1,JLVY00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48294,,,2.0,2.0,4402242.0,65.6,4353.0,,4004.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,34,,,,host_subject_id:43;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:No;previous mdr-tx:No;previous drug susceptible tb tx:No,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.412Z,2015-03-16T03:17:09.594Z
1397858_3,Mycobacterium tuberculosis TKK_02_0013,Mycobacterium tuberculosis TKK_02_0013,1397858.0,WGS,TKK_02_0013,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218230,SAMN02350413,GCA_000671875.1,JLVX00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48294,,,5.0,5.0,4397610.0,65.6,4341.0,,4000.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,34,,,,host_subject_id:43;treatment course:8w;co-morbidity:HIV Positive;previous tb treatment:No;previous mdr-tx:No;previous drug susceptible tb tx:No,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:NEG;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.421Z,2015-03-16T03:17:09.594Z
1397859_3,Mycobacterium tuberculosis TKK_02_0014,Mycobacterium tuberculosis TKK_02_0014,1397859.0,WGS,TKK_02_0014,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218231,SAMN02350414,GCA_000671895.1,JLVW00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48294,,,6.0,6.0,4404534.0,65.6,4347.0,,4005.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,19,,,,host_subject_id:44;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:1+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.431Z,2015-03-16T03:17:09.594Z
1397860_3,Mycobacterium tuberculosis TKK_02_0015,Mycobacterium tuberculosis TKK_02_0015,1397860.0,WGS,TKK_02_0015,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218232,SAMN02350415,GCA_000671915.1,JLVV00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48294,,,9.0,9.0,4399572.0,65.6,4339.0,,4004.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,19,,,,host_subject_id:44;treatment course:8w;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:NEG;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.440Z,2015-03-16T03:17:09.594Z
1397861_3,Mycobacterium tuberculosis TKK_02_0016,Mycobacterium tuberculosis TKK_02_0016,1397861.0,WGS,TKK_02_0016,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218233,SAMN02350416,GCA_000671935.1,JLVU00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48294,,,7.0,7.0,4399964.0,65.6,4344.0,,4005.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,25,,,,host_subject_id:45;treatment course:adm;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.449Z,2015-03-16T03:17:09.594Z
1397862_3,Mycobacterium tuberculosis TKK_02_0017,Mycobacterium tuberculosis TKK_02_0017,1397862.0,WGS,TKK_02_0017,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218234,SAMN02350417,GCA_000671955.1,JLVT00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48084,,,10.0,10.0,4393953.0,65.6,4332.0,,4002.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,25,,,,host_subject_id:45;treatment course:8w;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:2+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.458Z,2015-03-16T03:17:09.594Z
1397863_3,Mycobacterium tuberculosis TKK_02_0018,Mycobacterium tuberculosis TKK_02_0018,1397863.0,WGS,TKK_02_0018,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218235,SAMN02350418,GCA_000671975.1,JLVS00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48294,,,19.0,20.0,4405771.0,65.6,4340.0,,4018.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,52,,,,host_subject_id:46;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Pre-XDR (Kana S);microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.467Z,2015-03-16T03:17:09.594Z
1397864_3,Mycobacterium tuberculosis TKK_02_0019,Mycobacterium tuberculosis TKK_02_0019,1397864.0,WGS,TKK_02_0019,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218236,SAMN02350419,GCA_000671995.1,JLVR00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48294,,,15.0,15.0,4403346.0,65.6,4346.0,,4018.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,52,,,,host_subject_id:46;treatment course:8w;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:Neg;phenotype:Pre-XDR (Kana S);microscopy ziehl-neelsen:scanty (6);microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.477Z,2015-03-16T03:17:09.594Z
1397865_3,Mycobacterium tuberculosis TKK_02_0020,Mycobacterium tuberculosis TKK_02_0020,1397865.0,WGS,TKK_02_0020,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218237,SAMN02350420,GCA_000672015.1,JLVQ00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48294,,,8.0,8.0,4397300.0,65.6,4334.0,,3995.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,23,,,,host_subject_id:48;treatment course:adm;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:NG;phenotype:Pre-XDR Oflox S;microscopy ziehl-neelsen:scanty;microscopy auramine:scanty;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.487Z,2015-03-16T03:17:09.594Z
1397866_3,Mycobacterium tuberculosis TKK_02_0021,Mycobacterium tuberculosis TKK_02_0021,1397866.0,WGS,TKK_02_0021,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218238,SAMN02350421,GCA_000672035.1,JLVP00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48294,,,2.0,2.0,4396398.0,65.6,4338.0,,4001.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,37,,,,host_subject_id:49;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:NG;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.497Z,2015-03-16T03:17:09.594Z
1397867_3,Mycobacterium tuberculosis TKK_02_0022,Mycobacterium tuberculosis TKK_02_0022,1397867.0,WGS,TKK_02_0022,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218239,SAMN02350422,GCA_000672055.1,JLVO00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48294,,,3.0,3.0,4398619.0,65.6,4340.0,,4002.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,37,,,,host_subject_id:49;treatment course:8w;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:N;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.506Z,2015-03-16T03:17:09.594Z
1397868_3,Mycobacterium tuberculosis TKK_02_0025,Mycobacterium tuberculosis TKK_02_0025,1397868.0,WGS,TKK_02_0025,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218240,SAMN02350423,GCA_000672075.1,JLVN00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48294,,,13.0,13.0,4409077.0,65.6,4357.0,,4018.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:52;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Pre-XDR (Kana S);microscopy ziehl-neelsen:1+;microscopy auramine:1+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.534Z,2015-03-16T03:17:09.594Z
1397869_3,Mycobacterium tuberculosis TKK_02_0027,Mycobacterium tuberculosis TKK_02_0027,1397869.0,WGS,TKK_02_0027,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218241,SAMN02350424,GCA_000672095.1,JLVM00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48294,,,12.0,13.0,4392340.0,65.6,4330.0,,3992.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,21,,,,host_subject_id:53;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.553Z,2015-03-16T03:17:09.594Z
1397871_3,Mycobacterium tuberculosis TKK_02_0033,Mycobacterium tuberculosis TKK_02_0033,1397871.0,WGS,TKK_02_0033,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218243,SAMN02350426,GCA_000672115.1,JLVL00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48294,,,6.0,6.0,4397097.0,65.6,4339.0,,4004.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:61;treatment course:3w;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.600Z,2015-03-16T03:17:09.594Z
1397872_3,Mycobacterium tuberculosis TKK_02_0034,Mycobacterium tuberculosis TKK_02_0034,1397872.0,WGS,TKK_02_0034,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218244,SAMN02350427,GCA_000672135.1,JLVK00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48294,,,8.0,9.0,4399982.0,65.6,4362.0,,4009.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:61;treatment course:8w;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:2+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.610Z,2015-03-16T03:17:09.594Z
1397873_3,Mycobacterium tuberculosis TKK_02_0036,Mycobacterium tuberculosis TKK_02_0036,1397873.0,WGS,TKK_02_0036,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218245,SAMN02350428,GCA_000672155.1,JLVJ00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48294,,,20.0,22.0,4393415.0,65.6,4341.0,,3992.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,37,,,,host_subject_id:64;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.632Z,2015-03-16T03:17:09.594Z
1397874_3,Mycobacterium tuberculosis TKK_02_0038,Mycobacterium tuberculosis TKK_02_0038,1397874.0,WGS,TKK_02_0038,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218246,SAMN02350429,GCA_000672175.1,JLVI00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48294,,,5.0,5.0,4400146.0,65.6,4344.0,,4002.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,40,,,,host_subject_id:67;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.652Z,2015-03-16T03:17:09.594Z
1397875_3,Mycobacterium tuberculosis TKK_02_0039,Mycobacterium tuberculosis TKK_02_0039,1397875.0,WGS,TKK_02_0039,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218247,SAMN02350430,GCA_000672195.1,JLVH00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48294,,,7.0,9.0,4395778.0,65.6,4337.0,,4002.0,,sputum,,2010,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,40,,,,host_subject_id:67;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.661Z,2015-03-16T03:17:09.594Z
1397876_3,Mycobacterium tuberculosis TKK_02_0045,Mycobacterium tuberculosis TKK_02_0045,1397876.0,WGS,TKK_02_0045,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218248,SAMN02350431,GCA_000672215.1,JLVG00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48294,,,7.0,7.0,4397500.0,65.6,4336.0,,4000.0,,sputum,,2011,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,56,,,,host_subject_id:75;treatment course:adm;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.716Z,2015-03-16T03:17:09.594Z
1397877_3,Mycobacterium tuberculosis TKK_02_0046,Mycobacterium tuberculosis TKK_02_0046,1397877.0,WGS,TKK_02_0046,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218249,SAMN02350432,GCA_000672235.1,JLVF00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48281,,,20.0,21.0,4403492.0,65.6,4367.0,,4003.0,,sputum,,2011,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:77;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:NG;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.724Z,2015-03-16T03:17:09.594Z
1397878_3,Mycobacterium tuberculosis TKK_02_0052,Mycobacterium tuberculosis TKK_02_0052,1397878.0,WGS,TKK_02_0052,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218250,SAMN02350433,GCA_000672255.1,JLVE00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48281,,,11.0,11.0,4394568.0,65.6,4341.0,,4001.0,,sputum,,2011,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,37,,,,host_subject_id:90;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.774Z,2015-03-16T03:17:09.594Z
1397879_3,Mycobacterium tuberculosis TKK_02_0061,Mycobacterium tuberculosis TKK_02_0061,1397879.0,WGS,TKK_02_0061,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218251,SAMN02350434,GCA_000672275.1,JLVD00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48294,,,13.0,13.0,4407063.0,65.6,4362.0,,4012.0,,sputum,,2012,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,31,,,,host_subject_id:97;treatment course:8w;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.845Z,2015-03-16T03:17:09.594Z
1397880_3,Mycobacterium tuberculosis TKK_02_0062,Mycobacterium tuberculosis TKK_02_0062,1397880.0,WGS,TKK_02_0062,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218252,SAMN02350435,GCA_000672295.1,JLVC00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48084,,,24.0,25.0,4418373.0,65.6,4383.0,,4015.0,,sputum,,2011,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,20,,,,host_subject_id:98;treatment course:adm;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Pre-XDR (Kana S);microscopy ziehl-neelsen:scanty;microscopy auramine:scanty;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.855Z,2015-03-16T03:17:09.594Z
1397881_3,Mycobacterium tuberculosis TKK_02_0063,Mycobacterium tuberculosis TKK_02_0063,1397881.0,WGS,TKK_02_0063,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218253,SAMN02350436,GCA_000672315.1,JLVB00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48294,,,23.0,23.0,4409200.0,65.6,4372.0,,4005.0,,sputum,,2011,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,20,,,,host_subject_id:98;treatment course:8w;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:1+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.865Z,2015-03-16T03:17:09.594Z
1397882_3,Mycobacterium tuberculosis TKK_02_0068,Mycobacterium tuberculosis TKK_02_0068,1397882.0,WGS,TKK_02_0068,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218254,SAMN02350437,GCA_000672335.1,JLVA00000000,-,Broad Institute,WGS,Illumina,73.0x,allpaths v. R48084,,,46.0,47.0,4374958.0,65.6,4354.0,,4005.0,,sputum,,2011,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,34,,,,host_subject_id:104;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Pre-XDR (Oflox S);microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.914Z,2015-03-16T03:17:09.594Z
1397883_3,Mycobacterium tuberculosis TKK_02_0069,Mycobacterium tuberculosis TKK_02_0069,1397883.0,WGS,TKK_02_0069,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218255,SAMN02350438,GCA_000672355.1,JLUZ00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48084,,,16.0,19.0,4411573.0,65.6,4381.0,,4031.0,,sputum,,2011,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,34,,,,host_subject_id:104;treatment course:8w;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Pre-XDR (Oflox S);microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.924Z,2015-03-16T03:17:09.594Z
1397884_3,Mycobacterium tuberculosis TKK_02_0070,Mycobacterium tuberculosis TKK_02_0070,1397884.0,WGS,TKK_02_0070,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218256,SAMN02350439,GCA_000672375.1,JLUY00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48294,,,18.0,18.0,4398969.0,65.6,4358.0,,3993.0,,sputum,,2012,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,34,,,,host_subject_id:104;treatment course:3m;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Pre-XDR (Oflox S);microscopy ziehl-neelsen:1+;microscopy auramine:1+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.934Z,2015-03-16T03:17:09.594Z
1397885_3,Mycobacterium tuberculosis TKK_02_0071,Mycobacterium tuberculosis TKK_02_0071,1397885.0,WGS,TKK_02_0071,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218257,SAMN02350440,GCA_000672395.1,JLUX00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48294,,,5.0,5.0,4396524.0,65.6,4338.0,,4001.0,,sputum,,2011,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,18,,,,host_subject_id:105;treatment course:8w;co-morbidity:HIV Negative;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.945Z,2015-03-16T03:17:09.594Z
1397886_3,Mycobacterium tuberculosis TKK_02_0073,Mycobacterium tuberculosis TKK_02_0073,1397886.0,WGS,TKK_02_0073,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218258,SAMN02350441,GCA_000672415.1,JLUW00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48294,,,33.0,33.0,4410153.0,65.6,4360.0,,4017.0,,sputum,,2011,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,23,,,,host_subject_id:106;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Pre-XDR (Kana S);microscopy ziehl-neelsen:3+;microscopy auramine:3+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.954Z,2015-03-16T03:17:09.594Z
1397887_3,Mycobacterium tuberculosis TKK_02_0077,Mycobacterium tuberculosis TKK_02_0077,1397887.0,WGS,TKK_02_0077,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218259,SAMN02350442,GCA_000672435.1,JLUV00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48294,,,18.0,18.0,4406464.0,65.6,4344.0,,4008.0,,sputum,,2011,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,40,,,,host_subject_id:108;treatment course:8w;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:No;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:None;microscopy auramine:None;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:18.990Z,2015-03-16T03:17:09.594Z
1397888_3,Mycobacterium tuberculosis TKK_02_0067,Mycobacterium tuberculosis TKK_02_0067,1397888.0,WGS,TKK_02_0067,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218260,SAMN02350443,GCA_000672455.1,JLUU00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48294,,,14.0,14.0,4407189.0,65.6,4364.0,,4020.0,,sputum,,2011,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,29,,,,host_subject_id:103;treatment course:adm;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:Yes,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Pre-XDR (Oflox S);microscopy ziehl-neelsen:1+;microscopy auramine:1+;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:18.905Z,2015-03-16T03:17:09.594Z
1397889_3,Mycobacterium tuberculosis TKK_03_0018,Mycobacterium tuberculosis TKK_03_0018,1397889.0,WGS,TKK_03_0018,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218261,SAMN02350444,GCA_000672475.1,JLUT00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48294,,,32.0,35.0,4424775.0,65.6,4374.0,,4032.0,,sputum,,2012,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,30,,,,host_subject_id:007-04-0018;treatment course:enrollment;co-morbidity:HIV Positive;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:19.039Z,2015-03-16T03:17:09.594Z
1397890_3,Mycobacterium tuberculosis TKK_03_0020,Mycobacterium tuberculosis TKK_03_0020,1397890.0,WGS,TKK_03_0020,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218262,SAMN02350445,GCA_000672495.1,JLUS00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48294,,,15.0,15.0,4409614.0,65.6,4377.0,,4025.0,,sputum,,2012,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,25,,,,host_subject_id:007-04-0020;treatment course:enrollment;co-morbidity:HIV Positive;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.049Z,2015-03-16T03:17:09.594Z
1397891_3,Mycobacterium tuberculosis TKK_03_0022,Mycobacterium tuberculosis TKK_03_0022,1397891.0,WGS,TKK_03_0022,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218263,SAMN02350446,GCA_000672515.1,JLUR00000000,-,Broad Institute,WGS,Illumina,28.0x,allpaths v. R48281,,,114.0,119.0,4307708.0,65.4,4336.0,,3977.0,,sputum,,2013,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,21,,,,host_subject_id:007-04-0022;treatment course:enrollment;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.069Z,2015-03-16T03:17:09.594Z
1397892_3,Mycobacterium tuberculosis TKK_03_0025,Mycobacterium tuberculosis TKK_03_0025,1397892.0,WGS,TKK_03_0025,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218264,SAMN02350447,GCA_000672535.1,JLUQ00000000,-,Broad Institute,WGS,Illumina,48.0x,allpaths v. R48084,,,59.0,68.0,4339658.0,65.4,4359.0,,3990.0,,sputum,,2013,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,23,,,,host_subject_id:007-04-0025;treatment course:enrollment;co-morbidity:HIV Positive;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.097Z,2015-03-16T03:17:09.594Z
1397893_3,Mycobacterium tuberculosis TKK_03_0026,Mycobacterium tuberculosis TKK_03_0026,1397893.0,WGS,TKK_03_0026,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218265,SAMN02350448,GCA_000672555.1,JLUP00000000,-,Broad Institute,WGS,Illumina,116.0x,allpaths v. R48294,,,15.0,15.0,4418062.0,65.6,4382.0,,4016.0,,sputum,,2013,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,28,,,,host_subject_id:007-04-0026;treatment course:enrollment;co-morbidity:HIV Positive;previous tb treatment:Yes;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:scanty;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.106Z,2015-03-16T03:17:09.594Z
1397894_3,Mycobacterium tuberculosis TKK_03_0027,Mycobacterium tuberculosis TKK_03_0027,1397894.0,WGS,TKK_03_0027,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218266,SAMN02350449,GCA_000672575.1,JLUO00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48294,,,15.0,15.0,4392552.0,65.6,4363.0,,3987.0,,sputum,,2013,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,28,,,,host_subject_id:007-04-0027;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.115Z,2015-03-16T03:17:09.594Z
1397895_3,Mycobacterium tuberculosis TKK_03_0029,Mycobacterium tuberculosis TKK_03_0029,1397895.0,WGS,TKK_03_0029,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218267,SAMN02350450,GCA_000672595.1,JLUN00000000,-,Broad Institute,WGS,Illumina,66.0x,allpaths v. R48084,,,30.0,35.0,4396245.0,65.5,4363.0,,3998.0,,sputum,,2013,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,50,,,,host_subject_id:007-04-0029;treatment course:enrollment;co-morbidity:HIV Negative;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.132Z,2015-03-16T03:17:09.594Z
1397896_3,Mycobacterium tuberculosis TKK_03_0030,Mycobacterium tuberculosis TKK_03_0030,1397896.0,WGS,TKK_03_0030,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218268,SAMN02350451,GCA_000672615.1,JLUM00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48294,,,14.0,14.0,4417970.0,65.6,4360.0,,4001.0,,sputum,,2013,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,24,,,,host_subject_id:007-04-0030;treatment course:enrollment;co-morbidity:HIV Negative;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.141Z,2015-03-16T03:17:09.594Z
1397897_3,Mycobacterium tuberculosis TKK_03_0031,Mycobacterium tuberculosis TKK_03_0031,1397897.0,WGS,TKK_03_0031,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218269,SAMN02350452,GCA_000672635.1,JLUL00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48294,,,15.0,15.0,4403090.0,65.6,4347.0,,3994.0,,sputum,,2013,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,33,,,,host_subject_id:007-04-0031;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.150Z,2015-03-16T03:17:09.594Z
1397899_3,Mycobacterium tuberculosis TKK_03_0033,Mycobacterium tuberculosis TKK_03_0033,1397899.0,WGS,TKK_03_0033,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218271,SAMN02350454,GCA_000672655.1,JLUK00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48294,,,13.0,14.0,4410852.0,65.6,4387.0,,4014.0,,sputum,,2013,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,24,,,,host_subject_id:007-04-0033;treatment course:enrollment;co-morbidity:HIV Negative;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.159Z,2015-03-16T03:17:09.594Z
1397900_3,Mycobacterium tuberculosis TKK_03_0034,Mycobacterium tuberculosis TKK_03_0034,1397900.0,WGS,TKK_03_0034,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218272,SAMN02350455,GCA_000672675.1,JLUJ00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48281,,,17.0,17.0,4402150.0,65.6,4352.0,,3999.0,,sputum,,2013,South Africa,South Africa,,,,,,"Human, Homo sapiens",Male,27,,,,host_subject_id:007-04-0034;treatment course:enrollment;co-morbidity:HIV Negative;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:scanty;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.168Z,2015-03-16T03:17:09.594Z
1397901_3,Mycobacterium tuberculosis TKK_03_0036,Mycobacterium tuberculosis TKK_03_0036,1397901.0,WGS,TKK_03_0036,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218273,SAMN02350456,GCA_000672695.1,JLUI00000000,-,Broad Institute,WGS,Illumina,46.0x,allpaths v. R48294,,,38.0,39.0,4395024.0,65.6,4365.0,,4006.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,20,,,,host_subject_id:007-04-0036;treatment course:enrollment;co-morbidity:HIV Positive;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.187Z,2015-03-16T03:17:09.594Z
1397902_3,Mycobacterium tuberculosis TKK_03_0043,Mycobacterium tuberculosis TKK_03_0043,1397902.0,WGS,TKK_03_0043,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218274,SAMN02350457,GCA_000672715.1,JLUH00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48294,,,16.0,16.0,4392650.0,65.6,4361.0,,3991.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,40,,,,host_subject_id:007-04-0043;treatment course:enrollment;co-morbidity:HIV Positive;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.246Z,2015-03-16T03:17:09.594Z
1397903_3,Mycobacterium tuberculosis TKK_03_0045,Mycobacterium tuberculosis TKK_03_0045,1397903.0,WGS,TKK_03_0045,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218275,SAMN02350458,GCA_000672735.1,JLUG00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48294,,,18.0,18.0,4396369.0,65.6,4375.0,,3994.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,48,,,,host_subject_id:007-04-0045;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.266Z,2015-03-16T03:17:09.594Z
1397904_3,Mycobacterium tuberculosis TKK_03_0078,Mycobacterium tuberculosis TKK_03_0078,1397904.0,WGS,TKK_03_0078,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218276,SAMN02350459,GCA_000672755.1,JLUF00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48281,,,14.0,14.0,4395640.0,65.6,4350.0,,3993.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,23,,,,host_subject_id:007-04-0078;treatment course:enrollment;co-morbidity:HIV Negative;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.368Z,2015-03-16T03:17:09.594Z
1397905_3,Mycobacterium tuberculosis TKK_03_0081,Mycobacterium tuberculosis TKK_03_0081,1397905.0,WGS,TKK_03_0081,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218277,SAMN02350460,GCA_000672775.1,JLUE00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48294,,,9.0,9.0,4400490.0,65.6,4332.0,,4006.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,29,,,,host_subject_id:007-04-0081;treatment course:enrollment;co-morbidity:HIV Positive;previous tb treatment:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.377Z,2015-03-16T03:17:09.594Z
1397906_3,Mycobacterium tuberculosis TKK_03_0082,Mycobacterium tuberculosis TKK_03_0082,1397906.0,WGS,TKK_03_0082,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218278,SAMN02350461,GCA_000672795.1,JLUD00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48294,,,15.0,15.0,4401349.0,65.6,4359.0,,4006.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,40,,,,host_subject_id:007-04-0082;treatment course:enrollment;co-morbidity:HIV Positive;previous tb treatment:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:ND;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:19.387Z,2015-03-16T03:17:09.594Z
1397907_3,Mycobacterium tuberculosis TKK_04_0001,Mycobacterium tuberculosis TKK_04_0001,1397907.0,WGS,TKK_04_0001,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218279,SAMN02350462,GCA_000672815.1,JLUC00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48294,,,14.0,14.0,4399148.0,65.6,4369.0,,3997.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,35,,,,host_subject_id:NL_001;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;lineage:Not tested,2014-12-08T22:12:19.678Z,2015-03-16T03:17:09.594Z
1397908_3,Mycobacterium tuberculosis TKK_04_0002,Mycobacterium tuberculosis TKK_04_0002,1397908.0,WGS,TKK_04_0002,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218280,SAMN02350463,GCA_000672835.1,JLUB00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48281,,,20.0,21.0,4387192.0,65.6,4336.0,,4001.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,47,,,,host_subject_id:NL_002;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;lineage:Not tested,2014-12-08T22:12:19.687Z,2015-03-16T03:17:09.594Z
1397909_3,Mycobacterium tuberculosis TKK_04_0003,Mycobacterium tuberculosis TKK_04_0003,1397909.0,WGS,TKK_04_0003,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218281,SAMN02350464,GCA_000672855.1,JLUA00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48294,,,22.0,24.0,4412656.0,65.6,4367.0,,3984.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,28,,,,host_subject_id:NL_003;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;lineage:Not tested,2014-12-08T22:12:19.696Z,2015-03-16T03:17:09.594Z
1397910_3,Mycobacterium tuberculosis TKK_04_0006,Mycobacterium tuberculosis TKK_04_0006,1397910.0,WGS,TKK_04_0006,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218282,SAMN02350465,GCA_000672875.1,JLTZ00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48294,,,19.0,19.0,4400374.0,65.6,4359.0,,3996.0,,sputum,,2013,South Africa,South Africa: Amatikulu,,,,,,"Human, Homo sapiens",Female,18,,,,host_subject_id:NL_006;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;lineage:Not tested,2014-12-08T22:12:19.716Z,2015-03-16T03:17:09.594Z
1397911_3,Mycobacterium tuberculosis TKK_04_0014,Mycobacterium tuberculosis TKK_04_0014,1397911.0,WGS,TKK_04_0014,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218283,SAMN02350466,GCA_000672895.1,JLTY00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48281,,,20.0,21.0,4402346.0,65.6,4367.0,,4001.0,,sputum,,2013,,,,,,,,"Human, Homo sapiens",Male,21,,,,host_subject_id:NL_014;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:19.753Z,2015-03-16T03:17:09.594Z
1397912_3,Mycobacterium tuberculosis TKK_04_0015,Mycobacterium tuberculosis TKK_04_0015,1397912.0,WGS,TKK_04_0015,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218284,SAMN02350467,GCA_000672915.1,JLTX00000000,-,Broad Institute,WGS,Illumina,116.0x,allpaths v. R48294,,,16.0,17.0,4408666.0,65.6,4362.0,,4013.0,,sputum,,2013,Kenya,Kenya: Kericho,,,,,,"Human, Homo sapiens",Male,34,,,,host_subject_id:NL_015;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:scanty;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.762Z,2015-03-16T03:17:09.594Z
1397913_3,Mycobacterium tuberculosis TKK_04_0017,Mycobacterium tuberculosis TKK_04_0017,1397913.0,WGS,TKK_04_0017,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218285,SAMN02350468,GCA_000672935.1,JLTW00000000,-,Broad Institute,WGS,Illumina,117.0x,allpaths v. R48294,,,18.0,18.0,4397612.0,65.6,4348.0,,3995.0,,sputum,,2013,South Africa,,,,,,,"Human, Homo sapiens",Female,30,,,,host_subject_id:NL_017;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.771Z,2015-03-16T03:17:09.594Z
1397914_3,Mycobacterium tuberculosis TKK_04_0018,Mycobacterium tuberculosis TKK_04_0018,1397914.0,WGS,TKK_04_0018,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218286,SAMN02350469,GCA_000672955.1,JLTV00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48294,,,20.0,20.0,4350164.0,65.6,4017.0,,3715.0,,sputum,,2013,Kenya,Kenya: Kericho,,,,,,"Human, Homo sapiens",Female,33,,,,host_subject_id:NL_018;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.780Z,2015-03-16T03:17:09.594Z
1397915_3,Mycobacterium tuberculosis TKK_04_0019,Mycobacterium tuberculosis TKK_04_0019,1397915.0,WGS,TKK_04_0019,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218287,SAMN02350470,GCA_000672975.1,JLTU00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48275,,,19.0,20.0,4383573.0,65.6,4336.0,,3979.0,,sputum,,2013,South Africa,,,,,,,"Human, Homo sapiens",Female,50,,,,host_subject_id:NL_019;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.789Z,2015-03-16T03:17:09.594Z
1397916_3,Mycobacterium tuberculosis TKK_04_0021,Mycobacterium tuberculosis TKK_04_0021,1397916.0,WGS,TKK_04_0021,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218288,SAMN02350471,GCA_000672995.1,JLTT00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48281,,,18.0,18.0,4405662.0,65.6,4368.0,,4021.0,,pleura,,2013,South Africa,,,,,,,"Human, Homo sapiens",Male,40,,,,host_subject_id:NL_021;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.808Z,2015-03-16T03:17:09.594Z
1397917_3,Mycobacterium tuberculosis TKK_04_0022,Mycobacterium tuberculosis TKK_04_0022,1397917.0,WGS,TKK_04_0022,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218289,SAMN02350472,GCA_000673015.1,JLTS00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48294,,,11.0,11.0,4394573.0,65.6,4323.0,,3990.0,,sputum,,2013,South Africa,South Africa: Pietermaritzburg,,,,,,"Human, Homo sapiens",Male,39,,,,host_subject_id:NL_022;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.817Z,2015-03-16T03:17:09.594Z
1397918_3,Mycobacterium tuberculosis TKK_04_0023,Mycobacterium tuberculosis TKK_04_0023,1397918.0,WGS,TKK_04_0023,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218290,SAMN02350473,GCA_000673035.1,JLTR00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48294,,,20.0,21.0,4384850.0,65.6,4333.0,,3979.0,,sputum,,2013,South Africa,,,,,,,"Human, Homo sapiens",Male,19,,,,host_subject_id:NL_023;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.826Z,2015-03-16T03:17:09.594Z
1397919_3,Mycobacterium tuberculosis TKK_04_0024,Mycobacterium tuberculosis TKK_04_0024,1397919.0,WGS,TKK_04_0024,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218291,SAMN02350474,GCA_000673055.1,JLTQ00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48294,,,12.0,13.0,4389255.0,65.6,4338.0,,4003.0,,sputum,,2013,Kenya,Kenya: Kericho,,,,,,"Human, Homo sapiens",Male,33,,,,host_subject_id:NL_024;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.835Z,2015-03-16T03:17:09.594Z
1397920_3,Mycobacterium tuberculosis TKK_04_0043,Mycobacterium tuberculosis TKK_04_0043,1397920.0,WGS,TKK_04_0043,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218292,SAMN02350475,GCA_000673075.1,JLTP00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48294,,,4.0,4.0,4398372.0,65.6,4336.0,,4001.0,,Sputum,,2013,India,India: Warangal,,,,,,"Human, Homo sapiens",Female,35,,,,host_subject_id:NL_043;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (Oflox susceptible);microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.949Z,2015-03-16T03:17:09.594Z
1397921_3,Mycobacterium tuberculosis TKK_04_0047,Mycobacterium tuberculosis TKK_04_0047,1397921.0,WGS,TKK_04_0047,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218293,SAMN02350476,GCA_000673095.1,JLTO00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48281,,,16.0,16.0,4412051.0,65.6,4347.0,,4015.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,unknown,,,,host_subject_id:NL_047;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.985Z,2015-03-16T03:17:09.594Z
1397922_3,Mycobacterium tuberculosis TKK_04_0048,Mycobacterium tuberculosis TKK_04_0048,1397922.0,WGS,TKK_04_0048,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218294,SAMN02350477,GCA_000673115.1,JLTN00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48294,,,6.0,6.0,4397502.0,65.6,4331.0,,4000.0,,sputum,,2013,India,India: Warangal,,,,,,"Human, Homo sapiens",Female,31,,,,host_subject_id:NL_048;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (Oflox susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.995Z,2015-03-16T03:17:09.594Z
1397923_3,Mycobacterium tuberculosis TKK_04_0005,Mycobacterium tuberculosis TKK_04_0005,1397923.0,WGS,TKK_04_0005,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218295,SAMN02350478,GCA_000673135.1,JLTM00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48294,,,26.0,31.0,4417825.0,65.6,4372.0,,3993.0,,sputum,,2013,India,India: Warangal,,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:NL_005;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.706Z,2015-03-16T03:17:09.594Z
1397924_3,Mycobacterium tuberculosis TKK_04_0007,Mycobacterium tuberculosis TKK_04_0007,1397924.0,WGS,TKK_04_0007,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218296,SAMN02350479,GCA_000673155.1,JLTL00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48294,,,17.0,17.0,4399809.0,65.6,4350.0,,4010.0,,sputum,,2013,Kenya,Kenya: Kericho,,,,,,"Human, Homo sapiens",Female,unknown,,,,host_subject_id:NL_007;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN susceptible);microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested,2014-12-08T22:12:19.725Z,2015-03-16T03:17:09.594Z
1397925_3,Mycobacterium tuberculosis TKK_04_0008,Mycobacterium tuberculosis TKK_04_0008,1397925.0,WGS,TKK_04_0008,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218297,SAMN02350480,GCA_000673175.1,JLTK00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48294,,,15.0,15.0,4403287.0,65.6,4356.0,,4020.0,,sputum,,2013,South Africa,,,,,,,"Human, Homo sapiens",Female,unknown,,,,host_subject_id:NL_008;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN susceptible);microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.734Z,2015-03-16T03:17:09.594Z
1397926_3,Mycobacterium tuberculosis TKK_04_0013,Mycobacterium tuberculosis TKK_04_0013,1397926.0,WGS,TKK_04_0013,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218298,SAMN02350481,GCA_000673195.1,JLTJ00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48294,,,10.0,10.0,4402500.0,65.6,4346.0,,4005.0,,sputum,,2013,South Africa,South Africa: Kwangwanase,,,,,,"Human, Homo sapiens",Female,28,,,,host_subject_id:NL_013;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.744Z,2015-03-16T03:17:09.594Z
1397927_3,Mycobacterium tuberculosis TKK_04_0020,Mycobacterium tuberculosis TKK_04_0020,1397927.0,WGS,TKK_04_0020,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218299,SAMN02350482,GCA_000673215.1,JLTI00000000,-,Broad Institute,WGS,Illumina,117.0x,allpaths v. R48281,,,14.0,15.0,4425117.0,65.6,4352.0,,3986.0,,sputum,,2013,South Africa,,,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:NL_020;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN susceptible);microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.798Z,2015-03-16T03:17:09.594Z
1397928_3,Mycobacterium tuberculosis TKK_04_0034,Mycobacterium tuberculosis TKK_04_0034,1397928.0,WGS,TKK_04_0034,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218300,SAMN02350483,GCA_000673235.1,JLTH00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48294,,,7.0,7.0,4394979.0,65.6,4336.0,,3990.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,unknown,,,,host_subject_id:NL_034;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.881Z,2015-03-16T03:17:09.594Z
1397929_3,Mycobacterium tuberculosis TKK_04_0036,Mycobacterium tuberculosis TKK_04_0036,1397929.0,WGS,TKK_04_0036,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218301,SAMN02350484,GCA_000673255.1,JLTG00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48294,,,17.0,18.0,4405483.0,65.6,4375.0,,4020.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,40,,,,host_subject_id:NL_036;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.891Z,2015-03-16T03:17:09.594Z
1397930_3,Mycobacterium tuberculosis TKK_04_0038,Mycobacterium tuberculosis TKK_04_0038,1397930.0,WGS,TKK_04_0038,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218302,SAMN02350485,GCA_000673275.1,JLTF00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48294,,,8.0,8.0,4399560.0,65.6,4346.0,,4004.0,,sputum,,2013,Kenya,Kenya: Kericho,,,,,,"Human, Homo sapiens",Male,17,,,,host_subject_id:NL_038;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN susceptible);microscopy ziehl-neelsen:scanty;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested,2014-12-08T22:12:19.911Z,2015-03-16T03:17:09.594Z
1397931_3,Mycobacterium tuberculosis TKK_04_0039,Mycobacterium tuberculosis TKK_04_0039,1397931.0,WGS,TKK_04_0039,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218303,SAMN02350486,GCA_000673295.1,JLTE00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48294,,,6.0,7.0,4396400.0,65.6,4339.0,,4000.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,33,,,,host_subject_id:NL_039;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.920Z,2015-03-16T03:17:09.594Z
1397932_3,Mycobacterium tuberculosis TKK_04_0040,Mycobacterium tuberculosis TKK_04_0040,1397932.0,WGS,TKK_04_0040,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218304,SAMN02350487,GCA_000673315.1,JLTD00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48294,,,14.0,14.0,4410341.0,65.6,4349.0,,3999.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,19,,,,host_subject_id:NL_040;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.929Z,2015-03-16T03:17:09.594Z
1397933_3,Mycobacterium tuberculosis TKK_04_0044,Mycobacterium tuberculosis TKK_04_0044,1397933.0,WGS,TKK_04_0044,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218305,SAMN02350488,GCA_000673335.1,JLTC00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48294,,,15.0,18.0,4401326.0,65.6,4348.0,,4008.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,16,,,,host_subject_id:NL_044;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.958Z,2015-03-16T03:17:09.594Z
1397934_3,Mycobacterium tuberculosis TKK_04_0045,Mycobacterium tuberculosis TKK_04_0045,1397934.0,WGS,TKK_04_0045,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218306,SAMN02350489,GCA_000673355.1,JLTB00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48294,,,14.0,14.0,4402853.0,65.6,4374.0,,4017.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,35,,,,host_subject_id:NL_045;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.967Z,2015-03-16T03:17:09.594Z
1397935_3,Mycobacterium tuberculosis TKK_04_0046,Mycobacterium tuberculosis TKK_04_0046,1397935.0,WGS,TKK_04_0046,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218307,SAMN02350490,GCA_000673375.1,JLTA00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48294,,,8.0,8.0,4395787.0,65.6,4352.0,,4002.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,22,,,,host_subject_id:NL_046;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.976Z,2015-03-16T03:17:09.594Z
1397936_3,Mycobacterium tuberculosis TKK_04_0042,Mycobacterium tuberculosis TKK_04_0042,1397936.0,WGS,TKK_04_0042,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218308,SAMN02350491,GCA_000673395.1,JLSZ00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48294,,,16.0,16.0,4404058.0,65.6,4356.0,,4016.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,41,,,,host_subject_id:NL_042;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.939Z,2015-03-16T03:17:09.594Z
1397937_3,Mycobacterium tuberculosis TKK_04_0037,Mycobacterium tuberculosis TKK_04_0037,1397937.0,WGS,TKK_04_0037,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218309,SAMN02350492,GCA_000673415.1,JLSY00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48294,,,13.0,13.0,4392732.0,65.6,4340.0,,4002.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,37,,,,host_subject_id:NL_037;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.901Z,2015-03-16T03:17:09.594Z
1397938_3,Mycobacterium tuberculosis TKK_04_0029,Mycobacterium tuberculosis TKK_04_0029,1397938.0,WGS,TKK_04_0029,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218310,SAMN02350493,GCA_000673435.1,JLSX00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48281,,,25.0,25.0,4416251.0,65.6,4372.0,,4022.0,,pleural fluid,,2013,India,India: Warangal,,,,,,"Human, Homo sapiens",Female,50,,,,host_subject_id:NL_029;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.844Z,2015-03-16T03:17:09.594Z
1397939_3,Mycobacterium tuberculosis TKK_04_0030,Mycobacterium tuberculosis TKK_04_0030,1397939.0,WGS,TKK_04_0030,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218311,SAMN02350494,GCA_000673455.1,JLSW00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48294,,,11.0,11.0,4398780.0,65.6,4351.0,,4015.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,53,,,,host_subject_id:NL_030;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.853Z,2015-03-16T03:17:09.594Z
1397940_3,Mycobacterium tuberculosis TKK_04_0031,Mycobacterium tuberculosis TKK_04_0031,1397940.0,WGS,TKK_04_0031,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218312,SAMN02350495,GCA_000673475.1,JLSV00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48294,,,22.0,22.0,4418196.0,65.6,4355.0,,4024.0,,Blood cx,,2013,India,India: Warangal,,,,,,"Human, Homo sapiens",Female,unknown,,,,host_subject_id:NL_031;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.863Z,2015-03-16T03:17:09.594Z
1397941_3,Mycobacterium tuberculosis TKK_04_0033,Mycobacterium tuberculosis TKK_04_0033,1397941.0,WGS,TKK_04_0033,,,,,,,,2014-04-30T00:00:00Z,,PRJNA218313,SAMN02350496,GCA_000673495.1,JLSU00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48294,,,17.0,18.0,4388109.0,65.6,4349.0,,3995.0,,Blood cx,,2013,India,India: Warangal,,,,,,"Human, Homo sapiens",Male,34,,,,host_subject_id:NL_033;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:ND;lineage:Not tested,2014-12-08T22:12:19.872Z,2015-03-16T03:17:09.594Z
1400870_3,Mycobacterium tuberculosis KT-0001,Mycobacterium tuberculosis KT-0001,1400870.0,WGS,KT-0001,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219753,SAMN02360548,GCA_000673515.1,JLSO00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R47903,,,25.0,26.0,4385988.0,65.6,4366.0,,3987.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.415Z,2015-03-16T03:17:09.594Z
1400871_3,Mycobacterium tuberculosis KT-0002,Mycobacterium tuberculosis KT-0002,1400871.0,WGS,KT-0002,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219754,SAMN02360549,GCA_000673535.1,JLSN00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47910,,,33.0,34.0,4381914.0,65.6,4352.0,,3986.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.427Z,2015-03-16T03:17:09.594Z
1400872_3,Mycobacterium tuberculosis KT-0003,Mycobacterium tuberculosis KT-0003,1400872.0,WGS,KT-0003,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219755,SAMN02360550,GCA_000673555.1,JLSM00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47903,,,24.0,25.0,4383183.0,65.6,4348.0,,3983.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.436Z,2015-03-16T03:17:09.594Z
1400873_3,Mycobacterium tuberculosis KT-0006,Mycobacterium tuberculosis KT-0006,1400873.0,WGS,KT-0006,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219756,SAMN02360551,GCA_000673575.1,JLSL00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47910,,,18.0,18.0,4387033.0,65.6,4337.0,,3973.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.454Z,2015-03-16T03:17:09.594Z
1400874_3,Mycobacterium tuberculosis KT-0007,Mycobacterium tuberculosis KT-0007,1400874.0,WGS,KT-0007,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219757,SAMN02360552,GCA_000673595.1,JLSK00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47910,,,28.0,29.0,4382096.0,65.6,4336.0,,3974.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.463Z,2015-03-16T03:17:09.594Z
1400875_3,Mycobacterium tuberculosis KT-0008,Mycobacterium tuberculosis KT-0008,1400875.0,WGS,KT-0008,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219758,SAMN02360553,GCA_000673615.1,JLSJ00000000,-,Broad Institute,WGS,Illumina,139.0x,allpaths v. R47910,,,23.0,24.0,4396330.0,65.6,4360.0,,3994.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.472Z,2015-03-16T03:17:09.594Z
1400877_3,Mycobacterium tuberculosis KT-0011,Mycobacterium tuberculosis KT-0011,1400877.0,WGS,KT-0011,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219760,SAMN02360555,GCA_000673635.1,JLSI00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R47910,,,18.0,19.0,4387808.0,65.6,4356.0,,3987.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.489Z,2015-03-16T03:17:09.594Z
1400879_3,Mycobacterium tuberculosis KT-0014,Mycobacterium tuberculosis KT-0014,1400879.0,WGS,KT-0014,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219762,SAMN02360557,GCA_000673655.1,JLSH00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47910,,,27.0,29.0,4392733.0,65.6,4344.0,,3994.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.507Z,2015-03-16T03:17:09.594Z
1400880_3,Mycobacterium tuberculosis KT-0015,Mycobacterium tuberculosis KT-0015,1400880.0,WGS,KT-0015,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219763,SAMN02360558,GCA_000673675.1,JLSG00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47910,,,26.0,29.0,4385844.0,65.6,4343.0,,3985.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.516Z,2015-03-16T03:17:09.594Z
1400881_3,Mycobacterium tuberculosis KT-0016,Mycobacterium tuberculosis KT-0016,1400881.0,WGS,KT-0016,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219764,SAMN02360559,GCA_000673695.1,JLSF00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R47910,,,26.0,27.0,4373085.0,65.6,4332.0,,3971.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.524Z,2015-03-16T03:17:09.594Z
1400882_3,Mycobacterium tuberculosis KT-0017,Mycobacterium tuberculosis KT-0017,1400882.0,WGS,KT-0017,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219765,SAMN02360560,GCA_000673715.1,JLSE00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47910,,,25.0,26.0,4364686.0,65.6,4332.0,,3964.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.532Z,2015-03-16T03:17:09.594Z
1400883_3,Mycobacterium tuberculosis KT-0019,Mycobacterium tuberculosis KT-0019,1400883.0,WGS,KT-0019,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219766,SAMN02360561,GCA_000673735.1,JLSD00000000,-,Broad Institute,WGS,Illumina,135.0x,allpaths v. R47910,,,30.0,31.0,4378161.0,65.6,4328.0,,3971.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.550Z,2015-03-16T03:17:09.594Z
1400884_3,Mycobacterium tuberculosis KT-0022,Mycobacterium tuberculosis KT-0022,1400884.0,WGS,KT-0022,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219767,SAMN02360562,GCA_000673755.1,JLSC00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R47910,,,19.0,20.0,4411836.0,65.6,4350.0,,4019.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.567Z,2015-03-16T03:17:09.594Z
1400885_3,Mycobacterium tuberculosis KT-0023,,1400885.0,WGS,KT-0023,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA219768,SAMN02360563,GCA_000706525.1,JLSB00000000,-,Broad Institute,,Illumina,69.0x,allpaths v. R47903,,,5.0,30.0,4414650.0,65.6,4275.0,,3972.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:41:43.288Z,2015-03-16T03:17:09.594Z
1400886_3,Mycobacterium tuberculosis KT-0024,Mycobacterium tuberculosis KT-0024,1400886.0,WGS,KT-0024,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219769,SAMN02360564,GCA_000673775.1,JLSA00000000,-,Broad Institute,WGS,Illumina,32.0x,allpaths v. R47903,,,81.0,86.0,4341648.0,65.5,4330.0,,3969.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.575Z,2015-03-16T03:17:09.594Z
1400887_3,Mycobacterium tuberculosis KT-0026,Mycobacterium tuberculosis KT-0026,1400887.0,WGS,KT-0026,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219770,SAMN02360565,GCA_000673795.1,JLRZ00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47910,,,11.0,11.0,4385326.0,65.6,4352.0,,3986.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.597Z,2015-03-16T03:17:09.594Z
1400888_3,Mycobacterium tuberculosis KT-0027,Mycobacterium tuberculosis KT-0027,1400888.0,WGS,KT-0027,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219771,SAMN02360566,GCA_000673815.1,JLRY00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47910,,,34.0,34.0,4383499.0,65.6,4325.0,,3970.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.608Z,2015-03-16T03:17:09.594Z
1400889_3,Mycobacterium tuberculosis KT-0028,Mycobacterium tuberculosis KT-0028,1400889.0,WGS,KT-0028,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219772,SAMN02360567,GCA_000673835.1,JLRX00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R47903,,,22.0,23.0,4383778.0,65.6,4337.0,,4000.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.617Z,2015-03-16T03:17:09.594Z
1400891_3,Mycobacterium tuberculosis KT-0035,Mycobacterium tuberculosis KT-0035,1400891.0,WGS,KT-0035,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219774,SAMN02360569,GCA_000673855.1,JLRW00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47903,,,25.0,27.0,4393384.0,65.6,4360.0,,3994.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.676Z,2015-03-16T03:17:09.594Z
1400893_3,Mycobacterium tuberculosis KT-0039,Mycobacterium tuberculosis KT-0039,1400893.0,WGS,KT-0039,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219776,SAMN02360571,GCA_000673875.1,JLRV00000000,-,Broad Institute,WGS,Illumina,26.0x,allpaths v. R47903,,,83.0,87.0,4356785.0,65.5,4348.0,,3987.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.696Z,2015-03-16T03:17:09.594Z
1400894_3,Mycobacterium tuberculosis KT-0041,Mycobacterium tuberculosis KT-0041,1400894.0,WGS,KT-0041,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219777,SAMN02360572,GCA_000673895.1,JLRU00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R47903,,,32.0,32.0,4381065.0,65.6,4345.0,,3983.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.713Z,2015-03-16T03:17:09.594Z
1400895_3,Mycobacterium tuberculosis KT-0043,Mycobacterium tuberculosis KT-0043,1400895.0,WGS,KT-0043,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219778,SAMN02360573,GCA_000673915.1,JLRT00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47910,,,37.0,40.0,4379961.0,65.6,4338.0,,3979.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.732Z,2015-03-16T03:17:09.594Z
1400897_3,Mycobacterium tuberculosis KT-0045,,1400897.0,WGS,KT-0045,,,,,,,,2014-06-13T00:00:00Z,-,PRJNA219780,SAMN02360575,GCA_000706785.1,JLRS00000000,-,Broad Institute,,Illumina,135.0x,allpaths v. R47903,,,5.0,29.0,4422410.0,65.6,4314.0,,3995.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:41:43.871Z,2015-03-16T03:17:09.594Z
1400898_3,Mycobacterium tuberculosis KT-0047,Mycobacterium tuberculosis KT-0047,1400898.0,WGS,KT-0047,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219781,SAMN02360576,GCA_000673935.1,JLRR00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47903,,,20.0,22.0,4394201.0,65.6,4353.0,,3989.0,,Bodily fluid,,2008,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.741Z,2015-03-16T03:17:09.594Z
1400899_3,Mycobacterium tuberculosis KT-0048,Mycobacterium tuberculosis KT-0048,1400899.0,WGS,KT-0048,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219782,SAMN02360577,GCA_000673955.1,JLRQ00000000,-,Broad Institute,WGS,Illumina,49.0x,allpaths v. R47903,,,58.0,63.0,4364921.0,65.6,4338.0,,3998.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.750Z,2015-03-16T03:17:09.594Z
1400902_3,Mycobacterium tuberculosis KT-0051,Mycobacterium tuberculosis KT-0051,1400902.0,WGS,KT-0051,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219785,SAMN02360580,GCA_000673975.1,JLRP00000000,-,Broad Institute,WGS,Illumina,69.0x,allpaths v. R47903,,,38.0,43.0,4385161.0,65.6,4366.0,,3993.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.760Z,2015-03-16T03:17:09.594Z
1400904_3,Mycobacterium tuberculosis KT-0053,Mycobacterium tuberculosis KT-0053,1400904.0,WGS,KT-0053,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219787,SAMN02360582,GCA_000673995.1,JLRO00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R47910,,,21.0,23.0,4378882.0,65.6,4329.0,,3980.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.769Z,2015-03-16T03:17:09.594Z
1400907_3,Mycobacterium tuberculosis KT-0056,Mycobacterium tuberculosis KT-0056,1400907.0,WGS,KT-0056,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219790,SAMN02360585,GCA_000674015.1,JLRN00000000,-,Broad Institute,WGS,Illumina,56.0x,allpaths v. R47903,,,56.0,59.0,4379108.0,65.5,4360.0,,4016.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.778Z,2015-03-16T03:17:09.594Z
1400908_3,Mycobacterium tuberculosis KT-0057,Mycobacterium tuberculosis KT-0057,1400908.0,WGS,KT-0057,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219791,SAMN02360586,GCA_000674035.1,JLRM00000000,-,Broad Institute,WGS,Illumina,60.0x,allpaths v. R47903,,,67.0,74.0,4367464.0,65.5,4384.0,,4002.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.787Z,2015-03-16T03:17:09.594Z
1400909_3,Mycobacterium tuberculosis KT-0058,Mycobacterium tuberculosis KT-0058,1400909.0,WGS,KT-0058,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219792,SAMN02360587,GCA_000674055.1,JLRL00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R47910,,,25.0,26.0,4372461.0,65.6,4330.0,,3972.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.796Z,2015-03-16T03:17:09.594Z
1400911_3,Mycobacterium tuberculosis KT-0063,Mycobacterium tuberculosis KT-0063,1400911.0,WGS,KT-0063,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219794,SAMN02360589,GCA_000674075.1,JLRK00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47910,,,25.0,25.0,4386910.0,65.6,4354.0,,3977.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.814Z,2015-03-16T03:17:09.594Z
1400912_3,Mycobacterium tuberculosis KT-0064,Mycobacterium tuberculosis KT-0064,1400912.0,WGS,KT-0064,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219795,SAMN02360590,GCA_000674095.1,JLRJ00000000,-,Broad Institute,WGS,Illumina,54.0x,allpaths v. R47903,,,56.0,64.0,4361368.0,65.6,4322.0,,3976.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.823Z,2015-03-16T03:17:09.594Z
1400914_3,Mycobacterium tuberculosis KT-0070,Mycobacterium tuberculosis KT-0070,1400914.0,WGS,KT-0070,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219797,SAMN02360592,GCA_000674115.1,JLRI00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47903,,,29.0,29.0,4381748.0,65.6,4324.0,,3967.0,,Bodily fluid,,2008,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.852Z,2015-03-16T03:17:09.594Z
1400915_3,Mycobacterium tuberculosis KT-0071,Mycobacterium tuberculosis KT-0071,1400915.0,WGS,KT-0071,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219798,SAMN02360593,GCA_000674135.1,JLRH00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47910,,,34.0,34.0,4386738.0,65.6,4348.0,,3985.0,,Bodily fluid,,2008,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.861Z,2015-03-16T03:17:09.594Z
1400916_3,Mycobacterium tuberculosis KT-0072,Mycobacterium tuberculosis KT-0072,1400916.0,WGS,KT-0072,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219799,SAMN02360594,GCA_000674155.1,JLRG00000000,-,Broad Institute,WGS,Illumina,138.0x,allpaths v. R47910,,,20.0,20.0,4379798.0,65.6,4332.0,,3973.0,,Bodily fluid,,2009,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.871Z,2015-03-16T03:17:09.594Z
1400918_3,Mycobacterium tuberculosis KT-0075,Mycobacterium tuberculosis KT-0075,1400918.0,WGS,KT-0075,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219801,SAMN02360596,GCA_000674175.1,JLRF00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47910,,,29.0,29.0,4432866.0,65.6,4393.0,,4034.0,,Bodily fluid,,2008,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.880Z,2015-03-16T03:17:09.594Z
1400920_3,Mycobacterium tuberculosis KT-0077,Mycobacterium tuberculosis KT-0077,1400920.0,WGS,KT-0077,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219803,SAMN02360598,GCA_000674195.1,JLRE00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R47910,,,16.0,17.0,4394534.0,65.6,4355.0,,3991.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.889Z,2015-03-16T03:17:09.594Z
1400921_3,Mycobacterium tuberculosis KT-0078,Mycobacterium tuberculosis KT-0078,1400921.0,WGS,KT-0078,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219804,SAMN02360599,GCA_000674215.1,JLRD00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R47910,,,18.0,18.0,4384803.0,65.6,4341.0,,3975.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.898Z,2015-03-16T03:17:09.594Z
1400922_3,Mycobacterium tuberculosis KT-0079,,1400922.0,WGS,KT-0079,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA219805,SAMN02360600,GCA_000706505.1,JLRC00000000,-,Broad Institute,,Illumina,131.0x,allpaths v. R47910,,,3.0,18.0,4424060.0,65.6,4332.0,,4009.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:41:44.435Z,2015-03-16T03:17:09.594Z
1400923_3,Mycobacterium tuberculosis KT-0080,Mycobacterium tuberculosis KT-0080,1400923.0,WGS,KT-0080,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219806,SAMN02360601,GCA_000674235.1,JLRB00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R47910,,,26.0,27.0,4372941.0,65.6,4317.0,,3972.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.907Z,2015-03-16T03:17:09.594Z
1400924_3,Mycobacterium tuberculosis KT-0083,Mycobacterium tuberculosis KT-0083,1400924.0,WGS,KT-0083,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219807,SAMN02360602,GCA_000674255.1,JLRA00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R47903,,,24.0,26.0,4408350.0,65.6,4361.0,,4031.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.934Z,2015-03-16T03:17:09.594Z
1400925_3,Mycobacterium tuberculosis KT-0084,Mycobacterium tuberculosis KT-0084,1400925.0,WGS,KT-0084,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219808,SAMN02360603,GCA_000674275.1,JLQZ00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R47910,,,27.0,28.0,4384988.0,65.6,4348.0,,3981.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.943Z,2015-03-16T03:17:09.594Z
1400926_3,Mycobacterium tuberculosis KT-0085,Mycobacterium tuberculosis KT-0085,1400926.0,WGS,KT-0085,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219809,SAMN02360604,GCA_000674295.1,JLQY00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R47910,,,24.0,26.0,4380147.0,65.6,4347.0,,3979.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.953Z,2015-03-16T03:17:09.594Z
1400927_3,Mycobacterium tuberculosis KT-0089,Mycobacterium tuberculosis KT-0089,1400927.0,WGS,KT-0089,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219810,SAMN02360605,GCA_000674315.1,JLQX00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R47910,,,10.0,11.0,4415349.0,65.6,4368.0,,4020.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.985Z,2015-03-16T03:17:09.594Z
1400928_3,Mycobacterium tuberculosis KT-0091,Mycobacterium tuberculosis KT-0091,1400928.0,WGS,KT-0091,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219811,SAMN02360606,GCA_000674335.1,JLQW00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R47903,,,24.0,24.0,4384853.0,65.6,4334.0,,3980.0,,Bodily fluid,,2010,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.993Z,2015-03-16T03:17:09.594Z
1400929_3,Mycobacterium tuberculosis KT-0092,Mycobacterium tuberculosis KT-0092,1400929.0,WGS,KT-0092,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219812,SAMN02360607,GCA_000674355.1,JLQV00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R47910,,,14.0,16.0,4377800.0,65.6,4328.0,,3971.0,,Bodily fluid,,2010,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:11.003Z,2015-03-16T03:17:09.594Z
1400930_3,Mycobacterium tuberculosis KT-0094,Mycobacterium tuberculosis KT-0094,1400930.0,WGS,KT-0094,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219813,SAMN02360608,GCA_000674375.1,JLQU00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47910,,,26.0,26.0,4462746.0,65.6,4411.0,,4050.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:11.012Z,2015-03-16T03:17:09.594Z
1400931_3,Mycobacterium tuberculosis KT-0096,Mycobacterium tuberculosis KT-0096,1400931.0,WGS,KT-0096,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219814,SAMN02360609,GCA_000674395.1,JLQT00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R47910,,,24.0,26.0,4377414.0,65.6,4333.0,,3975.0,,Bodily fluid,,2008,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:11.021Z,2015-03-16T03:17:09.594Z
1400932_3,Mycobacterium tuberculosis KT-0098,Mycobacterium tuberculosis KT-0098,1400932.0,WGS,KT-0098,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219815,SAMN02360610,GCA_000674415.1,JLQS00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R47903,,,20.0,23.0,4386045.0,65.6,4338.0,,3993.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:11.030Z,2015-03-16T03:17:09.594Z
1400933_3,Mycobacterium tuberculosis KT-0099,Mycobacterium tuberculosis KT-0099,1400933.0,WGS,KT-0099,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219816,SAMN02360611,GCA_000674435.1,JLQR00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47910,,,32.0,32.0,4375377.0,65.6,4319.0,,3969.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:11.039Z,2015-03-16T03:17:09.594Z
1400935_3,Mycobacterium tuberculosis KT-0102,Mycobacterium tuberculosis KT-0102,1400935.0,WGS,KT-0102,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219818,SAMN02360613,GCA_000674475.1,JLQP00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47910,,,30.0,34.0,4369260.0,65.6,4346.0,,3977.0,,Bodily fluid,,2008,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:11.048Z,2015-03-16T03:17:09.594Z
1400936_3,Mycobacterium tuberculosis KT-0104,Mycobacterium tuberculosis KT-0104,1400936.0,WGS,KT-0104,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219819,SAMN02360614,GCA_000674495.1,JLQO00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47910,,,34.0,34.0,4389345.0,65.6,4350.0,,3988.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:11.057Z,2015-03-16T03:17:09.594Z
1400937_3,Mycobacterium tuberculosis KT-0106,Mycobacterium tuberculosis KT-0106,1400937.0,WGS,KT-0106,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219820,SAMN02360615,GCA_000674515.1,JLQN00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R47910,,,30.0,32.0,4372075.0,65.6,4339.0,,3971.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:11.066Z,2015-03-16T03:17:09.594Z
1400938_3,Mycobacterium tuberculosis KT-0107,,1400938.0,WGS,KT-0107,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA219821,SAMN02360616,GCA_000706485.1,JLQM00000000,-,Broad Institute,,Illumina,126.0x,allpaths v. R47910,,,9.0,27.0,4396550.0,65.6,4271.0,,3977.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:41:45.230Z,2015-03-16T03:17:09.594Z
1400939_3,Mycobacterium tuberculosis KT-0108,Mycobacterium tuberculosis KT-0108,1400939.0,WGS,KT-0108,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219822,SAMN02360617,GCA_000674535.1,JLQL00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47910,,,27.0,27.0,4373612.0,65.6,4348.0,,3975.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:11.075Z,2015-03-16T03:17:09.594Z
1400940_3,Mycobacterium tuberculosis KT-0109,Mycobacterium tuberculosis KT-0109,1400940.0,WGS,KT-0109,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219823,SAMN02360618,GCA_000674555.1,JLQK00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47903,,,18.0,18.0,4386359.0,65.6,4344.0,,3983.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:11.084Z,2015-03-16T03:17:09.594Z
1400941_3,Mycobacterium tuberculosis KT-0110,Mycobacterium tuberculosis KT-0110,1400941.0,WGS,KT-0110,,,,,,,,2014-04-30T00:00:00Z,,PRJNA219824,SAMN02360619,GCA_000674575.1,JLQJ00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R47910,,,39.0,41.0,4379893.0,65.6,4356.0,,3972.0,,Bodily fluid,,2008,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:11.095Z,2015-03-16T03:17:09.594Z
1402583_3,Mycobacterium tuberculosis OFXR-1,Mycobacterium tuberculosis OFXR-1,1402583.0,WGS,OFXR-1,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221501,SAMN02364076,GCA_000667865.1,JLCN00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47737,,,18.0,18.0,4397064.0,65.6,4345.0,,3990.0,,Bodily Fluid,,2009,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",Female,36,MDR-TB,,,comorbidity:HIV negative;host_subject_id:3979948;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:94002077;phenotype:MDR,2014-12-08T22:12:14.515Z,2015-03-16T03:17:09.594Z
1402584_3,Mycobacterium tuberculosis OFXR-6,Mycobacterium tuberculosis OFXR-6,1402584.0,WGS,OFXR-6,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221502,SAMN02364077,GCA_000667885.1,JLCI00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47737,,,17.0,19.0,4423495.0,65.6,4373.0,,4035.0,,Bodily Fluid,,2007,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",Female,43,MDR-TB,,,comorbidity:HIV negative;host_subject_id:2422752;treatment course:adm,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:96001766;phenotype:MDR,2014-12-08T22:12:14.773Z,2015-03-16T03:17:09.594Z
1402585_3,Mycobacterium tuberculosis OFXR-8,Mycobacterium tuberculosis OFXR-8,1402585.0,WGS,OFXR-8,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221503,SAMN02364078,GCA_000667905.1,JLCG00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R47737,,,17.0,17.0,4398148.0,65.6,4351.0,,3994.0,,Bodily Fluid,,2007,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",Male,62,TB,,,comorbidity:HIV negative;host_subject_id:5146187;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:96001188;phenotype:Mono DR,2014-12-08T22:12:14.792Z,2015-03-16T03:17:09.594Z
1402586_3,Mycobacterium tuberculosis OFXR-9,Mycobacterium tuberculosis OFXR-9,1402586.0,WGS,OFXR-9,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221504,SAMN02364079,GCA_000681335.1,JLCF00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R47737,,,21.0,21.0,4396702.0,65.6,4361.0,,3994.0,,Bodily Fluid,,2011,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",Male,62,TB,,,comorbidity:HIV negative;host_subject_id:5146187;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:96000556;phenotype:Mono DR,2014-12-08T22:12:14.801Z,2015-03-16T03:17:09.594Z
1402587_3,Mycobacterium tuberculosis OFXR-17,Mycobacterium tuberculosis OFXR-17,1402587.0,WGS,OFXR-17,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221505,SAMN02364080,GCA_000667935.1,JLBX00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47737,,,13.0,13.0,4405946.0,65.6,4347.0,,3994.0,,Bodily Fluid,,,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",Female,28,TB,,,comorbidity:HIV negative;host_subject_id:5691058;treatment course:adm,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:MGIT;respository name:1000752;phenotype:Mono DR,2014-12-08T22:12:14.589Z,2015-03-16T03:17:09.594Z
1402588_3,Mycobacterium tuberculosis OFXR-18,Mycobacterium tuberculosis OFXR-18,1402588.0,WGS,OFXR-18,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221506,SAMN02364081,GCA_000667955.1,JLBW00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47737,,,15.0,15.0,4399670.0,65.6,4328.0,,4013.0,,Bodily Fluid,,,,,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.598Z,2015-03-16T03:17:09.594Z
1402589_3,Mycobacterium tuberculosis OFXR-19,Mycobacterium tuberculosis OFXR-19,1402589.0,WGS,OFXR-19,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221507,SAMN02364082,GCA_000667975.1,JLBV00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47737,,,18.0,21.0,4380885.0,65.6,4364.0,,4021.0,,Bodily Fluid,,,,,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.608Z,2015-03-16T03:17:09.594Z
1402590_3,Mycobacterium tuberculosis OFXR-20,Mycobacterium tuberculosis OFXR-20,1402590.0,WGS,OFXR-20,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221508,SAMN02364083,GCA_000667995.1,JLBU00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47737,,,10.0,10.0,4415002.0,65.6,4381.0,,4032.0,,Bodily Fluid,,,,,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.626Z,2015-03-16T03:17:09.594Z
1402591_3,Mycobacterium tuberculosis OFXR-21,Mycobacterium tuberculosis OFXR-21,1402591.0,WGS,OFXR-21,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221509,SAMN02364084,GCA_000668015.1,JLBT00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R47737,,,14.0,15.0,4398777.0,65.6,4332.0,,4002.0,,Bodily Fluid,,,,,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.635Z,2015-03-16T03:17:09.594Z
1402592_3,Mycobacterium tuberculosis OFXR-22,Mycobacterium tuberculosis OFXR-22,1402592.0,WGS,OFXR-22,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221510,SAMN02364085,GCA_000668035.1,JLBS00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R47737,,,12.0,14.0,4439236.0,65.6,4415.0,,4020.0,,Bodily Fluid,,,,,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.644Z,2015-03-16T03:17:09.594Z
1402593_3,Mycobacterium tuberculosis OFXR-23,Mycobacterium tuberculosis OFXR-23,1402593.0,WGS,OFXR-23,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221511,SAMN02364086,GCA_000668055.1,JLBR00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R47737,,,16.0,17.0,4393112.0,65.6,4336.0,,3973.0,,Bodily Fluid,,,,,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.652Z,2015-03-16T03:17:09.594Z
1402595_3,Mycobacterium tuberculosis OFXR-25,Mycobacterium tuberculosis OFXR-25,1402595.0,WGS,OFXR-25,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221513,SAMN02364088,GCA_000668075.1,JLBQ00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R47737,,,13.0,13.0,4392172.0,65.6,4353.0,,3988.0,,Bodily Fluid,,,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.661Z,2015-03-16T03:17:09.594Z
1402596_3,Mycobacterium tuberculosis OFXR-26,Mycobacterium tuberculosis OFXR-26,1402596.0,WGS,OFXR-26,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221514,SAMN02364089,GCA_000668095.1,JLBP00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47737,,,17.0,17.0,4396329.0,65.6,4350.0,,3995.0,,Bodily Fluid,,,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.670Z,2015-03-16T03:17:09.594Z
1402597_3,Mycobacterium tuberculosis OFXR-27,Mycobacterium tuberculosis OFXR-27,1402597.0,WGS,OFXR-27,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221515,SAMN02364090,GCA_000668115.1,JLBO00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R47737,,,17.0,19.0,4426602.0,65.6,4380.0,,2130.0,,Bodily Fluid,,,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.679Z,2015-03-16T03:17:09.594Z
1402598_3,Mycobacterium tuberculosis OFXR-29,Mycobacterium tuberculosis OFXR-29,1402598.0,WGS,OFXR-29,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221516,SAMN02364091,GCA_000668135.1,JLBM00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R47737,,,18.0,18.0,4408305.0,65.6,4346.0,,4017.0,,Bodily Fluid,,,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.697Z,2015-03-16T03:17:09.594Z
1402599_3,Mycobacterium tuberculosis OFXR-30,Mycobacterium tuberculosis OFXR-30,1402599.0,WGS,OFXR-30,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221517,SAMN02364092,GCA_000668155.1,JLBL00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R47737,,,11.0,11.0,4401194.0,65.6,4368.0,,3988.0,,Bodily Fluid,,,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.717Z,2015-03-16T03:17:09.594Z
1402600_3,Mycobacterium tuberculosis OFXR-31,Mycobacterium tuberculosis OFXR-31,1402600.0,WGS,OFXR-31,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221518,SAMN02364093,GCA_000668175.1,JLBK00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47737,,,17.0,17.0,4404838.0,65.6,4379.0,,3995.0,,Bodily Fluid,,,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.726Z,2015-03-16T03:17:09.594Z
1402601_3,Mycobacterium tuberculosis OFXR-32,Mycobacterium tuberculosis OFXR-32,1402601.0,WGS,OFXR-32,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221519,SAMN02364094,GCA_000668195.1,JLBJ00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R47737,,,14.0,15.0,4417181.0,65.6,4368.0,,3996.0,,Bodily Fluid,,,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.735Z,2015-03-16T03:17:09.594Z
1402602_3,Mycobacterium tuberculosis OFXR-33,Mycobacterium tuberculosis OFXR-33,1402602.0,WGS,OFXR-33,,,,,,,,2014-04-29T00:00:00Z,,PRJNA221520,SAMN02364095,GCA_000668215.1,JLBI00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R47737,,,20.0,21.0,4423802.0,65.6,4397.0,,4035.0,,Bodily Fluid,,,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.745Z,2015-03-16T03:17:09.594Z
1408904_4,Mycobacterium tuberculosis UT0001,,1408904.0,WGS,UT0001,,,,,,,,2014-04-30T00:00:00Z,-,PRJNA223536,SAMN02380981,GCA_000674675.1,JLQI00000000,-,Broad Institute,,Illumina,113.0x,allpaths v. R48105,,,7.0,21.0,4404210.0,65.6,4328.0,,3986.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:49.077Z,2015-03-16T03:17:09.594Z
1408905_4,Mycobacterium tuberculosis UT0002,,1408905.0,WGS,UT0002,,,,,,,,2014-04-30T00:00:00Z,-,PRJNA223537,SAMN02380982,GCA_000674695.1,JLQH00000000,-,Broad Institute,,Illumina,78.0x,allpaths v. R48294,,,8.0,46.0,4510030.0,65.7,4287.0,,3991.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:49.578Z,2015-03-16T03:17:09.594Z
1408906_4,Mycobacterium tuberculosis UT0003,,1408906.0,WGS,UT0003,,,,,,,,2014-04-30T00:00:00Z,-,PRJNA223538,SAMN02380983,GCA_000674715.1,JLQG00000000,-,Broad Institute,,Illumina,115.0x,allpaths v. R48294,,,9.0,20.0,4403240.0,65.6,4301.0,,4015.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:50.205Z,2015-03-16T03:17:09.594Z
1408907_4,Mycobacterium tuberculosis UT0004,,1408907.0,WGS,UT0004,,,,,,,,2014-04-30T00:00:00Z,-,PRJNA223539,SAMN02380984,GCA_000674735.1,JLQF00000000,-,Broad Institute,,Illumina,111.0x,allpaths v. R48168,,,7.0,25.0,4415780.0,65.6,4315.0,,4017.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:50.924Z,2015-03-16T03:17:09.594Z
1408909_4,Mycobacterium tuberculosis UT0009,,1408909.0,WGS,UT0009,,,,,,,,2014-04-30T00:00:00Z,-,PRJNA223541,SAMN02380986,GCA_000674755.1,JLQE00000000,-,Broad Institute,,Illumina,124.0x,allpaths v. R48294,,,7.0,16.0,4431440.0,65.6,4329.0,,4008.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:51.522Z,2015-03-16T03:17:09.594Z
1408911_4,Mycobacterium tuberculosis UT0015,,1408911.0,WGS,UT0015,,,,,,,,2014-04-30T00:00:00Z,-,PRJNA223543,SAMN02380988,GCA_000674775.1,JLQD00000000,-,Broad Institute,,Illumina,119.0x,allpaths v. R48105,,,5.0,18.0,4392380.0,65.6,4279.0,,4000.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:52.902Z,2015-03-16T03:17:09.594Z
1408912_4,Mycobacterium tuberculosis UT0016,,1408912.0,WGS,UT0016,,,,,,,,2014-04-30T00:00:00Z,-,PRJNA223544,SAMN02380989,GCA_000674795.1,JLQC00000000,-,Broad Institute,,Illumina,60.0x,allpaths v. R48123,,,75.0,77.0,4410970.0,65.6,4332.0,,3999.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:53.338Z,2015-03-16T03:17:09.594Z
1408913_4,Mycobacterium tuberculosis UT0020,,1408913.0,WGS,UT0020,,,,,,,,2014-04-30T00:00:00Z,-,PRJNA223545,SAMN02380990,GCA_000674815.1,JLQB00000000,-,Broad Institute,,Illumina,99.0x,allpaths v. R48105,,,47.0,58.0,4411280.0,65.6,4308.0,,4001.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:53.801Z,2015-03-16T03:17:09.594Z
1408914_4,Mycobacterium tuberculosis UT0022,,1408914.0,WGS,UT0022,,,,,,,,2014-04-30T00:00:00Z,-,PRJNA223546,SAMN02380991,GCA_000674835.1,JLQA00000000,-,Broad Institute,,Illumina,117.0x,allpaths v. R48168,,,6.0,31.0,4430950.0,65.6,4325.0,,4010.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:54.611Z,2015-03-16T03:17:09.594Z
1408915_4,Mycobacterium tuberculosis UT0024,,1408915.0,WGS,UT0024,,,,,,,,2014-04-30T00:00:00Z,-,PRJNA223547,SAMN02380992,GCA_000674855.1,JLPZ00000000,-,Broad Institute,,Illumina,126.0x,allpaths v. R48294,,,6.0,19.0,4357530.0,65.6,4276.0,,3979.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:55.136Z,2015-03-16T03:17:09.594Z
1408916_4,Mycobacterium tuberculosis UT0026,,1408916.0,WGS,UT0026,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223548,SAMN02380993,GCA_000657875.1,JLPY00000000,-,Broad Institute,,Illumina,83.0x,allpaths v. R48294,,,86.0,86.0,4425950.0,65.6,4339.0,,4027.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:55.702Z,2015-03-16T03:17:09.594Z
1408918_4,Mycobacterium tuberculosis UT0030,,1408918.0,WGS,UT0030,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223550,SAMN02380995,GCA_000668255.1,JLPX00000000,-,Broad Institute,,Illumina,126.0x,allpaths v. R48294,,,11.0,17.0,4412610.0,65.6,4317.0,,4008.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:56.282Z,2015-03-16T03:17:09.594Z
1408919_4,Mycobacterium tuberculosis UT0034,,1408919.0,WGS,UT0034,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223551,SAMN02380996,GCA_000668275.1,JLPW00000000,-,Broad Institute,,Illumina,85.0x,allpaths v. R48123,,,67.0,69.0,4397590.0,65.6,4318.0,,4014.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:57.234Z,2015-03-16T03:17:09.594Z
1408920_4,Mycobacterium tuberculosis UT0036,,1408920.0,WGS,UT0036,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223552,SAMN02380997,GCA_000668295.1,JLPV00000000,-,Broad Institute,,Illumina,108.0x,allpaths v. R48105,,,35.0,45.0,4408530.0,65.6,4301.0,,4009.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:57.853Z,2015-03-16T03:17:09.594Z
1408921_4,Mycobacterium tuberculosis UT0037,,1408921.0,WGS,UT0037,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223553,SAMN02380998,GCA_000668315.1,JLPU00000000,-,Broad Institute,,Illumina,121.0x,allpaths v. R48294,,,6.0,27.0,4434700.0,65.6,4320.0,,4036.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:59.110Z,2015-03-16T03:17:09.594Z
1408922_4,Mycobacterium tuberculosis UT0038,,1408922.0,WGS,UT0038,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223554,SAMN02380999,GCA_000668335.1,JLPT00000000,-,Broad Institute,,Illumina,114.0x,allpaths v. R48105,,,8.0,15.0,4409770.0,65.6,4293.0,,3989.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:42:59.610Z,2015-03-16T03:17:09.594Z
1408923_4,Mycobacterium tuberculosis UT0040,,1408923.0,WGS,UT0040,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223555,SAMN02381000,GCA_000668355.1,JLPS00000000,-,Broad Institute,,Illumina,123.0x,allpaths v. R48294,,,5.0,21.0,4437510.0,65.6,4339.0,,4011.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:00.085Z,2015-03-16T03:17:09.594Z
1408924_4,Mycobacterium tuberculosis UT0041,,1408924.0,WGS,UT0041,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223556,SAMN02381001,GCA_000668375.1,JLPR00000000,-,Broad Institute,,Illumina,116.0x,allpaths v. R48105,,,4.0,24.0,4405410.0,65.6,4292.0,,4009.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:00.611Z,2015-03-16T03:17:09.594Z
1408925_4,Mycobacterium tuberculosis UT0044,,1408925.0,WGS,UT0044,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223557,SAMN02381002,GCA_000668395.1,JLPQ00000000,-,Broad Institute,,Illumina,122.0x,allpaths v. R48294,,,37.0,55.0,4472660.0,65.5,4354.0,,4029.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:01.164Z,2015-03-16T03:17:09.594Z
1408926_4,Mycobacterium tuberculosis UT0045,,1408926.0,WGS,UT0045,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223558,SAMN02381003,GCA_000668415.1,JLPP00000000,-,Broad Institute,,Illumina,116.0x,allpaths v. R48168,,,6.0,23.0,4373290.0,65.6,4260.0,,3982.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:01.712Z,2015-03-16T03:17:09.594Z
1408927_4,Mycobacterium tuberculosis UT0046,,1408927.0,WGS,UT0046,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223559,SAMN02381004,GCA_000657895.1,JLPO00000000,-,Broad Institute,,Illumina,84.0x,allpaths v. R48123,,,58.0,58.0,4408970.0,65.6,4312.0,,3972.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:02.214Z,2015-03-16T03:17:09.594Z
1408928_4,Mycobacterium tuberculosis UT0048,,1408928.0,WGS,UT0048,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223560,SAMN02381005,GCA_000668435.1,JLPN00000000,-,Broad Institute,,Illumina,17.0x,allpaths v. R48294,,,133.0,148.0,4343420.0,65.5,4286.0,,4007.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:02.741Z,2015-03-16T03:17:09.594Z
1408929_4,Mycobacterium tuberculosis UT0050,,1408929.0,WGS,UT0050,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223561,SAMN02381006,GCA_000668455.1,JLPM00000000,-,Broad Institute,,Illumina,117.0x,allpaths v. R48105,,,5.0,23.0,4431290.0,65.6,4320.0,,3997.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:03.243Z,2015-03-16T03:17:09.594Z
1408930_4,Mycobacterium tuberculosis UT0051,,1408930.0,WGS,UT0051,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223562,SAMN02381007,GCA_000668475.1,JLPL00000000,-,Broad Institute,,Illumina,117.0x,allpaths v. R48105,,,5.0,26.0,4436770.0,65.6,4310.0,,4002.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:04.521Z,2015-03-16T03:17:09.594Z
1408931_4,Mycobacterium tuberculosis UT0052,,1408931.0,WGS,UT0052,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223563,SAMN02381008,GCA_000668495.1,JLPK00000000,-,Broad Institute,,Illumina,119.0x,allpaths v. R48105,,,6.0,24.0,4408070.0,65.6,4290.0,,4007.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:04.969Z,2015-03-16T03:17:09.594Z
1408932_4,Mycobacterium tuberculosis UT0053,,1408932.0,WGS,UT0053,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223564,SAMN02381009,GCA_000668515.1,JLPJ00000000,-,Broad Institute,,Illumina,151.0x,allpaths v. R48294,,,42.0,56.0,4461650.0,65.6,4358.0,,4085.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:05.870Z,2015-03-16T03:17:09.594Z
1408933_4,Mycobacterium tuberculosis UT0055,,1408933.0,WGS,UT0055,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223565,SAMN02381010,GCA_000668535.1,JLPI00000000,-,Broad Institute,,Illumina,105.0x,allpaths v. R48105,,,8.0,42.0,4370930.0,65.6,4279.0,,3991.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:06.311Z,2015-03-16T03:17:09.594Z
1408934_4,Mycobacterium tuberculosis UT0056,,1408934.0,WGS,UT0056,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223566,SAMN02381011,GCA_000668555.1,JLPH00000000,-,Broad Institute,,Illumina,89.0x,allpaths v. R48168,,,80.0,87.0,4414160.0,65.6,4316.0,,4008.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:06.818Z,2015-03-16T03:17:09.594Z
1408935_4,Mycobacterium tuberculosis UT0057,,1408935.0,WGS,UT0057,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223567,SAMN02381012,GCA_000668575.1,JLPG00000000,-,Broad Institute,,Illumina,113.0x,allpaths v. R48168,,,10.0,24.0,4418890.0,65.6,4306.0,,4017.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:07.356Z,2015-03-16T03:17:09.594Z
1408936_4,Mycobacterium tuberculosis UT0058,,1408936.0,WGS,UT0058,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223568,SAMN02381013,GCA_000668595.1,JLPF00000000,-,Broad Institute,,Illumina,119.0x,allpaths v. R48105,,,7.0,25.0,4429830.0,65.6,4322.0,,4006.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:08.024Z,2015-03-16T03:17:09.594Z
1408937_4,Mycobacterium tuberculosis UT0059,,1408937.0,WGS,UT0059,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223569,SAMN02381014,GCA_000668615.1,JLPE00000000,-,Broad Institute,,Illumina,122.0x,allpaths v. R48294,,,9.0,20.0,4401380.0,65.6,4296.0,,4019.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:08.764Z,2015-03-16T03:17:09.594Z
1408938_4,Mycobacterium tuberculosis UT0060,,1408938.0,WGS,UT0060,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223570,SAMN02381015,GCA_000668635.1,JLPD00000000,-,Broad Institute,,Illumina,123.0x,allpaths v. R48294,,,2.0,13.0,4390030.0,65.6,4289.0,,3997.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:09.296Z,2015-03-16T03:17:09.594Z
1408939_4,Mycobacterium tuberculosis UT0067,,1408939.0,WGS,UT0067,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223571,SAMN02381016,GCA_000668655.1,JLPC00000000,-,Broad Institute,,Illumina,89.0x,allpaths v. R48294,,,64.0,71.0,4414790.0,65.6,4318.0,,4015.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:10.366Z,2015-03-16T03:17:09.594Z
1408940_4,Mycobacterium tuberculosis UT0069,,1408940.0,WGS,UT0069,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223572,SAMN02381017,GCA_000668675.1,JLPB00000000,-,Broad Institute,,Illumina,107.0x,allpaths v. R48105,,,7.0,21.0,4431720.0,65.6,4347.0,,4021.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:10.839Z,2015-03-16T03:17:09.594Z
1408941_4,Mycobacterium tuberculosis UT0070,,1408941.0,WGS,UT0070,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223573,SAMN02381018,GCA_000668695.1,JLPA00000000,-,Broad Institute,,Illumina,111.0x,allpaths v. R48084,,,9.0,19.0,4394610.0,65.6,4297.0,,4005.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:11.285Z,2015-03-16T03:17:09.594Z
1408942_4,Mycobacterium tuberculosis UT0071,,1408942.0,WGS,UT0071,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223574,SAMN02381019,GCA_000668715.1,JLOZ00000000,-,Broad Institute,,Illumina,101.0x,allpaths v. R48105,,,6.0,31.0,4460290.0,65.6,4331.0,,4012.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:11.742Z,2015-03-16T03:17:09.594Z
1408943_4,Mycobacterium tuberculosis UT0075,,1408943.0,WGS,UT0075,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223575,SAMN02381020,GCA_000657915.1,JLOY00000000,-,Broad Institute,,Illumina,78.0x,allpaths v. R48123,,,74.0,74.0,4410420.0,65.6,4312.0,,3992.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:12.218Z,2015-03-16T03:17:09.594Z
1408944_4,Mycobacterium tuberculosis UT0077,,1408944.0,WGS,UT0077,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223576,SAMN02381021,GCA_000668735.1,JLOX00000000,-,Broad Institute,,Illumina,106.0x,allpaths v. R48168,,,4.0,20.0,4422010.0,65.6,4322.0,,4025.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:12.829Z,2015-03-16T03:17:09.594Z
1408945_4,Mycobacterium tuberculosis UT0079,,1408945.0,WGS,UT0079,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223577,SAMN02381022,GCA_000668755.1,JLOW00000000,-,Broad Institute,,Illumina,124.0x,allpaths v. R48294,,,3.0,15.0,4400920.0,65.6,4297.0,,4004.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:13.386Z,2015-03-16T03:17:09.594Z
1408946_4,Mycobacterium tuberculosis UT0080,,1408946.0,WGS,UT0080,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223578,SAMN02381023,GCA_000668775.1,JLOV00000000,-,Broad Institute,,Illumina,112.0x,allpaths v. R48105,,,13.0,29.0,4401390.0,65.6,4290.0,,3993.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 6654;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:13.915Z,2015-03-16T03:17:09.594Z
1408947_4,Mycobacterium tuberculosis UT0082,,1408947.0,WGS,UT0082,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223579,SAMN02381024,GCA_000668795.1,JLOU00000000,-,Broad Institute,,Illumina,115.0x,allpaths v. R48105,,,9.0,21.0,4407190.0,65.6,4305.0,,4016.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 4952;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:14.493Z,2015-03-16T03:17:09.594Z
1408948_4,Mycobacterium tuberculosis UT0083,,1408948.0,WGS,UT0083,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223580,SAMN02381025,GCA_000668815.1,JLOT00000000,-,Broad Institute,,Illumina,110.0x,allpaths v. R48168,,,5.0,23.0,4403830.0,65.6,4297.0,,4008.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 4188;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:15.728Z,2015-03-16T03:17:09.594Z
1408949_4,Mycobacterium tuberculosis UT0084,,1408949.0,WGS,UT0084,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223581,SAMN02381026,GCA_000668835.1,JLOS00000000,-,Broad Institute,,Illumina,107.0x,allpaths v. R48105,,,4.0,21.0,4397620.0,65.6,4300.0,,3979.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 8001;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:16.247Z,2015-03-16T03:17:09.594Z
1408950_4,Mycobacterium tuberculosis UT0085,,1408950.0,WGS,UT0085,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223582,SAMN02381027,GCA_000668855.1,JLOR00000000,-,Broad Institute,,Illumina,81.0x,allpaths v. R48168,,,14.0,33.0,4393800.0,65.6,4287.0,,3971.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 3247;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:17.056Z,2015-03-16T03:17:09.594Z
1408951_4,Mycobacterium tuberculosis UT0087,,1408951.0,WGS,UT0087,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223583,SAMN02381028,GCA_000668875.1,JLOQ00000000,-,Broad Institute,,Illumina,60.0x,allpaths v. R48294,,,32.0,50.0,4419490.0,65.6,4304.0,,4000.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 7210;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:17.490Z,2015-03-16T03:17:09.594Z
1408952_4,Mycobacterium tuberculosis UT0088,,1408952.0,WGS,UT0088,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223584,SAMN02381029,GCA_000668895.1,JLOP00000000,-,Broad Institute,,Illumina,60.0x,allpaths v. R48105,,,16.0,67.0,4392500.0,65.5,4307.0,,3977.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 6443;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:17.996Z,2015-03-16T03:17:09.594Z
1408953_4,Mycobacterium tuberculosis UT0089,,1408953.0,WGS,UT0089,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223585,SAMN02381030,GCA_000668915.1,JLOO00000000,-,Broad Institute,,Illumina,55.0x,allpaths v. R48168,,,6.0,22.0,4402010.0,65.6,4298.0,,3996.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 3148;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:18.546Z,2015-03-16T03:17:09.594Z
1408954_4,Mycobacterium tuberculosis UT0090,,1408954.0,WGS,UT0090,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223586,SAMN02381031,GCA_000668935.1,JLON00000000,-,Broad Institute,,Illumina,122.0x,allpaths v. R48294,,,5.0,16.0,4408410.0,65.6,4300.0,,3997.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 8067;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:19.092Z,2015-03-16T03:17:09.594Z
1408955_4,Mycobacterium tuberculosis UT0091,,1408955.0,WGS,UT0091,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223587,SAMN02381032,GCA_000668955.1,JLOM00000000,-,Broad Institute,,Illumina,117.0x,allpaths v. R48294,,,24.0,48.0,4423090.0,65.6,4299.0,,3972.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 4995;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:20.006Z,2015-03-16T03:17:09.594Z
1408956_4,Mycobacterium tuberculosis UT0092,,1408956.0,WGS,UT0092,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223588,SAMN02381033,GCA_000668975.1,JLOL00000000,-,Broad Institute,,Illumina,123.0x,allpaths v. R48168,,,5.0,22.0,4421740.0,65.6,4296.0,,4017.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:20.537Z,2015-03-16T03:17:09.594Z
1408957_4,Mycobacterium tuberculosis UT0093,,1408957.0,WGS,UT0093,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223589,SAMN02381034,GCA_000668995.1,JLOK00000000,-,Broad Institute,,Illumina,109.0x,allpaths v. R48168,,,19.0,49.0,4466030.0,65.6,4327.0,,4011.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:22.008Z,2015-03-16T03:17:09.594Z
1408958_4,Mycobacterium tuberculosis UT0094,,1408958.0,WGS,UT0094,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223590,SAMN02381035,GCA_000669015.1,JLOJ00000000,-,Broad Institute,,Illumina,97.0x,allpaths v. R48084,,,6.0,20.0,4398770.0,65.6,4309.0,,4010.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:22.465Z,2015-03-16T03:17:09.594Z
1408959_4,Mycobacterium tuberculosis UT0096,,1408959.0,WGS,UT0096,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223591,SAMN02381036,GCA_000669035.1,JLOI00000000,-,Broad Institute,,Illumina,78.0x,allpaths v. R48105,,,65.0,71.0,4382890.0,65.6,4311.0,,4002.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:22.915Z,2015-03-16T03:17:09.594Z
1408960_4,Mycobacterium tuberculosis UT0097,,1408960.0,WGS,UT0097,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223592,SAMN02381037,GCA_000669055.1,JLOH00000000,-,Broad Institute,,Illumina,77.0x,allpaths v. R48105,,,5.0,31.0,4443980.0,65.6,4331.0,,4020.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:23.368Z,2015-03-16T03:17:09.594Z
1408962_4,Mycobacterium tuberculosis UT0100,,1408962.0,WGS,UT0100,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223594,SAMN02381039,GCA_000669075.1,JLOG00000000,-,Broad Institute,,Illumina,124.0x,allpaths v. R48294,,,15.0,30.0,4383260.0,65.6,4260.0,,3980.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:23.960Z,2015-03-16T03:17:09.594Z
1408963_4,Mycobacterium tuberculosis UT0104,,1408963.0,WGS,UT0104,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223595,SAMN02381040,GCA_000669095.1,JLOF00000000,-,Broad Institute,,Illumina,118.0x,allpaths v. R48294,,,11.0,31.0,4414870.0,65.6,4311.0,,4014.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 4152;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:24.560Z,2015-03-16T03:17:09.594Z
1408964_4,Mycobacterium tuberculosis UT0105,,1408964.0,WGS,UT0105,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223596,SAMN02381041,GCA_000669115.1,JLOE00000000,-,Broad Institute,,Illumina,100.0x,allpaths v. R48168,,,5.0,11.0,4398700.0,65.6,4294.0,,3986.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:25.125Z,2015-03-16T03:17:09.594Z
1408965_4,Mycobacterium tuberculosis UT0106,,1408965.0,WGS,UT0106,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223597,SAMN02381042,GCA_000669135.1,JLOD00000000,-,Broad Institute,,Illumina,90.0x,allpaths v. R48105,,,53.0,77.0,4439610.0,65.6,4313.0,,3994.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab.,   3511;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:25.747Z,2015-03-16T03:17:09.594Z
1408967_4,Mycobacterium tuberculosis UT0110,,1408967.0,WGS,UT0110,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223599,SAMN02381044,GCA_000669155.1,JLOC00000000,-,Broad Institute,,Illumina,121.0x,allpaths v. R48294,,,9.0,25.0,4422690.0,65.6,4321.0,,4019.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 3527;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:26.348Z,2015-03-16T03:17:09.594Z
1408968_4,Mycobacterium tuberculosis UT0112,,1408968.0,WGS,UT0112,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223600,SAMN02381045,GCA_000669175.1,JLOB00000000,-,Broad Institute,,Illumina,97.0x,allpaths v. R48105,,,4.0,23.0,4417440.0,65.6,4320.0,,4033.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:27.415Z,2015-03-16T03:17:09.594Z
1408969_4,Mycobacterium tuberculosis UT0113,,1408969.0,WGS,UT0113,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223601,SAMN02381046,GCA_000669195.1,JLOA00000000,-,Broad Institute,,Illumina,122.0x,allpaths v. R48168,,,8.0,21.0,4407770.0,65.6,4306.0,,4024.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 8037;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:28.290Z,2015-03-16T03:17:09.594Z
1408970_4,Mycobacterium tuberculosis UT0115,,1408970.0,WGS,UT0115,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223602,SAMN02381047,GCA_000669215.1,JLNZ00000000,-,Broad Institute,,Illumina,63.0x,allpaths v. R48294,,,16.0,46.0,4517930.0,65.6,4339.0,,4028.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:28.746Z,2015-03-16T03:17:09.594Z
1408971_4,Mycobacterium tuberculosis UT0116,,1408971.0,WGS,UT0116,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223603,SAMN02381048,GCA_000669235.1,JLNY00000000,-,Broad Institute,,Illumina,117.0x,allpaths v. R48168,,,2.0,15.0,4417060.0,65.6,4297.0,,4007.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 2158;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:29.222Z,2015-03-16T03:17:09.594Z
1408972_3,Mycobacterium tuberculosis UT0118,,1408972.0,WGS,UT0118,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA223604,SAMN02381049,GCA_000706465.1,JLNX00000000,-,Broad Institute,,Illumina,84.0x,allpaths v. R48168,,,69.0,74.0,4405840.0,65.6,4292.0,,3993.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 3165;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:29.708Z,2015-03-16T03:17:09.594Z
1408973_4,Mycobacterium tuberculosis UT0123,,1408973.0,WGS,UT0123,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223605,SAMN02381050,GCA_000669255.1,JLNW00000000,-,Broad Institute,,Illumina,115.0x,allpaths v. R48168,,,4.0,12.0,4358550.0,65.6,4249.0,,3982.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:30.189Z,2015-03-16T03:17:09.594Z
1408974_4,Mycobacterium tuberculosis UT0124,,1408974.0,WGS,UT0124,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223606,SAMN02381051,GCA_000669275.1,JLNV00000000,-,Broad Institute,,Illumina,63.0x,allpaths v. R48294,,,8.0,50.0,4436430.0,65.6,4309.0,,4007.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:31.405Z,2015-03-16T03:17:09.594Z
1408975_4,Mycobacterium tuberculosis UT0017,,1408975.0,WGS,UT0017,,,,,,,,2014-04-29T00:00:00Z,-,PRJNA223607,SAMN02381052,GCA_000669295.1,JLNU00000000,-,Broad Institute,,Illumina,120.0x,allpaths v. R48294,,,11.0,30.0,4381450.0,65.6,4294.0,,3997.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:43:31.949Z,2015-03-16T03:17:09.594Z
1417008_3,Mycobacterium tuberculosis KT-0004,Mycobacterium tuberculosis KT-0004,1417008.0,WGS,KT-0004,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226758,SAMN02398693,GCA_000669315.1,JLNT00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48416,,,65.0,71.0,4364921.0,65.6,4341.0,,3977.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.445Z,2015-03-16T03:17:09.594Z
1417009_3,Mycobacterium tuberculosis KT-0010,Mycobacterium tuberculosis KT-0010,1417009.0,WGS,KT-0010,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226759,SAMN02398694,GCA_000669335.1,JLNS00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48416,,,31.0,34.0,4384105.0,65.6,4352.0,,3994.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.480Z,2015-03-16T03:17:09.594Z
1417010_3,Mycobacterium tuberculosis KT-0012,Mycobacterium tuberculosis KT-0012,1417010.0,WGS,KT-0012,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226760,SAMN02398695,GCA_000669355.1,JLNR00000000,-,Broad Institute,WGS,Illumina,101.0x,allpaths v. R48416,,,53.0,55.0,4368287.0,65.6,4339.0,,3972.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.498Z,2015-03-16T03:17:09.594Z
1417011_3,Mycobacterium tuberculosis KT-0018,Mycobacterium tuberculosis KT-0018,1417011.0,WGS,KT-0018,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226761,SAMN02398696,GCA_000657935.1,JLNQ00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48416,,,69.0,72.0,4378394.0,65.6,4342.0,,3978.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.541Z,2015-03-16T03:17:09.594Z
1417012_3,Mycobacterium tuberculosis KT-0020,Mycobacterium tuberculosis KT-0020,1417012.0,WGS,KT-0020,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226762,SAMN02398697,GCA_000669375.1,JLNP00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48416,,,35.0,35.0,4380210.0,65.6,4321.0,,3976.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.559Z,2015-03-16T03:17:09.594Z
1417013_3,Mycobacterium tuberculosis KT-0025,Mycobacterium tuberculosis KT-0025,1417013.0,WGS,KT-0025,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226763,SAMN02398698,GCA_000669395.1,JLNO00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48416,,,30.0,32.0,4384571.0,65.6,4339.0,,3976.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.587Z,2015-03-16T03:17:09.594Z
1417014_3,Mycobacterium tuberculosis KT-0029,Mycobacterium tuberculosis KT-0029,1417014.0,WGS,KT-0029,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226764,SAMN02398699,GCA_000669415.1,JLNN00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48416,,,70.0,76.0,4129439.0,65.6,4118.0,,3784.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.627Z,2015-03-16T03:17:09.594Z
1417015_3,Mycobacterium tuberculosis KT-0031,Mycobacterium tuberculosis KT-0031,1417015.0,WGS,KT-0031,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226765,SAMN02398700,GCA_000669435.1,JLNM00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48416,,,74.0,77.0,4365699.0,65.6,4331.0,,3970.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.636Z,2015-03-16T03:17:09.594Z
1417016_3,Mycobacterium tuberculosis KT-0032,Mycobacterium tuberculosis KT-0032,1417016.0,WGS,KT-0032,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226766,SAMN02398701,GCA_000669455.1,JLNL00000000,-,Broad Institute,WGS,Illumina,92.0x,allpaths v. R48416,,,72.0,75.0,4381632.0,65.6,4351.0,,3980.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.645Z,2015-03-16T03:17:09.594Z
1417017_3,Mycobacterium tuberculosis KT-0033,Mycobacterium tuberculosis KT-0033,1417017.0,WGS,KT-0033,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226767,SAMN02398702,GCA_000669475.1,JLNK00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48416,,,22.0,22.0,4412607.0,65.6,4357.0,,4000.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.655Z,2015-03-16T03:17:09.594Z
1417018_3,Mycobacterium tuberculosis KT-0034,Mycobacterium tuberculosis KT-0034,1417018.0,WGS,KT-0034,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226768,SAMN02398703,GCA_000669495.1,JLNJ00000000,-,Broad Institute,WGS,Illumina,93.0x,allpaths v. R48416,,,67.0,69.0,4368402.0,65.6,4341.0,,3972.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.664Z,2015-03-16T03:17:09.594Z
1417019_3,Mycobacterium tuberculosis KT-0037,Mycobacterium tuberculosis KT-0037,1417019.0,WGS,KT-0037,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226769,SAMN02398704,GCA_000657955.1,JLNI00000000,-,Broad Institute,WGS,Illumina,100.0x,allpaths v. R48416,,,72.0,74.0,4361455.0,65.61,4326.0,,3959.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.686Z,2015-03-16T03:17:09.594Z
1417020_3,Mycobacterium tuberculosis KT-0040,Mycobacterium tuberculosis KT-0040,1417020.0,WGS,KT-0040,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226770,SAMN02398705,GCA_000657975.1,JLNH00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48416,,,59.0,62.0,4374201.0,65.6,4339.0,,3991.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.704Z,2015-03-16T03:17:09.594Z
1417021_3,Mycobacterium tuberculosis KT-0042,Mycobacterium tuberculosis KT-0042,1417021.0,WGS,KT-0042,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226771,SAMN02398706,GCA_000669515.1,JLNG00000000,-,Broad Institute,WGS,Illumina,97.0x,allpaths v. R48416,,,33.0,35.0,4357015.0,65.6,4326.0,,3955.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.722Z,2015-03-16T03:17:09.594Z
1417023_3,Mycobacterium tuberculosis KT-0060,Mycobacterium tuberculosis KT-0060,1417023.0,WGS,KT-0060,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226773,SAMN02398708,GCA_000669535.1,JLNF00000000,-,Broad Institute,WGS,Illumina,92.0x,allpaths v. R48416,,,71.0,74.0,4374893.0,65.6,4333.0,,3979.0,,Bodily fluid,,2006,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.805Z,2015-03-16T03:17:09.594Z
1417026_3,Mycobacterium tuberculosis KT-0067,Mycobacterium tuberculosis KT-0067,1417026.0,WGS,KT-0067,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226776,SAMN02398711,GCA_000657995.1,JLNE00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48416,,,66.0,70.0,4373083.0,65.61,4336.0,,3978.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.833Z,2015-03-16T03:17:09.594Z
1417027_3,Mycobacterium tuberculosis KT-0069,Mycobacterium tuberculosis KT-0069,1417027.0,WGS,KT-0069,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226777,SAMN02398712,GCA_000669555.1,JLND00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48416,,,70.0,75.0,4365550.0,65.6,4341.0,,3970.0,,Bodily fluid,,2008,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.843Z,2015-03-16T03:17:09.594Z
1417028_3,Mycobacterium tuberculosis KT-0081,Mycobacterium tuberculosis KT-0081,1417028.0,WGS,KT-0081,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226778,SAMN02398713,GCA_000658015.1,JLNC00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48416,,,73.0,79.0,4369351.0,65.6,4343.0,,3976.0,,Bodily fluid,,2008,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.916Z,2015-03-16T03:17:09.594Z
1417029_3,Mycobacterium tuberculosis KT-0082,Mycobacterium tuberculosis KT-0082,1417029.0,WGS,KT-0082,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226779,SAMN02398714,GCA_000669575.1,JLNB00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48416,,,67.0,72.0,4362573.0,65.6,4317.0,,3971.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.925Z,2015-03-16T03:17:09.594Z
1417030_3,Mycobacterium tuberculosis KT-0086,Mycobacterium tuberculosis KT-0086,1417030.0,WGS,KT-0086,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226780,SAMN02398715,GCA_000669595.1,JLNA00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48416,,,13.0,13.0,4376904.0,65.6,4314.0,,3974.0,,Bodily fluid,,2005,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.964Z,2015-03-16T03:17:09.594Z
1417031_3,Mycobacterium tuberculosis KT-0087,Mycobacterium tuberculosis KT-0087,1417031.0,WGS,KT-0087,,,,,,,,2014-04-29T00:00:00Z,,PRJNA226781,SAMN02398716,GCA_000669615.1,JLMZ00000000,-,Broad Institute,WGS,Illumina,92.0x,allpaths v. R48416,,,69.0,73.0,4376258.0,65.6,4343.0,,3985.0,,Bodily fluid,,2007,South Korea,South Korea,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:10.975Z,2015-03-16T03:17:09.594Z
1418250_3,Mycobacterium tuberculosis OFXR-28,Mycobacterium tuberculosis OFXR-28,1418250.0,WGS,OFXR-28,,,,,,,,2014-04-29T00:00:00Z,,PRJNA227749,SAMN02402660,GCA_000669695.1,JLBN00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R47737,,,11.0,12.0,4408269.0,65.6,4355.0,,1899.0,,Bodily Fluid,,,Taiwan,Taiwan,,,,,,"Human, Homo sapiens",,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:14.688Z,2015-03-16T03:17:09.594Z
1418251_3,Mycobacterium tuberculosis 38765,Mycobacterium tuberculosis 38765,1418251.0,WGS,38765,,,,,,,,2014-04-29T00:00:00Z,,PRJNA227751,SAMN02402662,GCA_000669735.1,JLBF00000000,-,Broad Institute,WGS,Illumina,40.0x,allpaths v. R48559,,,87.0,95.0,4378389.0,65.6,4355.0,,3987.0,,Sputum,,2007,Colombia,"Colombia: Buenaventura, Valle del Cauca",,,,,,"Human, Homo sapiens",Male,26,MDR-TB,,,host_subject_id:patient 1;treatment course:into treatment,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:L�wenstein-Jensen culture;respository name:Biobank/TB/CIDEIM;phenotype:MDR,2014-12-08T22:12:08.444Z,2015-03-16T03:17:09.594Z
1418252_3,Mycobacterium tuberculosis 49375,Mycobacterium tuberculosis 49375,1418252.0,WGS,49375,,,,,,,,2014-04-29T00:00:00Z,,PRJNA227752,SAMN02402663,GCA_000669755.1,JLBE00000000,-,Broad Institute,WGS,Illumina,78.0x,allpaths v. R48559,,,84.0,92.0,4369134.0,65.6,4347.0,,3977.0,,Sputum,,2009,Colombia,"Colombia: Buenaventura, Valle del Cauca",,,,,,"Human, Homo sapiens",Male,29,XDR-TB,,,host_subject_id:patient 1;treatment course:into treatment,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:L�wenstein-Jensen culture;respository name:Biobank/TB/CIDEIM;phenotype:XDR,2014-12-08T22:12:08.472Z,2015-03-16T03:17:09.594Z
1418253_3,Mycobacterium tuberculosis 44503,Mycobacterium tuberculosis 44503,1418253.0,WGS,44503,,,,,,,,2014-04-29T00:00:00Z,,PRJNA227753,SAMN02402664,GCA_000669775.1,JLBD00000000,-,Broad Institute,WGS,Illumina,24.0x,allpaths v. R48559,,,78.0,85.0,4371852.0,65.6,4339.0,,4021.0,,Sputum,,2008,Colombia,"Colombia: Buenaventura, Valle del Cauca",,,,,,"Human, Homo sapiens",Female,42,MDR-TB,,,host_subject_id:patient 2;treatment course:into treatment,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:L�wenstein-Jensen culture;respository name:Biobank/TB/CIDEIM;phenotype:MDR,2014-12-08T22:12:08.462Z,2015-03-16T03:17:09.594Z
1418254_3,Mycobacterium tuberculosis 51628,Mycobacterium tuberculosis 51628,1418254.0,WGS,51628,,,,,,,,2014-04-29T00:00:00Z,,PRJNA227754,SAMN02402665,GCA_000669795.1,JLBC00000000,-,Broad Institute,WGS,Illumina,77.0x,allpaths v. R48559,,,68.0,75.0,4374594.0,65.6,4345.0,,4013.0,,Sputum,,2009,Colombia,"Colombia: Buenaventura, Valle del Cauca",,,,,,"Human, Homo sapiens",Female,43,XDR-TB,,,host_subject_id:patient 2;treatment course:into treatment,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:L�wenstein-Jensen culture;respository name:Biobank/TB/CIDEIM;phenotype:XDR,2014-12-08T22:12:08.481Z,2015-03-16T03:17:09.594Z
1418255_3,Mycobacterium tuberculosis 38088,Mycobacterium tuberculosis 38088,1418255.0,WGS,38088,,,,,,,,2014-04-29T00:00:00Z,,PRJNA227755,SAMN02402666,GCA_000669815.1,JLBB00000000,-,Broad Institute,WGS,Illumina,69.0x,allpaths v. R48559,,,91.0,96.0,4371771.0,65.6,4356.0,,3979.0,,Sputum,,2007,Colombia,"Colombia: Buenaventura, Valle del Cauca",,,,,,"Human, Homo sapiens",Female,,TB,,,host_subject_id:patient 3;treatment course:admission,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:L�wenstein-Jensen culture;respository name:Biobank/TB/CIDEIM;phenotype:TB,2014-12-08T22:12:08.436Z,2015-03-16T03:17:09.594Z
1418256_3,Mycobacterium tuberculosis 36361,Mycobacterium tuberculosis 36361,1418256.0,WGS,36361,,,,,,,,2014-04-29T00:00:00Z,,PRJNA227756,SAMN02402667,GCA_000669835.1,JLBA00000000,-,Broad Institute,WGS,Illumina,63.0x,allpaths v. R48559,,,67.0,71.0,4393387.0,65.6,4372.0,,4018.0,,Sputum,,2007,Colombia,"Colombia: Buenaventura, Valle del Cauca",,,,,,"Human, Homo sapiens",Male,,TB,,,host_subject_id:patient 4;treatment course:admission,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Taiwan,ziehl-neelsen stain:None;organism detection method:L�wenstein-Jensen culture;respository name:Biobank/TB/CIDEIM;phenotype:TB,2014-12-08T22:12:08.426Z,2015-03-16T03:17:09.594Z
1421917_3,Mycobacterium tuberculosis TB_RSA01,Mycobacterium tuberculosis TB_RSA01,1421917.0,WGS,TB_RSA01,,,,,,,,2014-04-29T00:00:00Z,,PRJNA227995,SAMN02403442,GCA_000669855.1,JKXL00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,23.0,24.0,4390819.0,65.6,4350.0,,3997.0,,Excreted bodily substance,,07/12/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11226;treatment course:11 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.712Z,2015-03-16T03:17:09.594Z
1421918_3,Mycobacterium tuberculosis TB_RSA02,Mycobacterium tuberculosis TB_RSA02,1421918.0,WGS,TB_RSA02,,,,,,,,2014-04-29T00:00:00Z,,PRJNA227996,SAMN02403443,GCA_000669875.1,JKXK00000000,-,Broad Institute,WGS,Illumina,115.0x,allpaths v. R48559,,,25.0,27.0,4389271.0,65.6,4351.0,,3992.0,,Excreted bodily substance,,08/27/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11226;treatment course:Pre - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.722Z,2015-03-16T03:17:09.594Z
1421919_3,Mycobacterium tuberculosis TB_RSA03,Mycobacterium tuberculosis TB_RSA03,1421919.0,WGS,TB_RSA03,,,,,,,,2014-04-29T00:00:00Z,,PRJNA227997,SAMN02403444,GCA_000669895.1,JKXJ00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,15.0,15.0,4394261.0,65.6,4356.0,,3982.0,,Excreted bodily substance,,10/10/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11176;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.732Z,2015-03-16T03:17:09.594Z
1421920_3,Mycobacterium tuberculosis TB_RSA04,Mycobacterium tuberculosis TB_RSA04,1421920.0,WGS,TB_RSA04,,,,,,,,2014-04-29T00:00:00Z,,PRJNA227998,SAMN02403445,GCA_000669915.1,JKXI00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,18.0,18.0,4397172.0,65.6,4351.0,,3999.0,,Excreted bodily substance,,09/11/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,37,,,,host_subject_id:11176;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.741Z,2015-03-16T03:17:09.594Z
1421921_3,Mycobacterium tuberculosis TB_RSA05,Mycobacterium tuberculosis TB_RSA05,1421921.0,WGS,TB_RSA05,,,,,,,,2014-04-29T00:00:00Z,,PRJNA227999,SAMN02403446,GCA_000669935.1,JKXH00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,26.0,27.0,4383286.0,65.6,4331.0,,3982.0,,Excreted bodily substance,,08/27/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,35,,,,host_subject_id:11127;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.751Z,2015-03-16T03:17:09.594Z
1421922_3,Mycobacterium tuberculosis TB_RSA06,Mycobacterium tuberculosis TB_RSA06,1421922.0,WGS,TB_RSA06,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228000,SAMN02403447,GCA_000669955.1,JKXG00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,15.0,17.0,4383236.0,65.6,4329.0,,3987.0,,Excreted bodily substance,,12/03/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11127;treatment course:16 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.760Z,2015-03-16T03:17:09.594Z
1421923_3,Mycobacterium tuberculosis TB_RSA07,Mycobacterium tuberculosis TB_RSA07,1421923.0,WGS,TB_RSA07,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228001,SAMN02403448,GCA_000669975.1,JKXF00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,25.0,25.0,4394847.0,65.6,4338.0,,4007.0,,Excreted bodily substance,,04/24/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,28,,,,host_subject_id:11894;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.769Z,2015-03-16T03:17:09.594Z
1421924_3,Mycobacterium tuberculosis TB_RSA08,Mycobacterium tuberculosis TB_RSA08,1421924.0,WGS,TB_RSA08,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228002,SAMN02403449,GCA_000669995.1,JKXE00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,20.0,22.0,4396627.0,65.6,4333.0,,3995.0,,Excreted bodily substance,,03/01/09,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11894;treatment course:10 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.778Z,2015-03-16T03:17:09.594Z
1421925_3,Mycobacterium tuberculosis TB_RSA09,Mycobacterium tuberculosis TB_RSA09,1421925.0,WGS,TB_RSA09,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228003,SAMN02403450,GCA_000670015.1,JKXD00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,21.0,22.0,4389035.0,65.6,4344.0,,3988.0,,Excreted bodily substance,,08/27/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11226;treatment course:Pre - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.788Z,2015-03-16T03:17:09.594Z
1421926_3,Mycobacterium tuberculosis TB_RSA10,Mycobacterium tuberculosis TB_RSA10,1421926.0,WGS,TB_RSA10,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228004,SAMN02403451,GCA_000670035.1,JKXC00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,15.0,15.0,4386152.0,65.6,4329.0,,3979.0,,Excreted bodily substance,,03/04/10,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11226;treatment course:31 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.797Z,2015-03-16T03:17:09.594Z
1421927_3,Mycobacterium tuberculosis TB_RSA11,Mycobacterium tuberculosis TB_RSA11,1421927.0,WGS,TB_RSA11,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228005,SAMN02403452,GCA_000670055.1,JKXB00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,20.0,20.0,4387660.0,65.6,4351.0,,3980.0,,Excreted bodily substance,,08/14/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11958;treatment course:2 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.902Z,2015-03-16T03:17:09.594Z
1421928_3,Mycobacterium tuberculosis TB_RSA12,,1421928.0,WGS,TB_RSA12,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228006,SAMN02403453,GCA_000670075.1,JKXA00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,17.0,27.0,4383050.0,65.6,4337.0,,3987.0,,Excreted bodily substance,,06/06/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,52,,,,host_subject_id:11958;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.973Z,2015-03-16T03:17:09.594Z
1421929_3,Mycobacterium tuberculosis TB_RSA13,,1421929.0,WGS,TB_RSA13,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228007,SAMN02403454,GCA_000670095.1,JKWZ00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,8.0,28.0,4388047.0,65.6,4359.0,,3988.0,,Excreted bodily substance,,02/26/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11102;treatment course:6 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.053Z,2015-03-16T03:17:09.594Z
1421930_3,Mycobacterium tuberculosis TB_RSA14,Mycobacterium tuberculosis TB_RSA14,1421930.0,WGS,TB_RSA14,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228008,SAMN02403455,GCA_000670115.1,JKWY00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,26.0,26.0,4394142.0,65.6,4338.0,,3986.0,,Excreted bodily substance,,08/16/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11102;treatment course:Pre - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.136Z,2015-03-16T03:17:09.594Z
1421931_3,Mycobacterium tuberculosis TB_RSA15,Mycobacterium tuberculosis TB_RSA15,1421931.0,WGS,TB_RSA15,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228009,SAMN02403456,GCA_000670135.1,JKWX00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48559,,,26.0,27.0,4392471.0,65.6,4359.0,,3988.0,,Excreted bodily substance,,11/10/09,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11197;treatment course:27 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.245Z,2015-03-16T03:17:09.594Z
1421932_3,Mycobacterium tuberculosis TB_RSA16,Mycobacterium tuberculosis TB_RSA16,1421932.0,WGS,TB_RSA16,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228010,SAMN02403457,GCA_000670155.1,JKWW00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,23.0,25.0,4387218.0,65.6,4343.0,,3981.0,,Excreted bodily substance,,08/20/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,47,,,,host_subject_id:11197;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.348Z,2015-03-16T03:17:09.594Z
1421933_3,Mycobacterium tuberculosis TB_RSA17,Mycobacterium tuberculosis TB_RSA17,1421933.0,WGS,TB_RSA17,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228011,SAMN02403458,GCA_000670175.1,JKWV00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,26.0,27.0,4391185.0,65.6,4347.0,,3994.0,,Excreted bodily substance,,08/16/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,45,,,,host_subject_id:11193;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:NEG;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2 col;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.449Z,2015-03-16T03:17:09.594Z
1421934_3,Mycobacterium tuberculosis TB_RSA18,Mycobacterium tuberculosis TB_RSA18,1421934.0,WGS,TB_RSA18,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228012,SAMN02403459,GCA_000670195.1,JKWU00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,22.0,23.0,4383970.0,65.6,4337.0,,3988.0,,Excreted bodily substance,,02/26/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11193;treatment course:6 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.556Z,2015-03-16T03:17:09.594Z
1421935_3,Mycobacterium tuberculosis TB_RSA19,Mycobacterium tuberculosis TB_RSA19,1421935.0,WGS,TB_RSA19,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228013,SAMN02403460,GCA_000670215.1,JKWT00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,23.0,25.0,4388205.0,65.6,4355.0,,3985.0,,Excreted bodily substance,,03/24/10,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11880;treatment course:24 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.613Z,2015-03-16T03:17:09.594Z
1421936_3,Mycobacterium tuberculosis TB_RSA20,Mycobacterium tuberculosis TB_RSA20,1421936.0,WGS,TB_RSA20,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228014,SAMN02403461,GCA_000670235.1,JKWS00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,27.0,27.0,4385165.0,65.6,4341.0,,3981.0,,Excreted bodily substance,,02/29/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,31,,,,host_subject_id:11880;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.708Z,2015-03-16T03:17:09.594Z
1421937_3,Mycobacterium tuberculosis TB_RSA21,Mycobacterium tuberculosis TB_RSA21,1421937.0,WGS,TB_RSA21,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228015,SAMN02403462,GCA_000670255.1,JKWR00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,23.0,24.0,4389164.0,65.6,4351.0,,3982.0,,Excreted bodily substance,,04/15/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,36,,,,host_subject_id:11882;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.725Z,2015-03-16T03:17:09.594Z
1421938_3,Mycobacterium tuberculosis TB_RSA22,Mycobacterium tuberculosis TB_RSA22,1421938.0,WGS,TB_RSA22,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228016,SAMN02403463,GCA_000670275.1,JKWQ00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,18.0,19.0,4389369.0,65.6,4338.0,,3979.0,,Excreted bodily substance,,05/08/09,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11882;treatment course:13 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB MGIT POS;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.735Z,2015-03-16T03:17:09.594Z
1421939_3,Mycobacterium tuberculosis TB_RSA23,Mycobacterium tuberculosis TB_RSA23,1421939.0,WGS,TB_RSA23,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228017,SAMN02403464,GCA_000670295.1,JKWP00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,35.0,36.0,4390233.0,65.6,4355.0,,3983.0,,Excreted bodily substance,,05/21/09,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11862;treatment course:13 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB MGIT POS;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.744Z,2015-03-16T03:17:09.594Z
1421940_3,Mycobacterium tuberculosis TB_RSA24,Mycobacterium tuberculosis TB_RSA24,1421940.0,WGS,TB_RSA24,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228018,SAMN02403465,GCA_000670315.1,JKWO00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,27.0,28.0,4392276.0,65.6,4344.0,,3984.0,,Excreted bodily substance,,04/22/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,18,,,,host_subject_id:11862;treatment course:1 mnth - Rx;comorbidity:HIV negative,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.753Z,2015-03-16T03:17:09.594Z
1421941_3,Mycobacterium tuberculosis TB_RSA25,Mycobacterium tuberculosis TB_RSA25,1421941.0,WGS,TB_RSA25,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228019,SAMN02403466,GCA_000670335.1,JKWN00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,22.0,22.0,4404119.0,65.6,4362.0,,4020.0,,Excreted bodily substance,,03/03/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,39,,,,host_subject_id:11394;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.762Z,2015-03-16T03:17:09.594Z
1421942_3,Mycobacterium tuberculosis TB_RSA26,Mycobacterium tuberculosis TB_RSA26,1421942.0,WGS,TB_RSA26,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228020,SAMN02403467,GCA_000670355.1,JKWM00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,5.0,5.0,4401943.0,65.6,4329.0,,4004.0,,Excreted bodily substance,,10/31/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11394;treatment course:8 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.771Z,2015-03-16T03:17:09.594Z
1421943_3,Mycobacterium tuberculosis TB_RSA27,Mycobacterium tuberculosis TB_RSA27,1421943.0,WGS,TB_RSA27,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228021,SAMN02403468,GCA_000670375.1,JKWL00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,15.0,15.0,4399503.0,65.6,4347.0,,3992.0,,Excreted bodily substance,,05/12/10,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11833;treatment course:28 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.785Z,2015-03-16T03:17:09.594Z
1421944_3,Mycobacterium tuberculosis TB_RSA28,Mycobacterium tuberculosis TB_RSA28,1421944.0,WGS,TB_RSA28,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228022,SAMN02403469,GCA_000670395.1,JKWK00000000,-,Broad Institute,WGS,Illumina,30.0x,allpaths v. R48559,,,100.0,109.0,4346157.0,65.6,4358.0,,3977.0,,Excreted bodily substance,,02/07/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,33,,,,host_subject_id:11833;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.796Z,2015-03-16T03:17:09.594Z
1421945_3,Mycobacterium tuberculosis TB_RSA29,Mycobacterium tuberculosis TB_RSA29,1421945.0,WGS,TB_RSA29,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228023,SAMN02403470,GCA_000670415.1,JKWJ00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,13.0,14.0,4388680.0,65.6,4339.0,,3984.0,,Excreted bodily substance,,07/08/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,34,,,,host_subject_id:11963;treatment course:1 mnth - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.806Z,2015-03-16T03:17:09.594Z
1421946_3,Mycobacterium tuberculosis TB_RSA30,Mycobacterium tuberculosis TB_RSA30,1421946.0,WGS,TB_RSA30,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228024,SAMN02403471,GCA_000670435.1,JKWI00000000,-,Broad Institute,WGS,Illumina,94.0x,allpaths v. R48559,,,53.0,59.0,4388122.0,65.6,4346.0,,3991.0,,Excreted bodily substance,,08/05/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11867;treatment course:4 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.817Z,2015-03-16T03:17:09.594Z
1421947_3,Mycobacterium tuberculosis TB_RSA31,Mycobacterium tuberculosis TB_RSA31,1421947.0,WGS,TB_RSA31,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228025,SAMN02403472,GCA_000670455.1,JKWH00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,25.0,25.0,4393646.0,65.6,4332.0,,3987.0,,Excreted bodily substance,,04/15/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,52,,,,host_subject_id:11867;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.826Z,2015-03-16T03:17:09.594Z
1421948_3,Mycobacterium tuberculosis TB_RSA32,Mycobacterium tuberculosis TB_RSA32,1421948.0,WGS,TB_RSA32,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228026,SAMN02403473,GCA_000670475.1,JKWG00000000,-,Broad Institute,WGS,Illumina,75.0x,allpaths v. R48559,,,31.0,35.0,4380430.0,65.6,4343.0,,3989.0,,Excreted bodily substance,,11/21/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11196;treatment course:3 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.835Z,2015-03-16T03:17:09.594Z
1421949_3,Mycobacterium tuberculosis TB_RSA33,Mycobacterium tuberculosis TB_RSA33,1421949.0,WGS,TB_RSA33,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228027,SAMN02403474,GCA_000670495.1,JKWF00000000,-,Broad Institute,WGS,Illumina,109.0x,allpaths v. R48559,,,28.0,28.0,4377815.0,65.6,4316.0,,3975.0,,Excreted bodily substance,,08/16/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,31,,,,host_subject_id:11196;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.844Z,2015-03-16T03:17:09.594Z
1421950_3,Mycobacterium tuberculosis TB_RSA34,Mycobacterium tuberculosis TB_RSA34,1421950.0,WGS,TB_RSA34,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228028,SAMN02403475,GCA_000670515.1,JKWE00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,26.0,26.0,4387983.0,65.6,4349.0,,3985.0,,Excreted bodily substance,,09/02/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11949;treatment course:4 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.855Z,2015-03-16T03:17:09.594Z
1421951_3,Mycobacterium tuberculosis TB_RSA35,Mycobacterium tuberculosis TB_RSA35,1421951.0,WGS,TB_RSA35,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228029,SAMN02403476,GCA_000670535.1,JKWD00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,26.0,27.0,4392451.0,65.6,4353.0,,3989.0,,Excreted bodily substance,,05/30/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,30,,,,host_subject_id:11949;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.865Z,2015-03-16T03:17:09.594Z
1421952_3,Mycobacterium tuberculosis TB_RSA36,Mycobacterium tuberculosis TB_RSA36,1421952.0,WGS,TB_RSA36,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228030,SAMN02403477,GCA_000670555.1,JKWC00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,24.0,26.0,4385206.0,65.6,4338.0,,3988.0,,Excreted bodily substance,,08/16/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11102;treatment course:Pre - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.873Z,2015-03-16T03:17:09.594Z
1421953_3,Mycobacterium tuberculosis TB_RSA37,Mycobacterium tuberculosis TB_RSA37,1421953.0,WGS,TB_RSA37,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228031,SAMN02403478,GCA_000670575.1,JKWB00000000,-,Broad Institute,WGS,Illumina,115.0x,allpaths v. R48559,,,36.0,37.0,4420244.0,65.6,4386.0,,4008.0,,Excreted bodily substance,,05/21/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11102;treatment course:9 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.883Z,2015-03-16T03:17:09.594Z
1421954_3,Mycobacterium tuberculosis TB_RSA38,Mycobacterium tuberculosis TB_RSA38,1421954.0,WGS,TB_RSA38,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228032,SAMN02403479,GCA_000670595.1,JKWA00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,27.0,33.0,4382119.0,65.6,4321.0,,3989.0,,Excreted bodily substance,,05/14/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,36,,,,host_subject_id:11848;treatment course:1 mnth - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.893Z,2015-03-16T03:17:09.594Z
1421955_3,Mycobacterium tuberculosis TB_RSA39,Mycobacterium tuberculosis TB_RSA39,1421955.0,WGS,TB_RSA39,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228033,SAMN02403480,GCA_000670615.1,JKVZ00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,18.0,18.0,4400518.0,65.6,4364.0,,4004.0,,Excreted bodily substance,,05/06/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11878;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.902Z,2015-03-16T03:17:09.594Z
1421956_3,Mycobacterium tuberculosis TB_RSA40,Mycobacterium tuberculosis TB_RSA40,1421956.0,WGS,TB_RSA40,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228034,SAMN02403481,GCA_000670635.1,JKVY00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,20.0,21.0,4397810.0,65.6,4341.0,,3996.0,,Excreted bodily substance,,04/08/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,33,,,,host_subject_id:11878;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.911Z,2015-03-16T03:17:09.594Z
1421957_3,Mycobacterium tuberculosis TB_RSA41,Mycobacterium tuberculosis TB_RSA41,1421957.0,WGS,TB_RSA41,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228035,SAMN02403482,GCA_000670655.1,JKVX00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,30.0,30.0,4401663.0,65.6,4374.0,,3998.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,57,,,,host_subject_id:11940;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.921Z,2015-03-16T03:17:09.594Z
1421958_3,Mycobacterium tuberculosis TB_RSA42,Mycobacterium tuberculosis TB_RSA42,1421958.0,WGS,TB_RSA42,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228036,SAMN02403483,GCA_000670675.1,JKVW00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,24.0,25.0,4388761.0,65.6,4348.0,,3981.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11940;treatment course:10 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.930Z,2015-03-16T03:17:09.594Z
1421959_3,Mycobacterium tuberculosis TB_RSA43,Mycobacterium tuberculosis TB_RSA43,1421959.0,WGS,TB_RSA43,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228037,SAMN02403484,GCA_000670695.1,JKVV00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,41.0,42.0,4394759.0,65.6,4362.0,,3992.0,,Excreted bodily substance,,04/18/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,44,,,,host_subject_id:11876;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.939Z,2015-03-16T03:17:09.594Z
1421960_3,Mycobacterium tuberculosis TB_RSA44,Mycobacterium tuberculosis TB_RSA44,1421960.0,WGS,TB_RSA44,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228038,SAMN02403485,GCA_000670715.1,JKVU00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,19.0,19.0,4392495.0,65.6,4330.0,,3986.0,,Excreted bodily substance,,07/16/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11876;treatment course:3 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.949Z,2015-03-16T03:17:09.594Z
1421961_3,Mycobacterium tuberculosis TB_RSA45,Mycobacterium tuberculosis TB_RSA45,1421961.0,WGS,TB_RSA45,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228039,SAMN02403486,GCA_000670735.1,JKVT00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,18.0,18.0,4391498.0,65.6,4344.0,,3988.0,,Excreted bodily substance,,12/04/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11863;treatment course:8 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.958Z,2015-03-16T03:17:09.594Z
1421962_3,Mycobacterium tuberculosis TB_RSA46,Mycobacterium tuberculosis TB_RSA46,1421962.0,WGS,TB_RSA46,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228040,SAMN02403487,GCA_000670755.1,JKVS00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48559,,,35.0,35.0,4392987.0,65.6,4349.0,,3991.0,,Excreted bodily substance,,04/03/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:11863;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.968Z,2015-03-16T03:17:09.594Z
1421964_3,Mycobacterium tuberculosis TB_RSA48,Mycobacterium tuberculosis TB_RSA48,1421964.0,WGS,TB_RSA48,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228042,SAMN02403489,GCA_000670775.1,JKVR00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,18.0,18.0,4397232.0,65.6,4361.0,,3991.0,,Excreted bodily substance,,08/20/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11844;treatment course:4 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2 col;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.977Z,2015-03-16T03:17:09.594Z
1421965_3,Mycobacterium tuberculosis TB_RSA49,Mycobacterium tuberculosis TB_RSA49,1421965.0,WGS,TB_RSA49,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228043,SAMN02403490,GCA_000670795.1,JKVQ00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,38.0,39.0,4395144.0,65.6,4354.0,,4001.0,,Excreted bodily substance,,08/14/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11895;treatment course:4 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.987Z,2015-03-16T03:17:09.594Z
1421966_3,Mycobacterium tuberculosis TB_RSA50,Mycobacterium tuberculosis TB_RSA50,1421966.0,WGS,TB_RSA50,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228044,SAMN02403491,GCA_000670815.1,JKVP00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,22.0,23.0,4388086.0,65.6,4358.0,,3984.0,,Excreted bodily substance,,04/24/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,31,,,,host_subject_id:11895;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.997Z,2015-03-16T03:17:09.594Z
1421967_3,Mycobacterium tuberculosis TB_RSA51,Mycobacterium tuberculosis TB_RSA51,1421967.0,WGS,TB_RSA51,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228045,SAMN02403492,GCA_000670835.1,JKVO00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,20.0,21.0,4385527.0,65.6,4336.0,,3984.0,,Excreted bodily substance,,09/22/00,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11960;treatment course:15 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.006Z,2015-03-16T03:17:09.594Z
1421968_3,Mycobacterium tuberculosis TB_RSA52,,1421968.0,WGS,TB_RSA52,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA228046,SAMN02403493,GCA_000706165.1,JKVN00000000,-,Broad Institute,,Illumina,133.0x,allpaths v. R48559,,,19.0,30.0,4404080.0,65.6,4295.0,,3987.0,,Excreted bodily substance,,06/13/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,46,,,,host_subject_id:11960;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:50:23.120Z,2015-03-16T03:17:09.594Z
1421969_3,Mycobacterium tuberculosis TB_RSA53,Mycobacterium tuberculosis TB_RSA53,1421969.0,WGS,TB_RSA53,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228047,SAMN02403494,GCA_000670855.1,JKVM00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,17.0,17.0,4398358.0,65.6,4336.0,,4012.0,,Excreted bodily substance,,05/11/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,33,,,,host_subject_id:11449;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.014Z,2015-03-16T03:17:09.594Z
1421970_3,Mycobacterium tuberculosis TB_RSA54,Mycobacterium tuberculosis TB_RSA54,1421970.0,WGS,TB_RSA54,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228048,SAMN02403495,GCA_000658315.1,JKVL00000000,-,Broad Institute,WGS,Illumina,94.0x,allpaths v. R48559,,,64.0,69.0,4373291.0,65.6,4345.0,,4003.0,,Excreted bodily substance,,02/08/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11449;treatment course:9 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.023Z,2015-03-16T03:17:09.594Z
1421971_3,Mycobacterium tuberculosis TB_RSA55,Mycobacterium tuberculosis TB_RSA55,1421971.0,WGS,TB_RSA55,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228049,SAMN02403496,GCA_000670875.1,JKVK00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,21.0,23.0,4386833.0,65.6,4350.0,,3982.0,,Excreted bodily substance,,08/27/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,35,,,,host_subject_id:11127;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.032Z,2015-03-16T03:17:09.594Z
1421972_3,Mycobacterium tuberculosis TB_RSA56,Mycobacterium tuberculosis TB_RSA56,1421972.0,WGS,TB_RSA56,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228050,SAMN02403497,GCA_000670895.1,JKVJ00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,20.0,20.0,4389221.0,65.6,4336.0,,3981.0,,Excreted bodily substance,,03/04/10,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11127;treatment course:31 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.041Z,2015-03-16T03:17:09.594Z
1421973_3,Mycobacterium tuberculosis TB_RSA57,Mycobacterium tuberculosis TB_RSA57,1421973.0,WGS,TB_RSA57,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228051,SAMN02403498,GCA_000670915.1,JKVI00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,21.0,22.0,4498274.0,65.6,4467.0,,4098.0,,Excreted bodily substance,,02/15/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,59,,,,host_subject_id:11389;treatment course:Pre - Rx,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.050Z,2015-03-16T03:17:09.594Z
1421974_3,Mycobacterium tuberculosis TB_RSA58,Mycobacterium tuberculosis TB_RSA58,1421974.0,WGS,TB_RSA58,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228052,SAMN02403499,GCA_000670935.1,JKVH00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,19.0,21.0,4471490.0,65.6,4412.0,,4068.0,,Excreted bodily substance,,04/20/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11389;treatment course:2 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:scanty;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.059Z,2015-03-16T03:17:09.594Z
1421975_3,Mycobacterium tuberculosis TB_RSA59,Mycobacterium tuberculosis TB_RSA59,1421975.0,WGS,TB_RSA59,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228053,SAMN02403500,GCA_000670955.1,JKVG00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,28.0,28.0,4397178.0,65.6,4359.0,,3996.0,,Excreted bodily substance,,03/30/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,33,,,,host_subject_id:11413;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.068Z,2015-03-16T03:17:09.594Z
1421976_3,Mycobacterium tuberculosis TB_RSA60,Mycobacterium tuberculosis TB_RSA60,1421976.0,WGS,TB_RSA60,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228054,SAMN02403501,GCA_000670975.1,JKVF00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,28.0,28.0,4407337.0,65.6,4361.0,,3992.0,,Excreted bodily substance,,08/24/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11413;treatment course:5 mnth  -Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4 col;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.077Z,2015-03-16T03:17:09.594Z
1421977_3,Mycobacterium tuberculosis TB_RSA61,Mycobacterium tuberculosis TB_RSA61,1421977.0,WGS,TB_RSA61,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228055,SAMN02403502,GCA_000670995.1,JKVE00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,21.0,25.0,4406300.0,65.6,4374.0,,4022.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,24,,,,host_subject_id:11417;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.086Z,2015-03-16T03:17:09.594Z
1421978_3,Mycobacterium tuberculosis TB_RSA62,Mycobacterium tuberculosis TB_RSA62,1421978.0,WGS,TB_RSA62,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228056,SAMN02403503,GCA_000671015.1,JKVD00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,23.0,23.0,4410464.0,65.6,4368.0,,4020.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11417,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.096Z,2015-03-16T03:17:09.594Z
1421979_3,Mycobacterium tuberculosis TB_RSA63,Mycobacterium tuberculosis TB_RSA63,1421979.0,WGS,TB_RSA63,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228057,SAMN02403504,GCA_000671035.1,JKVC00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,8.0,8.0,4403698.0,65.6,4357.0,,4007.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11420,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.105Z,2015-03-16T03:17:09.594Z
1421980_3,Mycobacterium tuberculosis TB_RSA64,Mycobacterium tuberculosis TB_RSA64,1421980.0,WGS,TB_RSA64,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228058,SAMN02403505,GCA_000671055.1,JKVB00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,2.0,2.0,4398460.0,65.6,4344.0,,4001.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11420,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.116Z,2015-03-16T03:17:09.594Z
1421982_3,Mycobacterium tuberculosis TB_RSA66,Mycobacterium tuberculosis TB_RSA66,1421982.0,WGS,TB_RSA66,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228060,SAMN02403507,GCA_000671075.1,JKVA00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,16.0,17.0,4403680.0,65.6,4363.0,,4018.0,,Excreted bodily substance,,05/11/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,35,,,,host_subject_id:11448;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.126Z,2015-03-16T03:17:09.594Z
1421983_3,Mycobacterium tuberculosis TB_RSA67,Mycobacterium tuberculosis TB_RSA67,1421983.0,WGS,TB_RSA67,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228061,SAMN02403508,GCA_000671095.1,JKUZ00000000,-,Broad Institute,WGS,Illumina,112.0x,allpaths v. R48559,,,25.0,27.0,4392452.0,65.6,4352.0,,4018.0,,Excreted bodily substance,,02/17/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,33,,,,host_subject_id:11375;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.136Z,2015-03-16T03:17:09.594Z
1421984_3,Mycobacterium tuberculosis TB_RSA68,Mycobacterium tuberculosis TB_RSA68,1421984.0,WGS,TB_RSA68,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228062,SAMN02403509,GCA_000671115.1,JKUY00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,28.0,30.0,4401160.0,65.6,4357.0,,4022.0,,Excreted bodily substance,,03/20/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11375;treatment course:25 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.145Z,2015-03-16T03:17:09.594Z
1421985_3,Mycobacterium tuberculosis TB_RSA69,Mycobacterium tuberculosis TB_RSA69,1421985.0,WGS,TB_RSA69,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228063,SAMN02403510,GCA_000671135.1,JKUX00000000,-,Broad Institute,WGS,Illumina,135.0x,allpaths v. R48559,,,17.0,17.0,4389818.0,65.6,4324.0,,3986.0,,Excreted bodily substance,,11/16/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11374;treatment course:9 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.155Z,2015-03-16T03:17:09.594Z
1421986_3,Mycobacterium tuberculosis TB_RSA70,Mycobacterium tuberculosis TB_RSA70,1421986.0,WGS,TB_RSA70,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228064,SAMN02403511,GCA_000671155.1,JKUW00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,15.0,16.0,4389905.0,65.6,4344.0,,3993.0,,Excreted bodily substance,,02/06/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,24,,,,host_subject_id:11374;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.165Z,2015-03-16T03:17:09.594Z
1421987_3,Mycobacterium tuberculosis TB_RSA71,Mycobacterium tuberculosis TB_RSA71,1421987.0,WGS,TB_RSA71,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228065,SAMN02403512,GCA_000671175.1,JKUV00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,14.0,14.0,4396106.0,65.6,4349.0,,4007.0,,Excreted bodily substance,,09/13/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11494;treatment course:3 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.174Z,2015-03-16T03:17:09.594Z
1421988_3,Mycobacterium tuberculosis TB_RSA72,Mycobacterium tuberculosis TB_RSA72,1421988.0,WGS,TB_RSA72,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228066,SAMN02403513,GCA_000671195.1,JKUU00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,9.0,9.0,4402799.0,65.6,4354.0,,4005.0,,Excreted bodily substance,,06/15/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,34,,,,host_subject_id:11494;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.183Z,2015-03-16T03:17:09.594Z
1421989_3,Mycobacterium tuberculosis TB_RSA73,Mycobacterium tuberculosis TB_RSA73,1421989.0,WGS,TB_RSA73,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228067,SAMN02403514,GCA_000671215.1,JKUT00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,20.0,21.0,4392876.0,65.6,4347.0,,4009.0,,Excreted bodily substance,,10/09/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11405;treatment course:33 mnth -Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.193Z,2015-03-16T03:17:09.594Z
1421990_3,Mycobacterium tuberculosis TB_RSA74,Mycobacterium tuberculosis TB_RSA74,1421990.0,WGS,TB_RSA74,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228068,SAMN02403515,GCA_000671235.1,JKUS00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,28.0,29.0,4399026.0,65.6,4354.0,,4004.0,,Excreted bodily substance,,03/23/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,19,,,,host_subject_id:11405;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.202Z,2015-03-16T03:17:09.594Z
1421991_3,Mycobacterium tuberculosis TB_RSA75,Mycobacterium tuberculosis TB_RSA75,1421991.0,WGS,TB_RSA75,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228069,SAMN02403516,GCA_000671255.1,JKUR00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,34.0,35.0,4415410.0,65.6,4372.0,,4015.0,,Excreted bodily substance,,07/17/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11403;treatment course:16 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:1+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.212Z,2015-03-16T03:17:09.594Z
1421992_3,Mycobacterium tuberculosis TB_RSA76,Mycobacterium tuberculosis TB_RSA76,1421992.0,WGS,TB_RSA76,,,,,,,,2014-04-29T00:00:00Z,,PRJNA228070,SAMN02403517,GCA_000671275.1,JKUQ00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,20.0,21.0,4419678.0,65.6,4381.0,,4015.0,,Excreted bodily substance,,03/03/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,33,,,,host_subject_id:11403;treatment course:Pre - Rx,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.221Z,2015-03-16T03:17:09.594Z
1421993_3,Mycobacterium tuberculosis TB_RSA77,Mycobacterium tuberculosis TB_RSA77,1421993.0,WGS,TB_RSA77,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228071,SAMN02403518,GCA_000658835.1,JKUP00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,19.0,21.0,4401842.0,65.6,4357.0,,4018.0,,Excreted bodily substance,,02/11/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,39,,,,host_subject_id:11376;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.230Z,2015-03-16T03:17:09.594Z
1421994_3,Mycobacterium tuberculosis TB_RSA78,Mycobacterium tuberculosis TB_RSA78,1421994.0,WGS,TB_RSA78,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228072,SAMN02403519,GCA_000674875.1,JKUO00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,12.0,14.0,4400418.0,65.6,4352.0,,4015.0,,Excreted bodily substance,,03/17/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11376;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:1+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.239Z,2015-03-16T03:17:09.594Z
1421995_3,Mycobacterium tuberculosis TB_RSA79,Mycobacterium tuberculosis TB_RSA79,1421995.0,WGS,TB_RSA79,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228073,SAMN02403520,GCA_000674895.1,JKUN00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,14.0,15.0,4400425.0,65.6,4354.0,,4014.0,,Excreted bodily substance,,06/14/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,23,,,,host_subject_id:11435;treatment course:1 mnth - Rx;comorbidity:HIV positive,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:scanty;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.248Z,2015-03-16T03:17:09.594Z
1421996_3,Mycobacterium tuberculosis TB_RSA80,Mycobacterium tuberculosis TB_RSA80,1421996.0,WGS,TB_RSA80,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228074,SAMN02403521,GCA_000674915.1,JKUM00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,25.0,27.0,4390259.0,65.6,4334.0,,4012.0,,Excreted bodily substance,,05/11/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11435;treatment course:Pre - Rx,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.257Z,2015-03-16T03:17:09.594Z
1421997_3,Mycobacterium tuberculosis TB_RSA81,Mycobacterium tuberculosis TB_RSA81,1421997.0,WGS,TB_RSA81,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228075,SAMN02403522,GCA_000674935.1,JKUL00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,16.0,19.0,4387144.0,65.6,4324.0,,3993.0,,Excreted bodily substance,,05/11/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,44,,,,host_subject_id:11452;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.266Z,2015-03-16T03:17:09.594Z
1421998_3,Mycobacterium tuberculosis TB_RSA82,Mycobacterium tuberculosis TB_RSA82,1421998.0,WGS,TB_RSA82,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228076,SAMN02403523,GCA_000674955.1,JKUK00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,23.0,27.0,4384092.0,65.6,4349.0,,3994.0,,Excreted bodily substance,,02/08/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11452;treatment course:9 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.276Z,2015-03-16T03:17:09.594Z
1421999_3,Mycobacterium tuberculosis TB_RSA83,Mycobacterium tuberculosis TB_RSA83,1421999.0,WGS,TB_RSA83,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228077,SAMN02403524,GCA_000674975.1,JKUJ00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,20.0,21.0,4398033.0,65.6,4361.0,,4024.0,,Excreted bodily substance,,04/01/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11425;treatment course:Pre - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB  3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.284Z,2015-03-16T03:17:09.594Z
1422000_3,Mycobacterium tuberculosis TB_RSA84,Mycobacterium tuberculosis TB_RSA84,1422000.0,WGS,TB_RSA84,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228078,SAMN02403525,GCA_000674995.1,JKUI00000000,-,Broad Institute,WGS,Illumina,115.0x,allpaths v. R48559,,,22.0,22.0,4397778.0,65.6,4331.0,,3995.0,,Excreted bodily substance,,09/20/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11425;treatment course:18 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.293Z,2015-03-16T03:17:09.594Z
1422001_3,Mycobacterium tuberculosis TB_RSA85,Mycobacterium tuberculosis TB_RSA85,1422001.0,WGS,TB_RSA85,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228079,SAMN02403526,GCA_000675015.1,JKUH00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,22.0,24.0,4399746.0,65.6,4366.0,,3999.0,,Excreted bodily substance,,05/04/00,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,36,,,,host_subject_id:11445;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.303Z,2015-03-16T03:17:09.594Z
1422002_3,Mycobacterium tuberculosis TB_RSA86,Mycobacterium tuberculosis TB_RSA86,1422002.0,WGS,TB_RSA86,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228080,SAMN02403527,GCA_000675035.1,JKUG00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,25.0,27.0,4401593.0,65.6,4383.0,,4005.0,,Excreted bodily substance,,11/21/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11445;treatment course:6 month - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.313Z,2015-03-16T03:17:09.594Z
1422003_3,Mycobacterium tuberculosis TB_RSA87,Mycobacterium tuberculosis TB_RSA87,1422003.0,WGS,TB_RSA87,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228081,SAMN02403528,GCA_000675055.1,JKUF00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,20.0,20.0,4387583.0,65.6,4322.0,,4003.0,,Excreted bodily substance,,05/04/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,35,,,,host_subject_id:11444;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.322Z,2015-03-16T03:17:09.594Z
1422004_3,Mycobacterium tuberculosis TB_RSA88,Mycobacterium tuberculosis TB_RSA88,1422004.0,WGS,TB_RSA88,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228082,SAMN02403529,GCA_000675075.1,JKUE00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,17.0,17.0,4391760.0,65.6,4334.0,,4005.0,,Excreted bodily substance,,08/04/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11444;treatment course:3 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3 col;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.331Z,2015-03-16T03:17:09.594Z
1422005_3,Mycobacterium tuberculosis TB_RSA89,Mycobacterium tuberculosis TB_RSA89,1422005.0,WGS,TB_RSA89,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228083,SAMN02403530,GCA_000675095.1,JKUD00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,18.0,20.0,4414652.0,65.6,4358.0,,4024.0,,Excreted bodily substance,,07/28/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,57,,,,host_subject_id:11532;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.339Z,2015-03-16T03:17:09.594Z
1422006_3,Mycobacterium tuberculosis TB_RSA90,Mycobacterium tuberculosis TB_RSA90,1422006.0,WGS,TB_RSA90,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228084,SAMN02403531,GCA_000675115.1,JKUC00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,28.0,29.0,4422922.0,65.6,4373.0,,4017.0,,Excreted bodily substance,,09/27/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11532;treatment course:2 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.348Z,2015-03-16T03:17:09.594Z
1422007_3,Mycobacterium tuberculosis TB_RSA91,Mycobacterium tuberculosis TB_RSA91,1422007.0,WGS,TB_RSA91,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228085,SAMN02403532,GCA_000675135.1,JKUB00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,18.0,20.0,4383873.0,65.6,4318.0,,3990.0,,Excreted bodily substance,,11/20/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11439;treatment course:19 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.356Z,2015-03-16T03:17:09.594Z
1422008_3,Mycobacterium tuberculosis TB_RSA92,Mycobacterium tuberculosis TB_RSA92,1422008.0,WGS,TB_RSA92,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228086,SAMN02403533,GCA_000675155.1,JKUA00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,14.0,15.0,4383702.0,65.6,4343.0,,3988.0,,Excreted bodily substance,,06/15/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,37,,,,host_subject_id:11439;treatment course:1 mnth - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:scanty;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.364Z,2015-03-16T03:17:09.594Z
1422009_3,Mycobacterium tuberculosis TB_RSA93,Mycobacterium tuberculosis TB_RSA93,1422009.0,WGS,TB_RSA93,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228087,SAMN02403534,GCA_000675175.1,JKTZ00000000,-,Broad Institute,WGS,Illumina,96.0x,allpaths v. R48559,,,17.0,17.0,4389964.0,65.6,4332.0,,3999.0,,Excreted bodily substance,,04/07/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,45,,,,host_subject_id:11426;treatment course:Pre - Rx,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.373Z,2015-03-16T03:17:09.594Z
1422010_3,Mycobacterium tuberculosis TB_RSA94,Mycobacterium tuberculosis TB_RSA94,1422010.0,WGS,TB_RSA94,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228088,SAMN02403535,GCA_000675195.1,JKTY00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48559,,,23.0,23.0,4395679.0,65.6,4341.0,,4004.0,,Excreted bodily substance,,06/05/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11426;treatment course:3 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:scanty;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2 col;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.382Z,2015-03-16T03:17:09.594Z
1422011_3,Mycobacterium tuberculosis TB_RSA95,Mycobacterium tuberculosis TB_RSA95,1422011.0,WGS,TB_RSA95,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228089,SAMN02403536,GCA_000675215.1,JKTX00000000,-,Broad Institute,WGS,Illumina,54.0x,allpaths v. R48559,,,126.0,134.0,4366578.0,65.5,4359.0,,4005.0,,Excreted bodily substance,,07/28/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11500;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 6 col;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.391Z,2015-03-16T03:17:09.594Z
1422012_3,Mycobacterium tuberculosis TB_RSA96,Mycobacterium tuberculosis TB_RSA96,1422012.0,WGS,TB_RSA96,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228090,SAMN02403537,GCA_000675235.1,JKTW00000000,-,Broad Institute,WGS,Illumina,104.0x,allpaths v. R48559,,,19.0,19.0,4354019.0,65.6,4329.0,,3985.0,,Excreted bodily substance,,06/28/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,17,,,,host_subject_id:11500;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:scanty;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.401Z,2015-03-16T03:17:09.594Z
1422013_3,Mycobacterium tuberculosis TB_RSA97,Mycobacterium tuberculosis TB_RSA97,1422013.0,WGS,TB_RSA97,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228091,SAMN02403538,GCA_000675255.1,JKTV00000000,-,Broad Institute,WGS,Illumina,103.0x,allpaths v. R48559,,,15.0,16.0,4392446.0,65.6,4367.0,,3989.0,,Excreted bodily substance,,08/25/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,60,,,,host_subject_id:11566;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.412Z,2015-03-16T03:17:09.594Z
1422014_3,Mycobacterium tuberculosis TB_RSA98,Mycobacterium tuberculosis TB_RSA98,1422014.0,WGS,TB_RSA98,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228092,SAMN02403539,GCA_000675275.1,JKTU00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R48559,,,20.0,20.0,4430896.0,65.6,4395.0,,4021.0,,Excreted bodily substance,,05/17/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,42,,,,host_subject_id:11463;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.423Z,2015-03-16T03:17:09.594Z
1422015_3,Mycobacterium tuberculosis TB_RSA99,Mycobacterium tuberculosis TB_RSA99,1422015.0,WGS,TB_RSA99,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228093,SAMN02403540,GCA_000675295.1,JKTT00000000,-,Broad Institute,WGS,Illumina,77.0x,allpaths v. R48559,,,42.0,43.0,4410311.0,65.6,4409.0,,4012.0,,Excreted bodily substance,,08/16/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11463;treatment course:3 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:17.432Z,2015-03-16T03:17:09.594Z
1422016_3,Mycobacterium tuberculosis TB_RSA100,Mycobacterium tuberculosis TB_RSA100,1422016.0,WGS,TB_RSA100,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228094,SAMN02403541,GCA_000675315.1,JKTS00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,11.0,11.0,4389976.0,65.6,4332.0,,3991.0,,Excreted bodily substance,,08/25/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,50,,,,host_subject_id:11565;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.807Z,2015-03-16T03:17:09.594Z
1422017_3,Mycobacterium tuberculosis TB_RSA101,Mycobacterium tuberculosis TB_RSA101,1422017.0,WGS,TB_RSA101,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228095,SAMN02403542,GCA_000675335.1,JKTR00000000,-,Broad Institute,WGS,Illumina,75.0x,allpaths v. R48559,,,45.0,51.0,4389747.0,65.6,4351.0,,3998.0,,Excreted bodily substance,,09/22/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11565;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.816Z,2015-03-16T03:17:09.594Z
1422018_3,Mycobacterium tuberculosis TB_RSA102,Mycobacterium tuberculosis TB_RSA102,1422018.0,WGS,TB_RSA102,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228096,SAMN02403543,GCA_000675355.1,JKTQ00000000,-,Broad Institute,WGS,Illumina,74.0x,allpaths v. R48559,,,28.0,28.0,4406512.0,65.6,4346.0,,4017.0,,Excreted bodily substance,,08/11/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,36,,,,host_subject_id:11548;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.825Z,2015-03-16T03:17:09.594Z
1422019_3,Mycobacterium tuberculosis TB_RSA103,Mycobacterium tuberculosis TB_RSA103,1422019.0,WGS,TB_RSA103,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228097,SAMN02403544,GCA_000675375.1,JKTP00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R48559,,,34.0,35.0,4410664.0,65.6,4375.0,,4027.0,,Excreted bodily substance,,10/11/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11548;treatment course:2 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB  2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.836Z,2015-03-16T03:17:09.594Z
1422020_3,Mycobacterium tuberculosis TB_RSA104,Mycobacterium tuberculosis TB_RSA104,1422020.0,WGS,TB_RSA104,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228098,SAMN02403545,GCA_000675395.1,JKTO00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,27.0,28.0,4385451.0,65.6,4342.0,,3991.0,,Excreted bodily substance,,09/12/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11547;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.846Z,2015-03-16T03:17:09.594Z
1422021_3,Mycobacterium tuberculosis TB_RSA105,Mycobacterium tuberculosis TB_RSA105,1422021.0,WGS,TB_RSA105,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228099,SAMN02403546,GCA_000675415.1,JKTN00000000,-,Broad Institute,WGS,Illumina,74.0x,allpaths v. R48559,,,23.0,23.0,4385177.0,65.6,4349.0,,3991.0,,Excreted bodily substance,,08/11/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,31,,,,host_subject_id:11547;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.855Z,2015-03-16T03:17:09.594Z
1422022_3,Mycobacterium tuberculosis TB_RSA106,Mycobacterium tuberculosis TB_RSA106,1422022.0,WGS,TB_RSA106,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228100,SAMN02403547,GCA_000675435.1,JKTM00000000,-,Broad Institute,WGS,Illumina,101.0x,allpaths v. R48559,,,15.0,16.0,4407734.0,65.6,4368.0,,4022.0,,Excreted bodily substance,,05/15/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,31,,,,host_subject_id:11458;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.864Z,2015-03-16T03:17:09.594Z
1422023_3,Mycobacterium tuberculosis TB_RSA107,Mycobacterium tuberculosis TB_RSA107,1422023.0,WGS,TB_RSA107,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228101,SAMN02403548,GCA_000675455.1,JKTL00000000,-,Broad Institute,WGS,Illumina,80.0x,allpaths v. R48559,,,74.0,81.0,4385318.0,65.5,4366.0,,4020.0,,Excreted bodily substance,,07/14/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11458;treatment course:2 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4 col;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.874Z,2015-03-16T03:17:09.594Z
1422024_3,Mycobacterium tuberculosis TB_RSA108,Mycobacterium tuberculosis TB_RSA108,1422024.0,WGS,TB_RSA108,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228102,SAMN02403549,GCA_000675475.1,JKTK00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,5.0,5.0,4399244.0,65.6,4348.0,,4000.0,,Excreted bodily substance,,05/29/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,44,,,,host_subject_id:11473;treatment course:Pre - Rx,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.884Z,2015-03-16T03:17:09.594Z
1422025_3,Mycobacterium tuberculosis TB_RSA109,Mycobacterium tuberculosis TB_RSA109,1422025.0,WGS,TB_RSA109,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228103,SAMN02403550,GCA_000675495.1,JKTJ00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,5.0,5.0,4403924.0,65.6,4338.0,,4007.0,,Excreted bodily substance,,07/28/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11473;treatment course:2 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.894Z,2015-03-16T03:17:09.594Z
1422026_3,Mycobacterium tuberculosis TB_RSA110,,1422026.0,WGS,TB_RSA110,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228104,SAMN02403551,GCA_000675515.1,JKTI00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,8.0,17.0,4402771.0,65.6,4368.0,,4019.0,,Excreted bodily substance,,10/13/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,28,,,,host_subject_id:11584;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.911Z,2015-03-16T03:17:09.594Z
1422027_3,Mycobacterium tuberculosis TB_RSA111,,1422027.0,WGS,TB_RSA111,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228105,SAMN02403552,GCA_000675535.1,JKTH00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,4.0,20.0,4405587.0,65.6,4365.0,,4021.0,,Excreted bodily substance,,01/17/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11584;treatment course:3 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:scanty;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3 col;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.920Z,2015-03-16T03:17:09.594Z
1422029_3,Mycobacterium tuberculosis TB_RSA113,,1422029.0,WGS,TB_RSA113,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228107,SAMN02403554,GCA_000675555.1,JKTG00000000,-,Broad Institute,WGS,Illumina,66.0x,allpaths v. R48559,,,19.0,73.0,4363028.0,65.5,4344.0,,4021.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",,26,,,,host_subject_id:SS409,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB MGIT POS;tb culture 7h11:no growth;organism detection method:MGIT,2014-12-08T22:12:15.928Z,2015-03-16T03:17:09.594Z
1422030_3,Mycobacterium tuberculosis TB_RSA114,,1422030.0,WGS,TB_RSA114,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228108,SAMN02403555,GCA_000675575.1,JKTF00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48559,,,29.0,45.0,4406870.0,65.6,4369.0,,4020.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,25,,,,host_subject_id:SS213,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB MGIT POS;tb culture 7h11:no growth;phenotype:MDR;organism detection method:MGIT,2014-12-08T22:12:15.937Z,2015-03-16T03:17:09.594Z
1422033_3,Mycobacterium tuberculosis TB_RSA117,,1422033.0,WGS,TB_RSA117,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228111,SAMN02403558,GCA_000675595.1,JKTE00000000,-,Broad Institute,WGS,Illumina,113.0x,allpaths v. R48559,,,13.0,25.0,4400952.0,65.6,4364.0,,3996.0,,Excreted bodily substance,,09/01/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11537;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.946Z,2015-03-16T03:17:09.594Z
1422034_3,Mycobacterium tuberculosis TB_RSA118,,1422034.0,WGS,TB_RSA118,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228112,SAMN02403559,GCA_000675615.1,JKTD00000000,-,Broad Institute,WGS,Illumina,94.0x,allpaths v. R48559,,,13.0,25.0,4392603.0,65.6,4353.0,,3992.0,,Excreted bodily substance,,08/04/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,35,,,,host_subject_id:11537;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.956Z,2015-03-16T03:17:09.594Z
1422035_3,Mycobacterium tuberculosis TB_RSA119,,1422035.0,WGS,TB_RSA119,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228113,SAMN02403560,GCA_000675635.1,JKTC00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,10.0,25.0,4395660.0,65.6,4380.0,,3996.0,,Excreted bodily substance,,03/10/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11595;treatment course:5 mnth  -Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.965Z,2015-03-16T03:17:09.594Z
1422036_3,Mycobacterium tuberculosis TB_RSA120,,1422036.0,WGS,TB_RSA120,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228114,SAMN02403561,GCA_000675655.1,JKTB00000000,-,Broad Institute,WGS,Illumina,99.0x,allpaths v. R48559,,,5.0,18.0,4402558.0,65.6,4365.0,,4003.0,,Excreted bodily substance,,10/30/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,33,,,,host_subject_id:11595;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.982Z,2015-03-16T03:17:09.594Z
1422037_3,Mycobacterium tuberculosis TB_RSA121,,1422037.0,WGS,TB_RSA121,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228115,SAMN02403562,GCA_000675675.1,JKTA00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,75.0,79.0,4385751.0,65.6,4363.0,,4017.0,,Excreted bodily substance,,07/10/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11450;treatment course:2 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4 col;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:15.992Z,2015-03-16T03:17:09.594Z
1422038_3,Mycobacterium tuberculosis TB_RSA122,,1422038.0,WGS,TB_RSA122,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228117,SAMN02403563,GCA_000675695.1,JKSZ00000000,-,Broad Institute,WGS,Illumina,77.0x,allpaths v. R48559,,,4.0,17.0,4404499.0,65.6,4367.0,,4018.0,,Excreted bodily substance,,05/11/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,55,,,,host_subject_id:11450;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16Z,2015-03-16T03:17:09.594Z
1422039_3,Mycobacterium tuberculosis TB_RSA123,,1422039.0,WGS,TB_RSA123,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228118,SAMN02403564,GCA_000675715.1,JKSY00000000,-,Broad Institute,WGS,Illumina,110.0x,allpaths v. R48559,,,20.0,35.0,4409502.0,65.6,4392.0,,4023.0,,Excreted bodily substance,,03/13/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11600;treatment course:16 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.009Z,2015-03-16T03:17:09.594Z
1422040_3,Mycobacterium tuberculosis TB_RSA124,,1422040.0,WGS,TB_RSA124,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228119,SAMN02403565,GCA_000675735.1,JKSX00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,6.0,36.0,4386804.0,65.6,4356.0,,4019.0,,Excreted bodily substance,,10/03/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,39,,,,host_subject_id:11600;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.019Z,2015-03-16T03:17:09.594Z
1422041_3,Mycobacterium tuberculosis TB_RSA125,,1422041.0,WGS,TB_RSA125,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228120,SAMN02403566,GCA_000675755.1,JKSW00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,5.0,14.0,4356364.0,65.6,4337.0,,3985.0,,Excreted bodily substance,,09/09/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11535;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.028Z,2015-03-16T03:17:09.594Z
1422042_3,Mycobacterium tuberculosis TB_RSA126,,1422042.0,WGS,TB_RSA126,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228121,SAMN02403567,GCA_000675775.1,JKSV00000000,-,Broad Institute,WGS,Illumina,75.0x,allpaths v. R48559,,,5.0,15.0,4401342.0,65.6,4361.0,,4004.0,,Excreted bodily substance,,08/01/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,23,,,,host_subject_id:11535;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:13:55.778Z,2015-03-16T03:17:09.594Z
1422043_3,Mycobacterium tuberculosis TB_RSA127,,1422043.0,WGS,TB_RSA127,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228122,SAMN02403568,GCA_000675795.1,JKSU00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,1.0,9.0,4395478.0,65.6,4345.0,,4004.0,,Excreted bodily substance,,01/22/09,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11466;treatment course:33 mnth -Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.036Z,2015-03-16T03:17:09.594Z
1422044_3,Mycobacterium tuberculosis TB_RSA128,,1422044.0,WGS,TB_RSA128,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228123,SAMN02403569,GCA_000675815.1,JKST00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,1.0,7.0,4404417.0,65.6,4355.0,,4002.0,,Excreted bodily substance,,05/24/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,31,,,,host_subject_id:11466;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.045Z,2015-03-16T03:17:09.594Z
1422045_3,Mycobacterium tuberculosis TB_RSA129,,1422045.0,WGS,TB_RSA129,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228124,SAMN02403570,GCA_000675835.1,JKSS00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,1.0,13.0,4409492.0,65.6,4364.0,,4010.0,,Excreted bodily substance,,10/27/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,30,,,,host_subject_id:11592;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:13:55.786Z,2015-03-16T03:17:09.594Z
1422046_3,Mycobacterium tuberculosis TB_RSA130,,1422046.0,WGS,TB_RSA130,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228125,SAMN02403571,GCA_000675855.1,JKSR00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,3.0,12.0,4387994.0,65.6,4331.0,,3999.0,,Excreted bodily substance,,01/05/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11592;treatment course:3 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:scanty;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:13:55.797Z,2015-03-16T03:17:09.594Z
1422047_3,Mycobacterium tuberculosis TB_RSA131,Mycobacterium tuberculosis TB_RSA131,1422047.0,WGS,TB_RSA131,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228126,SAMN02403572,GCA_000675875.1,JKSQ00000000,-,Broad Institute,WGS,Illumina,76.0x,allpaths v. R48559,,,35.0,35.0,4413971.0,65.6,4368.0,,4010.0,,Excreted bodily substance,,08/14/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,20,,,,host_subject_id:11517;treatment course:1 mnth - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.062Z,2015-03-16T03:17:09.594Z
1422048_3,Mycobacterium tuberculosis TB_RSA132,Mycobacterium tuberculosis TB_RSA132,1422048.0,WGS,TB_RSA132,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228127,SAMN02403573,GCA_000675895.1,JKSP00000000,-,Broad Institute,WGS,Illumina,72.0x,allpaths v. R48559,,,11.0,11.0,4401263.0,65.6,4350.0,,4002.0,,Excreted bodily substance,,03/27/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11517;treatment course:8 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:1+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.071Z,2015-03-16T03:17:09.594Z
1422049_3,Mycobacterium tuberculosis TB_RSA133,Mycobacterium tuberculosis TB_RSA133,1422049.0,WGS,TB_RSA133,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228128,SAMN02403574,GCA_000675915.1,JKSO00000000,-,Broad Institute,WGS,Illumina,77.0x,allpaths v. R48559,,,26.0,27.0,4389120.0,65.6,4331.0,,3979.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,33,,,,host_subject_id:11515;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.080Z,2015-03-16T03:17:09.594Z
1422050_3,Mycobacterium tuberculosis TB_RSA134,Mycobacterium tuberculosis TB_RSA134,1422050.0,WGS,TB_RSA134,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228129,SAMN02403575,GCA_000675935.1,JKSN00000000,-,Broad Institute,WGS,Illumina,69.0x,allpaths v. R48559,,,37.0,37.0,4420002.0,65.6,4360.0,,3987.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11515,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:13:55.807Z,2015-03-16T03:17:09.594Z
1422051_3,Mycobacterium tuberculosis TB_RSA135,Mycobacterium tuberculosis TB_RSA135,1422051.0,WGS,TB_RSA135,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228130,SAMN02403576,GCA_000675955.1,JKSM00000000,-,Broad Institute,WGS,Illumina,62.0x,allpaths v. R48559,,,43.0,46.0,4378052.0,65.6,4347.0,,4001.0,,Excreted bodily substance,,09/11/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11506;treatment course:27 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.090Z,2015-03-16T03:17:09.594Z
1422052_3,Mycobacterium tuberculosis TB_RSA136,Mycobacterium tuberculosis TB_RSA136,1422052.0,WGS,TB_RSA136,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228131,SAMN02403577,GCA_000675975.1,JKSL00000000,-,Broad Institute,WGS,Illumina,74.0x,allpaths v. R48559,,,21.0,21.0,4401451.0,65.6,4331.0,,3993.0,,Excreted bodily substance,,08/07/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,41,,,,host_subject_id:11506;treatment course:1 mnth - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.099Z,2015-03-16T03:17:09.594Z
1422053_3,Mycobacterium tuberculosis TB_RSA137,Mycobacterium tuberculosis TB_RSA137,1422053.0,WGS,TB_RSA137,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228132,SAMN02403578,GCA_000675995.1,JKSK00000000,-,Broad Institute,WGS,Illumina,107.0x,allpaths v. R48559,,,11.0,11.0,4401320.0,65.6,4356.0,,4011.0,,Excreted bodily substance,,02/14/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11511;treatment course:20 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.109Z,2015-03-16T03:17:09.594Z
1422054_3,Mycobacterium tuberculosis TB_RSA138,Mycobacterium tuberculosis TB_RSA138,1422054.0,WGS,TB_RSA138,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228133,SAMN02403579,GCA_000676015.1,JKSJ00000000,-,Broad Institute,WGS,Illumina,96.0x,allpaths v. R48559,,,17.0,19.0,4400415.0,65.6,4359.0,,4015.0,,Excreted bodily substance,,07/10/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,32,,,,host_subject_id:11511;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.117Z,2015-03-16T03:17:09.594Z
1422055_3,Mycobacterium tuberculosis TB_RSA139,Mycobacterium tuberculosis TB_RSA139,1422055.0,WGS,TB_RSA139,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228134,SAMN02403580,GCA_000676035.1,JKSI00000000,-,Broad Institute,WGS,Illumina,77.0x,allpaths v. R48559,,,38.0,41.0,4385807.0,65.6,4347.0,,3998.0,,Excreted bodily substance,,04/05/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,23,,,,host_subject_id:11418;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.126Z,2015-03-16T03:17:09.594Z
1422056_3,Mycobacterium tuberculosis TB_RSA140,Mycobacterium tuberculosis TB_RSA140,1422056.0,WGS,TB_RSA140,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228135,SAMN02403581,GCA_000676055.1,JKSH00000000,-,Broad Institute,WGS,Illumina,104.0x,allpaths v. R48559,,,10.0,11.0,4393587.0,65.6,4328.0,,3999.0,,Excreted bodily substance,,05/05/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11418;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.145Z,2015-03-16T03:17:09.594Z
1422057_3,Mycobacterium tuberculosis TB_RSA141,Mycobacterium tuberculosis TB_RSA141,1422057.0,WGS,TB_RSA141,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228136,SAMN02403582,GCA_000676075.1,JKSG00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,25.0,26.0,4388282.0,65.6,4335.0,,4008.0,,Excreted bodily substance,,03/03/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,32,,,,host_subject_id:11399;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.156Z,2015-03-16T03:17:09.594Z
1422058_3,Mycobacterium tuberculosis TB_RSA142,Mycobacterium tuberculosis TB_RSA142,1422058.0,WGS,TB_RSA142,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228137,SAMN02403583,GCA_000676095.1,JKSF00000000,-,Broad Institute,WGS,Illumina,73.0x,allpaths v. R48559,,,18.0,19.0,4392745.0,65.6,4348.0,,4002.0,,Excreted bodily substance,,06/09/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11399;treatment course:3 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2 col;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.165Z,2015-03-16T03:17:09.594Z
1422059_3,Mycobacterium tuberculosis TB_RSA143,Mycobacterium tuberculosis TB_RSA143,1422059.0,WGS,TB_RSA143,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228138,SAMN02403584,GCA_000676115.1,JKSE00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,19.0,20.0,4383882.0,65.6,4328.0,,4004.0,,Excreted bodily substance,,10/13/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,24,,,,host_subject_id:11589;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.176Z,2015-03-16T03:17:09.594Z
1422060_3,Mycobacterium tuberculosis TB_RSA144,Mycobacterium tuberculosis TB_RSA144,1422060.0,WGS,TB_RSA144,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228139,SAMN02403585,GCA_000676135.1,JKSD00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,67.0,73.0,4373052.0,65.5,4363.0,,4027.0,,Excreted bodily substance,,11/13/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11589;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:1+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.185Z,2015-03-16T03:17:09.594Z
1422061_3,Mycobacterium tuberculosis TB_RSA145,Mycobacterium tuberculosis TB_RSA145,1422061.0,WGS,TB_RSA145,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228140,SAMN02403586,GCA_000676155.1,JKSC00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,16.0,17.0,4403937.0,65.6,4345.0,,4022.0,,Excreted bodily substance,,06/05/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,23,,,,host_subject_id:11479;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.195Z,2015-03-16T03:17:09.594Z
1422062_3,Mycobacterium tuberculosis TB_RSA146,Mycobacterium tuberculosis TB_RSA146,1422062.0,WGS,TB_RSA146,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228141,SAMN02403587,GCA_000676175.1,JKSB00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R48559,,,41.0,42.0,4405853.0,65.6,4363.0,,4008.0,,Excreted bodily substance,,09/12/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11479;treatment course:3 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.206Z,2015-03-16T03:17:09.594Z
1422063_3,Mycobacterium tuberculosis TB_RSA147,Mycobacterium tuberculosis TB_RSA147,1422063.0,WGS,TB_RSA147,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228142,SAMN02403588,GCA_000676195.1,JKSA00000000,-,Broad Institute,WGS,Illumina,78.0x,allpaths v. R48559,,,43.0,44.0,4382863.0,65.6,4357.0,,4008.0,,Excreted bodily substance,,03/30/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11392;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:NEG;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.216Z,2015-03-16T03:17:09.594Z
1422064_3,Mycobacterium tuberculosis TB_RSA148,Mycobacterium tuberculosis TB_RSA148,1422064.0,WGS,TB_RSA148,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228143,SAMN02403589,GCA_000676215.1,JKRZ00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,18.0,19.0,4344672.0,65.6,4299.0,,3969.0,,Excreted bodily substance,,02/17/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,25,,,,host_subject_id:11392;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.225Z,2015-03-16T03:17:09.594Z
1422065_3,Mycobacterium tuberculosis TB_RSA149,Mycobacterium tuberculosis TB_RSA149,1422065.0,WGS,TB_RSA149,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228144,SAMN02403590,GCA_000676235.1,JKRY00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,36.0,39.0,4407659.0,65.6,4413.0,,4017.0,,Excreted bodily substance,,08/25/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,39,,,,host_subject_id:11570;treatment course:Pre - Rx,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.235Z,2015-03-16T03:17:09.594Z
1422066_3,Mycobacterium tuberculosis TB_RSA150,Mycobacterium tuberculosis TB_RSA150,1422066.0,WGS,TB_RSA150,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228145,SAMN02403591,GCA_000676255.1,JKRX00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48559,,,18.0,19.0,4412914.0,65.6,4366.0,,4008.0,,Excreted bodily substance,,04/20/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11570;treatment course:8 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.255Z,2015-03-16T03:17:09.594Z
1422067_3,Mycobacterium tuberculosis TB_RSA151,Mycobacterium tuberculosis TB_RSA151,1422067.0,WGS,TB_RSA151,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228146,SAMN02403592,GCA_000676275.1,JKRW00000000,-,Broad Institute,WGS,Illumina,98.0x,allpaths v. R48559,,,20.0,20.0,4388434.0,65.6,4326.0,,4008.0,,Excreted bodily substance,,10/31/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11520;treatment course:3 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.264Z,2015-03-16T03:17:09.594Z
1422068_3,Mycobacterium tuberculosis TB_RSA152,Mycobacterium tuberculosis TB_RSA152,1422068.0,WGS,TB_RSA152,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228147,SAMN02403593,GCA_000676295.1,JKRV00000000,-,Broad Institute,WGS,Illumina,76.0x,allpaths v. R48559,,,30.0,30.0,4398244.0,65.6,4346.0,,3999.0,,Excreted bodily substance,,08/16/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,43,,,,host_subject_id:11520;treatment course:1 mnth - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB  3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.273Z,2015-03-16T03:17:09.594Z
1422069_3,Mycobacterium tuberculosis TB_RSA153,Mycobacterium tuberculosis TB_RSA153,1422069.0,WGS,TB_RSA153,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228148,SAMN02403594,GCA_000676315.1,JKRU00000000,-,Broad Institute,WGS,Illumina,75.0x,allpaths v. R48559,,,25.0,26.0,4384195.0,65.6,4335.0,,4003.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,24,,,,host_subject_id:11514;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.284Z,2015-03-16T03:17:09.594Z
1422070_3,Mycobacterium tuberculosis TB_RSA154,Mycobacterium tuberculosis TB_RSA154,1422070.0,WGS,TB_RSA154,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228149,SAMN02403595,GCA_000676335.1,JKRT00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,25.0,25.0,4386801.0,65.6,4324.0,,4005.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",,24,,,,host_subject_id:11514,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.293Z,2015-03-16T03:17:09.594Z
1422071_3,Mycobacterium tuberculosis TB_RSA155,Mycobacterium tuberculosis TB_RSA155,1422071.0,WGS,TB_RSA155,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228150,SAMN02403596,GCA_000676355.1,JKRS00000000,-,Broad Institute,WGS,Illumina,25.0x,allpaths v. R48559,,,75.0,81.0,4375425.0,65.6,4360.0,,4013.0,,Excreted bodily substance,,01/29/08,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11593;treatment course:16 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.303Z,2015-03-16T03:17:09.594Z
1422072_3,Mycobacterium tuberculosis TB_RSA156,Mycobacterium tuberculosis TB_RSA156,1422072.0,WGS,TB_RSA156,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228151,SAMN02403597,GCA_000676375.1,JKRR00000000,-,Broad Institute,WGS,Illumina,47.0x,allpaths v. R48559,,,69.0,74.0,4392584.0,65.6,4354.0,,4015.0,,Excreted bodily substance,,10/27/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,27,,,,host_subject_id:11593;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB  4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.312Z,2015-03-16T03:17:09.594Z
1422073_3,Mycobacterium tuberculosis TB_RSA157,Mycobacterium tuberculosis TB_RSA157,1422073.0,WGS,TB_RSA157,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228152,SAMN02403598,GCA_000676395.1,JKRQ00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,14.0,15.0,4398695.0,65.6,4341.0,,4014.0,,Excreted bodily substance,,08/07/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,33,,,,host_subject_id:11544;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.321Z,2015-03-16T03:17:09.594Z
1422074_3,Mycobacterium tuberculosis TB_RSA158,Mycobacterium tuberculosis TB_RSA158,1422074.0,WGS,TB_RSA158,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228153,SAMN02403599,GCA_000676415.1,JKRP00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,27.0,28.0,4411641.0,65.6,4351.0,,4017.0,,Excreted bodily substance,,10/06/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11544;treatment course:2 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.330Z,2015-03-16T03:17:09.594Z
1422075_3,Mycobacterium tuberculosis TB_RSA159,Mycobacterium tuberculosis TB_RSA159,1422075.0,WGS,TB_RSA159,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228154,SAMN02403600,GCA_000676435.1,JKRO00000000,-,Broad Institute,WGS,Illumina,76.0x,allpaths v. R48559,,,21.0,22.0,4367458.0,65.6,4348.0,,3996.0,,Excreted bodily substance,,10/25/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11581;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.339Z,2015-03-16T03:17:09.594Z
1422076_3,Mycobacterium tuberculosis TB_RSA160,Mycobacterium tuberculosis TB_RSA160,1422076.0,WGS,TB_RSA160,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228155,SAMN02403601,GCA_000676455.1,JKRN00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,48.0,52.0,4351582.0,65.6,4334.0,,3986.0,,Excreted bodily substance,,09/18/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,30,,,,host_subject_id:11581;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.357Z,2015-03-16T03:17:09.594Z
1422077_3,Mycobacterium tuberculosis TB_RSA161,Mycobacterium tuberculosis TB_RSA161,1422077.0,WGS,TB_RSA161,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228156,SAMN02403602,GCA_000676475.1,JKRM00000000,-,Broad Institute,WGS,Illumina,78.0x,allpaths v. R48559,,,21.0,22.0,4381790.0,65.6,4339.0,,3979.0,,Excreted bodily substance,,08/08/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11419;treatment course:16 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.366Z,2015-03-16T03:17:09.594Z
1422078_3,Mycobacterium tuberculosis TB_RSA162,Mycobacterium tuberculosis TB_RSA162,1422078.0,WGS,TB_RSA162,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228157,SAMN02403603,GCA_000676495.1,JKRL00000000,-,Broad Institute,WGS,Illumina,78.0x,allpaths v. R48559,,,19.0,19.0,4390987.0,65.6,4351.0,,3987.0,,Excreted bodily substance,,05/10/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11419;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.375Z,2015-03-16T03:17:09.594Z
1422079_3,Mycobacterium tuberculosis TB_RSA163,Mycobacterium tuberculosis TB_RSA163,1422079.0,WGS,TB_RSA163,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228158,SAMN02403604,GCA_000676515.1,JKRK00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,11.0,11.0,4404837.0,65.6,4341.0,,4006.0,,Excreted bodily substance,,04/05/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,44,,,,host_subject_id:11419;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.384Z,2015-03-16T03:17:09.594Z
1422080_3,Mycobacterium tuberculosis TB_RSA164,Mycobacterium tuberculosis TB_RSA164,1422080.0,WGS,TB_RSA164,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228159,SAMN02403605,GCA_000676535.1,JKRJ00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,23.0,23.0,4403279.0,65.6,4346.0,,4002.0,,Excreted bodily substance,,06/24/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,49,,,,host_subject_id:11496;treatment course:1 mnth - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.393Z,2015-03-16T03:17:09.594Z
1422081_3,Mycobacterium tuberculosis TB_RSA165,Mycobacterium tuberculosis TB_RSA165,1422081.0,WGS,TB_RSA165,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228160,SAMN02403606,GCA_000676555.1,JKRI00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,53.0,55.0,4392899.0,65.6,4365.0,,3993.0,,Excreted bodily substance,,10/27/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11563;treatment course:2 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:1+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2 Col;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.402Z,2015-03-16T03:17:09.594Z
1422082_3,Mycobacterium tuberculosis TB_RSA166,Mycobacterium tuberculosis TB_RSA166,1422082.0,WGS,TB_RSA166,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228161,SAMN02403607,GCA_000676575.1,JKRH00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,17.0,19.0,4393708.0,65.6,4361.0,,3991.0,,Excreted bodily substance,,08/21/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,45,,,,host_subject_id:11563;treatment course:Pre - Rx,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.412Z,2015-03-16T03:17:09.594Z
1422083_3,Mycobacterium tuberculosis TB_RSA167,Mycobacterium tuberculosis TB_RSA167,1422083.0,WGS,TB_RSA167,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228162,SAMN02403608,GCA_000676595.1,JKRG00000000,-,Broad Institute,WGS,Illumina,107.0x,allpaths v. R48559,,,20.0,20.0,4401714.0,65.6,4345.0,,4013.0,,Excreted bodily substance,,07/12/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11488;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 5 col;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.421Z,2015-03-16T03:17:09.594Z
1422084_3,Mycobacterium tuberculosis TB_RSA168,Mycobacterium tuberculosis TB_RSA168,1422084.0,WGS,TB_RSA168,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228163,SAMN02403609,GCA_000676615.1,JKRF00000000,-,Broad Institute,WGS,Illumina,77.0x,allpaths v. R48559,,,24.0,27.0,4399875.0,65.6,4369.0,,4021.0,,Excreted bodily substance,,06/14/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,42,,,,host_subject_id:11488;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.430Z,2015-03-16T03:17:09.594Z
1422085_3,Mycobacterium tuberculosis TB_RSA169,Mycobacterium tuberculosis TB_RSA169,1422085.0,WGS,TB_RSA169,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228164,SAMN02403610,GCA_000676635.1,JKRE00000000,-,Broad Institute,WGS,Illumina,58.0x,allpaths v. R48559,,,145.0,150.0,4343014.0,65.4,4361.0,,4008.0,,Excreted bodily substance,,06/12/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,32,,,,host_subject_id:11443;treatment course:1 mnth - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.440Z,2015-03-16T03:17:09.594Z
1422087_3,Mycobacterium tuberculosis TB_RSA171,Mycobacterium tuberculosis TB_RSA171,1422087.0,WGS,TB_RSA171,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228166,SAMN02403612,GCA_000676675.1,JKRC00000000,-,Broad Institute,WGS,Illumina,97.0x,allpaths v. R48559,,,21.0,23.0,4401660.0,65.6,4348.0,,4018.0,,Excreted bodily substance,,08/18/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,21,,,,host_subject_id:11559;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.468Z,2015-03-16T03:17:09.594Z
1422088_3,Mycobacterium tuberculosis TB_RSA172,Mycobacterium tuberculosis TB_RSA172,1422088.0,WGS,TB_RSA172,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228167,SAMN02403613,GCA_000676695.1,JKRB00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,20.0,22.0,4397384.0,65.6,4354.0,,4012.0,,Excreted bodily substance,,09/19/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11559;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.477Z,2015-03-16T03:17:09.594Z
1422089_3,Mycobacterium tuberculosis TB_RSA173,Mycobacterium tuberculosis TB_RSA173,1422089.0,WGS,TB_RSA173,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228168,SAMN02403614,GCA_000676715.1,JKRA00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,30.0,32.0,4397424.0,65.6,4361.0,,3989.0,,Excreted bodily substance,,08/04/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,29,,,,host_subject_id:11536;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.487Z,2015-03-16T03:17:09.594Z
1422090_3,Mycobacterium tuberculosis TB_RSA174,Mycobacterium tuberculosis TB_RSA174,1422090.0,WGS,TB_RSA174,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228169,SAMN02403615,GCA_000676735.1,JKQZ00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,27.0,28.0,4391951.0,65.6,4358.0,,3986.0,,Excreted bodily substance,,09/01/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11536;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:1+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.497Z,2015-03-16T03:17:09.594Z
1422091_3,Mycobacterium tuberculosis TB_RSA175,Mycobacterium tuberculosis TB_RSA175,1422091.0,WGS,TB_RSA175,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228170,SAMN02403616,GCA_000676755.1,JKQY00000000,-,Broad Institute,WGS,Illumina,94.0x,allpaths v. R48559,,,24.0,25.0,4394743.0,65.6,4361.0,,3988.0,,Excreted bodily substance,,10/25/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11580;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.507Z,2015-03-16T03:17:09.594Z
1422092_3,Mycobacterium tuberculosis TB_RSA176,Mycobacterium tuberculosis TB_RSA176,1422092.0,WGS,TB_RSA176,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228171,SAMN02403617,GCA_000676775.1,JKQX00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,76.0,78.0,4390672.0,65.6,4360.0,,3987.0,,Excreted bodily substance,,09/18/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,51,,,,host_subject_id:11580;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.517Z,2015-03-16T03:17:09.594Z
1422093_3,Mycobacterium tuberculosis TB_RSA177,Mycobacterium tuberculosis TB_RSA177,1422093.0,WGS,TB_RSA177,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228172,SAMN02403618,GCA_000676795.1,JKQW00000000,-,Broad Institute,WGS,Illumina,114.0x,allpaths v. R48559,,,26.0,28.0,4392623.0,65.6,4358.0,,3985.0,,Excreted bodily substance,,10/13/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,21,,,,host_subject_id:11583;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.527Z,2015-03-16T03:17:09.594Z
1422094_3,Mycobacterium tuberculosis TB_RSA178,Mycobacterium tuberculosis TB_RSA178,1422094.0,WGS,TB_RSA178,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228173,SAMN02403619,GCA_000676815.1,JKQV00000000,-,Broad Institute,WGS,Illumina,74.0x,allpaths v. R48559,,,27.0,27.0,4389303.0,65.6,4350.0,,3989.0,,Excreted bodily substance,,11/20/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11583;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:1+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 1+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.536Z,2015-03-16T03:17:09.594Z
1422095_3,Mycobacterium tuberculosis TB_RSA179,Mycobacterium tuberculosis TB_RSA179,1422095.0,WGS,TB_RSA179,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228174,SAMN02403620,GCA_000676835.1,JKQU00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,12.0,13.0,4394620.0,65.6,4352.0,,4004.0,,Excreted bodily substance,,02/17/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,40,,,,host_subject_id:11388;treatment course:Pre - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.545Z,2015-03-16T03:17:09.594Z
1422096_3,Mycobacterium tuberculosis TB_RSA180,Mycobacterium tuberculosis TB_RSA180,1422096.0,WGS,TB_RSA180,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228175,SAMN02403621,GCA_000676855.1,JKQT00000000,-,Broad Institute,WGS,Illumina,69.0x,allpaths v. R48559,,,10.0,10.0,4400044.0,65.6,4337.0,,4001.0,,Excreted bodily substance,,03/17/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11388;treatment course:1 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:1+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.568Z,2015-03-16T03:17:09.594Z
1422097_3,Mycobacterium tuberculosis TB_RSA181,Mycobacterium tuberculosis TB_RSA181,1422097.0,WGS,TB_RSA181,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228176,SAMN02403622,GCA_000676875.1,JKQS00000000,-,Broad Institute,WGS,Illumina,37.0x,allpaths v. R48559,,,72.0,75.0,4402908.0,65.6,4338.0,,4010.0,,Excreted bodily substance,,11/22/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11564;treatment course:3 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:neg;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2 col;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.577Z,2015-03-16T03:17:09.594Z
1422098_3,Mycobacterium tuberculosis TB_RSA182,Mycobacterium tuberculosis TB_RSA182,1422098.0,WGS,TB_RSA182,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228177,SAMN02403623,GCA_000676895.1,JKQR00000000,-,Broad Institute,WGS,Illumina,92.0x,allpaths v. R48559,,,24.0,28.0,4382173.0,65.6,4346.0,,4016.0,,Excreted bodily substance,,08/21/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,26,,,,host_subject_id:11564;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.586Z,2015-03-16T03:17:09.594Z
1422100_3,Mycobacterium tuberculosis TB_RSA184,Mycobacterium tuberculosis TB_RSA184,1422100.0,WGS,TB_RSA184,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228179,SAMN02403625,GCA_000676915.1,JKQQ00000000,-,Broad Institute,WGS,Illumina,57.0x,allpaths v. R48559,,,63.0,68.0,4374155.0,65.6,4326.0,,3998.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:SS1019,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB MGIT POS;tb culture 7h11:no growth;organism detection method:MGIT,2014-12-08T22:12:16.595Z,2015-03-16T03:17:09.594Z
1422103_3,Mycobacterium tuberculosis TB_RSA189,Mycobacterium tuberculosis TB_RSA189,1422103.0,WGS,TB_RSA189,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228182,SAMN02403628,GCA_000676935.1,JKQP00000000,-,Broad Institute,WGS,Illumina,78.0x,allpaths v. R48559,,,31.0,32.0,4396763.0,65.6,4361.0,,3984.0,,Excreted bodily substance,,05/11/05,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,34,,,,host_subject_id:11014;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:2+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.604Z,2015-03-16T03:17:09.594Z
1422104_3,Mycobacterium tuberculosis TB_RSA190,Mycobacterium tuberculosis TB_RSA190,1422104.0,WGS,TB_RSA190,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228183,SAMN02403629,GCA_000676955.1,JKQO00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,11.0,11.0,4406152.0,65.6,4365.0,,4003.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,35,,,,host_subject_id:11870;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.623Z,2015-03-16T03:17:09.594Z
1422105_3,Mycobacterium tuberculosis TB_RSA191,Mycobacterium tuberculosis TB_RSA191,1422105.0,WGS,TB_RSA191,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228184,SAMN02403630,GCA_000676975.1,JKQN00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,11.0,11.0,4402531.0,65.6,4359.0,,3998.0,,Excreted bodily substance,,08/14/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,35,,,,host_subject_id:11070;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.632Z,2015-03-16T03:17:09.594Z
1422106_3,Mycobacterium tuberculosis TB_RSA192,Mycobacterium tuberculosis TB_RSA192,1422106.0,WGS,TB_RSA192,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228185,SAMN02403631,GCA_000676995.1,JKQM00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,15.0,17.0,4390785.0,65.6,4348.0,,3990.0,,Excreted bodily substance,,07/04/09,South Africa,South Africa,,,,,,"Human, Homo sapiens",,Adult,,,,host_subject_id:11225;treatment course:22 mnth - Rx,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.641Z,2015-03-16T03:17:09.594Z
1422107_3,Mycobacterium tuberculosis TB_RSA193,Mycobacterium tuberculosis TB_RSA193,1422107.0,WGS,TB_RSA193,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228186,SAMN02403632,GCA_000677015.1,JKQL00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,20.0,21.0,4399793.0,65.6,4349.0,,3998.0,,Excreted bodily substance,,08/27/07,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,34,,,,host_subject_id:11225;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 4+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.652Z,2015-03-16T03:17:09.594Z
1422108_3,Mycobacterium tuberculosis TB_RSA194,Mycobacterium tuberculosis TB_RSA194,1422108.0,WGS,TB_RSA194,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228187,SAMN02403633,GCA_000677035.1,JKQK00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,19.0,20.0,4389539.0,65.6,4343.0,,3983.0,,Excreted bodily substance,,06/14/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,41,,,,host_subject_id:11053;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.662Z,2015-03-16T03:17:09.594Z
1422109_3,Mycobacterium tuberculosis TB_RSA195,Mycobacterium tuberculosis TB_RSA195,1422109.0,WGS,TB_RSA195,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228188,SAMN02403634,GCA_000677055.1,JKQJ00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,12.0,12.0,4432323.0,65.6,4371.0,,4025.0,,Excreted bodily substance,,08/10/05,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,38,,,,host_subject_id:11036;treatment course:1 mnth - Rx;comorbidity:HIV positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 2+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.671Z,2015-03-16T03:17:09.594Z
1422110_3,Mycobacterium tuberculosis TB_RSA196,Mycobacterium tuberculosis TB_RSA196,1422110.0,WGS,TB_RSA196,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228189,SAMN02403635,GCA_000677075.1,JKQI00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,74.0,79.0,4371094.0,65.6,4347.0,,3981.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,45,,,,host_subject_id:11157;comorbidity:HIV negative,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.680Z,2015-03-16T03:17:09.594Z
1422111_3,Mycobacterium tuberculosis TB_RSA197,Mycobacterium tuberculosis TB_RSA197,1422111.0,WGS,TB_RSA197,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228190,SAMN02403636,GCA_000677095.1,JKQH00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,17.0,18.0,4394560.0,65.6,4351.0,,3987.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",,45,,,,host_subject_id:11157,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.689Z,2015-03-16T03:17:09.594Z
1422112_3,Mycobacterium tuberculosis TB_RSA199,Mycobacterium tuberculosis TB_RSA199,1422112.0,WGS,TB_RSA199,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228191,SAMN02403637,GCA_000677115.1,JKQG00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,20.0,20.0,4411445.0,65.6,4350.0,,4009.0,,Excreted bodily substance,,06/04/06,South Africa,South Africa,,,,,,"Human, Homo sapiens",Female,Adult,,,,host_subject_id:11055;treatment course:Pre - Rx;comorbidity:HIV negative,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy ziehl-neelsen stain:3+;microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB 3+;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.698Z,2015-03-16T03:17:09.594Z
1422113_3,Mycobacterium tuberculosis TB_RSA200,Mycobacterium tuberculosis TB_RSA200,1422113.0,WGS,TB_RSA200,,,,,,,,2014-04-30T00:00:00Z,,PRJNA228192,SAMN02403638,GCA_000677135.1,JKQF00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,27.0,29.0,4402607.0,65.6,4342.0,,4002.0,,Excreted bodily substance,,,South Africa,South Africa,,,,,,"Human, Homo sapiens",male,21,,,,host_subject_id:11287;comorbidity:HIV negative,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - MRC SA,microscopy auramine stain:none;tb culture l�wenstein-jensen:MTB;tb culture 7h11:no growth;phenotype:MDR;organism detection method:L�wenstein-Jensen,2014-12-08T22:12:16.716Z,2015-03-16T03:17:09.594Z
1423425_3,Mycobacterium tuberculosis BTB03-012,Mycobacterium tuberculosis BTB03-012,1423425.0,WGS,BTB03-012,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229206,SAMN02414841,GCA_000677155.1,JKHP00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,19.0,20.0,4413957.0,65.6,4379.0,,4035.0,,punctuat,,2003,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:1,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:not MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB03-012,2014-12-08T22:12:08.527Z,2015-03-16T03:17:09.594Z
1423426_3,Mycobacterium tuberculosis BTB03-108,Mycobacterium tuberculosis BTB03-108,1423426.0,WGS,BTB03-108,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229207,SAMN02414842,GCA_000677175.1,JKHO00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48559,,,32.0,33.0,4393614.0,65.6,4349.0,,4017.0,,sputum,,2003,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:2,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB03-108,2014-12-08T22:12:08.536Z,2015-03-16T03:17:09.594Z
1423427_3,Mycobacterium tuberculosis BTB04-120,,1423427.0,WGS,BTB04-120,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA229208,SAMN02414843,GCA_000706005.1,JKHN00000000,-,Broad Institute,,Illumina,113.0x,allpaths v. R48559,,,40.0,78.0,4474040.0,65.6,4351.0,,4038.0,,sputum,,2004,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:6,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB04-120,2014-12-08T22:56:50.358Z,2015-03-16T03:17:09.594Z
1423428_3,Mycobacterium tuberculosis BTB05-481,Mycobacterium tuberculosis BTB05-481,1423428.0,WGS,BTB05-481,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229209,SAMN02414844,GCA_000677195.1,JKHM00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,17.0,17.0,4411572.0,65.6,4351.0,,4027.0,,sputum,,2005,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:5,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB05-481,2014-12-08T22:12:08.724Z,2015-03-16T03:17:09.594Z
1423429_3,Mycobacterium tuberculosis BTB07-168,Mycobacterium tuberculosis BTB07-168,1423429.0,WGS,BTB07-168,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229210,SAMN02414845,GCA_000658415.1,JKHL00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,60.0,63.0,4385096.0,65.6,4348.0,,3993.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:29,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-168,2014-12-08T22:12:08.855Z,2015-03-16T03:17:09.594Z
1423430_3,Mycobacterium tuberculosis BTB03-168,Mycobacterium tuberculosis BTB03-168,1423430.0,WGS,BTB03-168,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229211,SAMN02414846,GCA_000677215.1,JKHK00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,19.0,20.0,4399881.0,65.6,4359.0,,4019.0,,sputum,,2003,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:6,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB03-168,2014-12-08T22:12:08.573Z,2015-03-16T03:17:09.594Z
1423431_3,Mycobacterium tuberculosis BTB03-169,Mycobacterium tuberculosis BTB03-169,1423431.0,WGS,BTB03-169,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229212,SAMN02414847,GCA_000677235.1,JKHJ00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,19.0,21.0,4432729.0,65.6,4395.0,,4012.0,,gland,,2003,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:7,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB03-169,2014-12-08T22:12:08.582Z,2015-03-16T03:17:09.594Z
1423432_3,Mycobacterium tuberculosis BTB04-001,Mycobacterium tuberculosis BTB04-001,1423432.0,WGS,BTB04-001,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229213,SAMN02414848,GCA_000677255.1,JKHI00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48559,,,33.0,34.0,4386648.0,65.6,4331.0,,3943.0,,lymph galnd,,2003,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:8,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:susceptible;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB04-001,2014-12-08T22:12:08.591Z,2015-03-16T03:17:09.594Z
1423435_3,Mycobacterium tuberculosis BTB04-011,Mycobacterium tuberculosis BTB04-011,1423435.0,WGS,BTB04-011,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229216,SAMN02414851,GCA_000677275.1,JKHH00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,27.0,28.0,4399118.0,65.6,4369.0,,3997.0,,sputum,,2003,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:2,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB04-011,2014-12-08T22:12:08.600Z,2015-03-16T03:17:09.594Z
1423436_3,Mycobacterium tuberculosis BTB04-097,Mycobacterium tuberculosis BTB04-097,1423436.0,WGS,BTB04-097,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229217,SAMN02414852,GCA_000677295.1,JKHG00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,16.0,17.0,4405359.0,65.6,4355.0,,4010.0,,sputum,,2004,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:11,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB04-097,2014-12-08T22:12:08.609Z,2015-03-16T03:17:09.594Z
1423437_3,Mycobacterium tuberculosis BTB03-142,Mycobacterium tuberculosis BTB03-142,1423437.0,WGS,BTB03-142,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229218,SAMN02414853,GCA_000677315.1,JKHF00000000,-,Broad Institute,WGS,Illumina,116.0x,allpaths v. R48559,,,16.0,16.0,4396453.0,65.6,4352.0,,3991.0,,na,,2003,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:3,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB03-142,2014-12-08T22:12:08.545Z,2015-03-16T03:17:09.594Z
1423438_3,Mycobacterium tuberculosis BTB04-128,Mycobacterium tuberculosis BTB04-128,1423438.0,WGS,BTB04-128,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229219,SAMN02414854,GCA_000677335.1,JKHE00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,20.0,21.0,4407934.0,65.6,4366.0,,4035.0,,sputum,,2004,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:12,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB04-128,2014-12-08T22:12:08.619Z,2015-03-16T03:17:09.594Z
1423439_3,Mycobacterium tuberculosis BTB04-158,Mycobacterium tuberculosis BTB04-158,1423439.0,WGS,BTB04-158,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229220,SAMN02414855,GCA_000677355.1,JKHD00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,17.0,17.0,4397074.0,65.6,4352.0,,3995.0,,VSK,,2004,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:13,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB04-158,2014-12-08T22:12:08.629Z,2015-03-16T03:17:09.594Z
1423440_3,Mycobacterium tuberculosis BTB04-172,Mycobacterium tuberculosis BTB04-172,1423440.0,WGS,BTB04-172,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229221,SAMN02414856,GCA_000677375.1,JKHC00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,15.0,15.0,4354928.0,65.6,4320.0,,3986.0,,sputum,,2004,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:10,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB04-172,2014-12-08T22:12:08.640Z,2015-03-16T03:17:09.594Z
1423441_3,Mycobacterium tuberculosis BTB04-388,Mycobacterium tuberculosis BTB04-388,1423441.0,WGS,BTB04-388,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229222,SAMN02414857,GCA_000677395.1,JKHB00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,25.0,26.0,4411252.0,65.6,4379.0,,4006.0,,sputum,,2004,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:14,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB04-388,2014-12-08T22:12:08.651Z,2015-03-16T03:17:09.594Z
1423442_3,Mycobacterium tuberculosis BTB04-416,Mycobacterium tuberculosis BTB04-416,1423442.0,WGS,BTB04-416,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229223,SAMN02414858,GCA_000677415.1,JKHA00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,34.0,38.0,4376323.0,65.6,4336.0,,3980.0,,sputum,,2004,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:15,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB04-416,2014-12-08T22:12:08.660Z,2015-03-16T03:17:09.594Z
1423443_3,Mycobacterium tuberculosis BTB04-452,Mycobacterium tuberculosis BTB04-452,1423443.0,WGS,BTB04-452,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229224,SAMN02414859,GCA_000677435.1,JKGZ00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,31.0,35.0,4379070.0,65.6,4349.0,,3983.0,,sputum,,2004,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:2,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB04-452,2014-12-08T22:12:08.669Z,2015-03-16T03:17:09.594Z
1423444_3,Mycobacterium tuberculosis BTB05-001,Mycobacterium tuberculosis BTB05-001,1423444.0,WGS,BTB05-001,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229225,SAMN02414860,GCA_000677455.1,JKGY00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,21.0,21.0,4417401.0,65.6,4390.0,,4013.0,,VSK,,2004,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:16,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:susceptible;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB05-001,2014-12-08T22:12:08.678Z,2015-03-16T03:17:09.594Z
1423445_3,Mycobacterium tuberculosis BTB05-013,Mycobacterium tuberculosis BTB05-013,1423445.0,WGS,BTB05-013,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229226,SAMN02414861,GCA_000677475.1,JKGX00000000,-,Broad Institute,WGS,Illumina,107.0x,allpaths v. R48559,,,22.0,23.0,4397006.0,65.6,4353.0,,3593.0,,sputum,,2005,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:17,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB05-013,2014-12-08T22:12:08.688Z,2015-03-16T03:17:09.594Z
1423446_3,Mycobacterium tuberculosis BTB05-285,Mycobacterium tuberculosis BTB05-285,1423446.0,WGS,BTB05-285,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229227,SAMN02414862,GCA_000677495.1,JKGW00000000,-,Broad Institute,WGS,Illumina,102.0x,allpaths v. R48559,,,22.0,23.0,4398413.0,65.6,4380.0,,4005.0,,sputum,,2005,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:14,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB05-285,2014-12-08T22:12:08.697Z,2015-03-16T03:17:09.594Z
1423447_3,Mycobacterium tuberculosis BTB05-348,Mycobacterium tuberculosis BTB05-348,1423447.0,WGS,BTB05-348,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229228,SAMN02414863,GCA_000677515.1,JKGV00000000,-,Broad Institute,WGS,Illumina,65.0x,allpaths v. R48559,,,64.0,67.0,4398114.0,65.6,4366.0,,2114.0,,retroper. abscess,,2005,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:18,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB05-348,2014-12-08T22:12:08.706Z,2015-03-16T03:17:09.594Z
1423448_3,Mycobacterium tuberculosis BTB05-371,Mycobacterium tuberculosis BTB05-371,1423448.0,WGS,BTB05-371,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229229,SAMN02414864,GCA_000677535.1,JKGU00000000,-,Broad Institute,WGS,Illumina,106.0x,allpaths v. R48559,,,11.0,11.0,4405485.0,65.6,4356.0,,3993.0,,lymph galnd,,2005,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:19,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB05-371,2014-12-08T22:12:08.716Z,2015-03-16T03:17:09.594Z
1423449_3,Mycobacterium tuberculosis BTB03-143,Mycobacterium tuberculosis BTB03-143,1423449.0,WGS,BTB03-143,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229230,SAMN02414865,GCA_000677555.1,JKGT00000000,-,Broad Institute,WGS,Illumina,117.0x,allpaths v. R48559,,,27.0,27.0,4402509.0,65.6,4384.0,,4005.0,,bronchial,,2003,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:4,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB03-143,2014-12-08T22:12:08.554Z,2015-03-16T03:17:09.594Z
1423450_3,Mycobacterium tuberculosis BTB05-650,Mycobacterium tuberculosis BTB05-650,1423450.0,WGS,BTB05-650,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229231,SAMN02414866,GCA_000677575.1,JKGS00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,60.0,63.0,4363714.0,65.6,4327.0,,3968.0,,sputum,,2005,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:20,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB05-650,2014-12-08T22:12:08.753Z,2015-03-16T03:17:09.594Z
1423451_3,Mycobacterium tuberculosis BTB05-660,Mycobacterium tuberculosis BTB05-660,1423451.0,WGS,BTB05-660,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229232,SAMN02414867,GCA_000677595.1,JKGR00000000,-,Broad Institute,WGS,Illumina,116.0x,allpaths v. R48559,,,15.0,15.0,4412999.0,65.6,4376.0,,4025.0,,lymph galnd,,2005,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:21,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB05-660,2014-12-08T22:12:08.761Z,2015-03-16T03:17:09.594Z
1423452_3,Mycobacterium tuberculosis BTB06-001,Mycobacterium tuberculosis BTB06-001,1423452.0,WGS,BTB06-001,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229233,SAMN02414868,GCA_000677615.1,JKGQ00000000,-,Broad Institute,WGS,Illumina,104.0x,allpaths v. R48559,,,13.0,14.0,4381056.0,65.6,4341.0,,3992.0,,lung tissue,,2006,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:22,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:susceptible;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB06-001,2014-12-08T22:12:08.771Z,2015-03-16T03:17:09.594Z
1423453_3,Mycobacterium tuberculosis BTB06-340,Mycobacterium tuberculosis BTB06-340,1423453.0,WGS,BTB06-340,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229234,SAMN02414869,GCA_000677635.1,JKGP00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,21.0,21.0,4396041.0,65.6,4363.0,,3996.0,,sputum,,2006,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:20,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB06-340,2014-12-08T22:12:08.780Z,2015-03-16T03:17:09.594Z
1423454_3,Mycobacterium tuberculosis BTB06-467,Mycobacterium tuberculosis BTB06-467,1423454.0,WGS,BTB06-467,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229235,SAMN02414870,GCA_000677655.1,JKGO00000000,-,Broad Institute,WGS,Illumina,117.0x,allpaths v. R48559,,,20.0,24.0,4419833.0,65.6,4397.0,,4024.0,,lymph galnd,,2006,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:23,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB06-467,2014-12-08T22:12:08.789Z,2015-03-16T03:17:09.594Z
1423455_3,Mycobacterium tuberculosis BTB06-494,Mycobacterium tuberculosis BTB06-494,1423455.0,WGS,BTB06-494,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229236,SAMN02414871,GCA_000677675.1,JKGN00000000,-,Broad Institute,WGS,Illumina,74.0x,allpaths v. R48559,,,64.0,68.0,4386435.0,65.6,4356.0,,3998.0,,sputum,,2006,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:24,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB06-494,2014-12-08T22:12:08.798Z,2015-03-16T03:17:09.594Z
1423456_3,Mycobacterium tuberculosis BTB07-001,Mycobacterium tuberculosis BTB07-001,1423456.0,WGS,BTB07-001,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229237,SAMN02414872,GCA_000677695.1,JKGM00000000,-,Broad Institute,WGS,Illumina,111.0x,allpaths v. R48559,,,23.0,25.0,4396903.0,65.6,4371.0,,4019.0,,BAL,,2006,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:25,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:susceptible;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-001,2014-12-08T22:12:08.808Z,2015-03-16T03:17:09.594Z
1423457_3,Mycobacterium tuberculosis BTB07-034,Mycobacterium tuberculosis BTB07-034,1423457.0,WGS,BTB07-034,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229238,SAMN02414873,GCA_000677715.1,JKGL00000000,-,Broad Institute,WGS,Illumina,99.0x,allpaths v. R48559,,,21.0,22.0,4391594.0,65.6,4347.0,,3999.0,,sputum,,2006,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:26,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-034,2014-12-08T22:12:08.817Z,2015-03-16T03:17:09.594Z
1423458_3,Mycobacterium tuberculosis BTB07-070,Mycobacterium tuberculosis BTB07-070,1423458.0,WGS,BTB07-070,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229239,SAMN02414874,GCA_000677735.1,JKGK00000000,-,Broad Institute,WGS,Illumina,103.0x,allpaths v. R48559,,,21.0,21.0,4399294.0,65.6,4346.0,,3999.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:27,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-070,2014-12-08T22:12:08.827Z,2015-03-16T03:17:09.594Z
1423459_3,Mycobacterium tuberculosis BTB07-123,Mycobacterium tuberculosis BTB07-123,1423459.0,WGS,BTB07-123,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229240,SAMN02414875,GCA_000677755.1,JKGJ00000000,-,Broad Institute,WGS,Illumina,118.0x,allpaths v. R48559,,,18.0,22.0,4361015.0,65.6,4323.0,,4002.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:28,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-123,2014-12-08T22:12:08.837Z,2015-03-16T03:17:09.594Z
1423460_3,Mycobacterium tuberculosis BTB07-126,Mycobacterium tuberculosis BTB07-126,1423460.0,WGS,BTB07-126,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229241,SAMN02414876,GCA_000677775.1,JKGI00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48559,,,23.0,23.0,4394782.0,65.6,4362.0,,3995.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:26,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-126,2014-12-08T22:12:08.845Z,2015-03-16T03:17:09.594Z
1423461_3,Mycobacterium tuberculosis BTB03-144,Mycobacterium tuberculosis BTB03-144,1423461.0,WGS,BTB03-144,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229242,SAMN02414877,GCA_000677795.1,JKGH00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,16.0,17.0,4409846.0,65.6,4360.0,,4023.0,,sputum,,2003,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:5,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB03-144,2014-12-08T22:12:08.564Z,2015-03-16T03:17:09.594Z
1423462_3,Mycobacterium tuberculosis BTB07-170,Mycobacterium tuberculosis BTB07-170,1423462.0,WGS,BTB07-170,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229243,SAMN02414878,GCA_000677815.1,JKGG00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,16.0,16.0,4404602.0,65.6,4364.0,,3993.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:28,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-170,2014-12-08T22:12:08.865Z,2015-03-16T03:17:09.594Z
1423463_3,Mycobacterium tuberculosis BTB07-206,Mycobacterium tuberculosis BTB07-206,1423463.0,WGS,BTB07-206,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229244,SAMN02414879,GCA_000677835.1,JKGF00000000,-,Broad Institute,WGS,Illumina,102.0x,allpaths v. R48559,,,17.0,17.0,4393447.0,65.6,4354.0,,4018.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:30,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-206,2014-12-08T22:12:08.875Z,2015-03-16T03:17:09.594Z
1423464_3,Mycobacterium tuberculosis BTB07-234,,1423464.0,WGS,BTB07-234,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA229245,SAMN02414880,GCA_000705985.1,JKGE00000000,-,Broad Institute,,Illumina,128.0x,allpaths v. R48559,,,5.0,22.0,4401070.0,65.6,4288.0,,3980.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:31,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-234,2014-12-08T22:56:52.040Z,2015-03-16T03:17:09.594Z
1423465_3,Mycobacterium tuberculosis BTB07-243,Mycobacterium tuberculosis BTB07-243,1423465.0,WGS,BTB07-243,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229246,SAMN02414881,GCA_000677855.1,JKGD00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,75.0,77.0,4392165.0,65.6,4364.0,,4004.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:32,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-243,2014-12-08T22:12:08.890Z,2015-03-16T03:17:09.594Z
1423467_3,Mycobacterium tuberculosis BTB07-254,Mycobacterium tuberculosis BTB07-254,1423467.0,WGS,BTB07-254,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229248,SAMN02414883,GCA_000677895.1,JKGB00000000,-,Broad Institute,WGS,Illumina,72.0x,allpaths v. R48559,,,68.0,70.0,4398325.0,65.6,4350.0,,4006.0,,BAL,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:34,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-254,2014-12-08T22:12:08.911Z,2015-03-16T03:17:09.594Z
1423468_3,Mycobacterium tuberculosis BTB07-261,Mycobacterium tuberculosis BTB07-261,1423468.0,WGS,BTB07-261,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229249,SAMN02414884,GCA_000677915.1,JKGA00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48559,,,15.0,17.0,4395717.0,65.6,4336.0,,3995.0,,abscess,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:34,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-261,2014-12-08T22:12:08.922Z,2015-03-16T03:17:09.594Z
1423469_3,Mycobacterium tuberculosis BTB07-275,Mycobacterium tuberculosis BTB07-275,1423469.0,WGS,BTB07-275,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229250,SAMN02414885,GCA_000677935.1,JKFZ00000000,-,Broad Institute,WGS,Illumina,72.0x,allpaths v. R48559,,,55.0,58.0,4391174.0,65.6,4338.0,,3996.0,,feces,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:35,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-275,2014-12-08T22:12:08.930Z,2015-03-16T03:17:09.594Z
1423470_3,Mycobacterium tuberculosis BTB07-283,Mycobacterium tuberculosis BTB07-283,1423470.0,WGS,BTB07-283,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229251,SAMN02414886,GCA_000677955.1,JKFY00000000,-,Broad Institute,WGS,Illumina,100.0x,allpaths v. R48559,,,14.0,16.0,4390439.0,65.6,4321.0,,4003.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:33,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-283,2014-12-08T22:12:08.940Z,2015-03-16T03:17:09.594Z
1423471_3,Mycobacterium tuberculosis BTB07-299,Mycobacterium tuberculosis BTB07-299,1423471.0,WGS,BTB07-299,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229252,SAMN02414887,GCA_000677975.1,JKFX00000000,-,Broad Institute,WGS,Illumina,116.0x,allpaths v. R48559,,,23.0,23.0,4396161.0,65.6,4338.0,,3995.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:36,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-299,2014-12-08T22:12:08.949Z,2015-03-16T03:17:09.594Z
1423472_3,Mycobacterium tuberculosis BTB07-300,Mycobacterium tuberculosis BTB07-300,1423472.0,WGS,BTB07-300,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229253,SAMN02414888,GCA_000677995.1,JKFW00000000,-,Broad Institute,WGS,Illumina,102.0x,allpaths v. R48559,,,18.0,19.0,4391998.0,65.6,4347.0,,3996.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:28,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-300,2014-12-08T22:12:08.960Z,2015-03-16T03:17:09.594Z
1423473_3,Mycobacterium tuberculosis BTB07-314,,1423473.0,WGS,BTB07-314,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA229254,SAMN02414889,GCA_000705965.1,JKFV00000000,-,Broad Institute,,Illumina,85.0x,allpaths v. R48559,,,71.0,73.0,4381760.0,65.6,4285.0,,3977.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:31,Resistant,AMR Panel,,,,,,,,,,,TB Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-314,2014-12-08T22:56:52.572Z,2015-03-16T03:17:09.594Z
1423474_3,Mycobacterium tuberculosis BTB07-323,Mycobacterium tuberculosis BTB07-323,1423474.0,WGS,BTB07-323,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229255,SAMN02414890,GCA_000678015.1,JKFU00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,15.0,16.0,4393466.0,65.6,4364.0,,3990.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:37,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-323,2014-12-08T22:12:08.970Z,2015-03-16T03:17:09.594Z
1423475_3,Mycobacterium tuberculosis BTB07-324,Mycobacterium tuberculosis BTB07-324,1423475.0,WGS,BTB07-324,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229256,SAMN02414891,GCA_000678035.1,JKFT00000000,-,Broad Institute,WGS,Illumina,99.0x,allpaths v. R48559,,,15.0,16.0,4393017.0,65.6,4336.0,,3991.0,,bronchial,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:31,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-324,2014-12-08T22:12:08.979Z,2015-03-16T03:17:09.594Z
1423476_3,Mycobacterium tuberculosis BTB07-325,Mycobacterium tuberculosis BTB07-325,1423476.0,WGS,BTB07-325,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229257,SAMN02414892,GCA_000678055.1,JKFS00000000,-,Broad Institute,WGS,Illumina,101.0x,allpaths v. R48559,,,12.0,12.0,4359784.0,65.6,4335.0,,3989.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:38,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-325,2014-12-08T22:12:08.987Z,2015-03-16T03:17:09.594Z
1423477_3,Mycobacterium tuberculosis BTB07-327,,1423477.0,WGS,BTB07-327,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA229258,SAMN02414893,GCA_000705945.1,JKFR00000000,-,Broad Institute,,Illumina,124.0x,allpaths v. R48559,,,8.0,42.0,4430840.0,65.6,4332.0,,4012.0,,abscess,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:39,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-327,2014-12-08T22:56:53.585Z,2015-03-16T03:17:09.594Z
1423478_3,Mycobacterium tuberculosis BTB07-354,Mycobacterium tuberculosis BTB07-354,1423478.0,WGS,BTB07-354,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229259,SAMN02414894,GCA_000678075.1,JKFQ00000000,-,Broad Institute,WGS,Illumina,109.0x,allpaths v. R48559,,,25.0,28.0,4415217.0,65.6,4377.0,,4021.0,,lgl,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:40,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB07-354,2014-12-08T22:12:09.005Z,2015-03-16T03:17:09.594Z
1423479_3,Mycobacterium tuberculosis BTB08-001,Mycobacterium tuberculosis BTB08-001,1423479.0,WGS,BTB08-001,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229260,SAMN02414895,GCA_000678095.1,JKFP00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,22.0,23.0,4402639.0,65.6,4371.0,,4010.0,,bronchial,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:41,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:susceptible;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-001,2014-12-08T22:12:09.016Z,2015-03-16T03:17:09.594Z
1423480_3,Mycobacterium tuberculosis BTB08-014,Mycobacterium tuberculosis BTB08-014,1423480.0,WGS,BTB08-014,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229261,SAMN02414896,GCA_000678115.1,JKFO00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,21.0,21.0,4396961.0,65.6,4354.0,,3998.0,,sputum,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:36,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-014,2014-12-08T22:12:09.026Z,2015-03-16T03:17:09.594Z
1423481_3,Mycobacterium tuberculosis BTB08-022,Mycobacterium tuberculosis BTB08-022,1423481.0,WGS,BTB08-022,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229262,SAMN02414897,GCA_000678135.1,JKFN00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,22.0,22.0,4375186.0,65.6,4346.0,,3996.0,,VSK,,2007,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:42,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-022,2014-12-08T22:12:09.035Z,2015-03-16T03:17:09.594Z
1423482_3,Mycobacterium tuberculosis BTB08-043,Mycobacterium tuberculosis BTB08-043,1423482.0,WGS,BTB08-043,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229263,SAMN02414898,GCA_000678155.1,JKFM00000000,-,Broad Institute,WGS,Illumina,97.0x,allpaths v. R48559,,,19.0,19.0,4404864.0,65.6,4371.0,,4005.0,,halscysta,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:43,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-043,2014-12-08T22:12:09.044Z,2015-03-16T03:17:09.594Z
1423483_3,Mycobacterium tuberculosis BTB08-072,Mycobacterium tuberculosis BTB08-072,1423483.0,WGS,BTB08-072,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229264,SAMN02414899,GCA_000678175.1,JKFL00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,22.0,23.0,4400569.0,65.6,4339.0,,4003.0,,BAL,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:44,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-072,2014-12-08T22:12:09.053Z,2015-03-16T03:17:09.594Z
1423484_3,Mycobacterium tuberculosis BTB08-093,Mycobacterium tuberculosis BTB08-093,1423484.0,WGS,BTB08-093,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229265,SAMN02414900,GCA_000678195.1,JKFK00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,20.0,20.0,4401325.0,65.6,4367.0,,3995.0,,sputum,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:45,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-093,2014-12-08T22:12:09.063Z,2015-03-16T03:17:09.594Z
1423485_3,Mycobacterium tuberculosis BTB08-148,Mycobacterium tuberculosis BTB08-148,1423485.0,WGS,BTB08-148,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229266,SAMN02414901,GCA_000678215.1,JKFJ00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,31.0,34.0,4403359.0,65.6,4351.0,,3973.0,,sputum,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:46,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-148,2014-12-08T22:12:09.072Z,2015-03-16T03:17:09.594Z
1423486_3,Mycobacterium tuberculosis BTB08-183,Mycobacterium tuberculosis BTB08-183,1423486.0,WGS,BTB08-183,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229267,SAMN02414902,GCA_000678235.1,JKFI00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,33.0,37.0,4387442.0,65.6,4343.0,,3993.0,,saknas,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:47,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-183,2014-12-08T22:12:09.081Z,2015-03-16T03:17:09.594Z
1423487_3,Mycobacterium tuberculosis BTB08-221,Mycobacterium tuberculosis BTB08-221,1423487.0,WGS,BTB08-221,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229268,SAMN02414903,GCA_000678255.1,JKFH00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,46.0,48.0,4404656.0,65.6,4361.0,,4002.0,,sputum,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:48,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-221,2014-12-08T22:12:09.091Z,2015-03-16T03:17:09.594Z
1423488_3,Mycobacterium tuberculosis BTB08-283,Mycobacterium tuberculosis BTB08-283,1423488.0,WGS,BTB08-283,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229269,SAMN02414904,GCA_000678275.1,JKFG00000000,-,Broad Institute,WGS,Illumina,101.0x,allpaths v. R48559,,,11.0,11.0,4393905.0,65.6,4335.0,,4000.0,,sputum,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:49,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-283,2014-12-08T22:12:09.101Z,2015-03-16T03:17:09.594Z
1423489_3,Mycobacterium tuberculosis BTB08-288,Mycobacterium tuberculosis BTB08-288,1423489.0,WGS,BTB08-288,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229270,SAMN02414905,GCA_000678295.1,JKFF00000000,-,Broad Institute,WGS,Illumina,116.0x,allpaths v. R48559,,,12.0,12.0,4400159.0,65.6,4338.0,,4001.0,,punctuat,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:50,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-288,2014-12-08T22:12:09.111Z,2015-03-16T03:17:09.594Z
1423490_3,Mycobacterium tuberculosis BTB08-309,Mycobacterium tuberculosis BTB08-309,1423490.0,WGS,BTB08-309,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229271,SAMN02414906,GCA_000678315.1,JKFE00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,12.0,12.0,4368289.0,65.6,4307.0,,3966.0,,Sputum,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:51,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-309,2014-12-08T22:12:09.120Z,2015-03-16T03:17:09.594Z
1423492_3,Mycobacterium tuberculosis BTB08-356,Mycobacterium tuberculosis BTB08-356,1423492.0,WGS,BTB08-356,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229273,SAMN02414908,GCA_000678335.1,JKFD00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,13.0,15.0,4422375.0,65.6,4381.0,,3989.0,,bronchial,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:52,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-356,2014-12-08T22:12:09.129Z,2015-03-16T03:17:09.594Z
1423493_3,Mycobacterium tuberculosis BTB08-362,Mycobacterium tuberculosis BTB08-362,1423493.0,WGS,BTB08-362,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229274,SAMN02414909,GCA_000678355.1,JKFC00000000,-,Broad Institute,WGS,Illumina,111.0x,allpaths v. R48559,,,16.0,17.0,4382758.0,65.6,4340.0,,3997.0,,faeces,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:53,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-362,2014-12-08T22:12:09.139Z,2015-03-16T03:17:09.594Z
1423494_3,Mycobacterium tuberculosis BTB08-394,Mycobacterium tuberculosis BTB08-394,1423494.0,WGS,BTB08-394,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229275,SAMN02414910,GCA_000678375.1,JKFB00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,20.0,20.0,4389904.0,65.6,4350.0,,3995.0,,sputum,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:53,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-394,2014-12-08T22:12:09.150Z,2015-03-16T03:17:09.594Z
1423495_3,Mycobacterium tuberculosis BTB08-395,,1423495.0,WGS,BTB08-395,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA229276,SAMN02414911,GCA_000705925.1,JKFA00000000,-,Broad Institute,,Illumina,99.0x,allpaths v. R48559,,,8.0,24.0,4411640.0,65.6,4299.0,,4018.0,,sputum,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:54,Resistant,AMR Panel,,,,,,,,,,,TB Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB08-395,2014-12-08T22:56:54.023Z,2015-03-16T03:17:09.594Z
1423496_3,Mycobacterium tuberculosis BTB09-001,Mycobacterium tuberculosis BTB09-001,1423496.0,WGS,BTB09-001,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229277,SAMN02414912,GCA_000678395.1,JKEZ00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,26.0,28.0,4407219.0,65.6,4373.0,,3989.0,,PUS,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:55,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:susceptible;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-001,2014-12-08T22:12:09.160Z,2015-03-16T03:17:09.594Z
1423497_3,Mycobacterium tuberculosis BTB09-036,Mycobacterium tuberculosis BTB09-036,1423497.0,WGS,BTB09-036,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229278,SAMN02414913,GCA_000678415.1,JKEY00000000,-,Broad Institute,WGS,Illumina,112.0x,allpaths v. R48559,,,21.0,21.0,4409388.0,65.6,4372.0,,4005.0,,bronchial,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:56,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-036,2014-12-08T22:12:09.169Z,2015-03-16T03:17:09.594Z
1423498_3,Mycobacterium tuberculosis BTB09-058,Mycobacterium tuberculosis BTB09-058,1423498.0,WGS,BTB09-058,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229279,SAMN02414914,GCA_000678435.1,JKEX00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,21.0,21.0,4390402.0,65.6,4352.0,,3985.0,,pericard,,2008,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:57,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-058,2014-12-08T22:12:09.179Z,2015-03-16T03:17:09.594Z
1423499_3,Mycobacterium tuberculosis BTB09-085,Mycobacterium tuberculosis BTB09-085,1423499.0,WGS,BTB09-085,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229280,SAMN02414915,GCA_000678455.1,JKEW00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,30.0,34.0,4388146.0,65.6,4373.0,,3999.0,,pericard,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:57,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-085,2014-12-08T22:12:09.189Z,2015-03-16T03:17:09.594Z
1423500_3,Mycobacterium tuberculosis BTB09-086,Mycobacterium tuberculosis BTB09-086,1423500.0,WGS,BTB09-086,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229281,SAMN02414916,GCA_000678475.1,JKEV00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,28.0,28.0,4392989.0,65.6,4351.0,,3993.0,,sputum,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:58,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-086,2014-12-08T22:12:09.198Z,2015-03-16T03:17:09.594Z
1423501_3,Mycobacterium tuberculosis BTB09-091,Mycobacterium tuberculosis BTB09-091,1423501.0,WGS,BTB09-091,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229282,SAMN02414917,GCA_000678495.1,JKEU00000000,-,Broad Institute,WGS,Illumina,115.0x,allpaths v. R48559,,,20.0,22.0,4398398.0,65.6,4361.0,,4004.0,,sputum,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:59,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-091,2014-12-08T22:12:09.208Z,2015-03-16T03:17:09.594Z
1423502_3,Mycobacterium tuberculosis BTB09-151,Mycobacterium tuberculosis BTB09-151,1423502.0,WGS,BTB09-151,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229283,SAMN02414918,GCA_000678515.1,JKET00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48559,,,18.0,19.0,4396406.0,65.6,4362.0,,4014.0,,secrete,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:60,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-151,2014-12-08T22:12:09.217Z,2015-03-16T03:17:09.594Z
1423503_3,Mycobacterium tuberculosis BTB09-157,Mycobacterium tuberculosis BTB09-157,1423503.0,WGS,BTB09-157,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229284,SAMN02414919,GCA_000678535.1,JKES00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,20.0,21.0,4400791.0,65.6,4371.0,,3993.0,,sputum,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:61,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-157,2014-12-08T22:12:09.226Z,2015-03-16T03:17:09.594Z
1423504_3,Mycobacterium tuberculosis BTB09-184,Mycobacterium tuberculosis BTB09-184,1423504.0,WGS,BTB09-184,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229285,SAMN02414920,GCA_000678555.1,JKER00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,21.0,21.0,4398418.0,65.6,4369.0,,3992.0,,sputum,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:62,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-184,2014-12-08T22:12:09.235Z,2015-03-16T03:17:09.594Z
1423505_3,Mycobacterium tuberculosis BTB09-230,Mycobacterium tuberculosis BTB09-230,1423505.0,WGS,BTB09-230,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229286,SAMN02414921,GCA_000678575.1,JKEQ00000000,-,Broad Institute,WGS,Illumina,106.0x,allpaths v. R48559,,,19.0,20.0,4389053.0,65.6,4334.0,,3967.0,,abscess,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:63,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-230,2014-12-08T22:12:09.245Z,2015-03-16T03:17:09.594Z
1423506_3,Mycobacterium tuberculosis BTB09-377,Mycobacterium tuberculosis BTB09-377,1423506.0,WGS,BTB09-377,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229287,SAMN02414922,GCA_000658855.1,JKEP00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,69.0,73.0,4368782.0,65.6,4339.0,,3974.0,,sputum,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:62,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-377,2014-12-08T22:12:09.257Z,2015-03-16T03:17:09.594Z
1423507_3,Mycobacterium tuberculosis BTB09-382,Mycobacterium tuberculosis BTB09-382,1423507.0,WGS,BTB09-382,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229288,SAMN02414923,GCA_000678595.1,JKEO00000000,-,Broad Institute,WGS,Illumina,110.0x,allpaths v. R48559,,,21.0,23.0,4395187.0,65.6,4331.0,,4016.0,,PX colon,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:64,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-382,2014-12-08T22:12:09.268Z,2015-03-16T03:17:09.594Z
1423508_3,Mycobacterium tuberculosis BTB09-453,Mycobacterium tuberculosis BTB09-453,1423508.0,WGS,BTB09-453,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229289,SAMN02414924,GCA_000678615.1,JKEN00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,85.0,89.0,4395646.0,65.6,4365.0,,3992.0,,sekret,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:65,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-453,2014-12-08T22:12:09.278Z,2015-03-16T03:17:09.594Z
1423509_3,Mycobacterium tuberculosis BTB09-485,Mycobacterium tuberculosis BTB09-485,1423509.0,WGS,BTB09-485,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229290,SAMN02414925,GCA_000678635.1,JKEM00000000,-,Broad Institute,WGS,Illumina,74.0x,allpaths v. R48559,,,71.0,76.0,4370525.0,65.6,4344.0,,3976.0,,sekret,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:66,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-485,2014-12-08T22:12:09.288Z,2015-03-16T03:17:09.594Z
1423510_3,Mycobacterium tuberculosis BTB09-553,Mycobacterium tuberculosis BTB09-553,1423510.0,WGS,BTB09-553,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229291,SAMN02414926,GCA_000678655.1,JKEL00000000,-,Broad Institute,WGS,Illumina,104.0x,allpaths v. R48559,,,15.0,18.0,4393672.0,65.6,4353.0,,3996.0,,pleura,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:67,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-553,2014-12-08T22:12:09.297Z,2015-03-16T03:17:09.594Z
1423511_3,Mycobacterium tuberculosis BTB09-554,Mycobacterium tuberculosis BTB09-554,1423511.0,WGS,BTB09-554,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229292,SAMN02414927,GCA_000678675.1,JKEK00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,57.0,60.0,4405682.0,65.6,4378.0,,4017.0,,bronchial,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:68,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-554,2014-12-08T22:12:09.307Z,2015-03-16T03:17:09.594Z
1423512_3,Mycobacterium tuberculosis BTB09-565,Mycobacterium tuberculosis BTB09-565,1423512.0,WGS,BTB09-565,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229293,SAMN02414928,GCA_000658875.1,JKEJ00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,25.0,26.0,4400721.0,65.6,4353.0,,3982.0,,secrete,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:69,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB09-565,2014-12-08T22:12:09.316Z,2015-03-16T03:17:09.594Z
1423513_3,Mycobacterium tuberculosis BTB10-001,Mycobacterium tuberculosis BTB10-001,1423513.0,WGS,BTB10-001,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229294,SAMN02414929,GCA_000678695.1,JKEI00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,20.0,21.0,4411561.0,65.6,4377.0,,4007.0,,sputum,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:70,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:susceptible;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-001,2014-12-08T22:12:09.325Z,2015-03-16T03:17:09.594Z
1423514_3,Mycobacterium tuberculosis BTB10-005,Mycobacterium tuberculosis BTB10-005,1423514.0,WGS,BTB10-005,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229295,SAMN02414930,GCA_000678715.1,JKEH00000000,-,Broad Institute,WGS,Illumina,115.0x,allpaths v. R48559,,,18.0,18.0,4401203.0,65.6,4348.0,,3998.0,,secrete,,2009,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:71,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-005,2014-12-08T22:12:09.334Z,2015-03-16T03:17:09.594Z
1423515_3,Mycobacterium tuberculosis BTB10-092,Mycobacterium tuberculosis BTB10-092,1423515.0,WGS,BTB10-092,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229296,SAMN02414931,GCA_000659005.1,JKEG00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48559,,,23.0,24.0,4417060.0,65.6,4383.0,,3979.0,,sputum,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:72,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-092,2014-12-08T22:12:09.344Z,2015-03-16T03:17:09.594Z
1423516_3,Mycobacterium tuberculosis BTB10-097,Mycobacterium tuberculosis BTB10-097,1423516.0,WGS,BTB10-097,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229297,SAMN02414932,GCA_000678735.1,JKEF00000000,-,Broad Institute,WGS,Illumina,113.0x,allpaths v. R48559,,,19.0,19.0,4402929.0,65.6,4358.0,,3997.0,,sputum,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:73,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-097,2014-12-08T22:12:09.353Z,2015-03-16T03:17:09.594Z
1423517_3,Mycobacterium tuberculosis BTB10-120,Mycobacterium tuberculosis BTB10-120,1423517.0,WGS,BTB10-120,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229298,SAMN02414933,GCA_000678755.1,JKEE00000000,-,Broad Institute,WGS,Illumina,110.0x,allpaths v. R48559,,,26.0,27.0,4407265.0,65.6,4363.0,,3968.0,,bronchail,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:74,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-120,2014-12-08T22:12:09.363Z,2015-03-16T03:17:09.594Z
1423518_3,Mycobacterium tuberculosis BTB10-142,Mycobacterium tuberculosis BTB10-142,1423518.0,WGS,BTB10-142,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229299,SAMN02414934,GCA_000678775.1,JKED00000000,-,Broad Institute,WGS,Illumina,102.0x,allpaths v. R48559,,,21.0,22.0,4421661.0,65.6,4397.0,,4021.0,,sputum,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:75,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-142,2014-12-08T22:12:09.373Z,2015-03-16T03:17:09.594Z
1423519_3,Mycobacterium tuberculosis BTB10-253,Mycobacterium tuberculosis BTB10-253,1423519.0,WGS,BTB10-253,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229300,SAMN02414935,GCA_000658905.1,JKEC00000000,-,Broad Institute,WGS,Illumina,95.0x,allpaths v. R48559,,,25.0,26.0,4380767.0,65.6,4327.0,,3992.0,,sputum,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:76,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-253,2014-12-08T22:12:09.383Z,2015-03-16T03:17:09.594Z
1423520_3,Mycobacterium tuberculosis BTB10-257,Mycobacterium tuberculosis BTB10-257,1423520.0,WGS,BTB10-257,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229301,SAMN02414936,GCA_000678795.1,JKEB00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48559,,,22.0,24.0,4381409.0,65.6,4349.0,,3989.0,,sputum,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:77,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-257,2014-12-08T22:12:09.393Z,2015-03-16T03:17:09.594Z
1423521_3,Mycobacterium tuberculosis BTB10-258,Mycobacterium tuberculosis BTB10-258,1423521.0,WGS,BTB10-258,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229302,SAMN02414937,GCA_000658925.1,JKEA00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,39.0,43.0,4376969.0,65.6,4345.0,,3992.0,,tissue,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:78,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-258,2014-12-08T22:12:09.402Z,2015-03-16T03:17:09.594Z
1423522_3,Mycobacterium tuberculosis BTB10-277,Mycobacterium tuberculosis BTB10-277,1423522.0,WGS,BTB10-277,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229303,SAMN02414938,GCA_000678815.1,JKDZ00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,15.0,18.0,4428147.0,65.6,4375.0,,4017.0,,sputum,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:79,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-277,2014-12-08T22:12:09.412Z,2015-03-16T03:17:09.594Z
1423523_3,Mycobacterium tuberculosis BTB10-295,Mycobacterium tuberculosis BTB10-295,1423523.0,WGS,BTB10-295,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229304,SAMN02414939,GCA_000678835.1,JKDY00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48559,,,16.0,16.0,4411497.0,65.6,4354.0,,4005.0,,na,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:80,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-295,2014-12-08T22:12:09.421Z,2015-03-16T03:17:09.594Z
1423524_3,Mycobacterium tuberculosis BTB10-305,,1423524.0,WGS,BTB10-305,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA229305,SAMN02414940,GCA_000705905.1,JKDX00000000,-,Broad Institute,,Illumina,114.0x,allpaths v. R48559,,,10.0,22.0,4405950.0,65.6,4298.0,,4012.0,,sputum,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:81,Resistant,AMR Panel,,,,,,,,,,,TB Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-305,2014-12-08T22:56:54.640Z,2015-03-16T03:17:09.594Z
1423526_3,Mycobacterium tuberculosis BTB10-357,Mycobacterium tuberculosis BTB10-357,1423526.0,WGS,BTB10-357,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229307,SAMN02414942,GCA_000678855.1,JKDV00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,15.0,15.0,4398505.0,65.6,4351.0,,3984.0,,BAL,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:83,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-357,2014-12-08T22:12:09.439Z,2015-03-16T03:17:09.594Z
1423527_3,Mycobacterium tuberculosis BTB10-367,Mycobacterium tuberculosis BTB10-367,1423527.0,WGS,BTB10-367,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229308,SAMN02414943,GCA_000678875.1,JKDU00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,17.0,17.0,4409483.0,65.6,4368.0,,4019.0,,sputum,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:81,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-367,2014-12-08T22:12:09.448Z,2015-03-16T03:17:09.594Z
1423528_3,Mycobacterium tuberculosis BTB10-406,Mycobacterium tuberculosis BTB10-406,1423528.0,WGS,BTB10-406,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229309,SAMN02414944,GCA_000678895.1,JKDT00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48559,,,21.0,21.0,4395288.0,65.6,4331.0,,3993.0,,sputum,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:84,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-406,2014-12-08T22:12:09.457Z,2015-03-16T03:17:09.594Z
1423529_3,Mycobacterium tuberculosis BTB10-422,Mycobacterium tuberculosis BTB10-422,1423529.0,WGS,BTB10-422,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229310,SAMN02414945,GCA_000678915.1,JKDS00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48559,,,21.0,22.0,4419093.0,65.6,4376.0,,4008.0,,punctuat,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:85,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-422,2014-12-08T22:12:09.467Z,2015-03-16T03:17:09.594Z
1423530_3,Mycobacterium tuberculosis BTB10-426,Mycobacterium tuberculosis BTB10-426,1423530.0,WGS,BTB10-426,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229311,SAMN02414946,GCA_000678935.1,JKDR00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,14.0,14.0,4390947.0,65.6,4340.0,,3992.0,,sputum,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:86,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-426,2014-12-08T22:12:09.475Z,2015-03-16T03:17:09.594Z
1423531_3,Mycobacterium tuberculosis BTB10-472,Mycobacterium tuberculosis BTB10-472,1423531.0,WGS,BTB10-472,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229312,SAMN02414947,GCA_000678955.1,JKDQ00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48559,,,35.0,40.0,4369322.0,65.6,4347.0,,3973.0,,sputum,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:83,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-472,2014-12-08T22:12:09.484Z,2015-03-16T03:17:09.594Z
1423532_3,Mycobacterium tuberculosis BTB10-487,Mycobacterium tuberculosis BTB10-487,1423532.0,WGS,BTB10-487,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229313,SAMN02414948,GCA_000678975.1,JKDP00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48559,,,18.0,20.0,4396508.0,65.6,4354.0,,4002.0,,punctuat,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:87,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB10-487,2014-12-08T22:12:09.495Z,2015-03-16T03:17:09.594Z
1423533_3,Mycobacterium tuberculosis BTB11-001,Mycobacterium tuberculosis BTB11-001,1423533.0,WGS,BTB11-001,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229314,SAMN02414949,GCA_000678995.1,JKDO00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48559,,,33.0,38.0,4389898.0,65.6,4355.0,,3998.0,,BAL,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:88,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:susceptible;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-001,2014-12-08T22:12:09.503Z,2015-03-16T03:17:09.594Z
1423534_3,Mycobacterium tuberculosis BTB11-027,Mycobacterium tuberculosis BTB11-027,1423534.0,WGS,BTB11-027,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229315,SAMN02414950,GCA_000679015.1,JKDN00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,19.0,19.0,4390437.0,65.6,4336.0,,3984.0,,sputum,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:89,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-027,2014-12-08T22:12:09.513Z,2015-03-16T03:17:09.594Z
1423535_3,Mycobacterium tuberculosis BTB11-047,Mycobacterium tuberculosis BTB11-047,1423535.0,WGS,BTB11-047,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229316,SAMN02414951,GCA_000679035.1,JKDM00000000,-,Broad Institute,WGS,Illumina,113.0x,allpaths v. R48559,,,18.0,19.0,4344024.0,65.6,4316.0,,3975.0,,sputum,,2010,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:90,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-047,2014-12-08T22:12:09.523Z,2015-03-16T03:17:09.594Z
1423536_3,Mycobacterium tuberculosis BTB11-112,Mycobacterium tuberculosis BTB11-112,1423536.0,WGS,BTB11-112,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229317,SAMN02414952,GCA_000679055.1,JKDL00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,72.0,75.0,4392669.0,65.6,4348.0,,4004.0,,punctuat,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:91,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-112,2014-12-08T22:12:09.533Z,2015-03-16T03:17:09.594Z
1423537_3,Mycobacterium tuberculosis BTB11-133,Mycobacterium tuberculosis BTB11-133,1423537.0,WGS,BTB11-133,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229318,SAMN02414953,GCA_000679075.1,JKDK00000000,-,Broad Institute,WGS,Illumina,100.0x,allpaths v. R48559,,,19.0,20.0,4372557.0,65.6,4324.0,,3985.0,,punctuat,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:92,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-133,2014-12-08T22:12:09.542Z,2015-03-16T03:17:09.594Z
1423538_3,Mycobacterium tuberculosis BTB11-139,Mycobacterium tuberculosis BTB11-139,1423538.0,WGS,BTB11-139,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229319,SAMN02414954,GCA_000679095.1,JKDJ00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48559,,,25.0,26.0,4387887.0,65.6,4356.0,,3985.0,,bronchial,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:93,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-139,2014-12-08T22:12:09.551Z,2015-03-16T03:17:09.594Z
1423539_3,Mycobacterium tuberculosis BTB11-160,Mycobacterium tuberculosis BTB11-160,1423539.0,WGS,BTB11-160,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229320,SAMN02414955,GCA_000679115.1,JKDI00000000,-,Broad Institute,WGS,Illumina,113.0x,allpaths v. R48559,,,21.0,22.0,4398705.0,65.6,4353.0,,3976.0,,cerebrospinal,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:94,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-160,2014-12-08T22:12:09.560Z,2015-03-16T03:17:09.594Z
1423540_3,Mycobacterium tuberculosis BTB11-192,Mycobacterium tuberculosis BTB11-192,1423540.0,WGS,BTB11-192,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229321,SAMN02414956,GCA_000679135.1,JKDH00000000,-,Broad Institute,WGS,Illumina,111.0x,allpaths v. R48559,,,12.0,13.0,4407363.0,65.6,4357.0,,4028.0,,sputum,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:95,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-192,2014-12-08T22:12:09.569Z,2015-03-16T03:17:09.594Z
1423541_3,Mycobacterium tuberculosis BTB11-195,Mycobacterium tuberculosis BTB11-195,1423541.0,WGS,BTB11-195,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229322,SAMN02414957,GCA_000679155.1,JKDG00000000,-,Broad Institute,WGS,Illumina,118.0x,allpaths v. R48559,,,14.0,14.0,4397331.0,65.6,4355.0,,3994.0,,gland,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:96,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-195,2014-12-08T22:12:09.578Z,2015-03-16T03:17:09.594Z
1423542_3,Mycobacterium tuberculosis BTB11-207,Mycobacterium tuberculosis BTB11-207,1423542.0,WGS,BTB11-207,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229323,SAMN02414958,GCA_000679175.1,JKDF00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,25.0,31.0,4424988.0,65.6,4388.0,,4018.0,,sputum,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:97,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-207,2014-12-08T22:12:09.587Z,2015-03-16T03:17:09.594Z
1423543_3,Mycobacterium tuberculosis BTB11-210,Mycobacterium tuberculosis BTB11-210,1423543.0,WGS,BTB11-210,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229324,SAMN02414959,GCA_000679195.1,JKDE00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,21.0,26.0,4411678.0,65.6,4371.0,,3987.0,,punctuat,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:98,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-210,2014-12-08T22:12:09.595Z,2015-03-16T03:17:09.594Z
1423544_3,Mycobacterium tuberculosis BTB11-214,Mycobacterium tuberculosis BTB11-214,1423544.0,WGS,BTB11-214,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229325,SAMN02414960,GCA_000679215.1,JKDD00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,61.0,62.0,4350309.0,65.6,4322.0,,3971.0,,bronchial,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:99,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-214,2014-12-08T22:12:09.604Z,2015-03-16T03:17:09.594Z
1423545_3,Mycobacterium tuberculosis BTB11-236,Mycobacterium tuberculosis BTB11-236,1423545.0,WGS,BTB11-236,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229326,SAMN02414961,GCA_000679235.1,JKDC00000000,-,Broad Institute,WGS,Illumina,118.0x,allpaths v. R48559,,,17.0,20.0,4396259.0,65.6,4358.0,,3996.0,,na,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:96,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-236,2014-12-08T22:12:09.613Z,2015-03-16T03:17:09.594Z
1423546_3,Mycobacterium tuberculosis BTB11-250,Mycobacterium tuberculosis BTB11-250,1423546.0,WGS,BTB11-250,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229327,SAMN02414962,GCA_000679255.1,JKDB00000000,-,Broad Institute,WGS,Illumina,118.0x,allpaths v. R48559,,,20.0,21.0,4391870.0,65.6,4336.0,,3994.0,,Sputum,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:100,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-250,2014-12-08T22:12:09.622Z,2015-03-16T03:17:09.594Z
1423547_3,Mycobacterium tuberculosis BTB11-289,Mycobacterium tuberculosis BTB11-289,1423547.0,WGS,BTB11-289,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229328,SAMN02414963,GCA_000679275.1,JKDA00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,70.0,72.0,4378465.0,65.6,4348.0,,3979.0,,sputum,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:101,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-289,2014-12-08T22:12:09.631Z,2015-03-16T03:17:09.594Z
1423548_3,Mycobacterium tuberculosis BTB11-299,Mycobacterium tuberculosis BTB11-299,1423548.0,WGS,BTB11-299,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229329,SAMN02414964,GCA_000679295.1,JKCZ00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,20.0,20.0,4400907.0,65.6,4367.0,,3995.0,,VSK,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:102,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-299,2014-12-08T22:12:09.640Z,2015-03-16T03:17:09.594Z
1423549_3,Mycobacterium tuberculosis BTB11-300,Mycobacterium tuberculosis BTB11-300,1423549.0,WGS,BTB11-300,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229330,SAMN02414965,GCA_000679315.1,JKCY00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,29.0,31.0,4389220.0,65.6,4370.0,,3993.0,,VSK,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:37,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-300,2014-12-08T22:12:09.649Z,2015-03-16T03:17:09.594Z
1423551_3,Mycobacterium tuberculosis BTB11-371,Mycobacterium tuberculosis BTB11-371,1423551.0,WGS,BTB11-371,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229332,SAMN02414967,GCA_000679355.1,JKCW00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,38.0,39.0,4390018.0,65.6,4360.0,,3981.0,,sputum,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:104,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB11-371,2014-12-08T22:12:09.668Z,2015-03-16T03:17:09.594Z
1423552_3,Mycobacterium tuberculosis BTB12-001,Mycobacterium tuberculosis BTB12-001,1423552.0,WGS,BTB12-001,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229333,SAMN02414968,GCA_000679375.1,JKCV00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,19.0,20.0,4398821.0,65.6,4352.0,,4003.0,,gland,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:105,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-001,2014-12-08T22:12:09.677Z,2015-03-16T03:17:09.594Z
1423553_3,Mycobacterium tuberculosis BTB12-002,Mycobacterium tuberculosis BTB12-002,1423553.0,WGS,BTB12-002,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229334,SAMN02414969,GCA_000679395.1,JKCU00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,21.0,22.0,4399883.0,65.6,4373.0,,3993.0,,sputum,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:106,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:susceptible;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-002,2014-12-08T22:12:09.687Z,2015-03-16T03:17:09.594Z
1423554_3,Mycobacterium tuberculosis BTB12-046,Mycobacterium tuberculosis BTB12-046,1423554.0,WGS,BTB12-046,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229335,SAMN02414970,GCA_000679415.1,JKCT00000000,-,Broad Institute,WGS,Illumina,115.0x,allpaths v. R48559,,,21.0,22.0,4409504.0,65.6,4367.0,,4004.0,,sputum,,2011,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:107,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-046,2014-12-08T22:12:09.704Z,2015-03-16T03:17:09.594Z
1423555_3,Mycobacterium tuberculosis BTB12-054,Mycobacterium tuberculosis BTB12-054,1423555.0,WGS,BTB12-054,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229336,SAMN02414971,GCA_000679435.1,JKCS00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48559,,,16.0,16.0,4397463.0,65.6,4336.0,,3998.0,,tissue,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:108,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-054,2014-12-08T22:12:09.716Z,2015-03-16T03:17:09.594Z
1423556_3,Mycobacterium tuberculosis BTB12-094,Mycobacterium tuberculosis BTB12-094,1423556.0,WGS,BTB12-094,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229337,SAMN02414972,GCA_000679455.1,JKCR00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,29.0,30.0,4395192.0,65.6,4355.0,,3994.0,,sputum,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:109,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-094,2014-12-08T22:12:09.725Z,2015-03-16T03:17:09.594Z
1423557_3,Mycobacterium tuberculosis BTB12-162,Mycobacterium tuberculosis BTB12-162,1423557.0,WGS,BTB12-162,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229338,SAMN02414973,GCA_000679475.1,JKCQ00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,25.0,27.0,4408001.0,65.6,4369.0,,4007.0,,punctuat,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:110,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-162,2014-12-08T22:12:09.734Z,2015-03-16T03:17:09.594Z
1423558_3,Mycobacterium tuberculosis BTB12-206,Mycobacterium tuberculosis BTB12-206,1423558.0,WGS,BTB12-206,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229339,SAMN02414974,GCA_000679495.1,JKCP00000000,-,Broad Institute,WGS,Illumina,117.0x,allpaths v. R48559,,,21.0,21.0,4394023.0,65.6,4355.0,,3991.0,,sputum,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:111,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-206,2014-12-08T22:12:09.743Z,2015-03-16T03:17:09.594Z
1423559_3,Mycobacterium tuberculosis BTB12-211,Mycobacterium tuberculosis BTB12-211,1423559.0,WGS,BTB12-211,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229340,SAMN02414975,GCA_000679515.1,JKCO00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,32.0,33.0,4407376.0,65.6,4363.0,,3995.0,,sputum,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:112,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-211,2014-12-08T22:12:09.753Z,2015-03-16T03:17:09.594Z
1423560_3,Mycobacterium tuberculosis BTB12-294,Mycobacterium tuberculosis BTB12-294,1423560.0,WGS,BTB12-294,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229341,SAMN02414976,GCA_000679535.1,JKCN00000000,-,Broad Institute,WGS,Illumina,118.0x,allpaths v. R48559,,,20.0,22.0,4414816.0,65.6,4382.0,,4010.0,,sputum,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:113,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-294,2014-12-08T22:12:09.762Z,2015-03-16T03:17:09.594Z
1423561_3,Mycobacterium tuberculosis BTB12-304,Mycobacterium tuberculosis BTB12-304,1423561.0,WGS,BTB12-304,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229342,SAMN02414977,GCA_000679555.1,JKCM00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,16.0,17.0,4390190.0,65.6,4323.0,,3994.0,,punctuat,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:114,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-304,2014-12-08T22:12:09.771Z,2015-03-16T03:17:09.594Z
1423562_3,Mycobacterium tuberculosis BTB12-305,Mycobacterium tuberculosis BTB12-305,1423562.0,WGS,BTB12-305,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229343,SAMN02414978,GCA_000679575.1,JKCL00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,27.0,29.0,4396612.0,65.6,4392.0,,3991.0,,sputum,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:115,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-305,2014-12-08T22:12:09.781Z,2015-03-16T03:17:09.594Z
1423563_3,Mycobacterium tuberculosis BTB12-313,Mycobacterium tuberculosis BTB12-313,1423563.0,WGS,BTB12-313,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229344,SAMN02414979,GCA_000679595.1,JKCK00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,22.0,23.0,4423478.0,65.6,4395.0,,4020.0,,sputum,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:116,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-313,2014-12-08T22:12:09.790Z,2015-03-16T03:17:09.594Z
1423564_3,Mycobacterium tuberculosis BTB12-314,Mycobacterium tuberculosis BTB12-314,1423564.0,WGS,BTB12-314,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229345,SAMN02414980,GCA_000679615.1,JKCJ00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,29.0,29.0,4400953.0,65.6,4375.0,,3999.0,,abscess,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:117,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-314,2014-12-08T22:12:09.800Z,2015-03-16T03:17:09.594Z
1423565_3,Mycobacterium tuberculosis BTB12-315,Mycobacterium tuberculosis BTB12-315,1423565.0,WGS,BTB12-315,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229346,SAMN02414981,GCA_000679635.1,JKCI00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,20.0,21.0,4385988.0,65.6,4339.0,,3997.0,,na,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:118,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-315,2014-12-08T22:12:09.810Z,2015-03-16T03:17:09.594Z
1423566_3,Mycobacterium tuberculosis BTB12-384,Mycobacterium tuberculosis BTB12-384,1423566.0,WGS,BTB12-384,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229347,SAMN02414982,GCA_000679655.1,JKCH00000000,-,Broad Institute,WGS,Illumina,78.0x,allpaths v. R48559,,,77.0,80.0,4392517.0,65.6,4346.0,,4001.0,,abscess,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:119,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-384,2014-12-08T22:12:09.820Z,2015-03-16T03:17:09.594Z
1423567_3,Mycobacterium tuberculosis BTB12-400,Mycobacterium tuberculosis BTB12-400,1423567.0,WGS,BTB12-400,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229348,SAMN02414983,GCA_000679675.1,JKCG00000000,-,Broad Institute,WGS,Illumina,116.0x,allpaths v. R48559,,,29.0,32.0,4388501.0,65.6,4343.0,,4003.0,,sputum,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:120,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB12-400,2014-12-08T22:12:09.829Z,2015-03-16T03:17:09.594Z
1423569_3,Mycobacterium tuberculosis BTB13-001,,1423569.0,WGS,BTB13-001,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA229350,SAMN02414985,GCA_000705885.1,JKCE00000000,-,Broad Institute,,Illumina,124.0x,allpaths v. R48559,,,2.0,19.0,4432540.0,65.6,4350.0,,4014.0,,gland,,2012,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:121,Susceptible,AMR Panel,,,,,,,,,,,TB Sweden,phenotype:susceptible;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB13-001,2014-12-08T22:56:55.124Z,2015-03-16T03:17:09.594Z
1423570_3,Mycobacterium tuberculosis BTB13-063,Mycobacterium tuberculosis BTB13-063,1423570.0,WGS,BTB13-063,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229351,SAMN02414986,GCA_000679715.1,JKCD00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,16.0,16.0,4405897.0,65.6,4382.0,,4004.0,,tissue,,2013,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:122,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB13-063,2014-12-08T22:12:09.847Z,2015-03-16T03:17:09.594Z
1423571_3,Mycobacterium tuberculosis BTB13-089,Mycobacterium tuberculosis BTB13-089,1423571.0,WGS,BTB13-089,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229352,SAMN02414987,GCA_000679735.1,JKCC00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,26.0,26.0,4387261.0,65.6,4358.0,,3983.0,,sputum,,2013,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:123,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB13-089,2014-12-08T22:12:09.856Z,2015-03-16T03:17:09.594Z
1423572_3,Mycobacterium tuberculosis BTB13-127,Mycobacterium tuberculosis BTB13-127,1423572.0,WGS,BTB13-127,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229353,SAMN02414988,GCA_000679755.1,JKCB00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,69.0,70.0,4370936.0,65.6,4331.0,,3973.0,,sputum,,2013,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:124,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB13-127,2014-12-08T22:12:09.864Z,2015-03-16T03:17:09.594Z
1423573_3,Mycobacterium tuberculosis BTB13-128,Mycobacterium tuberculosis BTB13-128,1423573.0,WGS,BTB13-128,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229354,SAMN02414989,GCA_000679775.1,JKCA00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,64.0,66.0,4370559.0,65.6,4352.0,,3978.0,,sputum,,2013,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:125,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB13-128,2014-12-08T22:12:09.874Z,2015-03-16T03:17:09.594Z
1423574_3,Mycobacterium tuberculosis BTB13-156,Mycobacterium tuberculosis BTB13-156,1423574.0,WGS,BTB13-156,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229355,SAMN02414990,GCA_000679795.1,JKBZ00000000,-,Broad Institute,WGS,Illumina,118.0x,allpaths v. R48559,,,26.0,27.0,4421924.0,65.6,4385.0,,4013.0,,BAL,,2013,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:126,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB13-156,2014-12-08T22:12:09.883Z,2015-03-16T03:17:09.594Z
1423575_3,Mycobacterium tuberculosis BTB13-206,Mycobacterium tuberculosis BTB13-206,1423575.0,WGS,BTB13-206,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229356,SAMN02414991,GCA_000679815.1,JKBY00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,29.0,29.0,4386731.0,65.6,4326.0,,4000.0,,sputum,,2013,Sweden,Sweden,,,,,,"Human, Homo sapiens",,,,,,host_subject_id:127,Resistant,AMR Panel,,,,,,,,,,,TB-ARC Sweden,phenotype:MDR-TB or XDR-TB;specimen repository name:Swedish Institute for Communicable Disease Control;specimen sample id:BTB13-206,2014-12-08T22:12:09.892Z,2015-03-16T03:17:09.594Z
1427177_3,Mycobacterium tuberculosis XTB13-081,Mycobacterium tuberculosis XTB13-081,1427177.0,WGS,XTB13-081,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229570,SAMN02419533,GCA_000679875.1,JLMJ00000000,-,Broad Institute,WGS,Illumina,113.0x,allpaths v. R48559,,,3.0,4.0,4418150.0,65.6,4363.0,,3996.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:<1 year;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-07-14T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2012-05-28T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-12-28,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1.2013,2014-12-08T22:12:22.060Z,2015-03-16T03:17:09.594Z
1427178_3,Mycobacterium tuberculosis XTB13-082,Mycobacterium tuberculosis XTB13-082,1427178.0,WGS,XTB13-082,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229571,SAMN02419534,GCA_000679895.1,JLMI00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,5.0,5.0,4417961.0,65.6,4352.0,,3996.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:1 month;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:lower lobe of the right lung;patient history | date of current tb diagnosis:2012-10-29T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:11.2013,2014-12-08T22:12:22.069Z,2015-03-16T03:17:09.594Z
1427179_3,Mycobacterium tuberculosis XTB13-083,Mycobacterium tuberculosis XTB13-083,1427179.0,WGS,XTB13-083,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229572,SAMN02419535,GCA_000679915.1,JLMH00000000,-,Broad Institute,WGS,Illumina,96.0x,allpaths v. R48559,,,12.0,14.0,4438600.0,65.4,4380.0,,4009.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:1 month;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:cured;patient history| date of previous (most recent) tb diagnosis:2010-07-16T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | worsening of tb diagnosed prior to cart initiation?:no;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:positive;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:yes;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:the lower and the upper lobe of both lungs;patient history | date of current tb diagnosis:2012-05-22T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb diagnosis after initiation of cart?:yes;patient treatment history | changed antiretroviral therapy for reasons other than toxicity?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-07-15,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:100.2012,2014-12-08T22:12:22.078Z,2015-03-16T03:17:09.594Z
1427180_3,Mycobacterium tuberculosis XTB13-084,Mycobacterium tuberculosis XTB13-084,1427180.0,WGS,XTB13-084,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229573,SAMN02419536,GCA_000679935.1,JLMG00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,35.0,38.0,4384970.0,65.6,4371.0,,3990.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:yes;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:yes;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the right lung;patient history | date of current tb diagnosis:2011-07-12T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | if the patient received other anti-tb chemoprophylaxis, which drug(s)?:- Rifapentine - -",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1002.2011,2014-12-08T22:12:22.088Z,2015-03-16T03:17:09.594Z
1427181_3,Mycobacterium tuberculosis XTB13-086,Mycobacterium tuberculosis XTB13-086,1427181.0,WGS,XTB13-086,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229574,SAMN02419537,GCA_000679955.1,JLMF00000000,-,Broad Institute,WGS,Illumina,108.0x,allpaths v. R48559,,,22.0,25.0,4369113.0,65.6,4329.0,,4001.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:dissimination in both lungs;patient history | date of current tb diagnosis:2011-08-24T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1015.2011,2014-12-08T22:12:22.096Z,2015-03-16T03:17:09.594Z
1427182_3,Mycobacterium tuberculosis XTB13-088,Mycobacterium tuberculosis XTB13-088,1427182.0,WGS,XTB13-088,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229575,SAMN02419538,GCA_000679975.1,JLME00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,6.0,6.0,4419668.0,65.6,4369.0,,4001.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:6 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:2006;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:left lung, upper lobe of the right lung, cavitation;patient history | date of current tb diagnosis:2011-08-31T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:Afganistan;patient treatment history | date when the last tb treatment was ended:2006",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1024.2011,2014-12-08T22:12:22.105Z,2015-03-16T03:17:09.594Z
1427183_3,Mycobacterium tuberculosis XTB13-089,Mycobacterium tuberculosis XTB13-089,1427183.0,WGS,XTB13-089,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229576,SAMN02419539,GCA_000679995.1,JLMD00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,22.0,22.0,4385965.0,65.6,4329.0,,4008.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:1.5;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2010-06-01T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient history | alcohol abuse?:yes;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.3;patient history | chest x-ray/ct-scan description:Both lung, cavitations;patient history | date of current tb diagnosis:2012-07-26T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010-07-22",Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1034.2012,2014-12-08T22:12:22.115Z,2015-03-16T03:17:09.594Z
1427185_3,Mycobacterium tuberculosis XTB13-091,Mycobacterium tuberculosis XTB13-091,1427185.0,WGS,XTB13-091,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229578,SAMN02419541,GCA_000680015.1,JLMC00000000,-,Broad Institute,WGS,Illumina,117.0x,allpaths v. R48559,,,23.0,24.0,4429961.0,65.6,4396.0,,4015.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:3 year;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2009;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper and middle parts of the lungs, cavitations;patient history | date of current tb diagnosis:2011-07-13T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1057.2012,2014-12-08T22:12:22.124Z,2015-03-16T03:17:09.594Z
1427186_3,Mycobacterium tuberculosis XTB13-092,Mycobacterium tuberculosis XTB13-092,1427186.0,WGS,XTB13-092,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229579,SAMN02419542,GCA_000680035.1,JLMB00000000,-,Broad Institute,WGS,Illumina,115.0x,allpaths v. R48559,,,10.0,10.0,4407259.0,65.6,4364.0,,3997.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2011-01-27T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2011-08-09T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-06-29,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1059.2011,2014-12-08T22:12:22.134Z,2015-03-16T03:17:09.594Z
1427187_3,Mycobacterium tuberculosis XTB13-093,Mycobacterium tuberculosis XTB13-093,1427187.0,WGS,XTB13-093,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229580,SAMN02419543,GCA_000680055.1,JLMA00000000,-,Broad Institute,WGS,Illumina,100.0x,allpaths v. R48559,,,18.0,19.0,4416256.0,65.6,4372.0,,4002.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1 year;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:from 2006;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:upper lung zones, cavitation;patient history | date of current tb diagnosis:2011-09-14T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-09-09",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1060.2011,2014-12-08T22:12:22.143Z,2015-03-16T03:17:09.594Z
1427188_3,Mycobacterium tuberculosis XTB13-094,Mycobacterium tuberculosis XTB13-094,1427188.0,WGS,XTB13-094,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229581,SAMN02419544,GCA_000680075.1,JLLZ00000000,-,Broad Institute,WGS,Illumina,93.0x,allpaths v. R48559,,,16.0,16.0,4416163.0,65.6,4382.0,,4004.0,,Excreted bodily substance,,2009,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<2 year;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:upper lung zones and S6 of the right lung;patient history | date of current tb diagnosis:2009-11-14T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1061.2009,2014-12-08T22:12:22.153Z,2015-03-16T03:17:09.594Z
1427189_3,Mycobacterium tuberculosis XTB13-095,Mycobacterium tuberculosis XTB13-095,1427189.0,WGS,XTB13-095,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229582,SAMN02419545,GCA_000680095.1,JLLY00000000,-,Broad Institute,WGS,Illumina,108.0x,allpaths v. R48559,,,15.0,15.0,4406326.0,65.6,4370.0,,3992.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | ofloxacine | ofl:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient treatment history | tb drug use dosage | ofloxacine | ofl | grams:0.8;patient history | chest x-ray/ct-scan description:the upper lobe of the left lung;patient history | date of current tb diagnosis:2011-09-05T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1063.2011,2014-12-08T22:12:22.166Z,2015-03-16T03:17:09.594Z
1427190_3,Mycobacterium tuberculosis XTB13-096,Mycobacterium tuberculosis XTB13-096,1427190.0,WGS,XTB13-096,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229583,SAMN02419546,GCA_000680115.1,JLLX00000000,-,Broad Institute,WGS,Illumina,115.0x,allpaths v. R48559,,,17.0,17.0,4402154.0,65.6,4351.0,,4014.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:3 year;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2011-09-21T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1067.2011,2014-12-08T22:12:22.177Z,2015-03-16T03:17:09.594Z
1427191_3,Mycobacterium tuberculosis XTB13-097,Mycobacterium tuberculosis XTB13-097,1427191.0,WGS,XTB13-097,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229584,SAMN02419547,GCA_000680135.1,JLLW00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48559,,,5.0,6.0,4415804.0,65.6,4354.0,,3995.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:4 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:2006;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | ofloxacine | ofl:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | ofloxacine | ofl | grams:0.8;patient history | chest x-ray/ct-scan description:right lung, cavitations;patient history | date of current tb diagnosis:2011-09-01T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2008",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1087.2011,2014-12-08T22:12:22.188Z,2015-03-16T03:17:09.594Z
1427192_3,Mycobacterium tuberculosis XTB13-098,Mycobacterium tuberculosis XTB13-098,1427192.0,WGS,XTB13-098,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229585,SAMN02419548,GCA_000680155.1,JLLV00000000,-,Broad Institute,WGS,Illumina,101.0x,allpaths v. R48559,,,11.0,11.0,4415287.0,65.6,4367.0,,3997.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:<1 year;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-06-30T00:00:00;patient history| previous tb treatment?:yes;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper lung zones, cavitation;patient history | date of current tb diagnosis:2011-12-29T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-12-29",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:109.2012,2014-12-08T22:12:22.197Z,2015-03-16T03:17:09.594Z
1427193_3,Mycobacterium tuberculosis XTB13-100,Mycobacterium tuberculosis XTB13-100,1427193.0,WGS,XTB13-100,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229586,SAMN02419549,GCA_000680175.1,JLLU00000000,-,Broad Institute,WGS,Illumina,67.0x,allpaths v. R48559,,,62.0,66.0,4370270.0,65.6,4331.0,,3985.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2009-02-16T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | ofloxacine | ofl:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient treatment history | tb drug use dosage | ofloxacine | ofl | grams:0.8;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2010-10-01T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009-07-01,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1103.2012,2014-12-08T22:12:22.205Z,2015-03-16T03:17:09.594Z
1427194_3,Mycobacterium tuberculosis XTB13-102,Mycobacterium tuberculosis XTB13-102,1427194.0,WGS,XTB13-102,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229587,SAMN02419550,GCA_000680195.1,JLLT00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,13.0,13.0,4416028.0,65.6,4378.0,,3996.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | ofloxacine | ofl:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient treatment history | tb drug use dosage | ofloxacine | ofl | grams:0.8;patient history | chest x-ray/ct-scan description:the upper lobe of the left lung;patient history | date of current tb diagnosis:2011-09-05T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:113.2012,2014-12-08T22:12:22.213Z,2015-03-16T03:17:09.594Z
1427195_3,Mycobacterium tuberculosis XTB13-103,Mycobacterium tuberculosis XTB13-103,1427195.0,WGS,XTB13-103,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229588,SAMN02419551,GCA_000680215.1,JLLS00000000,-,Broad Institute,WGS,Illumina,106.0x,allpaths v. R48559,,,16.0,16.0,4379165.0,65.6,4322.0,,3995.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:dissimination in both lungs;patient history | date of current tb diagnosis:2011-07-12T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1133.2011,2014-12-08T22:12:22.228Z,2015-03-16T03:17:09.594Z
1427196_3,Mycobacterium tuberculosis XTB13-104,Mycobacterium tuberculosis XTB13-104,1427196.0,WGS,XTB13-104,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229589,SAMN02419552,GCA_000680235.1,JLLR00000000,-,Broad Institute,WGS,Illumina,77.0x,allpaths v. R48559,,,13.0,13.0,4409217.0,65.6,4352.0,,4007.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:the upper zone of the right lung;patient history | date of current tb diagnosis:2011-11-23T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:115.2012,2014-12-08T22:12:22.239Z,2015-03-16T03:17:09.594Z
1427197_3,Mycobacterium tuberculosis XTB13-105,Mycobacterium tuberculosis XTB13-105,1427197.0,WGS,XTB13-105,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229590,SAMN02419553,GCA_000680255.1,JLLQ00000000,-,Broad Institute,WGS,Illumina,107.0x,allpaths v. R48559,,,15.0,15.0,4402585.0,65.6,4365.0,,3992.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-07-31T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:yes;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the right lung;patient history | date of current tb diagnosis:2012-04-02T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-10-07,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1159.2011,2014-12-08T22:12:22.249Z,2015-03-16T03:17:09.594Z
1427199_3,Mycobacterium tuberculosis XTB13-107,Mycobacterium tuberculosis XTB13-107,1427199.0,WGS,XTB13-107,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229593,SAMN02419555,GCA_000680275.1,JLLP00000000,-,Broad Institute,WGS,Illumina,118.0x,allpaths v. R48559,,,32.0,32.0,4373484.0,65.6,4327.0,,3998.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:6 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2009-02-10T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2012-02-20T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010-01-29,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1172.2012,2014-12-08T22:12:22.260Z,2015-03-16T03:17:09.594Z
1427200_3,Mycobacterium tuberculosis XTB13-108,Mycobacterium tuberculosis XTB13-108,1427200.0,WGS,XTB13-108,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229594,SAMN02419556,GCA_000680295.1,JLLO00000000,-,Broad Institute,WGS,Illumina,110.0x,allpaths v. R48559,,,9.0,9.0,4422764.0,65.6,4374.0,,4007.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1 year;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper and midle lung zones, cavitations;patient history | date of current tb diagnosis:2011-12-13T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1176.2012,2014-12-08T22:12:22.270Z,2015-03-16T03:17:09.594Z
1427202_3,Mycobacterium tuberculosis XTB13-110,Mycobacterium tuberculosis XTB13-110,1427202.0,WGS,XTB13-110,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229596,SAMN02419558,GCA_000658095.1,JLLN00000000,-,Broad Institute,WGS,Illumina,96.0x,allpaths v. R48559,,,31.0,32.0,4418696.0,65.6,4377.0,,4008.0,,excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:2004;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones, cavitations;patient history | date of current tb diagnosis:2011-11-12T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2006",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1182.2012,2014-12-08T22:12:22.281Z,2015-03-16T03:17:09.594Z
1427203_3,Mycobacterium tuberculosis XTB13-111,Mycobacterium tuberculosis XTB13-111,1427203.0,WGS,XTB13-111,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229597,SAMN02419559,GCA_000680315.1,JLLM00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,16.0,16.0,4417764.0,65.6,4379.0,,4003.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:1.5;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | worsening of tb diagnosed prior to cart initiation?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:positive;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.2;patient treatment history | initiated antiretroviral therapy/regimen?:yes;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:yes;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:right lung;patient history | date of current tb diagnosis:2012-01-21T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb diagnosis after initiation of cart?:yes;patient treatment history | changed antiretroviral therapy for reasons other than toxicity?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1192.2012,2014-12-08T22:12:22.290Z,2015-03-16T03:17:09.594Z
1427204_3,Mycobacterium tuberculosis XTB13-112,Mycobacterium tuberculosis XTB13-112,1427204.0,WGS,XTB13-112,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229598,SAMN02419560,GCA_000680335.1,JLLL00000000,-,Broad Institute,WGS,Illumina,116.0x,allpaths v. R48559,,,14.0,14.0,4417592.0,65.6,4362.0,,4002.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:yes;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:yes;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the right lung;patient history | date of current tb diagnosis:2011-07-12T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | if the patient received other anti-tb chemoprophylaxis, which drug(s)?:- Rifapentine - -",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1206.2012,2014-12-08T22:12:22.304Z,2015-03-16T03:17:09.594Z
1427205_3,Mycobacterium tuberculosis XTB13-113,Mycobacterium tuberculosis XTB13-113,1427205.0,WGS,XTB13-113,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229599,SAMN02419561,GCA_000680355.1,JLLK00000000,-,Broad Institute,WGS,Illumina,97.0x,allpaths v. R48559,,,4.0,4.0,4420337.0,65.6,4369.0,,3995.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-06-21T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:the upper zone of the right lung;patient history | date of current tb diagnosis:2011-10-13T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2012-01-02,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1223.2011,2014-12-08T22:12:22.314Z,2015-03-16T03:17:09.594Z
1427206_3,Mycobacterium tuberculosis XTB13-114,Mycobacterium tuberculosis XTB13-114,1427206.0,WGS,XTB13-114,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229600,SAMN02419562,GCA_000680375.1,JLLJ00000000,-,Broad Institute,WGS,Illumina,112.0x,allpaths v. R48559,,,10.0,10.0,4423682.0,65.6,4367.0,,4003.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:2002;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:0.75;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2011-09-16T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1229.2011,2014-12-08T22:12:22.324Z,2015-03-16T03:17:09.594Z
1427207_3,Mycobacterium tuberculosis XTB13-115,Mycobacterium tuberculosis XTB13-115,1427207.0,WGS,XTB13-115,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229601,SAMN02419563,GCA_000680395.1,JLLI00000000,-,Broad Institute,WGS,Illumina,105.0x,allpaths v. R48559,,,29.0,30.0,4355140.0,65.6,4304.0,,3980.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:6 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-09-13T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | tb drug use frequency | clarithromycin | clari:every day;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2011-12-26T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb drug use dosage | clarithromycin | clari | grams:1;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-12-21,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:124.2012,2014-12-08T22:12:22.333Z,2015-03-16T03:17:09.594Z
1427208_3,Mycobacterium tuberculosis XTB13-116,Mycobacterium tuberculosis XTB13-116,1427208.0,WGS,XTB13-116,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229602,SAMN02419564,GCA_000680415.1,JLLH00000000,-,Broad Institute,WGS,Illumina,73.0x,allpaths v. R48559,,,15.0,17.0,4408791.0,65.6,4376.0,,4002.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:0.75;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:lower and middle lobe of the right lung;patient history | date of current tb diagnosis:2011-09-28T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1251.2011,2014-12-08T22:12:22.342Z,2015-03-16T03:17:09.594Z
1427209_3,Mycobacterium tuberculosis XTB13-117,Mycobacterium tuberculosis XTB13-117,1427209.0,WGS,XTB13-117,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229603,SAMN02419565,GCA_000680435.1,JLLG00000000,-,Broad Institute,WGS,Illumina,98.0x,allpaths v. R48559,,,6.0,6.0,4418304.0,65.6,4361.0,,3998.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:4 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:2006;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | ofloxacine | ofl:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | ofloxacine | ofl | grams:0.8;patient history | chest x-ray/ct-scan description:right lung, cavitations;patient history | date of current tb diagnosis:2011-09-01T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2008",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1253.2012,2014-12-08T22:12:22.351Z,2015-03-16T03:17:09.594Z
1427210_3,Mycobacterium tuberculosis XTB13-119,Mycobacterium tuberculosis XTB13-119,1427210.0,WGS,XTB13-119,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229604,SAMN02419566,GCA_000680455.1,JLLF00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,14.0,14.0,4389312.0,65.6,4333.0,,3987.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1 year;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:Oct-05;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones, cavitation;patient history | date of current tb diagnosis:2011-11-29T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:Nov-06",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:127.2012,2014-12-08T22:12:22.360Z,2015-03-16T03:17:09.594Z
1427211_3,Mycobacterium tuberculosis XTB13-120,Mycobacterium tuberculosis XTB13-120,1427211.0,WGS,XTB13-120,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229605,SAMN02419567,GCA_000680475.1,JLLE00000000,-,Broad Institute,WGS,Illumina,97.0x,allpaths v. R48559,,,5.0,5.0,4418738.0,65.6,4371.0,,3997.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:1905-07-02T00:00:00;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the right lung ,  cavitation;patient history | date of current tb diagnosis:2011-09-15T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-09-15",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1272.2012,2014-12-08T22:12:22.375Z,2015-03-16T03:17:09.594Z
1427212_3,Mycobacterium tuberculosis XTB13-121,Mycobacterium tuberculosis XTB13-121,1427212.0,WGS,XTB13-121,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229606,SAMN02419568,GCA_000680495.1,JLLD00000000,-,Broad Institute,WGS,Illumina,106.0x,allpaths v. R48559,,,21.0,22.0,4394571.0,65.6,4361.0,,4017.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:1.2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:1 month;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:0.8;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.3;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2011-11-11T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1284.2011,2014-12-08T22:12:22.384Z,2015-03-16T03:17:09.594Z
1427213_3,Mycobacterium tuberculosis XTB13-122,Mycobacterium tuberculosis XTB13-122,1427213.0,WGS,XTB13-122,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229607,SAMN02419569,GCA_000680515.1,JLLC00000000,-,Broad Institute,WGS,Illumina,94.0x,allpaths v. R48559,,,6.0,6.0,4418556.0,65.6,4365.0,,3994.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:6 month;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2011-07-15T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | tb drug use frequency | clarithromycin | clari:every day;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2013-05-15T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb drug use dosage | clarithromycin | clari | grams:1;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2012-03-13,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:129.2013,2014-12-08T22:12:22.393Z,2015-03-16T03:17:09.594Z
1427214_3,Mycobacterium tuberculosis XTB13-123,Mycobacterium tuberculosis XTB13-123,1427214.0,WGS,XTB13-123,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229608,SAMN02419570,GCA_000658115.1,JLLB00000000,-,Broad Institute,WGS,Illumina,75.0x,allpaths v. R48559,,,50.0,53.0,4407174.0,65.59,4396.0,,4016.0,,excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | worsening of tb diagnosed prior to cart initiation?:no;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:positive;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:yes;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:yes;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | date of current tb diagnosis:2011-04-18T00:00:00;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb diagnosis after initiation of cart?:yes;patient treatment history | changed antiretroviral therapy for reasons other than toxicity?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1297.2012,2014-12-08T22:12:22.403Z,2015-03-16T03:17:09.594Z
1427215_3,Mycobacterium tuberculosis XTB13-124,Mycobacterium tuberculosis XTB13-124,1427215.0,WGS,XTB13-124,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229609,SAMN02419571,GCA_000680535.1,JLLA00000000,-,Broad Institute,WGS,Illumina,100.0x,allpaths v. R48559,,,9.0,9.0,4412345.0,65.6,4377.0,,3999.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:cured;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:lower lobe of the left lung;patient history | date of current tb diagnosis:2013-04-17T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:13.2011,2014-12-08T22:12:22.412Z,2015-03-16T03:17:09.594Z
1427216_3,Mycobacterium tuberculosis XTB13-125,Mycobacterium tuberculosis XTB13-125,1427216.0,WGS,XTB13-125,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229610,SAMN02419572,GCA_000680555.1,JLKZ00000000,-,Broad Institute,WGS,Illumina,110.0x,allpaths v. R48559,,,20.0,20.0,4376763.0,65.6,4316.0,,3995.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:2 month;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:cured;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lobe of the right lung;patient history | date of current tb diagnosis:2012-07-05T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:13.2013,2014-12-08T22:12:22.420Z,2015-03-16T03:17:09.594Z
1427217_3,Mycobacterium tuberculosis XTB13-126,Mycobacterium tuberculosis XTB13-126,1427217.0,WGS,XTB13-126,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229611,SAMN02419573,GCA_000680575.1,JLKY00000000,-,Broad Institute,WGS,Illumina,104.0x,allpaths v. R48559,,,7.0,7.0,4403866.0,65.6,4360.0,,3991.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-07-31T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:yes;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the right lung;patient history | date of current tb diagnosis:2012-04-02T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-10-07,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:131.2013,2014-12-08T22:12:22.428Z,2015-03-16T03:17:09.594Z
1427218_3,Mycobacterium tuberculosis XTB13-127,Mycobacterium tuberculosis XTB13-127,1427218.0,WGS,XTB13-127,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229612,SAMN02419574,GCA_000680595.1,JLKX00000000,-,Broad Institute,WGS,Illumina,107.0x,allpaths v. R48559,,,14.0,14.0,4409109.0,65.6,4369.0,,3994.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-08-14T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:dissimination in both lungs;patient history | date of current tb diagnosis:2012-02-16T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2012-02-16,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1333.2012,2014-12-08T22:12:22.437Z,2015-03-16T03:17:09.594Z
1427219_3,Mycobacterium tuberculosis XTB13-128,Mycobacterium tuberculosis XTB13-128,1427219.0,WGS,XTB13-128,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229613,SAMN02419575,GCA_000680615.1,JLKW00000000,-,Broad Institute,WGS,Illumina,109.0x,allpaths v. R48559,,,17.0,17.0,4404842.0,65.6,4350.0,,4020.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:the upper zone of the left lung, left-sided costal encysted effusion;patient history | date of current tb diagnosis:2011-11-01T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no",Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1336.2011,2014-12-08T22:12:22.447Z,2015-03-16T03:17:09.594Z
1427221_3,Mycobacterium tuberculosis XTB13-131,Mycobacterium tuberculosis XTB13-131,1427221.0,WGS,XTB13-131,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229615,SAMN02419577,GCA_000680635.1,JLKV00000000,-,Broad Institute,WGS,Illumina,65.0x,allpaths v. R48559,,,4.0,4.0,4418780.0,65.6,4364.0,,3997.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:1 month;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:cured;patient history| date of previous (most recent) tb diagnosis:2010-07-16T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | worsening of tb diagnosed prior to cart initiation?:no;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:positive;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:yes;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:the lower and the upper lobe of both lungs;patient history | date of current tb diagnosis:2012-05-22T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb diagnosis after initiation of cart?:yes;patient treatment history | changed antiretroviral therapy for reasons other than toxicity?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-07-15,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1363.2012,2014-12-08T22:12:22.464Z,2015-03-16T03:17:09.594Z
1427222_3,Mycobacterium tuberculosis XTB13-132,Mycobacterium tuberculosis XTB13-132,1427222.0,WGS,XTB13-132,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229616,SAMN02419578,GCA_000680655.1,JLKU00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,23.0,23.0,4373120.0,65.6,4325.0,,3994.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2,5 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:right and left lung, cavitation;patient history | date of current tb diagnosis:2011-10-31T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1365.2011,2014-12-08T22:12:22.475Z,2015-03-16T03:17:09.594Z
1427223_3,Mycobacterium tuberculosis XTB13-133,Mycobacterium tuberculosis XTB13-133,1427223.0,WGS,XTB13-133,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229618,SAMN02419579,GCA_000680675.1,JLKT00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,7.0,7.0,4417508.0,65.6,4351.0,,3997.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:4 years;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2011-10-12T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1367.2011,2014-12-08T22:12:22.484Z,2015-03-16T03:17:09.594Z
1427224_3,Mycobacterium tuberculosis XTB13-134,Mycobacterium tuberculosis XTB13-134,1427224.0,WGS,XTB13-134,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229619,SAMN02419580,GCA_000680695.1,JLKS00000000,-,Broad Institute,WGS,Illumina,101.0x,allpaths v. R48559,,,7.0,7.0,4414249.0,65.6,4376.0,,3995.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | worsening of tb diagnosed prior to cart initiation?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:positive;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:yes;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:yes;patient history | clinical presentation of current tb disease:TB bronchial and hilar lymph nodes;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:left basal areal;patient history | date of current tb diagnosis:2012-06-04T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb diagnosis after initiation of cart?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1371.2012,2014-12-08T22:12:22.493Z,2015-03-16T03:17:09.594Z
1427225_3,Mycobacterium tuberculosis XTB13-135,Mycobacterium tuberculosis XTB13-135,1427225.0,WGS,XTB13-135,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229620,SAMN02419581,GCA_000680715.1,JLKR00000000,-,Broad Institute,WGS,Illumina,97.0x,allpaths v. R48559,,,18.0,18.0,4376351.0,65.6,4345.0,,4000.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:1.5;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2010-06-01T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient history | alcohol abuse?:yes;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.3;patient history | chest x-ray/ct-scan description:Both lung, cavitations;patient history | date of current tb diagnosis:2012-07-26T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010-07-22",Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1376.2012,2014-12-08T22:12:22.502Z,2015-03-16T03:17:09.594Z
1427226_3,Mycobacterium tuberculosis XTB13-136,Mycobacterium tuberculosis XTB13-136,1427226.0,WGS,XTB13-136,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229621,SAMN02419582,GCA_000680735.1,JLKQ00000000,-,Broad Institute,WGS,Illumina,95.0x,allpaths v. R48559,,,7.0,7.0,4416960.0,65.6,4361.0,,3997.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the right lung;patient history | date of current tb diagnosis:2011-11-30T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1406.2011,2014-12-08T22:12:22.511Z,2015-03-16T03:17:09.594Z
1427227_3,Mycobacterium tuberculosis XTB13-137,Mycobacterium tuberculosis XTB13-137,1427227.0,WGS,XTB13-137,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229622,SAMN02419583,GCA_000680755.1,JLKP00000000,-,Broad Institute,WGS,Illumina,114.0x,allpaths v. R48559,,,7.0,7.0,4418007.0,65.6,4370.0,,3998.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | worsening of tb diagnosed prior to cart initiation?:no;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:positive;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:yes;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:lower lobe of the left lung, pleural effusion;patient history | date of current tb diagnosis:2011-12-16T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb diagnosis after initiation of cart?:yes;patient treatment history | changed antiretroviral therapy for reasons other than toxicity?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:141.2013,2014-12-08T22:12:22.520Z,2015-03-16T03:17:09.594Z
1427228_3,Mycobacterium tuberculosis XTB13-138,Mycobacterium tuberculosis XTB13-138,1427228.0,WGS,XTB13-138,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229623,SAMN02419584,GCA_000680775.1,JLKO00000000,-,Broad Institute,WGS,Illumina,117.0x,allpaths v. R48559,,,13.0,13.0,4416002.0,65.6,4368.0,,4004.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:1 month;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:dissimination in both lungs;patient history | date of current tb diagnosis:2012-08-10T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1410.2012,2014-12-08T22:12:22.529Z,2015-03-16T03:17:09.594Z
1427229_3,Mycobacterium tuberculosis XTB13-140,Mycobacterium tuberculosis XTB13-140,1427229.0,WGS,XTB13-140,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229624,SAMN02419585,GCA_000680795.1,JLKN00000000,-,Broad Institute,WGS,Illumina,113.0x,allpaths v. R48559,,,7.0,7.0,4418953.0,65.6,4385.0,,3999.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:1905-07-02T00:00:00;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the right lung ,  cavitation;patient history | date of current tb diagnosis:2011-09-15T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-09-15",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1417.2012,2014-12-08T22:12:22.538Z,2015-03-16T03:17:09.594Z
1427230_3,Mycobacterium tuberculosis XTB13-141,Mycobacterium tuberculosis XTB13-141,1427230.0,WGS,XTB13-141,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229625,SAMN02419586,GCA_000680815.1,JLKM00000000,-,Broad Institute,WGS,Illumina,98.0x,allpaths v. R48559,,,7.0,8.0,4410966.0,65.6,4380.0,,3997.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1 year;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:from 2006;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:upper lung zones, cavitation;patient history | date of current tb diagnosis:2011-09-14T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-09-09",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1426.2012,2014-12-08T22:12:22.548Z,2015-03-16T03:17:09.594Z
1427231_3,Mycobacterium tuberculosis XTB13-142,Mycobacterium tuberculosis XTB13-142,1427231.0,WGS,XTB13-142,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229626,SAMN02419587,GCA_000658135.1,JLKL00000000,-,Broad Institute,WGS,Illumina,103.0x,allpaths v. R48559,,,2.0,2.0,4417623.0,65.61,4359.0,,3995.0,,excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:4 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:2006;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | ofloxacine | ofl:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | ofloxacine | ofl | grams:0.8;patient history | chest x-ray/ct-scan description:right lung, cavitations;patient history | date of current tb diagnosis:2011-09-01T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2008",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1435.2012,2014-12-08T22:12:22.563Z,2015-03-16T03:17:09.594Z
1427232_3,Mycobacterium tuberculosis XTB13-143,Mycobacterium tuberculosis XTB13-143,1427232.0,WGS,XTB13-143,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229627,SAMN02419588,GCA_000680835.1,JLKK00000000,-,Broad Institute,WGS,Illumina,103.0x,allpaths v. R48559,,,6.0,6.0,4421159.0,65.6,4364.0,,4000.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2009-02-16T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | ofloxacine | ofl:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient treatment history | tb drug use dosage | ofloxacine | ofl | grams:0.8;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2010-10-01T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009-07-01,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1457.2012,2014-12-08T22:12:22.574Z,2015-03-16T03:17:09.594Z
1427233_3,Mycobacterium tuberculosis XTB13-144,Mycobacterium tuberculosis XTB13-144,1427233.0,WGS,XTB13-144,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229628,SAMN02419589,GCA_000680855.1,JLKJ00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,9.0,9.0,4392180.0,65.6,4345.0,,4003.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:1 year;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2011-12-21T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:146.2012,2014-12-08T22:12:22.585Z,2015-03-16T03:17:09.594Z
1427235_3,Mycobacterium tuberculosis XTB13-146,Mycobacterium tuberculosis XTB13-146,1427235.0,WGS,XTB13-146,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229630,SAMN02419591,GCA_000680895.1,JLKH00000000,-,Broad Institute,WGS,Illumina,77.0x,allpaths v. R48559,,,3.0,3.0,4418988.0,65.6,4365.0,,3996.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:1 year;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2011-02-09T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | tb drug use frequency | clarithromycin | clari:every day;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper and middle parts of the lungs;patient history | date of current tb diagnosis:2012-01-02T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb drug use dosage | clarithromycin | clari | grams:1;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-07-13,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:15.2013,2014-12-08T22:12:22.604Z,2015-03-16T03:17:09.594Z
1427236_3,Mycobacterium tuberculosis XTB13-147,Mycobacterium tuberculosis XTB13-147,1427236.0,WGS,XTB13-147,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229631,SAMN02419592,GCA_000680915.1,JLKG00000000,-,Broad Institute,WGS,Illumina,113.0x,allpaths v. R48559,,,6.0,6.0,4419855.0,65.6,4377.0,,3996.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2012-02-29T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:upper lung zones, cavitation;patient history | date of current tb diagnosis:2012-11-01T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2012-06-12",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1520.2012,2014-12-08T22:12:22.612Z,2015-03-16T03:17:09.594Z
1427237_3,Mycobacterium tuberculosis XTB13-150,Mycobacterium tuberculosis XTB13-150,1427237.0,WGS,XTB13-150,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229632,SAMN02419593,GCA_000680935.1,JLKF00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48559,,,8.0,8.0,4418121.0,65.6,4367.0,,3999.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:1905-07-02T00:00:00;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the right lung ,  cavitation;patient history | date of current tb diagnosis:2011-09-15T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-09-15",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:159.2013,2014-12-08T22:12:22.621Z,2015-03-16T03:17:09.594Z
1427238_3,Mycobacterium tuberculosis XTB13-152,Mycobacterium tuberculosis XTB13-152,1427238.0,WGS,XTB13-152,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229633,SAMN02419594,GCA_000680955.1,JLKE00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,16.0,16.0,4414480.0,65.6,4367.0,,4005.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:1.5;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:4 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.2;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:the upper zone of the right lung;patient history | date of current tb diagnosis:2012-01-10T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:176.2012,2014-12-08T22:12:22.630Z,2015-03-16T03:17:09.594Z
1427239_3,Mycobacterium tuberculosis XTB13-153,Mycobacterium tuberculosis XTB13-153,1427239.0,WGS,XTB13-153,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229634,SAMN02419595,GCA_000680975.1,JLKD00000000,-,Broad Institute,WGS,Illumina,94.0x,allpaths v. R48559,,,6.0,7.0,4409540.0,65.6,4377.0,,4000.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-10-12T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the left lung, calcifications in the right lung;patient history | date of current tb diagnosis:2012-06-13T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2012-06-13",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:191.2013,2014-12-08T22:12:22.639Z,2015-03-16T03:17:09.594Z
1427240_3,Mycobacterium tuberculosis XTB13-154,Mycobacterium tuberculosis XTB13-154,1427240.0,WGS,XTB13-154,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229635,SAMN02419596,GCA_000680995.1,JLKC00000000,-,Broad Institute,WGS,Illumina,96.0x,allpaths v. R48559,,,5.0,5.0,4420670.0,65.6,4369.0,,4000.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:2002;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:0.75;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2011-09-16T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:207.2012,2014-12-08T22:12:22.648Z,2015-03-16T03:17:09.594Z
1427241_3,Mycobacterium tuberculosis XTB13-155,Mycobacterium tuberculosis XTB13-155,1427241.0,WGS,XTB13-155,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229636,SAMN02419597,GCA_000681015.1,JLKB00000000,-,Broad Institute,WGS,Illumina,106.0x,allpaths v. R48559,,,5.0,5.0,4420212.0,65.6,4374.0,,3996.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:6 months;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-10-20T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2012-09-20T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2012-09-20,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:223.2013,2014-12-08T22:12:22.657Z,2015-03-16T03:17:09.594Z
1427242_3,Mycobacterium tuberculosis XTB13-156,Mycobacterium tuberculosis XTB13-156,1427242.0,WGS,XTB13-156,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229637,SAMN02419598,GCA_000681035.1,JLKA00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,12.0,12.0,4407747.0,65.6,4380.0,,3999.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:1 month;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2011-01-11T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:234.2012,2014-12-08T22:12:22.666Z,2015-03-16T03:17:09.594Z
1427243_3,Mycobacterium tuberculosis XTB13-158,Mycobacterium tuberculosis XTB13-158,1427243.0,WGS,XTB13-158,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229638,SAMN02419599,GCA_000681055.1,JLJZ00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,27.0,28.0,4412733.0,65.6,4383.0,,4018.0,,Excreted bodily substance,,2010,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:cured;patient history| date of previous (most recent) tb diagnosis:2007-02-22T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | ofloxacine | ofl:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient treatment history | tb drug use dosage | ofloxacine | ofl | grams:0.8;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2010-03-10T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2008-04-15,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:260.201,2014-12-08T22:12:22.675Z,2015-03-16T03:17:09.594Z
1427244_3,Mycobacterium tuberculosis XTB13-159,Mycobacterium tuberculosis XTB13-159,1427244.0,WGS,XTB13-159,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229639,SAMN02419600,GCA_000681075.1,JLJY00000000,-,Broad Institute,WGS,Illumina,110.0x,allpaths v. R48559,,,10.0,10.0,4378473.0,65.6,4321.0,,3990.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:the upper zone of the right lung, cavitation;patient history | date of current tb diagnosis:2011-07-19T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:27.2012,2014-12-08T22:12:22.685Z,2015-03-16T03:17:09.594Z
1427245_3,Mycobacterium tuberculosis XTB13-161,Mycobacterium tuberculosis XTB13-161,1427245.0,WGS,XTB13-161,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229640,SAMN02419601,GCA_000681095.1,JLJX00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,24.0,26.0,4410211.0,65.6,4376.0,,4020.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:1.5;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | worsening of tb diagnosed prior to cart initiation?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:positive;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.2;patient treatment history | initiated antiretroviral therapy/regimen?:yes;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:yes;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:right lung;patient history | date of current tb diagnosis:2012-01-21T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb diagnosis after initiation of cart?:yes;patient treatment history | changed antiretroviral therapy for reasons other than toxicity?:no;patient history | travelling in tb endemic area?:no,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:279.2012,2014-12-08T22:12:22.695Z,2015-03-16T03:17:09.594Z
1427246_3,Mycobacterium tuberculosis XTB13-162,Mycobacterium tuberculosis XTB13-162,1427246.0,WGS,XTB13-162,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229641,SAMN02419602,GCA_000681115.1,JLJW00000000,-,Broad Institute,WGS,Illumina,106.0x,allpaths v. R48559,,,5.0,5.0,4418024.0,65.6,4368.0,,3996.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2009;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper and midle lung zones;patient history | date of current tb diagnosis:2011-12-13T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:281.2012,2014-12-08T22:12:22.704Z,2015-03-16T03:17:09.594Z
1427248_3,Mycobacterium tuberculosis XTB13-165,Mycobacterium tuberculosis XTB13-165,1427248.0,WGS,XTB13-165,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229644,SAMN02419604,GCA_000681135.1,JLJV00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,18.0,20.0,4407545.0,65.6,4367.0,,4003.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<2 months;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2011-01-13T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:the upper zone of the left lung, cavitation;patient history | date of current tb diagnosis:2012-04-19T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2012-04-19",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:299.2012,2014-12-08T22:12:22.713Z,2015-03-16T03:17:09.594Z
1427249_3,Mycobacterium tuberculosis XTB13-167,Mycobacterium tuberculosis XTB13-167,1427249.0,WGS,XTB13-167,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229645,SAMN02419605,GCA_000681155.1,JLJU00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,29.0,29.0,4400994.0,65.6,4354.0,,4007.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | worsening of tb diagnosed prior to cart initiation?:no;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:positive;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:yes;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:lower lobe of the left lung, pleural effusion;patient history | date of current tb diagnosis:2011-12-16T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb diagnosis after initiation of cart?:yes;patient treatment history | changed antiretroviral therapy for reasons other than toxicity?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:309.2012,2014-12-08T22:12:22.722Z,2015-03-16T03:17:09.594Z
1427250_3,Mycobacterium tuberculosis XTB13-168,Mycobacterium tuberculosis XTB13-168,1427250.0,WGS,XTB13-168,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229646,SAMN02419606,GCA_000681175.1,JLJT00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,14.0,14.0,4423546.0,65.6,4383.0,,4007.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones, cavitation;patient history | date of current tb diagnosis:2012-02-17T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:323.2012,2014-12-08T22:12:22.732Z,2015-03-16T03:17:09.594Z
1427251_3,Mycobacterium tuberculosis XTB13-169,Mycobacterium tuberculosis XTB13-169,1427251.0,WGS,XTB13-169,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229647,SAMN02419607,GCA_000681195.1,JLJS00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48559,,,18.0,19.0,4394336.0,65.6,4341.0,,3982.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1 year;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:the upper zone of the right lung, cavitations;patient history | date of current tb diagnosis:2011-12-29T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:328.2013,2014-12-08T22:12:22.741Z,2015-03-16T03:17:09.594Z
1427252_3,Mycobacterium tuberculosis XTB13-172,Mycobacterium tuberculosis XTB13-172,1427252.0,WGS,XTB13-172,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229648,SAMN02419608,GCA_000681215.1,JLJR00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,22.0,23.0,4419272.0,65.6,4373.0,,4010.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<5 months;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2011-03-25T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:361.2013,2014-12-08T22:12:22.750Z,2015-03-16T03:17:09.594Z
1427253_3,Mycobacterium tuberculosis XTB13-173,Mycobacterium tuberculosis XTB13-173,1427253.0,WGS,XTB13-173,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229649,SAMN02419609,GCA_000658155.1,JLJQ00000000,-,Broad Institute,WGS,Illumina,92.0x,allpaths v. R48559,,,60.0,62.0,4418077.0,65.59,4394.0,,4021.0,,excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:6 month;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2011-07-15T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | tb drug use frequency | clarithromycin | clari:every day;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2013-05-15T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb drug use dosage | clarithromycin | clari | grams:1;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2012-03-13,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:367.2012,2014-12-08T22:12:22.760Z,2015-03-16T03:17:09.594Z
1427254_3,Mycobacterium tuberculosis XTB13-175,Mycobacterium tuberculosis XTB13-175,1427254.0,WGS,XTB13-175,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229650,SAMN02419610,GCA_000681235.1,JLJP00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,12.0,12.0,4414894.0,65.6,4372.0,,4002.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:0.75;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:lower and middle lobe of the right lung;patient history | date of current tb diagnosis:2011-09-28T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:373.2012,2014-12-08T22:12:22.769Z,2015-03-16T03:17:09.594Z
1427255_3,Mycobacterium tuberculosis XTB13-176,Mycobacterium tuberculosis XTB13-176,1427255.0,WGS,XTB13-176,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229651,SAMN02419611,GCA_000681255.1,JLJO00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,18.0,18.0,4421639.0,65.6,4386.0,,4014.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1 year;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2007;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones, cavitations;patient history | date of current tb diagnosis:2009-08-13T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:375.2013,2014-12-08T22:12:22.778Z,2015-03-16T03:17:09.594Z
1427256_3,Mycobacterium tuberculosis XTB13-177,Mycobacterium tuberculosis XTB13-177,1427256.0,WGS,XTB13-177,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229652,SAMN02419612,GCA_000681275.1,JLJN00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,13.0,13.0,4425527.0,65.6,4367.0,,4007.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones, cavitation;patient history | date of current tb diagnosis:2012-02-17T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:380.2013,2014-12-08T22:12:22.787Z,2015-03-16T03:17:09.594Z
1427257_3,Mycobacterium tuberculosis XTB13-178,Mycobacterium tuberculosis XTB13-178,1427257.0,WGS,XTB13-178,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229653,SAMN02419613,GCA_000681295.1,JLJM00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,38.0,40.0,4429691.0,65.6,4381.0,,4028.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1 year;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper and midle lung zones, cavitations;patient history | date of current tb diagnosis:2011-12-13T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:400.2013,2014-12-08T22:12:22.797Z,2015-03-16T03:17:09.594Z
1427258_3,Mycobacterium tuberculosis XTB13-179,Mycobacterium tuberculosis XTB13-179,1427258.0,WGS,XTB13-179,,,,,,,,2014-04-30T00:00:00Z,,PRJNA229654,SAMN02419614,GCA_000681315.1,JLJL00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,14.0,14.0,4424062.0,65.6,4376.0,,4015.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:1905-07-02T00:00:00;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the right lung ,  cavitation;patient history | date of current tb diagnosis:2011-09-15T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-09-15",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:402.2012,2014-12-08T22:12:22.806Z,2015-03-16T03:17:09.594Z
1427259_3,Mycobacterium tuberculosis XTB13-180,Mycobacterium tuberculosis XTB13-180,1427259.0,WGS,XTB13-180,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229655,SAMN02419615,GCA_000655095.1,JLJK00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,9.0,9.0,4414523.0,65.6,4380.0,,4000.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:6 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2012-02-29T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:421.2012,2014-12-08T22:12:22.814Z,2015-03-16T03:17:09.594Z
1427260_3,Mycobacterium tuberculosis XTB13-182,Mycobacterium tuberculosis XTB13-182,1427260.0,WGS,XTB13-182,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229656,SAMN02419616,GCA_000655115.1,JLJJ00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,15.0,15.0,4413109.0,65.6,4375.0,,3999.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1.5 year;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2012-01-09T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:422.2012,2014-12-08T22:12:22.823Z,2015-03-16T03:17:09.594Z
1427261_3,Mycobacterium tuberculosis XTB13-183,Mycobacterium tuberculosis XTB13-183,1427261.0,WGS,XTB13-183,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229657,SAMN02419617,GCA_000655135.1,JLJI00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,28.0,29.0,4368404.0,65.6,4322.0,,3994.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:4 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-07-23T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | tb drug use frequency | clarithromycin | clari:every day;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper lung zones, cavitations;patient history | date of current tb diagnosis:2012-05-18T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb drug use dosage | clarithromycin | clari | grams:1;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2012-03-04",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:441.2013,2014-12-08T22:12:22.832Z,2015-03-16T03:17:09.594Z
1427262_3,Mycobacterium tuberculosis XTB13-184,Mycobacterium tuberculosis XTB13-184,1427262.0,WGS,XTB13-184,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229658,SAMN02419618,GCA_000655155.1,JLJH00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,16.0,16.0,4377281.0,65.6,4323.0,,3993.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:2005;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | ofloxacine | ofl:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient treatment history | tb drug use dosage | ofloxacine | ofl | grams:0.8;patient history | chest x-ray/ct-scan description:the upper lobe of the left lung;patient history | date of current tb diagnosis:2012-01-12T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2007,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:459.2012,2014-12-08T22:12:22.840Z,2015-03-16T03:17:09.594Z
1427264_3,Mycobacterium tuberculosis XTB13-186,Mycobacterium tuberculosis XTB13-186,1427264.0,WGS,XTB13-186,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229660,SAMN02419620,GCA_000655175.1,JLJG00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,18.0,18.0,4402823.0,65.6,4365.0,,4000.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:1,5 month;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:the upper zone of the right lung;patient history | date of current tb diagnosis:2012-04-03T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no",Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:473.2013,2014-12-08T22:12:22.850Z,2015-03-16T03:17:09.594Z
1427265_3,Mycobacterium tuberculosis XTB13-187,Mycobacterium tuberculosis XTB13-187,1427265.0,WGS,XTB13-187,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229661,SAMN02419621,GCA_000655195.1,JLJF00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,25.0,26.0,4407198.0,65.6,4372.0,,4005.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<5 months;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2011-03-25T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:50.2013,2014-12-08T22:12:22.859Z,2015-03-16T03:17:09.594Z
1427266_3,Mycobacterium tuberculosis XTB13-188,Mycobacterium tuberculosis XTB13-188,1427266.0,WGS,XTB13-188,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229662,SAMN02419622,GCA_000655215.1,JLJE00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,9.0,9.0,4385031.0,65.6,4321.0,,3993.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:4 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2013-07-31T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:500.2011,2014-12-08T22:12:22.868Z,2015-03-16T03:17:09.594Z
1427268_3,Mycobacterium tuberculosis XTB13-190,Mycobacterium tuberculosis XTB13-190,1427268.0,WGS,XTB13-190,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229664,SAMN02419624,GCA_000655235.1,JLJD00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,16.0,16.0,4387535.0,65.6,4338.0,,4000.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:1 year;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2007-10-10T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:dissimination in both lungs;patient history | date of current tb diagnosis:2009-04-07T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2008-12-30,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:506.2012,2014-12-08T22:12:22.881Z,2015-03-16T03:17:09.594Z
1427269_3,Mycobacterium tuberculosis XTB13-191,Mycobacterium tuberculosis XTB13-191,1427269.0,WGS,XTB13-191,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229665,SAMN02419625,GCA_000655255.1,JLJC00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,18.0,19.0,4394083.0,65.6,4368.0,,3990.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2012-02-01T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:522.2012,2014-12-08T22:12:22.890Z,2015-03-16T03:17:09.594Z
1427270_3,Mycobacterium tuberculosis XTB13-192,Mycobacterium tuberculosis XTB13-192,1427270.0,WGS,XTB13-192,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229666,SAMN02419626,GCA_000655275.1,JLJB00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,20.0,21.0,4381862.0,65.6,4339.0,,3997.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1 year;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:dissimination in both lungs;patient history | date of current tb diagnosis:2012-02-21T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:524.2012,2014-12-08T22:12:22.901Z,2015-03-16T03:17:09.594Z
1427271_3,Mycobacterium tuberculosis XTB13-193,Mycobacterium tuberculosis XTB13-193,1427271.0,WGS,XTB13-193,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229667,SAMN02419627,GCA_000655295.1,JLJA00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,24.0,26.0,4428025.0,65.6,4404.0,,4035.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.2;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:the upper zone of the right lung;patient history | date of current tb diagnosis:2012-02-23T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:525.2012,2014-12-08T22:12:22.916Z,2015-03-16T03:17:09.594Z
1427272_3,Mycobacterium tuberculosis XTB13-194,Mycobacterium tuberculosis XTB13-194,1427272.0,WGS,XTB13-194,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229668,SAMN02419628,GCA_000655315.1,JLIZ00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,14.0,14.0,4418039.0,65.6,4383.0,,4006.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:2004;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones, cavitations;patient history | date of current tb diagnosis:2011-11-12T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2006",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:530.2012,2014-12-08T22:12:22.926Z,2015-03-16T03:17:09.594Z
1427273_3,Mycobacterium tuberculosis XTB13-195,Mycobacterium tuberculosis XTB13-195,1427273.0,WGS,XTB13-195,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229669,SAMN02419629,GCA_000655335.1,JLIY00000000,-,Broad Institute,WGS,Illumina,116.0x,allpaths v. R48559,,,18.0,20.0,4411452.0,65.6,4387.0,,4008.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | worsening of tb diagnosed prior to cart initiation?:no;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:positive;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:yes;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:yes;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | date of current tb diagnosis:2011-04-18T00:00:00;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb diagnosis after initiation of cart?:yes;patient treatment history | changed antiretroviral therapy for reasons other than toxicity?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:535.2012,2014-12-08T22:12:22.936Z,2015-03-16T03:17:09.594Z
1427274_3,Mycobacterium tuberculosis XTB13-196,Mycobacterium tuberculosis XTB13-196,1427274.0,WGS,XTB13-196,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229670,SAMN02419630,GCA_000655355.1,JLIX00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,15.0,15.0,4413620.0,65.6,4373.0,,4006.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:1 month;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2011-01-11T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:547.2011,2014-12-08T22:12:22.949Z,2015-03-16T03:17:09.594Z
1427275_3,Mycobacterium tuberculosis XTB13-197,Mycobacterium tuberculosis XTB13-197,1427275.0,WGS,XTB13-197,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229671,SAMN02419631,GCA_000655375.1,JLIW00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,11.0,11.0,4423729.0,65.6,4381.0,,4010.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2012-02-09T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:547.2012,2014-12-08T22:12:22.960Z,2015-03-16T03:17:09.594Z
1427276_3,Mycobacterium tuberculosis XTB13-198,Mycobacterium tuberculosis XTB13-198,1427276.0,WGS,XTB13-198,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229672,SAMN02419632,GCA_000655395.1,JLIV00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,16.0,16.0,4418445.0,65.6,4391.0,,4030.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:right and left lung;patient history | date of current tb diagnosis:2012-03-26T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:597.2012,2014-12-08T22:12:22.970Z,2015-03-16T03:17:09.594Z
1427277_3,Mycobacterium tuberculosis XTB13-199,Mycobacterium tuberculosis XTB13-199,1427277.0,WGS,XTB13-199,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229673,SAMN02419633,GCA_000655415.1,JLIU00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,24.0,27.0,4393283.0,65.6,4339.0,,4014.0,,Excreted bodily substance,,2010,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.2;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:S6 of the right lung;patient history | date of current tb diagnosis:2010-07-01T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:589.201,2014-12-08T22:12:22.979Z,2015-03-16T03:17:09.594Z
1427278_3,Mycobacterium tuberculosis XTB13-200,Mycobacterium tuberculosis XTB13-200,1427278.0,WGS,XTB13-200,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229674,SAMN02419634,GCA_000655435.1,JLIT00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,17.0,18.0,4410274.0,65.6,4371.0,,4000.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1 year;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2007;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones, cavitations;patient history | date of current tb diagnosis:2009-08-13T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:598.2012,2014-12-08T22:12:22.988Z,2015-03-16T03:17:09.594Z
1427279_3,Mycobacterium tuberculosis XTB13-201,,1427279.0,WGS,XTB13-201,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA229676,SAMN02419635,GCA_000706445.1,JLIS00000000,-,Broad Institute,,Illumina,123.0x,allpaths v. R48559,,,4.0,19.0,4392050.0,65.6,4266.0,,3988.0,,excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:the upper zone of the right lung, cavitation;patient history | date of current tb diagnosis:2012-03-26T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no",Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:601.2012,2014-12-08T22:56:55.638Z,2015-03-16T03:17:09.594Z
1427280_3,Mycobacterium tuberculosis XTB13-203,Mycobacterium tuberculosis XTB13-203,1427280.0,WGS,XTB13-203,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229677,SAMN02419636,GCA_000655455.1,JLIR00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48559,,,11.0,11.0,4413265.0,65.6,4370.0,,3995.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:1 year;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2011-02-09T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | tb drug use frequency | clarithromycin | clari:every day;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper and middle parts of the lungs;patient history | date of current tb diagnosis:2012-01-02T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb drug use dosage | clarithromycin | clari | grams:1;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-07-13,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:608.2012,2014-12-08T22:12:22.997Z,2015-03-16T03:17:09.594Z
1427281_3,Mycobacterium tuberculosis XTB13-204,Mycobacterium tuberculosis XTB13-204,1427281.0,WGS,XTB13-204,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229678,SAMN02419637,GCA_000655475.1,JLIQ00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,30.0,33.0,4378712.0,65.6,4348.0,,3982.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1 year;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:the upper zone of the right lung, cavitations;patient history | date of current tb diagnosis:2011-12-29T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:608.2013,2014-12-08T22:12:23.006Z,2015-03-16T03:17:09.594Z
1427282_3,Mycobacterium tuberculosis XTB13-205,Mycobacterium tuberculosis XTB13-205,1427282.0,WGS,XTB13-205,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229679,SAMN02419638,GCA_000655495.1,JLIP00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,8.0,8.0,4417947.0,65.6,4366.0,,4005.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the lower lobe of the right lung;patient history | date of current tb diagnosis:2012-04-03T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:610.2012,2014-12-08T22:12:23.016Z,2015-03-16T03:17:09.594Z
1427283_3,Mycobacterium tuberculosis XTB13-206,Mycobacterium tuberculosis XTB13-206,1427283.0,WGS,XTB13-206,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229680,SAMN02419639,GCA_000655515.1,JLIO00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,11.0,11.0,4418560.0,65.6,4372.0,,4003.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<5 months;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2011-03-25T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:645.2013,2014-12-08T22:12:23.025Z,2015-03-16T03:17:09.594Z
1427285_3,Mycobacterium tuberculosis XTB13-208,Mycobacterium tuberculosis XTB13-208,1427285.0,WGS,XTB13-208,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229682,SAMN02419641,GCA_000655535.1,JLIN00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,17.0,17.0,4414459.0,65.6,4383.0,,3997.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the right lung;patient history | date of current tb diagnosis:2011-11-30T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:660.2012,2014-12-08T22:12:23.035Z,2015-03-16T03:17:09.594Z
1427286_3,Mycobacterium tuberculosis XTB13-209,Mycobacterium tuberculosis XTB13-209,1427286.0,WGS,XTB13-209,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229683,SAMN02419642,GCA_000655555.1,JLIM00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,15.0,17.0,4411001.0,65.6,4370.0,,4020.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:1.5;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.2;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs and bronchus;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:the upper lobe of the right lung;patient history | date of current tb diagnosis:2012-02-08T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:662.2012,2014-12-08T22:12:23.045Z,2015-03-16T03:17:09.594Z
1427287_3,Mycobacterium tuberculosis XTB13-210,Mycobacterium tuberculosis XTB13-210,1427287.0,WGS,XTB13-210,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229685,SAMN02419643,GCA_000655575.1,JLIL00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,15.0,16.0,4403329.0,65.6,4364.0,,3998.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-08-14T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:dissimination in both lungs;patient history | date of current tb diagnosis:2012-02-16T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2012-02-16,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:662.2013,2014-12-08T22:12:23.054Z,2015-03-16T03:17:09.594Z
1427288_3,Mycobacterium tuberculosis XTB13-211,Mycobacterium tuberculosis XTB13-211,1427288.0,WGS,XTB13-211,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229686,SAMN02419644,GCA_000655595.1,JLIK00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48559,,,11.0,11.0,4389510.0,65.6,4325.0,,3992.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2013-02-28T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:675.2013,2014-12-08T22:12:23.064Z,2015-03-16T03:17:09.594Z
1427289_3,Mycobacterium tuberculosis XTB13-212,Mycobacterium tuberculosis XTB13-212,1427289.0,WGS,XTB13-212,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229687,SAMN02419645,GCA_000655615.1,JLIJ00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,27.0,27.0,4368620.0,65.6,4319.0,,3995.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1 year;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2011-02-21T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2012-06-04T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2012-06-04,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:679.2012,2014-12-08T22:12:23.074Z,2015-03-16T03:17:09.594Z
1427290_3,Mycobacterium tuberculosis XTB13-213,Mycobacterium tuberculosis XTB13-213,1427290.0,WGS,XTB13-213,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229688,SAMN02419646,GCA_000655635.1,JLII00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,19.0,19.0,4410955.0,65.6,4385.0,,4008.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:1.5;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:6 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.2;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:the upper zone of the left lung, encysted left-sided pleuritis;patient history | date of current tb diagnosis:2012-03-30T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no",Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:684.2012,2014-12-08T22:12:23.084Z,2015-03-16T03:17:09.594Z
1427291_3,Mycobacterium tuberculosis XTB13-214,Mycobacterium tuberculosis XTB13-214,1427291.0,WGS,XTB13-214,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229689,SAMN02419647,GCA_000655655.1,JLIH00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,16.0,16.0,4388842.0,65.6,4337.0,,4003.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:negative;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:negative;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2012-04-12T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:689.2012,2014-12-08T22:12:23.094Z,2015-03-16T03:17:09.594Z
1427292_3,Mycobacterium tuberculosis XTB13-216,Mycobacterium tuberculosis XTB13-216,1427292.0,WGS,XTB13-216,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229690,SAMN02419648,GCA_000655675.1,JLIG00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,30.0,32.0,4415103.0,65.6,4373.0,,4027.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:<1 year;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:the upper lobe of the right lung;patient history | date of current tb diagnosis:2012-04-11T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:692.2012,2014-12-08T22:12:23.103Z,2015-03-16T03:17:09.594Z
1427293_3,Mycobacterium tuberculosis XTB13-217,Mycobacterium tuberculosis XTB13-217,1427293.0,WGS,XTB13-217,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229691,SAMN02419649,GCA_000655695.1,JLIF00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,19.0,20.0,4432399.0,65.6,4391.0,,4016.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:cured;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:lower lobe of the left lung;patient history | date of current tb diagnosis:2013-04-17T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:704.2012,2014-12-08T22:12:23.112Z,2015-03-16T03:17:09.594Z
1427294_3,Mycobacterium tuberculosis XTB13-218,Mycobacterium tuberculosis XTB13-218,1427294.0,WGS,XTB13-218,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229692,SAMN02419650,GCA_000655715.1,JLIE00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,11.0,11.0,4422264.0,65.6,4382.0,,4011.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:cured;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:lower lobe of the left lung;patient history | date of current tb diagnosis:2013-04-17T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:705.2013,2014-12-08T22:12:23.120Z,2015-03-16T03:17:09.594Z
1427295_3,Mycobacterium tuberculosis XTB13-219,Mycobacterium tuberculosis XTB13-219,1427295.0,WGS,XTB13-219,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229693,SAMN02419651,GCA_000655735.1,JLID00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,12.0,12.0,4419583.0,65.6,4393.0,,4005.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:6 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:completed;patient history| date of previous (most recent) tb diagnosis:2006;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:left lung, upper lobe of the right lung, cavitation;patient history | date of current tb diagnosis:2011-08-31T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:Afganistan;patient treatment history | date when the last tb treatment was ended:2006",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:726.2012,2014-12-08T22:12:23.129Z,2015-03-16T03:17:09.594Z
1427297_3,Mycobacterium tuberculosis XTB13-225,Mycobacterium tuberculosis XTB13-225,1427297.0,WGS,XTB13-225,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229695,SAMN02419653,GCA_000655775.1,JLIB00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,20.0,21.0,4380480.0,65.6,4315.0,,4001.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2011-04-27T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:760.2011,2014-12-08T22:12:23.147Z,2015-03-16T03:17:09.594Z
1427298_3,Mycobacterium tuberculosis XTB13-227,Mycobacterium tuberculosis XTB13-227,1427298.0,WGS,XTB13-227,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229696,SAMN02419654,GCA_000655795.1,JLIA00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,15.0,15.0,4390682.0,65.6,4338.0,,4003.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:4 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2013-07-31T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:761.2013,2014-12-08T22:12:23.155Z,2015-03-16T03:17:09.594Z
1427299_3,Mycobacterium tuberculosis XTB13-228,Mycobacterium tuberculosis XTB13-228,1427299.0,WGS,XTB13-228,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229697,SAMN02419655,GCA_000655815.1,JLHZ00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,14.0,14.0,4424828.0,65.6,4379.0,,4016.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1,5 year;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2009;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper and midle lung zones, cavitations;patient history | date of current tb diagnosis:31.01.2012;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:763.2012,2014-12-08T22:12:23.164Z,2015-03-16T03:17:09.594Z
1427300_3,Mycobacterium tuberculosis XTB13-229,Mycobacterium tuberculosis XTB13-229,1427300.0,WGS,XTB13-229,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229698,SAMN02419656,GCA_000655835.1,JLHY00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,21.0,21.0,4422576.0,65.6,4385.0,,4011.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:0.75;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:the upper zone of the right lung;patient history | date of current tb diagnosis:2012-05-08T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:780.2012,2014-12-08T22:12:23.172Z,2015-03-16T03:17:09.594Z
1427301_3,Mycobacterium tuberculosis XTB13-230,Mycobacterium tuberculosis XTB13-230,1427301.0,WGS,XTB13-230,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229699,SAMN02419657,GCA_000655855.1,JLHX00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,21.0,22.0,4385822.0,65.6,4334.0,,3998.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:cured;patient history| date of previous (most recent) tb diagnosis:2011-04-07T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | ofloxacine | ofl:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient treatment history | tb drug use dosage | ofloxacine | ofl | grams:0.8;patient history | chest x-ray/ct-scan description:the upper zone of the right lung;patient history | date of current tb diagnosis:2012-06-05T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2012-01-02,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:788.2012,2014-12-08T22:12:23.180Z,2015-03-16T03:17:09.594Z
1427302_3,Mycobacterium tuberculosis XTB13-231,Mycobacterium tuberculosis XTB13-231,1427302.0,WGS,XTB13-231,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229700,SAMN02419658,GCA_000655875.1,JLHW00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,20.0,20.0,4427544.0,65.6,4375.0,,4016.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2012-02-09T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:810.2012,2014-12-08T22:12:23.189Z,2015-03-16T03:17:09.594Z
1427303_3,Mycobacterium tuberculosis XTB13-232,Mycobacterium tuberculosis XTB13-232,1427303.0,WGS,XTB13-232,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229701,SAMN02419659,GCA_000655895.1,JLHV00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,23.0,26.0,4434407.0,65.6,4407.0,,4021.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:1905-07-02T00:00:00;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the right lung ,  cavitation;patient history | date of current tb diagnosis:2011-09-15T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-09-15",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:819.2012,2014-12-08T22:12:23.197Z,2015-03-16T03:17:09.594Z
1427304_3,Mycobacterium tuberculosis XTB13-233,Mycobacterium tuberculosis XTB13-233,1427304.0,WGS,XTB13-233,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229702,SAMN02419660,GCA_000655915.1,JLHU00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,17.0,19.0,4378379.0,65.6,4337.0,,3991.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:4 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2009-03-11T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:upper lung zones, cavitation;patient history | date of current tb diagnosis:2011-05-25T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009-12-31",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:832.2011,2014-12-08T22:12:23.205Z,2015-03-16T03:17:09.594Z
1427305_3,Mycobacterium tuberculosis XTB13-234,Mycobacterium tuberculosis XTB13-234,1427305.0,WGS,XTB13-234,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229703,SAMN02419661,GCA_000655935.1,JLHT00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,30.0,32.0,4372155.0,65.6,4324.0,,3998.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:6 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2008-04-04T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper lung zones, cavitation;patient history | date of current tb diagnosis:2011-10-07T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:1905-07-01",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:861.2012,2014-12-08T22:12:23.213Z,2015-03-16T03:17:09.594Z
1427306_3,Mycobacterium tuberculosis XTB13-235,Mycobacterium tuberculosis XTB13-235,1427306.0,WGS,XTB13-235,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229704,SAMN02419662,GCA_000655955.1,JLHS00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,16.0,18.0,4413817.0,65.6,4371.0,,3997.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:<1 year;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-06-30T00:00:00;patient history| previous tb treatment?:yes;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper lung zones, cavitation;patient history | date of current tb diagnosis:2011-12-29T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-12-29",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:862.2012,2014-12-08T22:12:23.222Z,2015-03-16T03:17:09.594Z
1427307_3,Mycobacterium tuberculosis XTB13-237,Mycobacterium tuberculosis XTB13-237,1427307.0,WGS,XTB13-237,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229705,SAMN02419663,GCA_000655975.1,JLHR00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,10.0,10.0,4384772.0,65.6,4330.0,,3988.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | worsening of tb diagnosed prior to cart initiation?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:positive;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:yes;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:yes;patient history | clinical presentation of current tb disease:TB bronchial and hilar lymph nodes;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:left basal areal;patient history | date of current tb diagnosis:2012-06-04T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb diagnosis after initiation of cart?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:873.2012,2014-12-08T22:12:23.230Z,2015-03-16T03:17:09.594Z
1427308_3,Mycobacterium tuberculosis XTB13-238,Mycobacterium tuberculosis XTB13-238,1427308.0,WGS,XTB13-238,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229706,SAMN02419664,GCA_000655995.1,JLHQ00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,15.0,15.0,4412868.0,65.6,4378.0,,4001.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1 year;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-11-22T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:dissimination in both lungs;patient history | date of current tb diagnosis:2011-11-16T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-11-16,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:88.2012,2014-12-08T22:12:23.238Z,2015-03-16T03:17:09.594Z
1427309_3,Mycobacterium tuberculosis XTB13-239,Mycobacterium tuberculosis XTB13-239,1427309.0,WGS,XTB13-239,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229707,SAMN02419665,GCA_000656015.1,JLHP00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,18.0,18.0,4418399.0,65.6,4360.0,,4039.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:1,5 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:0.75;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Siberia RF;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:dissimination in both lungs;patient history | date of current tb diagnosis:2011-06-28T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:881.2011,2014-12-08T22:12:23.247Z,2015-03-16T03:17:09.594Z
1427310_3,Mycobacterium tuberculosis XTB13-240,Mycobacterium tuberculosis XTB13-240,1427310.0,WGS,XTB13-240,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229708,SAMN02419666,GCA_000656035.1,JLHO00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,18.0,20.0,4385372.0,65.6,4358.0,,4003.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:<2 year;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:dissemination in both lungs in the middle and lower regions;patient history | date of current tb diagnosis:2011-06-09T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:883.2011,2014-12-08T22:12:23.256Z,2015-03-16T03:17:09.594Z
1427311_3,Mycobacterium tuberculosis XTB13-241,Mycobacterium tuberculosis XTB13-241,1427311.0,WGS,XTB13-241,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229709,SAMN02419667,GCA_000656055.1,JLHN00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,14.0,14.0,4426543.0,65.6,4369.0,,4008.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1 year;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-11-22T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:dissimination in both lungs;patient history | date of current tb diagnosis:2011-11-16T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-11-16,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:885.2012,2014-12-08T22:12:23.264Z,2015-03-16T03:17:09.594Z
1427312_3,Mycobacterium tuberculosis XTB13-242,Mycobacterium tuberculosis XTB13-242,1427312.0,WGS,XTB13-242,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229710,SAMN02419668,GCA_000656075.1,JLHM00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,11.0,11.0,4422511.0,65.6,4384.0,,4014.0,,Excreted bodily substance,,2013,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<1.5 year;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2008;patient history| previous tb treatment?:yes;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2012-01-09T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:89.2013,2014-12-08T22:12:23.272Z,2015-03-16T03:17:09.594Z
1427313_3,Mycobacterium tuberculosis XTB13-244,Mycobacterium tuberculosis XTB13-244,1427313.0,WGS,XTB13-244,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229711,SAMN02419669,GCA_000656095.1,JLHL00000000,-,Broad Institute,WGS,Illumina,117.0x,allpaths v. R48559,,,31.0,31.0,4372890.0,65.6,4324.0,,3992.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2011-09-20T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:893.2011,2014-12-08T22:12:23.281Z,2015-03-16T03:17:09.594Z
1427314_3,Mycobacterium tuberculosis XTB13-245,Mycobacterium tuberculosis XTB13-245,1427314.0,WGS,XTB13-245,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229712,SAMN02419670,GCA_000656115.1,JLHK00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,17.0,18.0,4432625.0,65.6,4394.0,,4015.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:<2 year;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2009-03-06T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use dosage | moxifloxacin | moxi | grams:0.4;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | tb drug use frequency | clarithromycin | clari:every day;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper and midle lung zones, cavitations;patient history | date of current tb diagnosis:2011-12-29T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | moxifloxacin | moxi:every day;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb drug use dosage | clarithromycin | clari | grams:1;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:29.12.20111",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:900.2012,2014-12-08T22:12:23.292Z,2015-03-16T03:17:09.594Z
1427315_3,Mycobacterium tuberculosis XTB13-246,Mycobacterium tuberculosis XTB13-246,1427315.0,WGS,XTB13-246,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229713,SAMN02419671,GCA_000656135.1,JLHJ00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,10.0,11.0,4385029.0,65.6,4335.0,,3997.0,,Excreted bodily substance,,2010,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:6 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2010-04-29T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | worsening of tb diagnosed prior to cart initiation?:no;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:positive;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:yes;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:yes;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2010-09-10T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb diagnosis after initiation of cart?:yes;patient treatment history | changed antiretroviral therapy for reasons other than toxicity?:no;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2010-05-24,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:902.201,2014-12-08T22:12:23.300Z,2015-03-16T03:17:09.594Z
1427316_3,Mycobacterium tuberculosis XTB13-247,Mycobacterium tuberculosis XTB13-247,1427316.0,WGS,XTB13-247,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229714,SAMN02419672,GCA_000656155.1,JLHI00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,20.0,21.0,4372429.0,65.6,4307.0,,3991.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:the upper zone of the right lung, cavitation;patient history | date of current tb diagnosis:2011-07-19T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:914.2011,2014-12-08T22:12:23.310Z,2015-03-16T03:17:09.594Z
1427317_3,Mycobacterium tuberculosis XTB13-249,Mycobacterium tuberculosis XTB13-249,1427317.0,WGS,XTB13-249,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229715,SAMN02419673,GCA_000656175.1,JLHH00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,16.0,18.0,4396957.0,65.6,4358.0,,3996.0,,Excreted bodily substance,,2010,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:4 months;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2010-10-15T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:937.2012,2014-12-08T22:12:23.320Z,2015-03-16T03:17:09.594Z
1427318_3,Mycobacterium tuberculosis XTB13-250,Mycobacterium tuberculosis XTB13-250,1427318.0,WGS,XTB13-250,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229716,SAMN02419674,GCA_000656195.1,JLHG00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,14.0,14.0,4423916.0,65.6,4375.0,,4013.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-10-12T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:the upper zone of the left lung, calcifications in the right lung;patient history | date of current tb diagnosis:2012-06-13T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2012-06-13",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:950.2012,2014-12-08T22:12:23.329Z,2015-03-16T03:17:09.594Z
1427319_3,Mycobacterium tuberculosis XTB13-251,Mycobacterium tuberculosis XTB13-251,1427319.0,WGS,XTB13-251,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229717,SAMN02419675,GCA_000656215.1,JLHF00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,9.0,9.0,4423148.0,65.6,4373.0,,4000.0,,Excreted bodily substance,,2011,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:3 days a week  2.0;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:3 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:3 days a week 0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:5 days a week 1.0;patient treatment history | tb drug use frequency | capreomycin | c:days a week;patient treatment history | tb drug use frequency | cycloserine | cyclo:days a week;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:days a week;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:3 days a week 0.75;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:days a week;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:lower lobe of the left lung;patient history | date of current tb diagnosis:2011-07-25T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:965.2011,2014-12-08T22:12:23.338Z,2015-03-16T03:17:09.594Z
1427320_3,Mycobacterium tuberculosis XTB13-252,Mycobacterium tuberculosis XTB13-252,1427320.0,WGS,XTB13-252,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229718,SAMN02419676,GCA_000656235.1,JLHE00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,16.0,16.0,4421906.0,65.6,4381.0,,4003.0,,Excreted bodily substance,,2010,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2009-02-16T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | ofloxacine | ofl:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient treatment history | tb drug use dosage | ofloxacine | ofl | grams:0.8;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2010-10-01T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2009-07-01,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:966.201,2014-12-08T22:12:23.348Z,2015-03-16T03:17:09.594Z
1427321_3,Mycobacterium tuberculosis XTB13-253,Mycobacterium tuberculosis XTB13-253,1427321.0,WGS,XTB13-253,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229719,SAMN02419677,GCA_000656255.1,JLHD00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,20.0,21.0,4394200.0,65.6,4350.0,,3991.0,,Excreted bodily substance,,2010,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:2 months;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | ofloxacine | ofl:every day;patient history | clinical symptoms | weight loss?:yes;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient treatment history | tb drug use dosage | ofloxacine | ofl | grams:0.8;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2009-12-31T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:97.201,2014-12-08T22:12:23.357Z,2015-03-16T03:17:09.594Z
1427322_3,Mycobacterium tuberculosis XTB13-255,Mycobacterium tuberculosis XTB13-255,1427322.0,WGS,XTB13-255,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229720,SAMN02419678,GCA_000656275.1,JLHC00000000,-,Broad Institute,WGS,Illumina,137.0x,allpaths v. R48559,,,20.0,21.0,4379945.0,65.6,4331.0,,3994.0,,Excreted bodily substance,,2012,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,"patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:treatment failure;patient history| date of previous (most recent) tb diagnosis:2010-02-24T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | tb drug use frequency | clarithromycin | clari:every day;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:no;patient history | chest x-ray/ct-scan description:upper lung zones, cavitation;patient history | date of current tb diagnosis:2012-05-23T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient treatment history | tb drug use dosage | clarithromycin | clari | grams:1;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2011-11-22",Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:974.2012,2014-12-08T22:12:23.367Z,2015-03-16T03:17:09.594Z
1427323_3,Mycobacterium tuberculosis XTB13-256,Mycobacterium tuberculosis XTB13-256,1427323.0,WGS,XTB13-256,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229721,SAMN02419679,GCA_000656295.1,JLHB00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,12.0,12.0,4418535.0,65.6,4397.0,,4005.0,,Excreted bodily substance,,2009,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:2 months;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:cured;patient history| date of previous (most recent) tb diagnosis:1996-08-05T00:00:00;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient history | chest x-ray/ct-scan description:upper lung zones;patient history | date of current tb diagnosis:2009-10-30T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:1997-02-20,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:980.2009,2014-12-08T22:12:23.377Z,2015-03-16T03:17:09.594Z
1427324_3,Mycobacterium tuberculosis XTB13-262,Mycobacterium tuberculosis XTB13-262,1427324.0,WGS,XTB13-262,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229722,SAMN02419680,GCA_000656315.1,JLHA00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,14.0,14.0,4422637.0,65.6,4374.0,,4008.0,,Excreted bodily substance,,2009,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:3 month;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:no;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2009-08-25T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:970.2009,2014-12-08T22:12:23.387Z,2015-03-16T03:17:09.594Z
1427325_3,Mycobacterium tuberculosis XTB13-265,Mycobacterium tuberculosis XTB13-265,1427325.0,WGS,XTB13-265,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229723,SAMN02419681,GCA_000656335.1,JLGZ00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,10.0,10.0,4415753.0,65.6,4368.0,,4003.0,,Excreted bodily substance,,2009,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use frequency | rifampicin | rif:every day;patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:no;patient treatment history | tb drug use dosage | isoniazid | inh | grams:0.3;patient history| previous tb treatment?:no;patient treatment history | tb drug use frequency | ethambutol | eth:every day;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | isoniazid | inh:every day;patient history | history of injecting drug user?:no;patient treatment history | tb drug use dosage | ethambutol | eth | grams:1.6;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient history | clinical symptoms | fever?:no;patient treatment history | tb drug use dosage | rifampicin | rif | grams:0.6;patient history | chest x-ray/ct-scan description:the upper zone of the left lung;patient history | date of current tb diagnosis:2009-09-01T00:00:00;patient treatment history | was receiving methadone?:no;patient history | travelling in tb endemic area?:no,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:1000.2009,2014-12-08T22:12:23.396Z,2015-03-16T03:17:09.594Z
1427329_3,Mycobacterium tuberculosis XTB13-290,Mycobacterium tuberculosis XTB13-290,1427329.0,WGS,XTB13-290,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229727,SAMN02419685,GCA_000656375.1,JLGX00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,16.0,16.0,4422999.0,65.6,4388.0,,4007.0,,Excreted bodily substance,,2010,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient treatment history | tb drug use dosage | pyrazinamide | pza | grams:2;patient history | clinical symptoms | cough with expectorate?:yes;patient history | clinical symptoms | symptoms duration:4 month;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history| previous tb treatment?:no;patient treatment history | tb drug use dosage | capreomycin | c | grams:1;patient treatment history | tb drug use frequency | capreomycin | c:every day;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:no;patient treatment history | tb drug use frequency | levofloxacine | levo:every day;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:no;patient history | clinical symptoms | dry cough?:no;patient history | initiated antiretroviral therapy/regimen?:no;patient treatment history | tb drug use dosage | amoxicyllin clavulanate | amx/clv | grams:2;patient treatment history | tb drug use dosage | levofloxacine | levo | grams:1;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | pyrazinamide | pza:every day;patient treatment history | tb drug use frequency | amoxicyllin clavulanate | amx/clv:every day;patient history | clinical symptoms | weight loss?:no;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:no;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient history | chest x-ray/ct-scan description:lower lobe of the right lung;patient history | date of current tb diagnosis:2009-12-28T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:62.201,2014-12-08T22:12:23.423Z,2015-03-16T03:17:09.594Z
1427330_3,Mycobacterium tuberculosis XTB13-299,Mycobacterium tuberculosis XTB13-299,1427330.0,WGS,XTB13-299,,,,,,,,2014-04-29T00:00:00Z,,PRJNA229728,SAMN02419686,GCA_000656395.1,JLGW00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48559,,,16.0,16.0,4416807.0,65.6,4365.0,,4000.0,,Excreted bodily substance,,2010,Belarus,Belarus,,,,,,"Human, Homo sapiens",,,,,,patient history | clinical symptoms | cough with expectorate?:no;patient history | clinical symptoms | symptoms duration:6 month;patient treatment history | tb drug use dosage | cycloserine | cyclo | grams:0.75;patient history | treatment outcome of previous tb disease:default;patient history| date of previous (most recent) tb diagnosis:2007;patient history| previous tb treatment?:yes;patient treatment history | tb drug use dosage | kanamycin | k | grams:1;patient treatment history | tb drug use frequency | cycloserine | cyclo:every day;patient treatment history | tb drug use dosage | para-aminosalicyclic acid | para | grams:8;patient treatment history | has the patient ever received any other anti-tb chemoprophylaxis?:no;patient history | alcohol abuse?:yes;patient history | hiv status:negative;patient treatment history | tb drug use frequency | ethionamide | eth:every day;patient history | in prison within last 2 year?:yes;patient history | history of injecting drug user?:no;patient treatment history | initiated antiretroviral therapy/regimen?:yes;patient history | clinical symptoms | dry cough?:yes;patient history | initiated antiretroviral therapy/regimen?:no;patient history | clinical presentation of current tb disease:lungs;patient treatment history | tb drug use frequency | ofloxacine | ofl:every day;patient history | clinical symptoms | weight loss?:yes;patient history | reintroduced the same or a different antiretroviral therapy/regimen?:pulmonary;patient treatment history | other drug(s) for substitution therapy?:no;patient treatment history | reintroduced the same or a different antiretroviral therapy/regimen?:no;patient history | country of origin:Belarus;patient history | recent tb in the family/surroundings?:yes;patient treatment history | tb drug use frequency | pyridoxine | pyri:every other day (during the month);patient treatment history | tb drug use dosage | ethionamide | eth | grams:0.75;patient history | clinical symptoms | fever?:yes;patient treatment history | tb drug use frequency | kanamycin | k:every day;patient treatment history | tb drug use dosage | ofloxacine | ofl | grams:0.75;patient history | chest x-ray/ct-scan description:the upper lung zones;patient history | date of current tb diagnosis:2009-06-02T00:00:00;patient treatment history | was receiving methadone?:no;patient treatment history | tb drug use frequency | para-aminosalicyclic acid | para:every day;patient history | travelling in tb endemic area?:no;patient treatment history | date when the last tb treatment was ended:2008,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Belarus,minsk id:91.201,2014-12-08T22:12:23.435Z,2015-03-16T03:17:09.594Z
1438832_3,Mycobacterium tuberculosis UT0073,Mycobacterium tuberculosis UT0073,1438832.0,WGS,UT0073,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233339,SAMN02567679,GCA_000656535.1,JLMP00000000,-,Broad Institute,WGS,Illumina,67.0x,allpaths v. R48559,,,66.0,78.0,4373623.0,65.6,4353.0,,4010.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.919Z,2015-03-16T03:17:09.594Z
1438833_3,Mycobacterium tuberculosis 1010SM,Mycobacterium tuberculosis 1010SM,1438833.0,WGS,1010SM,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233384,SAMN02567732,GCA_000649615.1,JKAO00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,100.0,109.0,4384859.0,65.6,4372.0,,4006.0,,neg,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,72,,,,interval:chronic;host_source_id:1;interval:chronic;host_source_id:1,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:XDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:XDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.141Z,2015-03-16T03:17:09.594Z
1438834_3,Mycobacterium tuberculosis UT0074,Mycobacterium tuberculosis UT0074,1438834.0,WGS,UT0074,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233340,SAMN02567680,GCA_000656555.1,JLMO00000000,-,Broad Institute,WGS,Illumina,50.0x,allpaths v. R48559,,,70.0,72.0,4416429.0,65.6,4383.0,,4011.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.928Z,2015-03-16T03:17:09.594Z
1438835_3,Mycobacterium tuberculosis 1173CS,Mycobacterium tuberculosis 1173CS,1438835.0,WGS,1173CS,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233383,SAMN02567731,GCA_000649595.1,JKAP00000000,-,Broad Institute,WGS,Illumina,78.0x,allpaths v. R48559,,,87.0,90.0,4373086.0,65.6,4333.0,,3982.0,,Bodily fluid,,2012,Romania,Romania,,,,,,"Human, Homo sapiens",Male,37,,,,interval:relapse;host_source_id:2;interval:relapse;host_source_id:2,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.161Z,2015-03-16T03:17:09.594Z
1438836_3,Mycobacterium tuberculosis UT0054,Mycobacterium tuberculosis UT0054,1438836.0,WGS,UT0054,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233338,SAMN02567678,GCA_000656515.1,JLMQ00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,71.0,77.0,4406306.0,65.6,4363.0,,4006.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.909Z,2015-03-16T03:17:09.594Z
1438837_3,Mycobacterium tuberculosis 1429BH,Mycobacterium tuberculosis 1429BH,1438837.0,WGS,1429BH,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233382,SAMN02567730,GCA_000649575.1,JKAQ00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,84.0,92.0,4398204.0,65.6,4384.0,,4022.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,40,,,,interval:neg;host_source_id:3;interval:neg;host_source_id:3,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.171Z,2015-03-16T03:17:09.594Z
1438838_3,Mycobacterium tuberculosis 1430BH,Mycobacterium tuberculosis 1430BH,1438838.0,WGS,1430BH,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233381,SAMN02567729,GCA_000649555.1,JKAR00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,87.0,96.0,4397087.0,65.6,4383.0,,4023.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,50,,,,interval:neg;host_source_id:4;interval:neg;host_source_id:4,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.181Z,2015-03-16T03:17:09.594Z
1438839_3,Mycobacterium tuberculosis UT0014,Mycobacterium tuberculosis UT0014,1438839.0,WGS,UT0014,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233332,SAMN02567672,GCA_000656455.1,JLMV00000000,-,Broad Institute,WGS,Illumina,32.0x,allpaths v. R48559,,,104.0,111.0,4385158.0,65.5,4383.0,,4010.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.850Z,2015-03-16T03:17:09.594Z
1438840_3,Mycobacterium tuberculosis UT0043,Mycobacterium tuberculosis UT0043,1438840.0,WGS,UT0043,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233336,SAMN02567676,GCA_000658055.1,JLMS00000000,-,Broad Institute,WGS,Illumina,56.0x,allpaths v. R48559,,,64.0,68.0,4386948.0,65.59,4361.0,,4011.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.880Z,2015-03-16T03:17:09.594Z
1438841_3,Mycobacterium tuberculosis UT0028,Mycobacterium tuberculosis UT0028,1438841.0,WGS,UT0028,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233333,SAMN02567673,GCA_000656475.1,JLMU00000000,-,Broad Institute,WGS,Illumina,34.0x,allpaths v. R48559,,,95.0,105.0,4398092.0,65.5,4384.0,,4017.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.860Z,2015-03-16T03:17:09.594Z
1438842_3,Mycobacterium tuberculosis 1755BN,Mycobacterium tuberculosis 1755BN,1438842.0,WGS,1755BN,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233380,SAMN02567728,GCA_000649535.1,JKAS00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,86.0,93.0,4375665.0,65.6,4360.0,,3987.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,35,,,,interval:admin;host_source_id:5;interval:admin;host_source_id:5,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:3+;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:3+;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.191Z,2015-03-16T03:17:09.594Z
1438843_3,Mycobacterium tuberculosis 2074CJ,Mycobacterium tuberculosis 2074CJ,1438843.0,WGS,2074CJ,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233358,SAMN02567706,GCA_000649235.1,JKBN00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,101.0,111.0,4476348.0,65.6,4460.0,,4083.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,42,,,,interval:relapse;host_source_id:6;interval:relapse;host_source_id:6,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:1+;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:1+;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.201Z,2015-03-16T03:17:09.594Z
1438844_3,Mycobacterium tuberculosis 2088HD,Mycobacterium tuberculosis 2088HD,1438844.0,WGS,2088HD,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233378,SAMN02567726,GCA_000649495.1,JKAU00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,92.0,105.0,4369382.0,65.6,4370.0,,3999.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,45,,,,interval:relapse;host_source_id:7;interval:relapse;host_source_id:7,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.209Z,2015-03-16T03:17:09.594Z
1438845_3,Mycobacterium tuberculosis 2089HD,Mycobacterium tuberculosis 2089HD,1438845.0,WGS,2089HD,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233377,SAMN02567725,GCA_000649475.1,JKAV00000000,-,Broad Institute,WGS,Illumina,76.0x,allpaths v. R48559,,,79.0,87.0,4379125.0,65.6,4369.0,,4014.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,49,,,,interval:chronic;host_source_id:8;interval:chronic;host_source_id:8,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.218Z,2015-03-16T03:17:09.594Z
1438846_3,Mycobacterium tuberculosis 2091HD,Mycobacterium tuberculosis 2091HD,1438846.0,WGS,2091HD,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233373,SAMN02567721,GCA_000649415.1,JKAZ00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,97.0,106.0,4393549.0,65.6,4381.0,,4008.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,41,,,,interval:admin;host_source_id:9;interval:admin;host_source_id:9,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.228Z,2015-03-16T03:17:09.594Z
1438847_3,Mycobacterium tuberculosis 2092HD,,1438847.0,WGS,2092HD,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA233372,SAMN02567720,GCA_000705805.1,JKBA00000000,-,Broad Institute,,Illumina,78.0x,allpaths v. R48559,,,85.0,87.0,4406220.0,65.6,4303.0,,4011.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,49,,,,interval:24 month;host_source_id:10;interval:24 month;host_source_id:10,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:XDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:XDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:58:51.251Z,2015-03-16T03:17:09.594Z
1438848_3,Mycobacterium tuberculosis 2093HD,Mycobacterium tuberculosis 2093HD,1438848.0,WGS,2093HD,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233371,SAMN02567719,GCA_000649395.1,JKBB00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,81.0,87.0,4367723.0,65.6,4364.0,,3991.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,60,,,,interval:8 weeks;host_source_id:11;interval:8 weeks;host_source_id:11,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.237Z,2015-03-16T03:17:09.594Z
1438849_3,Mycobacterium tuberculosis 2094HD,Mycobacterium tuberculosis 2094HD,1438849.0,WGS,2094HD,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233368,SAMN02567716,GCA_000649375.1,JKBD00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R48559,,,112.0,124.0,4421466.0,65.6,4422.0,,4050.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,59,,,,interval:chronic;host_source_id:12;interval:chronic;host_source_id:12,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.247Z,2015-03-16T03:17:09.594Z
1438850_3,Mycobacterium tuberculosis 2097HD,,1438850.0,WGS,2097HD,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA233366,SAMN02567714,GCA_000705845.1,JKBF00000000,-,Broad Institute,,Illumina,77.0x,allpaths v. R48559,,,113.0,115.0,4456340.0,65.6,4373.0,,4043.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,39,,,,interval:chronic;host_source_id:14;interval:chronic;host_source_id:14,Resistant;Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:XDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:XDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:58:51.821Z,2015-03-16T03:17:09.594Z
1438851_3,Mycobacterium tuberculosis 2099HD,Mycobacterium tuberculosis 2099HD,1438851.0,WGS,2099HD,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233365,SAMN02567713,GCA_000649355.1,JKBG00000000,-,Broad Institute,WGS,Illumina,76.0x,allpaths v. R48559,,,168.0,185.0,4588649.0,65.7,4573.0,,4189.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,40,,,,interval:relapse;host_source_id:15;interval:relapse;host_source_id:15,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.257Z,2015-03-16T03:17:09.594Z
1438852_3,Mycobacterium tuberculosis 2100HD,Mycobacterium tuberculosis 2100HD,1438852.0,WGS,2100HD,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233364,SAMN02567712,GCA_000649335.1,JKBH00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,109.0,115.0,4516239.0,65.7,4471.0,,4116.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Female,33,,,,interval:chronic;host_source_id:16;interval:chronic;host_source_id:16,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.276Z,2015-03-16T03:17:09.594Z
1438853_3,Mycobacterium tuberculosis 2101HD,Mycobacterium tuberculosis 2101HD,1438853.0,WGS,2101HD,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233363,SAMN02567711,GCA_000658495.1,JKBI00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,89.0,90.0,4209035.0,65.63,4199.0,,3850.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,79,,,,interval:8 weeks;host_source_id:17;interval:8 weeks;host_source_id:17,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.285Z,2015-03-16T03:17:09.594Z
1438854_3,Mycobacterium tuberculosis 2104HD,,1438854.0,WGS,2104HD,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA233350,SAMN02567698,GCA_000711635.1,JKBV00000000,-,Broad Institute,,Illumina,79.0x,allpaths v. R48559,,,92.0,92.0,4412660.0,65.6,4317.0,,4030.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,46,,,,interval:chronic;host_source_id:18;interval:chronic;host_source_id:18,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:58:52.422Z,2015-03-16T03:17:09.594Z
1438856_3,Mycobacterium tuberculosis 2196MM,Mycobacterium tuberculosis 2196MM,1438856.0,WGS,2196MM,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233370,SAMN02567718,GCA_000658515.1,JKBC00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,76.0,81.0,4401042.0,65.59,4361.0,,4015.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,60,,,,interval:neg;host_source_id:19;interval:neg;host_source_id:19,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.295Z,2015-03-16T03:17:09.594Z
1438858_3,Mycobacterium tuberculosis 2228BH,Mycobacterium tuberculosis 2228BH,1438858.0,WGS,2228BH,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233361,SAMN02567709,GCA_000649295.1,JKBK00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,91.0,101.0,4396900.0,65.6,4393.0,,4023.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Female,28,,,,interval:neg;host_source_id:21;interval:neg;host_source_id:21,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.304Z,2015-03-16T03:17:09.594Z
1438859_3,Mycobacterium tuberculosis 2229BH,Mycobacterium tuberculosis 2229BH,1438859.0,WGS,2229BH,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233360,SAMN02567708,GCA_000649275.1,JKBL00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,120.0,128.0,4416367.0,65.6,4416.0,,4044.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,55,,,,interval:neg;host_source_id:22;interval:neg;host_source_id:22,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.314Z,2015-03-16T03:17:09.594Z
1438860_3,Mycobacterium tuberculosis 2230BH,Mycobacterium tuberculosis 2230BH,1438860.0,WGS,2230BH,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233359,SAMN02567707,GCA_000649255.1,JKBM00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,112.0,122.0,4455548.0,65.6,4452.0,,4076.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,50,,,,interval:neg;host_source_id:23;interval:neg;host_source_id:23,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.324Z,2015-03-16T03:17:09.594Z
1438861_3,Mycobacterium tuberculosis 2231BH,,1438861.0,WGS,2231BH,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA233352,SAMN02567700,GCA_000705865.1,JKBT00000000,-,Broad Institute,,Illumina,82.0x,allpaths v. R48559,,,95.0,97.0,4453260.0,65.6,4366.0,,4051.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,36,,,,interval:neg;host_source_id:24;interval:neg;host_source_id:24,Resistant;Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:XDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:XDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:58:53.448Z,2015-03-16T03:17:09.594Z
1438862_3,Mycobacterium tuberculosis 2233BH,Mycobacterium tuberculosis 2233BH,1438862.0,WGS,2233BH,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233351,SAMN02567699,GCA_000656655.1,JKBU00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,80.0,83.0,4411725.0,65.6,4382.0,,4015.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,47,,,,interval:neg;host_source_id:25;interval:neg;host_source_id:25,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.334Z,2015-03-16T03:17:09.594Z
1438863_3,Mycobacterium tuberculosis 2482AR,Mycobacterium tuberculosis 2482AR,1438863.0,WGS,2482AR,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233357,SAMN02567705,GCA_000658475.1,JKBO00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,84.0,91.0,4420276.0,65.61,4383.0,,4055.0,,Bodily fluid,,2012,Romania,Romania,,,,,,"Human, Homo sapiens",Male,44,,,,interval:neg;host_source_id:27;interval:neg;host_source_id:27,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.344Z,2015-03-16T03:17:09.594Z
1438864_3,Mycobacterium tuberculosis 2483AR,Mycobacterium tuberculosis 2483AR,1438864.0,WGS,2483AR,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233356,SAMN02567704,GCA_000658455.1,JKBP00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,97.0,101.0,4455708.0,65.61,4417.0,,4061.0,,Bodily fluid,,2012,Romania,Romania,,,,,,"Human, Homo sapiens",Male,55,,,,interval:neg;host_source_id:28;interval:neg;host_source_id:28,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.354Z,2015-03-16T03:17:09.594Z
1438865_3,Mycobacterium tuberculosis 2484AR,Mycobacterium tuberculosis 2484AR,1438865.0,WGS,2484AR,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233355,SAMN02567703,GCA_000649215.1,JKBQ00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,69.0,78.0,4377356.0,65.6,4338.0,,4001.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,42,,,,interval:neg;host_source_id:29;interval:neg;host_source_id:29,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.365Z,2015-03-16T03:17:09.594Z
1438866_3,Mycobacterium tuberculosis 2485AR,Mycobacterium tuberculosis 2485AR,1438866.0,WGS,2485AR,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233354,SAMN02567702,GCA_000658435.1,JKBR00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,109.0,115.0,4446408.0,65.66,4413.0,,4044.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,40,,,,interval:neg;host_source_id:30;interval:neg;host_source_id:30,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.374Z,2015-03-16T03:17:09.594Z
1438867_3,Mycobacterium tuberculosis UT0119,Mycobacterium tuberculosis UT0119,1438867.0,WGS,UT0119,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233345,SAMN02567685,GCA_000656635.1,JLMK00000000,-,Broad Institute,WGS,Illumina,29.0x,allpaths v. R48559,,,62.0,63.0,4361287.0,65.6,4319.0,,3965.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.977Z,2015-03-16T03:17:09.594Z
1438868_3,Mycobacterium tuberculosis 2541MS,Mycobacterium tuberculosis 2541MS,1438868.0,WGS,2541MS,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233376,SAMN02567724,GCA_000649455.1,JKAW00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,79.0,84.0,4397776.0,65.6,4387.0,,4016.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Female,23,,,,interval:neg;host_source_id:31;interval:neg;host_source_id:31,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.383Z,2015-03-16T03:17:09.594Z
1438869_3,Mycobacterium tuberculosis 2542MS,,1438869.0,WGS,2542MS,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA233375,SAMN02567723,GCA_000705785.1,JKAX00000000,-,Broad Institute,,Illumina,79.0x,allpaths v. R48559,,,88.0,89.0,4408740.0,65.6,4308.0,,4013.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,20,,,,interval:neg;host_source_id:32;interval:neg;host_source_id:32,Resistant;Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:XDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:XDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:58:54.542Z,2015-03-16T03:17:09.594Z
1438870_3,Mycobacterium tuberculosis 2543MS,Mycobacterium tuberculosis 2543MS,1438870.0,WGS,2543MS,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233374,SAMN02567722,GCA_000649435.1,JKAY00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,78.0,86.0,4388950.0,65.6,4372.0,,4012.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,21,,,,interval:neg;host_source_id:33;interval:neg;host_source_id:33,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:neg;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:neg;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.391Z,2015-03-16T03:17:09.594Z
1438871_3,Mycobacterium tuberculosis 2995AB,,1438871.0,WGS,2995AB,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA233367,SAMN02567715,GCA_000705825.1,JKBE00000000,-,Broad Institute,,Illumina,76.0x,allpaths v. R48559,,,91.0,93.0,4391390.0,65.5,4296.0,,4013.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,40,,,,host_source_id:37;host_source_id:37,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:58:55.449Z,2015-03-16T03:17:09.594Z
1438872_3,Mycobacterium tuberculosis 3067CJ,Mycobacterium tuberculosis 3067CJ,1438872.0,WGS,3067CJ,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233362,SAMN02567710,GCA_000649315.1,JKBJ00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,23.0,24.0,4407219.0,65.6,4370.0,,4003.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,51,,,,interval:relapse;host_source_id:34;interval:relapse;host_source_id:34,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:1+;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:1+;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.400Z,2015-03-16T03:17:09.594Z
1438873_3,Mycobacterium tuberculosis 3280CJ,Mycobacterium tuberculosis 3280CJ,1438873.0,WGS,3280CJ,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233353,SAMN02567701,GCA_000656675.1,JKBS00000000,-,Broad Institute,WGS,Illumina,74.0x,allpaths v. R48559,,,116.0,124.0,4468200.0,65.6,4450.0,,4078.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,25,,,,interval:relapse;host_source_id:35;interval:relapse;host_source_id:35,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,microscopy | zn:3+;phenotype:MDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;microscopy | zn:3+;phenotype:MDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.408Z,2015-03-16T03:17:09.594Z
1438874_3,Mycobacterium tuberculosis 3499MM,Mycobacterium tuberculosis 3499MM,1438874.0,WGS,3499MM,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233379,SAMN02567727,GCA_000649515.1,JKAT00000000,-,Broad Institute,WGS,Illumina,67.0x,allpaths v. R48559,,,74.0,81.0,4381012.0,65.6,4367.0,,4006.0,,Bodily fluid,,2013,Romania,Romania,,,,,,"Human, Homo sapiens",Male,44,,,,host_source_id:36;host_source_id:36,Resistant;Susceptible;Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Romania,phenotype:XDR;specimen source strain:Romanian native;organism detection method:LJ;specimen repository name:CJ;phenotype:XDR;organism detection method:LJ;specimen repository name:CJ,2014-12-08T22:12:08.416Z,2015-03-16T03:17:09.594Z
1438877_3,Mycobacterium tuberculosis UT0103,Mycobacterium tuberculosis UT0103,1438877.0,WGS,UT0103,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233344,SAMN02567684,GCA_000656615.1,JLML00000000,-,Broad Institute,WGS,Illumina,64.0x,allpaths v. R48559,,,77.0,82.0,4388192.0,65.6,4357.0,,3994.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"source if other than country location (with id):WHO Supranational Reference Lab., 6273;specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.956Z,2015-03-16T03:17:09.594Z
1438878_3,Mycobacterium tuberculosis UT0117,Mycobacterium tuberculosis UT0117,1438878.0,WGS,UT0117,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233322,SAMN02567662,GCA_000656415.1,JLMX00000000,-,Broad Institute,WGS,Illumina,35.0x,allpaths v. R48559,,,88.0,95.0,4382338.0,65.6,4366.0,,3986.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.967Z,2015-03-16T03:17:09.594Z
1438879_3,Mycobacterium tuberculosis UT0098,Mycobacterium tuberculosis UT0098,1438879.0,WGS,UT0098,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233342,SAMN02567682,GCA_000656575.1,JLMN00000000,-,Broad Institute,WGS,Illumina,77.0x,allpaths v. R48559,,,75.0,79.0,4383602.0,65.6,4362.0,,4010.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.936Z,2015-03-16T03:17:09.594Z
1438881_3,Mycobacterium tuberculosis UT0006,Mycobacterium tuberculosis UT0006,1438881.0,WGS,UT0006,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233330,SAMN02567670,GCA_000656435.1,JLMW00000000,-,Broad Institute,WGS,Illumina,63.0x,allpaths v. R48559,,,73.0,77.0,4385850.0,65.6,4365.0,,4015.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.841Z,2015-03-16T03:17:09.594Z
1438884_3,Mycobacterium tuberculosis UT0047,Mycobacterium tuberculosis UT0047,1438884.0,WGS,UT0047,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233337,SAMN02567677,GCA_000658075.1,JLMR00000000,-,Broad Institute,WGS,Illumina,62.0x,allpaths v. R48559,,,81.0,87.0,4394145.0,65.58,4375.0,,3998.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.890Z,2015-03-16T03:17:09.594Z
1438887_3,Mycobacterium tuberculosis UT0032,Mycobacterium tuberculosis UT0032,1438887.0,WGS,UT0032,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233334,SAMN02567674,GCA_000656495.1,JLMT00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,71.0,75.0,4364850.0,65.6,4346.0,,3991.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.869Z,2015-03-16T03:17:09.594Z
1438890_3,Mycobacterium tuberculosis UT0049,Mycobacterium tuberculosis UT0049,1438890.0,WGS,UT0049,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233321,SAMN02567661,GCA_000658035.1,JLMY00000000,-,Broad Institute,WGS,Illumina,50.0x,allpaths v. R48559,,,62.0,67.0,4380237.0,65.61,4344.0,,4005.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.900Z,2015-03-16T03:17:09.594Z
1438892_3,Mycobacterium tuberculosis UT0101,Mycobacterium tuberculosis UT0101,1438892.0,WGS,UT0101,,,,,,,,2014-04-29T00:00:00Z,,PRJNA233343,SAMN02567683,GCA_000656595.1,JLMM00000000,-,Broad Institute,WGS,Illumina,50.0x,allpaths v. R48559,,,70.0,74.0,4390251.0,65.6,4359.0,,4014.0,,Bodily fluid,,,Uganda,Uganda,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC CDRC Alland,"specimen repository:BEI Resources, Manassas, VA",2014-12-08T22:12:21.946Z,2015-03-16T03:17:09.594Z
1447434_3,Mycobacterium tuberculosis MD17902,Mycobacterium tuberculosis MD17902,1447434.0,WGS,MD17902,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234546,SAMN02584585,GCA_000649795.1,JLGT00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,101.0,113.0,4401480.0,65.6,4402.0,,4023.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,61,,,,previous tb treatment:smear-positive relapse;host_subject_id:267,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.938Z,2015-03-16T03:17:09.594Z
1447435_3,Mycobacterium tuberculosis MD18320,Mycobacterium tuberculosis MD18320,1447435.0,WGS,MD18320,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234547,SAMN02584586,GCA_000658175.1,JLGS00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,79.0,85.0,4401471.0,65.6,4372.0,,4024.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,45,,,,previous tb treatment:new TB case;host_subject_id:193,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.024Z,2015-03-16T03:17:09.594Z
1447436_3,Mycobacterium tuberculosis MD18486,Mycobacterium tuberculosis MD18486,1447436.0,WGS,MD18486,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234548,SAMN02584587,GCA_000658195.1,JLGR00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,71.0,73.0,4412726.0,65.61,4376.0,,4024.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,23,,,,previous tb treatment:new TB case;host_subject_id:305,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.052Z,2015-03-16T03:17:09.594Z
1447437_3,Mycobacterium tuberculosis MD16555,Mycobacterium tuberculosis MD16555,1447437.0,WGS,MD16555,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234549,SAMN02584588,GCA_000649815.1,JLGQ00000000,-,Broad Institute,WGS,Illumina,76.0x,allpaths v. R48559,,,83.0,90.0,4368979.0,65.6,4334.0,,3976.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,51,,,,previous tb treatment:new TB case;host_subject_id:176,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.694Z,2015-03-16T03:17:09.594Z
1447440_3,Mycobacterium tuberculosis MD19964,Mycobacterium tuberculosis MD19964,1447440.0,WGS,MD19964,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234553,SAMN02584591,GCA_000649875.1,JLGN00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,100.0,108.0,4357638.0,65.5,4362.0,,3979.0,,,,2011,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,39,,,,previous tb treatment:new TB case;host_subject_id:156,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.142Z,2015-03-16T03:17:09.594Z
1447441_3,Mycobacterium tuberculosis MD19693,Mycobacterium tuberculosis MD19693,1447441.0,WGS,MD19693,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234554,SAMN02584592,GCA_000649895.1,JLGM00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,92.0,100.0,4406409.0,65.6,4399.0,,4026.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,46,,,,previous tb treatment:smear-negative relapse;host_subject_id:231,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.133Z,2015-03-16T03:17:09.594Z
1447443_3,Mycobacterium tuberculosis MD17614,Mycobacterium tuberculosis MD17614,1447443.0,WGS,MD17614,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234556,SAMN02584594,GCA_000649935.1,JLGK00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,83.0,90.0,4358555.0,65.6,4352.0,,3979.0,,,,2011,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,55,,,,previous tb treatment:new TB case;host_subject_id:77,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.855Z,2015-03-16T03:17:09.594Z
1447444_3,Mycobacterium tuberculosis MD17615,Mycobacterium tuberculosis MD17615,1447444.0,WGS,MD17615,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234557,SAMN02584595,GCA_000649955.1,JLGJ00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,95.0,102.0,4409147.0,65.6,4394.0,,4027.0,,,,2011,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,41,,,,previous tb treatment:return after default;host_subject_id:73,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.866Z,2015-03-16T03:17:09.594Z
1447446_3,Mycobacterium tuberculosis MD17748,Mycobacterium tuberculosis MD17748,1447446.0,WGS,MD17748,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234559,SAMN02584597,GCA_000649975.1,JLGH00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,84.0,90.0,4372285.0,65.6,4348.0,,3979.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,36,,,,previous tb treatment:new TB case;host_subject_id:51,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.896Z,2015-03-16T03:17:09.594Z
1447447_3,Mycobacterium tuberculosis MD19043,Mycobacterium tuberculosis MD19043,1447447.0,WGS,MD19043,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234560,SAMN02584598,GCA_000649995.1,JLGG00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R48559,,,92.0,100.0,4356893.0,65.5,4322.0,,3978.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,49,,,,previous tb treatment:new TB case;host_subject_id:168,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.089Z,2015-03-16T03:17:09.594Z
1447448_3,Mycobacterium tuberculosis MD20344,Mycobacterium tuberculosis MD20344,1447448.0,WGS,MD20344,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234561,SAMN02584599,GCA_000658215.1,JLGF00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,110.0,119.0,4381027.0,65.51,4380.0,,4024.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,61,,,,previous tb treatment:new TB case;host_subject_id:204,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.152Z,2015-03-16T03:17:09.594Z
1447449_3,Mycobacterium tuberculosis MD20845,Mycobacterium tuberculosis MD20845,1447449.0,WGS,MD20845,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234562,SAMN02584600,GCA_000650015.1,JLGE00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R48559,,,89.0,96.0,4387247.0,65.5,4369.0,,4020.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,61,,,,previous tb treatment:failure;host_subject_id:137,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.161Z,2015-03-16T03:17:09.594Z
1447450_3,Mycobacterium tuberculosis MD17890,,1447450.0,WGS,MD17890,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA234563,SAMN02584601,GCA_000706425.1,JLGD00000000,-,Broad Institute,,Illumina,68.0x,allpaths v. R48559,,,95.0,99.0,4372860.0,65.6,4290.0,,3975.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,50,,,,previous tb treatment:new TB case;host_subject_id:97,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T23:06:38.985Z,2015-03-16T03:17:09.594Z
1447451_3,Mycobacterium tuberculosis MD19339,Mycobacterium tuberculosis MD19339,1447451.0,WGS,MD19339,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234564,SAMN02584602,GCA_000650035.1,JLGC00000000,-,Broad Institute,WGS,Illumina,42.0x,allpaths v. R48559,,,116.0,127.0,4371427.0,65.5,4377.0,,4030.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,21,,,,previous tb treatment:new TB case;host_subject_id:34,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.116Z,2015-03-16T03:17:09.594Z
1447452_3,Mycobacterium tuberculosis MD19591,Mycobacterium tuberculosis MD19591,1447452.0,WGS,MD19591,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234565,SAMN02584603,GCA_000650055.1,JLGB00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,85.0,90.0,4375467.0,65.6,4351.0,,3994.0,,,,2011,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,43,,,,previous tb treatment:smear-positive relapse;host_subject_id:296,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.125Z,2015-03-16T03:17:09.594Z
1447453_3,Mycobacterium tuberculosis MD18472,Mycobacterium tuberculosis MD18472,1447453.0,WGS,MD18472,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234566,SAMN02584604,GCA_000650075.1,JLGA00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,90.0,99.0,4393784.0,65.5,4376.0,,4024.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,40,,,,previous tb treatment:smear-negative relapse;host_subject_id:171,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.033Z,2015-03-16T03:17:09.594Z
1447454_3,Mycobacterium tuberculosis MD19323,Mycobacterium tuberculosis MD19323,1447454.0,WGS,MD19323,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234567,SAMN02584605,GCA_000650095.1,JLFZ00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,89.0,95.0,4362798.0,65.6,4355.0,,3978.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,29,,,,previous tb treatment:new TB case;host_subject_id:70,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.107Z,2015-03-16T03:17:09.594Z
1447456_3,Mycobacterium tuberculosis MD16764,Mycobacterium tuberculosis MD16764,1447456.0,WGS,MD16764,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234569,SAMN02584607,GCA_000658235.1,JLFX00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,87.0,96.0,4364550.0,65.61,4350.0,,3977.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,52,,,,previous tb treatment:return after default;host_subject_id:221,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.761Z,2015-03-16T03:17:09.594Z
1447457_3,Mycobacterium tuberculosis MD18096,Mycobacterium tuberculosis MD18096,1447457.0,WGS,MD18096,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234570,SAMN02584608,GCA_000650135.1,JLFW00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,82.0,90.0,4370502.0,65.6,4335.0,,3973.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,24,,,,previous tb treatment:new TB case;host_subject_id:218,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.986Z,2015-03-16T03:17:09.594Z
1447458_3,Mycobacterium tuberculosis MD17973,Mycobacterium tuberculosis MD17973,1447458.0,WGS,MD17973,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234571,SAMN02584609,GCA_000650155.1,JLFV00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,87.0,97.0,4366083.0,65.6,4348.0,,3978.0,,,,2011,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,38,,,,previous tb treatment:new TB case;host_subject_id:64,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.967Z,2015-03-16T03:17:09.594Z
1447459_3,Mycobacterium tuberculosis MD18112,Mycobacterium tuberculosis MD18112,1447459.0,WGS,MD18112,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234572,SAMN02584610,GCA_000650175.1,JLFU00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,78.0,84.0,4394730.0,65.6,4376.0,,4023.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,44,,,,previous tb treatment:new TB case;host_subject_id:247,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.995Z,2015-03-16T03:17:09.594Z
1447460_3,Mycobacterium tuberculosis MD17903,Mycobacterium tuberculosis MD17903,1447460.0,WGS,MD17903,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234573,SAMN02584611,GCA_000650195.1,JLFT00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,96.0,101.0,4418065.0,65.6,4378.0,,4019.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,52,,,,previous tb treatment:smear-positive relapse;host_subject_id:311,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.948Z,2015-03-16T03:17:09.594Z
1447461_3,Mycobacterium tuberculosis MD15594,Mycobacterium tuberculosis MD15594,1447461.0,WGS,MD15594,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234574,SAMN02584612,GCA_000650215.1,JLFS00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,84.0,92.0,4373401.0,65.6,4353.0,,3975.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,50,,,,previous tb treatment:smear-negative relapse;host_subject_id:316,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.529Z,2015-03-16T03:17:09.594Z
1447463_3,Mycobacterium tuberculosis MD18498,Mycobacterium tuberculosis MD18498,1447463.0,WGS,MD18498,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234576,SAMN02584614,GCA_000650255.1,JLFQ00000000,-,Broad Institute,WGS,Illumina,43.0x,allpaths v. R48559,,,99.0,108.0,4378727.0,65.5,4388.0,,4029.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,50,,,,previous tb treatment:smear-positive relapse;host_subject_id:206,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.071Z,2015-03-16T03:17:09.594Z
1447464_3,Mycobacterium tuberculosis MD18116,Mycobacterium tuberculosis MD18116,1447464.0,WGS,MD18116,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234577,SAMN02584615,GCA_000650275.1,JLFP00000000,-,Broad Institute,WGS,Illumina,74.0x,allpaths v. R48559,,,111.0,117.0,4314248.0,65.4,4306.0,,3988.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,52,,,,previous tb treatment:new TB case;host_subject_id:284,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.005Z,2015-03-16T03:17:09.594Z
1447465_3,Mycobacterium tuberculosis MD18090,Mycobacterium tuberculosis MD18090,1447465.0,WGS,MD18090,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234578,SAMN02584616,GCA_000650295.1,JLFO00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,91.0,103.0,4397042.0,65.6,4392.0,,4021.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,38,,,,previous tb treatment:return after default;host_subject_id:244,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.976Z,2015-03-16T03:17:09.594Z
1447466_3,Mycobacterium tuberculosis MD18314,Mycobacterium tuberculosis MD18314,1447466.0,WGS,MD18314,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234579,SAMN02584617,GCA_000650315.1,JLFN00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,88.0,95.0,4374513.0,65.6,4363.0,,4006.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,63,,,,previous tb treatment:new TB case;host_subject_id:53,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:14.014Z,2015-03-16T03:17:09.594Z
1447467_3,Mycobacterium tuberculosis MD16261,Mycobacterium tuberculosis MD16261,1447467.0,WGS,MD16261,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234580,SAMN02584618,GCA_000650335.1,JLFM00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,73.0,76.0,4389365.0,65.6,4325.0,,3999.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,52,,,,previous tb treatment:new TB case;host_subject_id:284,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.657Z,2015-03-16T03:17:09.594Z
1447468_3,Mycobacterium tuberculosis MD16732,Mycobacterium tuberculosis MD16732,1447468.0,WGS,MD16732,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234581,SAMN02584619,GCA_000650355.1,JLFL00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,96.0,102.0,4376264.0,65.6,4354.0,,3981.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,27,,,,previous tb treatment:new TB case;host_subject_id:233,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.751Z,2015-03-16T03:17:09.594Z
1447470_3,Mycobacterium tuberculosis MD17503,Mycobacterium tuberculosis MD17503,1447470.0,WGS,MD17503,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234583,SAMN02584621,GCA_000650395.1,JLFJ00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,111.0,117.0,4336410.0,65.4,4336.0,,3993.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,43,,,,previous tb treatment:new TB case;host_subject_id:143,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.826Z,2015-03-16T03:17:09.594Z
1447471_3,Mycobacterium tuberculosis MD17517,Mycobacterium tuberculosis MD17517,1447471.0,WGS,MD17517,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234584,SAMN02584622,GCA_000650415.1,JLFI00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,86.0,96.0,4396191.0,65.6,4399.0,,4022.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,21,,,,previous tb treatment:new TB case;host_subject_id:271,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.837Z,2015-03-16T03:17:09.594Z
1447472_3,Mycobacterium tuberculosis MD17647,Mycobacterium tuberculosis MD17647,1447472.0,WGS,MD17647,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234585,SAMN02584623,GCA_000650435.1,JLFH00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,87.0,92.0,4371899.0,65.6,4347.0,,3980.0,,,,2011,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,56,,,,previous tb treatment:return after default;host_subject_id:32,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.877Z,2015-03-16T03:17:09.594Z
1447473_3,Mycobacterium tuberculosis MD17646,,1447473.0,WGS,MD17646,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA234586,SAMN02584624,GCA_000706405.1,JLFG00000000,-,Broad Institute,,Illumina,88.0x,allpaths v. R48559,,,95.0,98.0,4423620.0,65.6,4334.0,,4023.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,54,,,,previous tb treatment:return after default;host_subject_id:102,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T23:06:40.304Z,2015-03-16T03:17:09.594Z
1447474_3,Mycobacterium tuberculosis MD17613,Mycobacterium tuberculosis MD17613,1447474.0,WGS,MD17613,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234587,SAMN02584625,GCA_000650455.1,JLFF00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,91.0,100.0,4405287.0,65.6,4395.0,,4026.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,52,,,,previous tb treatment:new TB case;host_subject_id:56,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.847Z,2015-03-16T03:17:09.594Z
1447475_3,Mycobacterium tuberculosis MD16775,Mycobacterium tuberculosis MD16775,1447475.0,WGS,MD16775,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234588,SAMN02584626,GCA_000650475.1,JLFE00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,94.0,101.0,4410013.0,65.6,4397.0,,4028.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,23,,,,previous tb treatment:new TB case;host_subject_id:91,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.780Z,2015-03-16T03:17:09.594Z
1447476_3,Mycobacterium tuberculosis MD17240,Mycobacterium tuberculosis MD17240,1447476.0,WGS,MD17240,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234589,SAMN02584627,GCA_000650495.1,JLFD00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,76.0,78.0,4383768.0,65.6,4327.0,,3998.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,21,,,,previous tb treatment:smear-positive relapse;host_subject_id:14,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.816Z,2015-03-16T03:17:09.594Z
1447477_3,Mycobacterium tuberculosis MD17749,Mycobacterium tuberculosis MD17749,1447477.0,WGS,MD17749,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234590,SAMN02584628,GCA_000658255.1,JLFC00000000,-,Broad Institute,WGS,Illumina,67.0x,allpaths v. R48559,,,87.0,96.0,4364633.0,65.59,4344.0,,3983.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,69,,,,previous tb treatment:new TB case;host_subject_id:100,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.905Z,2015-03-16T03:17:09.594Z
1447480_3,Mycobacterium tuberculosis MD17888,Mycobacterium tuberculosis MD17888,1447480.0,WGS,MD17888,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234593,SAMN02584631,GCA_000650535.1,JLEZ00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,91.0,101.0,4398248.0,65.6,4395.0,,4025.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,24,,,,previous tb treatment:new TB case;host_subject_id:272,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.918Z,2015-03-16T03:17:09.594Z
1447482_3,Mycobacterium tuberculosis MD17901,,1447482.0,WGS,MD17901,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA234595,SAMN02584633,GCA_000706385.1,JLEY00000000,-,Broad Institute,,Illumina,86.0x,allpaths v. R48559,,,88.0,92.0,4383690.0,65.6,4309.0,,3984.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,47,,,,previous tb treatment:new TB case;host_subject_id:99,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T23:06:40.768Z,2015-03-16T03:17:09.594Z
1447484_3,Mycobacterium tuberculosis MD16277,Mycobacterium tuberculosis MD16277,1447484.0,WGS,MD16277,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234597,SAMN02584635,GCA_000650575.1,JLEW00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,102.0,111.0,4401603.0,65.6,4394.0,,4026.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,21,,,,previous tb treatment:new TB case;host_subject_id:34,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.676Z,2015-03-16T03:17:09.594Z
1447485_3,Mycobacterium tuberculosis MD16553,Mycobacterium tuberculosis MD16553,1447485.0,WGS,MD16553,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234598,SAMN02584636,GCA_000650595.1,JLEV00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,78.0,84.0,4392844.0,65.6,4361.0,,4019.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,43,,,,previous tb treatment:new TB case;host_subject_id:139,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.685Z,2015-03-16T03:17:09.594Z
1447486_3,Mycobacterium tuberculosis MD15766,Mycobacterium tuberculosis MD15766,1447486.0,WGS,MD15766,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234599,SAMN02584637,GCA_000650615.1,JLEU00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,88.0,95.0,4405371.0,65.6,4387.0,,4022.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,57,,,,previous tb treatment:smear-positive relapse;host_subject_id:135,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.575Z,2015-03-16T03:17:09.594Z
1447488_3,Mycobacterium tuberculosis MD15958,,1447488.0,WGS,MD15958,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA234601,SAMN02584639,GCA_000706365.1,JLES00000000,-,Broad Institute,,Illumina,83.0x,allpaths v. R48559,,,104.0,105.0,4417180.0,65.6,4325.0,,4017.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,43,,,,previous tb treatment:smear-negative relapse;host_subject_id:230,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T23:06:41.675Z,2015-03-16T03:17:09.594Z
1447489_3,Mycobacterium tuberculosis MD16265,Mycobacterium tuberculosis MD16265,1447489.0,WGS,MD16265,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234602,SAMN02584640,GCA_000650655.1,JLER00000000,-,Broad Institute,WGS,Illumina,78.0x,allpaths v. R48559,,,90.0,99.0,4403143.0,65.6,4389.0,,4022.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,33,,,,previous tb treatment:new TB case;host_subject_id:241,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.666Z,2015-03-16T03:17:09.594Z
1447492_3,Mycobacterium tuberculosis MD16571,Mycobacterium tuberculosis MD16571,1447492.0,WGS,MD16571,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234607,SAMN02584643,GCA_000650715.1,JLEO00000000,-,Broad Institute,WGS,Illumina,73.0x,allpaths v. R48559,,,84.0,93.0,4357947.0,65.6,4342.0,,3978.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,29,,,,previous tb treatment:new TB case;host_subject_id:70,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.712Z,2015-03-16T03:17:09.594Z
1447493_3,Mycobacterium tuberculosis MD17006,Mycobacterium tuberculosis MD17006,1447493.0,WGS,MD17006,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234608,SAMN02584644,GCA_000650735.1,JLEN00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,129.0,139.0,4350924.0,65.6,4337.0,,3986.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,62,,,,previous tb treatment:new TB case;host_subject_id:33,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.789Z,2015-03-16T03:17:09.594Z
1447495_3,Mycobacterium tuberculosis MD17232,Mycobacterium tuberculosis MD17232,1447495.0,WGS,MD17232,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234611,SAMN02584646,GCA_000650775.1,JLEL00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,83.0,91.0,4369384.0,65.6,4352.0,,3985.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,63,,,,previous tb treatment:new TB case;host_subject_id:278,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.808Z,2015-03-16T03:17:09.594Z
1447496_3,Mycobacterium tuberculosis MD15956,Mycobacterium tuberculosis MD15956,1447496.0,WGS,MD15956,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234613,SAMN02584647,GCA_000650795.1,JLEK00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,96.0,107.0,4390374.0,65.6,4385.0,,2884.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,49,,,,previous tb treatment:new TB case;host_subject_id:185,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.602Z,2015-03-16T03:17:09.594Z
1447500_3,Mycobacterium tuberculosis MD15963,Mycobacterium tuberculosis MD15963,1447500.0,WGS,MD15963,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234619,SAMN02584651,GCA_000650855.1,JLEG00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,110.0,116.0,4376725.0,65.6,4334.0,,4014.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,54,,,,previous tb treatment:smear-positive relapse;host_subject_id:5,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.612Z,2015-03-16T03:17:09.594Z
1447501_3,Mycobacterium tuberculosis MD15855,Mycobacterium tuberculosis MD15855,1447501.0,WGS,MD15855,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234620,SAMN02584652,GCA_000650875.1,JLEF00000000,-,Broad Institute,WGS,Illumina,80.0x,allpaths v. R48559,,,81.0,88.0,4368705.0,65.6,4344.0,,3975.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,33,,,,previous tb treatment:smear-negative relapse;host_subject_id:61,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.593Z,2015-03-16T03:17:09.594Z
1447502_3,Mycobacterium tuberculosis MD16257,Mycobacterium tuberculosis MD16257,1447502.0,WGS,MD16257,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234622,SAMN02584653,GCA_000650895.1,JLEE00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,87.0,93.0,4367056.0,65.6,4337.0,,3969.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,24,,,,previous tb treatment:new TB case;host_subject_id:218,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.648Z,2015-03-16T03:17:09.594Z
1447503_3,Mycobacterium tuberculosis MD15774,,1447503.0,WGS,MD15774,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA234623,SAMN02584654,GCA_000706325.1,JLED00000000,-,Broad Institute,,Illumina,86.0x,allpaths v. R48559,,,92.0,98.0,4424810.0,65.6,4359.0,,4025.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,27,,,,previous tb treatment:smear-positive relapse;host_subject_id:309,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T23:06:42.626Z,2015-03-16T03:17:09.594Z
1447504_3,Mycobacterium tuberculosis MD14620,Mycobacterium tuberculosis MD14620,1447504.0,WGS,MD14620,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234625,SAMN02584655,GCA_000650915.1,JLEC00000000,-,Broad Institute,WGS,Illumina,43.0x,allpaths v. R48559,,,84.0,91.0,4362867.0,65.6,4323.0,,3971.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,67,,,,previous tb treatment:new TB case;host_subject_id:238,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.418Z,2015-03-16T03:17:09.594Z
1447505_3,Mycobacterium tuberculosis MD13744,,1447505.0,WGS,MD13744,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA234626,SAMN02584656,GCA_000706305.1,JLEB00000000,-,Broad Institute,,Illumina,86.0x,allpaths v. R48559,,,90.0,94.0,4427310.0,65.6,4338.0,,4019.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,74,,,,previous tb treatment:new TB case;host_subject_id:136,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T23:06:43.145Z,2015-03-16T03:17:09.594Z
1447506_3,Mycobacterium tuberculosis MD14839,,1447506.0,WGS,MD14839,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA234628,SAMN02584657,GCA_000706285.1,JLEA00000000,-,Broad Institute,,Illumina,88.0x,allpaths v. R48559,,,106.0,109.0,4424170.0,65.6,4339.0,,4027.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,53,,,,previous tb treatment:new TB case;host_subject_id:167,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T23:06:43.728Z,2015-03-16T03:17:09.594Z
1447507_3,Mycobacterium tuberculosis MD14844,Mycobacterium tuberculosis MD14844,1447507.0,WGS,MD14844,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234629,SAMN02584658,GCA_000650935.1,JLDZ00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,97.0,102.0,4420154.0,65.6,4400.0,,4026.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,38,,,,previous tb treatment:new TB case;host_subject_id:256,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.464Z,2015-03-16T03:17:09.594Z
1447508_3,Mycobacterium tuberculosis MD14847,Mycobacterium tuberculosis MD14847,1447508.0,WGS,MD14847,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234631,SAMN02584659,GCA_000650955.1,JLDY00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,85.0,91.0,4399838.0,65.6,4377.0,,4024.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,45,,,,previous tb treatment:new TB case;host_subject_id:129,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.474Z,2015-03-16T03:17:09.594Z
1447509_3,Mycobacterium tuberculosis MD15050,Mycobacterium tuberculosis MD15050,1447509.0,WGS,MD15050,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234633,SAMN02584660,GCA_000650975.1,JLDX00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,85.0,97.0,4355085.0,65.6,4339.0,,3975.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,50,,,,previous tb treatment:chronic;host_subject_id:188,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.484Z,2015-03-16T03:17:09.594Z
1447513_3,Mycobacterium tuberculosis MD15973,Mycobacterium tuberculosis MD15973,1447513.0,WGS,MD15973,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234639,SAMN02584664,GCA_000651055.1,JLDT00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,84.0,94.0,4386370.0,65.6,4375.0,,4007.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,30,,,,previous tb treatment:smear-positive relapse;host_subject_id:38,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.620Z,2015-03-16T03:17:09.594Z
1447514_3,Mycobacterium tuberculosis MD13878,Mycobacterium tuberculosis MD13878,1447514.0,WGS,MD13878,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234641,SAMN02584665,GCA_000651075.1,JLDS00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,89.0,100.0,4363950.0,65.6,4355.0,,4000.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,32,,,,previous tb treatment:smear-negative relapse;host_subject_id:72,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.378Z,2015-03-16T03:17:09.594Z
1447516_3,Mycobacterium tuberculosis MD14435,Mycobacterium tuberculosis MD14435,1447516.0,WGS,MD14435,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234643,SAMN02584667,GCA_000651115.1,JLDQ00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,96.0,105.0,4396980.0,65.6,4394.0,,4022.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,34,,,,previous tb treatment:new TB case;host_subject_id:306,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.400Z,2015-03-16T03:17:09.594Z
1447517_3,Mycobacterium tuberculosis MD14709,Mycobacterium tuberculosis MD14709,1447517.0,WGS,MD14709,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234644,SAMN02584668,GCA_000651135.1,JLDP00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,89.0,95.0,4367635.0,65.6,4335.0,,3983.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,32,,,,previous tb treatment:new TB case;host_subject_id:222,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.436Z,2015-03-16T03:17:09.594Z
1447518_3,Mycobacterium tuberculosis MD14825,,1447518.0,WGS,MD14825,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA234645,SAMN02584669,GCA_000706265.1,JLDO00000000,-,Broad Institute,,Illumina,45.0x,allpaths v. R48559,,,85.0,92.0,4438210.0,65.6,4336.0,,4028.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,48,,,,previous tb treatment:new TB case;host_subject_id:125,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T23:06:44.391Z,2015-03-16T03:17:09.594Z
1447519_3,Mycobacterium tuberculosis MD15597,Mycobacterium tuberculosis MD15597,1447519.0,WGS,MD15597,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234646,SAMN02584670,GCA_000651155.1,JLDN00000000,-,Broad Institute,WGS,Illumina,74.0x,allpaths v. R48559,,,98.0,110.0,4370635.0,65.6,4368.0,,3988.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,45,,,,previous tb treatment:smear-negative relapse;host_subject_id:262,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.538Z,2015-03-16T03:17:09.594Z
1447520_3,Mycobacterium tuberculosis MD14720,Mycobacterium tuberculosis MD14720,1447520.0,WGS,MD14720,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234648,SAMN02584671,GCA_000651175.1,JLDM00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,96.0,105.0,4407529.0,65.6,4397.0,,4028.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,33,,,,previous tb treatment:smear-negative relapse;host_subject_id:243,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.444Z,2015-03-16T03:17:09.594Z
1447521_3,Mycobacterium tuberculosis MD15212,Mycobacterium tuberculosis MD15212,1447521.0,WGS,MD15212,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234649,SAMN02584672,GCA_000651195.1,JLDL00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,82.0,87.0,4384402.0,65.6,4362.0,,4005.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,49,,,,previous tb treatment:new TB case;host_subject_id:289,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.493Z,2015-03-16T03:17:09.594Z
1447522_3,Mycobacterium tuberculosis MD14437,Mycobacterium tuberculosis MD14437,1447522.0,WGS,MD14437,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234650,SAMN02584673,GCA_000651215.1,JLDK00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,92.0,101.0,4386751.0,65.6,4335.0,,3999.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Female,34,,,,previous tb treatment:new TB case;host_subject_id:166,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.410Z,2015-03-16T03:17:09.594Z
1447523_3,Mycobacterium tuberculosis MD16573,Mycobacterium tuberculosis MD16573,1447523.0,WGS,MD16573,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234651,SAMN02584674,GCA_000651235.1,JLDJ00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,91.0,101.0,4399767.0,65.6,4383.0,,4022.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,43,,,,previous tb treatment:return after default;host_subject_id:147,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.721Z,2015-03-16T03:17:09.594Z
1447524_3,Mycobacterium tuberculosis MD15584,Mycobacterium tuberculosis MD15584,1447524.0,WGS,MD15584,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234652,SAMN02584675,GCA_000651255.1,JLDI00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,94.0,101.0,4406590.0,65.6,4390.0,,4022.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,36,,,,previous tb treatment:return after default;host_subject_id:182,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.520Z,2015-03-16T03:17:09.594Z
1447525_3,Mycobacterium tuberculosis MD15758,Mycobacterium tuberculosis MD15758,1447525.0,WGS,MD15758,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234653,SAMN02584676,GCA_000651275.1,JLDH00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R48559,,,92.0,100.0,4372049.0,65.6,4363.0,,3984.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,47,,,,previous tb treatment:smear-negative relapse;host_subject_id:39,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.547Z,2015-03-16T03:17:09.594Z
1447526_3,Mycobacterium tuberculosis MD15765,Mycobacterium tuberculosis MD15765,1447526.0,WGS,MD15765,,,,,,,,2014-04-29T00:00:00Z,,PRJNA234654,SAMN02584677,GCA_000651295.1,JLDG00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,101.0,111.0,4407350.0,65.6,4387.0,,4026.0,,,,2010,Moldova,Moldova: Chisinau,,,,,,"Human, Homo sapiens",Male,38,,,,previous tb treatment:smear-positive relapse;host_subject_id:26,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Moldova,primary disease:Tuberculosis,2014-12-08T22:12:13.565Z,2015-03-16T03:17:09.594Z
1448390_3,Mycobacterium tuberculosis TKK_03_0012,Mycobacterium tuberculosis TKK_03_0012,1448390.0,WGS,TKK_03_0012,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235395,SAMN02585885,GCA_000651335.1,JKAF00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48559,,,23.0,23.0,4396200.0,65.6,4350.0,,3986.0,,sputum,,2012,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,46,,,,host_subject_id:007-04-0012;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.018Z,2015-03-16T03:17:09.594Z
1448392_3,Mycobacterium tuberculosis TKK_03_0015,Mycobacterium tuberculosis TKK_03_0015,1448392.0,WGS,TKK_03_0015,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235397,SAMN02585887,GCA_000651355.1,JKAE00000000,-,Broad Institute,WGS,Illumina,109.0x,allpaths v. R48559,,,26.0,26.0,4395423.0,65.6,4331.0,,4009.0,,sputum,,2012,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,49,,,,host_subject_id:007-04-0015;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.029Z,2015-03-16T03:17:09.594Z
1448393_3,Mycobacterium tuberculosis TKK_03_0021,Mycobacterium tuberculosis TKK_03_0021,1448393.0,WGS,TKK_03_0021,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235398,SAMN02585888,GCA_000651375.1,JKAD00000000,-,Broad Institute,WGS,Illumina,112.0x,allpaths v. R48559,,,25.0,25.0,4404885.0,65.6,4343.0,,4021.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,29,,,,host_subject_id:007-04-0021;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:scanty;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.059Z,2015-03-16T03:17:09.594Z
1448394_3,Mycobacterium tuberculosis TKK_03_0023,Mycobacterium tuberculosis TKK_03_0023,1448394.0,WGS,TKK_03_0023,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235399,SAMN02585889,GCA_000651395.1,JKAC00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,10.0,11.0,4411754.0,65.6,4365.0,,4015.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,47,,,,host_subject_id:007-04-0023;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.079Z,2015-03-16T03:17:09.594Z
1448395_3,Mycobacterium tuberculosis TKK_03_0024,Mycobacterium tuberculosis TKK_03_0024,1448395.0,WGS,TKK_03_0024,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235400,SAMN02585890,GCA_000651415.1,JKAB00000000,-,Broad Institute,WGS,Illumina,118.0x,allpaths v. R48559,,,27.0,28.0,4401436.0,65.6,4371.0,,4011.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,38,,,,host_subject_id:007-04-0024;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.088Z,2015-03-16T03:17:09.594Z
1448396_3,Mycobacterium tuberculosis TKK_03_0028,Mycobacterium tuberculosis TKK_03_0028,1448396.0,WGS,TKK_03_0028,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235401,SAMN02585891,GCA_000651435.1,JKAA00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,19.0,19.0,4393843.0,65.6,4355.0,,3990.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,32,,,,host_subject_id:007-04-0028;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:scanty;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.124Z,2015-03-16T03:17:09.594Z
1448397_3,Mycobacterium tuberculosis TKK_03_0035,Mycobacterium tuberculosis TKK_03_0035,1448397.0,WGS,TKK_03_0035,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235402,SAMN02585892,GCA_000651455.1,JJZZ00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,16.0,17.0,4404529.0,65.6,4346.0,,4013.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,31,,,,host_subject_id:007-04-0035;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.178Z,2015-03-16T03:17:09.594Z
1448398_3,Mycobacterium tuberculosis TKK_03_0037,Mycobacterium tuberculosis TKK_03_0037,1448398.0,WGS,TKK_03_0037,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235403,SAMN02585893,GCA_000651475.1,JJZY00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,17.0,18.0,4402224.0,65.6,4355.0,,3994.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,34,,,,host_subject_id:007-04-0037;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:scanty;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.197Z,2015-03-16T03:17:09.594Z
1448399_3,Mycobacterium tuberculosis TKK_03_0038,Mycobacterium tuberculosis TKK_03_0038,1448399.0,WGS,TKK_03_0038,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235404,SAMN02585894,GCA_000651495.1,JJZX00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,24.0,26.0,4414348.0,65.6,4362.0,,4010.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,27,,,,host_subject_id:007-04-0038;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:scanty;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.207Z,2015-03-16T03:17:09.594Z
1448400_3,Mycobacterium tuberculosis TKK_03_0039,Mycobacterium tuberculosis TKK_03_0039,1448400.0,WGS,TKK_03_0039,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235405,SAMN02585895,GCA_000651515.1,JJZW00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,14.0,14.0,4399024.0,65.6,4365.0,,3996.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,23,,,,host_subject_id:007-04-0039;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.216Z,2015-03-16T03:17:09.594Z
1448401_3,Mycobacterium tuberculosis TKK_03_0040,Mycobacterium tuberculosis TKK_03_0040,1448401.0,WGS,TKK_03_0040,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235406,SAMN02585896,GCA_000651535.1,JJZV00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,16.0,16.0,4406850.0,65.6,4353.0,,3995.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,55,,,,host_subject_id:007-04-0040;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.226Z,2015-03-16T03:17:09.594Z
1448402_3,Mycobacterium tuberculosis TKK_03_0042,Mycobacterium tuberculosis TKK_03_0042,1448402.0,WGS,TKK_03_0042,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235407,SAMN02585897,GCA_000651555.1,JJZU00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,14.0,15.0,4391124.0,65.6,4343.0,,4011.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,27,,,,host_subject_id:007-04-0042;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.236Z,2015-03-16T03:17:09.594Z
1448403_3,Mycobacterium tuberculosis TKK_03_0044,Mycobacterium tuberculosis TKK_03_0044,1448403.0,WGS,TKK_03_0044,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235408,SAMN02585898,GCA_000651575.1,JJZT00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,13.0,13.0,4385788.0,65.6,4338.0,,4003.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,25,,,,host_subject_id:007-04-0044;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.256Z,2015-03-16T03:17:09.594Z
1448404_3,Mycobacterium tuberculosis TKK_03_0047,Mycobacterium tuberculosis TKK_03_0047,1448404.0,WGS,TKK_03_0047,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235409,SAMN02585899,GCA_000651595.1,JJZS00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,30.0,30.0,4398066.0,65.6,4374.0,,3995.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,34,,,,host_subject_id:007-04-0047;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.276Z,2015-03-16T03:17:09.594Z
1448405_3,Mycobacterium tuberculosis TKK_03_0050,Mycobacterium tuberculosis TKK_03_0050,1448405.0,WGS,TKK_03_0050,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235410,SAMN02585900,GCA_000651615.1,JJZR00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,14.0,14.0,4417360.0,65.6,4369.0,,4016.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,24,,,,host_subject_id:007-04-0050;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.285Z,2015-03-16T03:17:09.594Z
1448406_3,Mycobacterium tuberculosis TKK_03_0058,Mycobacterium tuberculosis TKK_03_0058,1448406.0,WGS,TKK_03_0058,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235411,SAMN02585901,GCA_000651635.1,JJZQ00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,16.0,16.0,4395638.0,65.6,4364.0,,3994.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:007-04-0058;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.294Z,2015-03-16T03:17:09.594Z
1448407_3,Mycobacterium tuberculosis TKK_03_0059,Mycobacterium tuberculosis TKK_03_0059,1448407.0,WGS,TKK_03_0059,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235412,SAMN02585902,GCA_000651655.1,JJZP00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,9.0,9.0,4409810.0,65.6,4353.0,,4022.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,53,,,,host_subject_id:007-04-0059;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.304Z,2015-03-16T03:17:09.594Z
1448409_3,Mycobacterium tuberculosis TKK_03_0062,Mycobacterium tuberculosis TKK_03_0062,1448409.0,WGS,TKK_03_0062,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235414,SAMN02585904,GCA_000651675.1,JJZO00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,25.0,25.0,4413150.0,65.6,4366.0,,4010.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,25,,,,host_subject_id:007-04-0062;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.312Z,2015-03-16T03:17:09.594Z
1448410_3,Mycobacterium tuberculosis TKK_03_0063,Mycobacterium tuberculosis TKK_03_0063,1448410.0,WGS,TKK_03_0063,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235415,SAMN02585905,GCA_000651695.1,JJZN00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,15.0,15.0,4405060.0,65.6,4342.0,,4000.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,33,,,,host_subject_id:007-04-0063;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.322Z,2015-03-16T03:17:09.594Z
1448411_3,Mycobacterium tuberculosis TKK_03_0064,Mycobacterium tuberculosis TKK_03_0064,1448411.0,WGS,TKK_03_0064,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235416,SAMN02585906,GCA_000651715.1,JJZM00000000,-,Broad Institute,WGS,Illumina,73.0x,allpaths v. R48559,,,78.0,83.0,4392394.0,65.6,4360.0,,4010.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,51,,,,host_subject_id:007-04-0064;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Negative;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.331Z,2015-03-16T03:17:09.594Z
1448412_3,Mycobacterium tuberculosis TKK_03_0065,Mycobacterium tuberculosis TKK_03_0065,1448412.0,WGS,TKK_03_0065,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235417,SAMN02585907,GCA_000651735.1,JJZL00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,12.0,12.0,4394451.0,65.6,4355.0,,3990.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,24,,,,host_subject_id:007-04-0065;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.341Z,2015-03-16T03:17:09.594Z
1448414_3,Mycobacterium tuberculosis TKK_03_0072,Mycobacterium tuberculosis TKK_03_0072,1448414.0,WGS,TKK_03_0072,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235419,SAMN02585909,GCA_000651755.1,JJZK00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,16.0,16.0,4389977.0,65.6,4343.0,,3989.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,37,,,,host_subject_id:007-04-0072;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.350Z,2015-03-16T03:17:09.594Z
1448417_3,Mycobacterium tuberculosis TKK_03_0075,Mycobacterium tuberculosis TKK_03_0075,1448417.0,WGS,TKK_03_0075,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235422,SAMN02585912,GCA_000651775.1,JJZJ00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,16.0,17.0,4394342.0,65.6,4362.0,,3997.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,23,,,,host_subject_id:007-04-0075;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.359Z,2015-03-16T03:17:09.594Z
1448421_3,Mycobacterium tuberculosis TKK_03_0083,Mycobacterium tuberculosis TKK_03_0083,1448421.0,WGS,TKK_03_0083,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235426,SAMN02585916,GCA_000651795.1,JJZI00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,18.0,19.0,4388429.0,65.6,4339.0,,3990.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,33,,,,host_subject_id:007-04-0083;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:Yes;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.396Z,2015-03-16T03:17:09.594Z
1448426_3,Mycobacterium tuberculosis TKK_03_0089,Mycobacterium tuberculosis TKK_03_0089,1448426.0,WGS,TKK_03_0089,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235431,SAMN02585921,GCA_000651815.1,JJZH00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,9.0,9.0,4361515.0,65.6,4307.0,,3984.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,41,,,,host_subject_id:007-04-0089;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:scanty;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.405Z,2015-03-16T03:17:09.594Z
1448427_3,Mycobacterium tuberculosis TKK_03_0090,Mycobacterium tuberculosis TKK_03_0090,1448427.0,WGS,TKK_03_0090,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235432,SAMN02585922,GCA_000651835.1,JJZG00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,22.0,22.0,4387806.0,65.6,4351.0,,3987.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,18,,,,host_subject_id:007-04-0090;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.414Z,2015-03-16T03:17:09.594Z
1448428_3,Mycobacterium tuberculosis TKK_03_0092,Mycobacterium tuberculosis TKK_03_0092,1448428.0,WGS,TKK_03_0092,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235433,SAMN02585923,GCA_000651855.1,JJZF00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,13.0,13.0,4407744.0,65.6,4365.0,,4005.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,25,,,,host_subject_id:007-04-0092;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.423Z,2015-03-16T03:17:09.594Z
1448430_3,Mycobacterium tuberculosis TKK_03_0094,Mycobacterium tuberculosis TKK_03_0094,1448430.0,WGS,TKK_03_0094,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235435,SAMN02585925,GCA_000651875.1,JJZE00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,17.0,17.0,4396795.0,65.6,4363.0,,4016.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,45,,,,host_subject_id:007-04-0094;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:Yes;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.432Z,2015-03-16T03:17:09.594Z
1448431_3,Mycobacterium tuberculosis TKK_03_0096,Mycobacterium tuberculosis TKK_03_0096,1448431.0,WGS,TKK_03_0096,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235436,SAMN02585926,GCA_000651895.1,JJZD00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,28.0,29.0,4413760.0,65.6,4344.0,,4015.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,31,,,,host_subject_id:007-04-0096;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.441Z,2015-03-16T03:17:09.594Z
1448432_3,Mycobacterium tuberculosis TKK_03_0098,Mycobacterium tuberculosis TKK_03_0098,1448432.0,WGS,TKK_03_0098,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235437,SAMN02585927,GCA_000651915.1,JJZC00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,15.0,16.0,4393878.0,65.6,4364.0,,4010.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,41,,,,host_subject_id:007-04-0098;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.450Z,2015-03-16T03:17:09.594Z
1448433_3,Mycobacterium tuberculosis TKK_03_0099,Mycobacterium tuberculosis TKK_03_0099,1448433.0,WGS,TKK_03_0099,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235438,SAMN02585928,GCA_000651935.1,JJZB00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,8.0,8.0,4400463.0,65.6,4358.0,,4002.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,24,,,,host_subject_id:007-04-0099;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.459Z,2015-03-16T03:17:09.594Z
1448434_3,Mycobacterium tuberculosis TKK_03_0100,Mycobacterium tuberculosis TKK_03_0100,1448434.0,WGS,TKK_03_0100,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235439,SAMN02585929,GCA_000651955.1,JJZA00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,18.0,19.0,4397828.0,65.6,4360.0,,3998.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,21,,,,host_subject_id:007-04-0100;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:scanty;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.468Z,2015-03-16T03:17:09.594Z
1448435_3,Mycobacterium tuberculosis TKK_03_0101,Mycobacterium tuberculosis TKK_03_0101,1448435.0,WGS,TKK_03_0101,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235440,SAMN02585930,GCA_000651975.1,JJYZ00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,17.0,18.0,4404058.0,65.6,4351.0,,4002.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,22,,,,host_subject_id:007-04-0101;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.477Z,2015-03-16T03:17:09.594Z
1448436_3,Mycobacterium tuberculosis TKK_03_0102,,1448436.0,WGS,TKK_03_0102,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA235441,SAMN02585931,GCA_000705765.1,JJYY00000000,-,Broad Institute,,Illumina,73.0x,allpaths v. R48559,,,71.0,74.0,4414030.0,65.6,4300.0,,4001.0,,sputum,,2013,South Africa,South Africa: Durban Chest Clinic,,,,,,"Human, Homo sapiens",Female,28,,,,host_subject_id:007-04-0102;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T23:06:59.203Z,2015-03-16T03:17:09.594Z
1448437_3,Mycobacterium tuberculosis TKK_03_0103,Mycobacterium tuberculosis TKK_03_0103,1448437.0,WGS,TKK_03_0103,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235442,SAMN02585932,GCA_000651995.1,JJYX00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,16.0,16.0,4408222.0,65.6,4376.0,,4003.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:007-04-0103;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.487Z,2015-03-16T03:17:09.594Z
1448439_3,Mycobacterium tuberculosis TKK_03_0105,Mycobacterium tuberculosis TKK_03_0105,1448439.0,WGS,TKK_03_0105,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235444,SAMN02585934,GCA_000652015.1,JJYW00000000,-,Broad Institute,WGS,Illumina,99.0x,allpaths v. R48559,,,38.0,40.0,4393941.0,65.6,4353.0,,4006.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,37,,,,host_subject_id:007-04-0105;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.497Z,2015-03-16T03:17:09.594Z
1448440_3,Mycobacterium tuberculosis TKK_03_0106,Mycobacterium tuberculosis TKK_03_0106,1448440.0,WGS,TKK_03_0106,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235445,SAMN02585935,GCA_000652035.1,JJYV00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,18.0,19.0,4413044.0,65.6,4372.0,,4014.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,38,,,,host_subject_id:007-04-0106;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Negative;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:scanty;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.506Z,2015-03-16T03:17:09.594Z
1448442_3,Mycobacterium tuberculosis TKK_03_0108,Mycobacterium tuberculosis TKK_03_0108,1448442.0,WGS,TKK_03_0108,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235447,SAMN02585937,GCA_000652055.1,JJYU00000000,-,Broad Institute,WGS,Illumina,41.0x,allpaths v. R48559,,,55.0,58.0,4393427.0,65.6,4330.0,,3991.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,31,,,,host_subject_id:007-04-0108;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.516Z,2015-03-16T03:17:09.594Z
1448443_3,Mycobacterium tuberculosis TKK_03_0109,Mycobacterium tuberculosis TKK_03_0109,1448443.0,WGS,TKK_03_0109,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235448,SAMN02585938,GCA_000652075.1,JJYT00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,17.0,17.0,4396685.0,65.6,4352.0,,3987.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,34,,,,host_subject_id:007-04-0109;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.525Z,2015-03-16T03:17:09.594Z
1448445_3,Mycobacterium tuberculosis TKK_03_0111,Mycobacterium tuberculosis TKK_03_0111,1448445.0,WGS,TKK_03_0111,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235450,SAMN02585940,GCA_000652095.1,JJYS00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,18.0,19.0,4392155.0,65.6,4366.0,,3985.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,23,,,,host_subject_id:007-04-0111;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.535Z,2015-03-16T03:17:09.594Z
1448446_3,Mycobacterium tuberculosis TKK_03_0112,Mycobacterium tuberculosis TKK_03_0112,1448446.0,WGS,TKK_03_0112,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235451,SAMN02585941,GCA_000652115.1,JJYR00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,18.0,18.0,4395421.0,65.6,4361.0,,3993.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,35,,,,host_subject_id:007-04-0112;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.544Z,2015-03-16T03:17:09.594Z
1448447_3,Mycobacterium tuberculosis TKK_03_0113,Mycobacterium tuberculosis TKK_03_0113,1448447.0,WGS,TKK_03_0113,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235452,SAMN02585942,GCA_000652135.1,JJYQ00000000,-,Broad Institute,WGS,Illumina,18.0x,allpaths v. R48559,,,166.0,172.0,4319171.0,65.5,4316.0,,3987.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,52,,,,host_subject_id:007-04-0113;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:Yes;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.553Z,2015-03-16T03:17:09.594Z
1448448_3,Mycobacterium tuberculosis TKK_03_0114,Mycobacterium tuberculosis TKK_03_0114,1448448.0,WGS,TKK_03_0114,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235453,SAMN02585943,GCA_000652155.1,JJYP00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,19.0,20.0,4387915.0,65.6,4349.0,,3984.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:007-04-0114;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.562Z,2015-03-16T03:17:09.594Z
1448449_3,Mycobacterium tuberculosis TKK_03_0115,Mycobacterium tuberculosis TKK_03_0115,1448449.0,WGS,TKK_03_0115,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235454,SAMN02585944,GCA_000652175.1,JJYO00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,15.0,16.0,4394939.0,65.6,4323.0,,3998.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,25,,,,host_subject_id:007-04-0115;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:Unknown;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.571Z,2015-03-16T03:17:09.594Z
1448450_3,Mycobacterium tuberculosis TKK_03_0116,Mycobacterium tuberculosis TKK_03_0116,1448450.0,WGS,TKK_03_0116,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235455,SAMN02585945,GCA_000652195.1,JJYN00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,34.0,36.0,4432485.0,65.6,4371.0,,4003.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,40,,,,host_subject_id:007-04-0116;treatment course:enrollment;co-morbidity:unknown;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.580Z,2015-03-16T03:17:09.594Z
1448452_3,Mycobacterium tuberculosis TKK_03_0118,Mycobacterium tuberculosis TKK_03_0118,1448452.0,WGS,TKK_03_0118,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235457,SAMN02585947,GCA_000652215.1,JJYM00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,11.0,11.0,4393921.0,65.6,4354.0,,3984.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,45,,,,host_subject_id:007-04-0118;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.589Z,2015-03-16T03:17:09.594Z
1448453_3,Mycobacterium tuberculosis TKK_03_0149,Mycobacterium tuberculosis TKK_03_0149,1448453.0,WGS,TKK_03_0149,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235458,SAMN02585948,GCA_000652235.1,JJYL00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,19.0,19.0,4394833.0,65.6,4363.0,,3992.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,50,,,,host_subject_id:007-04-0149;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.599Z,2015-03-16T03:17:09.594Z
1448454_3,Mycobacterium tuberculosis TKK_03_0150,Mycobacterium tuberculosis TKK_03_0150,1448454.0,WGS,TKK_03_0150,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235459,SAMN02585949,GCA_000652255.1,JJYK00000000,-,Broad Institute,WGS,Illumina,135.0x,allpaths v. R48559,,,19.0,20.0,4395172.0,65.6,4336.0,,4000.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:007-04-0150;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.608Z,2015-03-16T03:17:09.594Z
1448455_3,Mycobacterium tuberculosis TKK_03_0153,Mycobacterium tuberculosis TKK_03_0153,1448455.0,WGS,TKK_03_0153,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235460,SAMN02585950,GCA_000652275.1,JJYJ00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,18.0,18.0,4393805.0,65.6,4320.0,,3994.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,44,,,,host_subject_id:007-04-0153;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.618Z,2015-03-16T03:17:09.594Z
1448456_3,Mycobacterium tuberculosis TKK_03_0154,Mycobacterium tuberculosis TKK_03_0154,1448456.0,WGS,TKK_03_0154,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235461,SAMN02585951,GCA_000652295.1,JJYI00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,16.0,16.0,4398934.0,65.6,4363.0,,3998.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,30,,,,host_subject_id:007-04-0154;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.627Z,2015-03-16T03:17:09.594Z
1448458_3,Mycobacterium tuberculosis TKK_03_0156,Mycobacterium tuberculosis TKK_03_0156,1448458.0,WGS,TKK_03_0156,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235463,SAMN02585953,GCA_000652315.1,JJYH00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,17.0,17.0,4397373.0,65.6,4356.0,,3995.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,24,,,,host_subject_id:007-04-0156;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.636Z,2015-03-16T03:17:09.594Z
1448459_3,Mycobacterium tuberculosis TKK_03_0158,Mycobacterium tuberculosis TKK_03_0158,1448459.0,WGS,TKK_03_0158,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235464,SAMN02585954,GCA_000652335.1,JJYG00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,16.0,16.0,4404451.0,65.6,4347.0,,4007.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,57,,,,host_subject_id:007-04-0158;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:Yes;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.647Z,2015-03-16T03:17:09.594Z
1448460_3,Mycobacterium tuberculosis TKK_03_0159,Mycobacterium tuberculosis TKK_03_0159,1448460.0,WGS,TKK_03_0159,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235465,SAMN02585955,GCA_000652355.1,JJYF00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,7.0,7.0,4399233.0,65.6,4348.0,,3998.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Male,37,,,,host_subject_id:007-04-0159;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:Yes;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.658Z,2015-03-16T03:17:09.594Z
1448461_3,Mycobacterium tuberculosis TKK_03_0160,Mycobacterium tuberculosis TKK_03_0160,1448461.0,WGS,TKK_03_0160,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235466,SAMN02585956,GCA_000652375.1,JJYE00000000,-,Broad Institute,WGS,Illumina,135.0x,allpaths v. R48559,,,19.0,19.0,4395120.0,65.6,4354.0,,3992.0,,sputum,,2013,South Africa,South Africa: Durban,,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:007-04-0160;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:n/a,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:Positive;tb culture 7h11:ND;phenotype:Susceptible;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:19.668Z,2015-03-16T03:17:09.594Z
1448462_3,Mycobacterium tuberculosis TKK_04_0051,Mycobacterium tuberculosis TKK_04_0051,1448462.0,WGS,TKK_04_0051,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235467,SAMN02585957,GCA_000652395.1,JJYD00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,12.0,12.0,4396271.0,65.6,4348.0,,3997.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,38,,,,host_subject_id:NL_051;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.005Z,2015-03-16T03:17:09.594Z
1448463_3,Mycobacterium tuberculosis TKK_04_0054,Mycobacterium tuberculosis TKK_04_0054,1448463.0,WGS,TKK_04_0054,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235468,SAMN02585958,GCA_000652415.1,JJYC00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,13.0,13.0,4396936.0,65.6,4341.0,,3989.0,,sputum,,2011,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,27,,,,host_subject_id:NL_054;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.014Z,2015-03-16T03:17:09.594Z
1448464_3,Mycobacterium tuberculosis TKK_04_0059,Mycobacterium tuberculosis TKK_04_0059,1448464.0,WGS,TKK_04_0059,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235469,SAMN02585959,GCA_000652435.1,JJYB00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,4.0,5.0,4399293.0,65.6,4325.0,,4003.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,67,,,,host_subject_id:NL_059;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:scanty;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.024Z,2015-03-16T03:17:09.594Z
1448465_3,Mycobacterium tuberculosis TKK_04_0060,Mycobacterium tuberculosis TKK_04_0060,1448465.0,WGS,TKK_04_0060,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235470,SAMN02585960,GCA_000652455.1,JJYA00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,6.0,6.0,4398345.0,65.6,4338.0,,4000.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,18,,,,host_subject_id:NL_060;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.034Z,2015-03-16T03:17:09.594Z
1448466_3,Mycobacterium tuberculosis TKK_04_0061,Mycobacterium tuberculosis TKK_04_0061,1448466.0,WGS,TKK_04_0061,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235471,SAMN02585961,GCA_000652475.1,JJXZ00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,14.0,14.0,4413428.0,65.6,4380.0,,4008.0,,sputum,,2013,,,,,,,,"Human, Homo sapiens",Female,49,,,,host_subject_id:NL_061;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.043Z,2015-03-16T03:17:09.594Z
1448467_3,Mycobacterium tuberculosis TKK_04_0062,Mycobacterium tuberculosis TKK_04_0062,1448467.0,WGS,TKK_04_0062,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235472,SAMN02585962,GCA_000658575.1,JJXY00000000,-,Broad Institute,WGS,Illumina,135.0x,allpaths v. R48559,,,2.0,2.0,4397369.0,65.61,4338.0,,3997.0,,sputum,,2013,South Africa,South Africa: Mosvold Hospital,,,,,,"Human, Homo sapiens",Female,29,,,,host_subject_id:NL_062;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.053Z,2015-03-16T03:17:09.594Z
1448468_3,Mycobacterium tuberculosis TKK_04_0063,Mycobacterium tuberculosis TKK_04_0063,1448468.0,WGS,TKK_04_0063,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235473,SAMN02585963,GCA_000652495.1,JJXX00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,15.0,15.0,4389401.0,65.6,4323.0,,3989.0,,sputum,,2013,South Africa,,,,,,,"Human, Homo sapiens",Female,49,,,,host_subject_id:NL_061;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.062Z,2015-03-16T03:17:09.594Z
1448469_3,Mycobacterium tuberculosis TKK_04_0064,Mycobacterium tuberculosis TKK_04_0064,1448469.0,WGS,TKK_04_0064,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235474,SAMN02585964,GCA_000652515.1,JJXW00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,5.0,6.0,4398025.0,65.6,4351.0,,4009.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,42,,,,host_subject_id:NL_064;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.071Z,2015-03-16T03:17:09.594Z
1448470_3,Mycobacterium tuberculosis TKK_04_0066,Mycobacterium tuberculosis TKK_04_0066,1448470.0,WGS,TKK_04_0066,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235475,SAMN02585965,GCA_000652535.1,JJXV00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,7.0,9.0,4405607.0,65.6,4347.0,,4007.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,"Human, Homo sapiens",,,"Human, Homo sapiens",Female,26,,,,host_subject_id:NL_066;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.080Z,2015-03-16T03:17:09.594Z
1448471_3,Mycobacterium tuberculosis TKK_04_0067,Mycobacterium tuberculosis TKK_04_0067,1448471.0,WGS,TKK_04_0067,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235476,SAMN02585966,GCA_000652555.1,JJXU00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,14.0,14.0,4406743.0,65.6,4371.0,,4016.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,37,,,,host_subject_id:NL_067;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.090Z,2015-03-16T03:17:09.594Z
1448472_3,Mycobacterium tuberculosis TKK_04_0068,Mycobacterium tuberculosis TKK_04_0068,1448472.0,WGS,TKK_04_0068,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235477,SAMN02585967,GCA_000652575.1,JJXT00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,11.0,11.0,4389717.0,65.6,4340.0,,3990.0,,sputum,,2012,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,25,,,,host_subject_id:NL_068;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.100Z,2015-03-16T03:17:09.594Z
1448473_3,Mycobacterium tuberculosis TKK_04_0069,Mycobacterium tuberculosis TKK_04_0069,1448473.0,WGS,TKK_04_0069,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235478,SAMN02585968,GCA_000652595.1,JJXS00000000,-,Broad Institute,WGS,Illumina,135.0x,allpaths v. R48559,,,16.0,17.0,4405277.0,65.6,4360.0,,4002.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,19,,,,host_subject_id:NL_069;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.109Z,2015-03-16T03:17:09.594Z
1448474_3,Mycobacterium tuberculosis TKK_04_0070,Mycobacterium tuberculosis TKK_04_0070,1448474.0,WGS,TKK_04_0070,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235479,SAMN02585969,GCA_000652615.1,JJXR00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,6.0,6.0,4394048.0,65.6,4336.0,,3997.0,,Pus,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,31,,,,host_subject_id:NL_070;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.118Z,2015-03-16T03:17:09.594Z
1448475_3,Mycobacterium tuberculosis TKK_04_0071,Mycobacterium tuberculosis TKK_04_0071,1448475.0,WGS,TKK_04_0071,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235480,SAMN02585970,GCA_000652635.1,JJXQ00000000,-,Broad Institute,WGS,Illumina,137.0x,allpaths v. R48559,,,13.0,13.0,4393758.0,65.6,4335.0,,3992.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,21,,,,host_subject_id:NL_071;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.127Z,2015-03-16T03:17:09.594Z
1448476_3,Mycobacterium tuberculosis TKK_04_0072,Mycobacterium tuberculosis TKK_04_0072,1448476.0,WGS,TKK_04_0072,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235481,SAMN02585971,GCA_000652655.1,JJXP00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,13.0,13.0,4407159.0,65.6,4357.0,,4000.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,19,,,,host_subject_id:NL_069;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.136Z,2015-03-16T03:17:09.594Z
1448477_3,Mycobacterium tuberculosis TKK_04_0075,Mycobacterium tuberculosis TKK_04_0075,1448477.0,WGS,TKK_04_0075,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235482,SAMN02585972,GCA_000652675.1,JJXO00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,13.0,13.0,4417113.0,65.6,4381.0,,4008.0,,sputum,,2013,South Africa,,,,,,,"Human, Homo sapiens",Male,33,,,,host_subject_id:NL_075;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.156Z,2015-03-16T03:17:09.594Z
1448478_3,Mycobacterium tuberculosis TKK_04_0078,Mycobacterium tuberculosis TKK_04_0078,1448478.0,WGS,TKK_04_0078,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235483,SAMN02585973,GCA_000652695.1,JJXN00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,3.0,3.0,4401040.0,65.6,4339.0,,4003.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:NL_078;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.165Z,2015-03-16T03:17:09.594Z
1448479_3,Mycobacterium tuberculosis TKK_04_0079,Mycobacterium tuberculosis TKK_04_0079,1448479.0,WGS,TKK_04_0079,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235484,SAMN02585974,GCA_000652715.1,JJXM00000000,-,Broad Institute,WGS,Illumina,135.0x,allpaths v. R48559,,,15.0,15.0,4403526.0,65.6,4352.0,,3999.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,19,,,,host_subject_id:NL_069;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.174Z,2015-03-16T03:17:09.594Z
1448480_3,Mycobacterium tuberculosis TKK_04_0080,Mycobacterium tuberculosis TKK_04_0080,1448480.0,WGS,TKK_04_0080,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235485,SAMN02585975,GCA_000652735.1,JJXL00000000,-,Broad Institute,WGS,Illumina,107.0x,allpaths v. R48559,,,17.0,19.0,4398418.0,65.6,4356.0,,3969.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,29,,,,host_subject_id:NL_080;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:S;rifampicin hain result:R,2014-12-08T22:12:20.183Z,2015-03-16T03:17:09.594Z
1448481_3,Mycobacterium tuberculosis TKK_04_0081,Mycobacterium tuberculosis TKK_04_0081,1448481.0,WGS,TKK_04_0081,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235486,SAMN02585976,GCA_000652755.1,JJXK00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,7.0,7.0,4395655.0,65.6,4335.0,,3998.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,unknown,,,,host_subject_id:NL_081;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.192Z,2015-03-16T03:17:09.594Z
1448482_3,Mycobacterium tuberculosis TKK_04_0082,Mycobacterium tuberculosis TKK_04_0082,1448482.0,WGS,TKK_04_0082,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235487,SAMN02585977,GCA_000652775.1,JJXJ00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,7.0,7.0,4392923.0,65.6,4343.0,,3996.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,14,,,,host_subject_id:NL_082;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.200Z,2015-03-16T03:17:09.594Z
1448483_3,Mycobacterium tuberculosis TKK_04_0083,Mycobacterium tuberculosis TKK_04_0083,1448483.0,WGS,TKK_04_0083,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235488,SAMN02585978,GCA_000652795.1,JJXI00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,7.0,7.0,4399833.0,65.6,4351.0,,4005.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,42,,,,host_subject_id:NL_083;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.210Z,2015-03-16T03:17:09.594Z
1448484_3,Mycobacterium tuberculosis TKK_04_0084,Mycobacterium tuberculosis TKK_04_0084,1448484.0,WGS,TKK_04_0084,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235489,SAMN02585979,GCA_000652815.1,JJXH00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,19.0,19.0,4390088.0,65.6,4347.0,,3987.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,54,,,,host_subject_id:NL_084;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:S;rifampicin hain result:R,2014-12-08T22:12:20.221Z,2015-03-16T03:17:09.594Z
1448485_3,Mycobacterium tuberculosis TKK_04_0086,Mycobacterium tuberculosis TKK_04_0086,1448485.0,WGS,TKK_04_0086,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235490,SAMN02585980,GCA_000652835.1,JJXG00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,17.0,18.0,4389734.0,65.6,4354.0,,3986.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:NL_086;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:scanty;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.240Z,2015-03-16T03:17:09.594Z
1448488_3,Mycobacterium tuberculosis TKK_05MA_0004,Mycobacterium tuberculosis TKK_05MA_0004,1448488.0,WGS,TKK_05MA_0004,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235493,SAMN02585983,GCA_000652875.1,JJXE00000000,-,Broad Institute,WGS,Illumina,72.0x,allpaths v. R48559,,,78.0,85.0,4388156.0,65.6,4360.0,,4019.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,18,,,,host_subject_id:023-06-0004;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.661Z,2015-03-16T03:17:09.594Z
1448490_3,Mycobacterium tuberculosis TKK_05MA_0009,Mycobacterium tuberculosis TKK_05MA_0009,1448490.0,WGS,TKK_05MA_0009,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235495,SAMN02585985,GCA_000658595.1,JJXD00000000,-,Broad Institute,WGS,Illumina,47.0x,allpaths v. R48559,,,65.0,71.0,4388963.0,65.6,4351.0,,4021.0,,sputum,,2013,South Africa,South Africa: King Dinuzulu Hospital,,,,,,"Human, Homo sapiens",Male,37,,,,host_subject_id:023-06-0009;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible;Intermediate,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.672Z,2015-03-16T03:17:09.594Z
1448491_3,Mycobacterium tuberculosis TKK_05MA_0010,Mycobacterium tuberculosis TKK_05MA_0010,1448491.0,WGS,TKK_05MA_0010,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235496,SAMN02585986,GCA_000652895.1,JJXC00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,72.0,73.0,4446768.0,65.6,4367.0,,4011.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,47,,,,host_subject_id:023-06-0010;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.681Z,2015-03-16T03:17:09.594Z
1448492_3,Mycobacterium tuberculosis TKK_05MA_0011,Mycobacterium tuberculosis TKK_05MA_0011,1448492.0,WGS,TKK_05MA_0011,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235497,SAMN02585987,GCA_000652915.1,JJXB00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,65.0,68.0,4428834.0,65.6,4379.0,,4029.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,27,,,,host_subject_id:023-06-0011;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.690Z,2015-03-16T03:17:09.594Z
1448495_3,Mycobacterium tuberculosis TKK_05MA_0016,Mycobacterium tuberculosis TKK_05MA_0016,1448495.0,WGS,TKK_05MA_0016,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235500,SAMN02585990,GCA_000652955.1,JJWZ00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,74.0,79.0,4391193.0,65.6,4361.0,,4019.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,40,,,,host_subject_id:023-06-0016;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.707Z,2015-03-16T03:17:09.594Z
1448497_3,Mycobacterium tuberculosis TKK_05MA_0018,Mycobacterium tuberculosis TKK_05MA_0018,1448497.0,WGS,TKK_05MA_0018,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235502,SAMN02585992,GCA_000652995.1,JJWX00000000,-,Broad Institute,WGS,Illumina,72.0x,allpaths v. R48559,,,68.0,72.0,4390335.0,65.6,4353.0,,3992.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,49,,,,host_subject_id:023-06-0018;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.725Z,2015-03-16T03:17:09.594Z
1448498_3,Mycobacterium tuberculosis TKK_05MA_0020,Mycobacterium tuberculosis TKK_05MA_0020,1448498.0,WGS,TKK_05MA_0020,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235503,SAMN02585993,GCA_000653015.1,JJWW00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,78.0,85.0,4394253.0,65.6,4339.0,,4014.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,31,,,,host_subject_id:023-06-0020;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.734Z,2015-03-16T03:17:09.594Z
1448501_3,Mycobacterium tuberculosis TKK_05MA_0025,Mycobacterium tuberculosis TKK_05MA_0025,1448501.0,WGS,TKK_05MA_0025,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235506,SAMN02585996,GCA_000653035.1,JJWV00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,83.0,86.0,4403792.0,65.6,4367.0,,4011.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,42,,,,host_subject_id:023-06-0025;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.743Z,2015-03-16T03:17:09.594Z
1448505_3,Mycobacterium tuberculosis TKK_05MA_0033,Mycobacterium tuberculosis TKK_05MA_0033,1448505.0,WGS,TKK_05MA_0033,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235510,SAMN02586000,GCA_000653095.1,JJWS00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,74.0,82.0,4381534.0,65.6,4346.0,,4001.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,28,,,,host_subject_id:023-06-0033;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.771Z,2015-03-16T03:17:09.594Z
1448506_3,Mycobacterium tuberculosis TKK_05MA_0035,Mycobacterium tuberculosis TKK_05MA_0035,1448506.0,WGS,TKK_05MA_0035,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235511,SAMN02586001,GCA_000653115.1,JJWR00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,73.0,80.0,4386788.0,65.6,4348.0,,4015.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,37,,,,host_subject_id:023-06-0035;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.781Z,2015-03-16T03:17:09.594Z
1448508_3,Mycobacterium tuberculosis TKK_05MA_0037,Mycobacterium tuberculosis TKK_05MA_0037,1448508.0,WGS,TKK_05MA_0037,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235513,SAMN02586003,GCA_000653155.1,JJWP00000000,-,Broad Institute,WGS,Illumina,72.0x,allpaths v. R48559,,,65.0,71.0,4337481.0,65.6,4316.0,,3978.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,24,,,,host_subject_id:023-06-0037;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.799Z,2015-03-16T03:17:09.594Z
1448509_3,Mycobacterium tuberculosis TKK_05MA_0040,Mycobacterium tuberculosis TKK_05MA_0040,1448509.0,WGS,TKK_05MA_0040,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235514,SAMN02586004,GCA_000653175.1,JJWO00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,76.0,82.0,4389620.0,65.6,4337.0,,4000.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,34,,,,host_subject_id:023-06-0040;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.808Z,2015-03-16T03:17:09.594Z
1448512_3,Mycobacterium tuberculosis TKK_05MA_0044,Mycobacterium tuberculosis TKK_05MA_0044,1448512.0,WGS,TKK_05MA_0044,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235517,SAMN02586007,GCA_000653195.1,JJWN00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,72.0,76.0,4398326.0,65.6,4335.0,,4009.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,32,,,,host_subject_id:023-06-0044;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.817Z,2015-03-16T03:17:09.594Z
1448513_3,Mycobacterium tuberculosis TKK_05MA_0046,Mycobacterium tuberculosis TKK_05MA_0046,1448513.0,WGS,TKK_05MA_0046,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235518,SAMN02586008,GCA_000653215.1,JJWM00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,86.0,90.0,4372338.0,65.6,4353.0,,3983.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,31,,,,host_subject_id:023-06-0046;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.827Z,2015-03-16T03:17:09.594Z
1448514_3,Mycobacterium tuberculosis TKK_05MA_0048,Mycobacterium tuberculosis TKK_05MA_0048,1448514.0,WGS,TKK_05MA_0048,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235519,SAMN02586009,GCA_000653235.1,JJWL00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,64.0,67.0,4415165.0,65.6,4345.0,,4030.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,52,,,,host_subject_id:023-06-0048;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.836Z,2015-03-16T03:17:09.594Z
1448516_3,Mycobacterium tuberculosis TKK_05MA_0051,Mycobacterium tuberculosis TKK_05MA_0051,1448516.0,WGS,TKK_05MA_0051,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235521,SAMN02586011,GCA_000658615.1,JJWK00000000,-,Broad Institute,WGS,Illumina,68.0x,allpaths v. R48559,,,59.0,62.0,4429561.0,65.61,4372.0,,4034.0,,sputum,,2013,South Africa,South Africa: King Dinuzulu Hospital,,,,,,"Human, Homo sapiens",Female,21,,,,host_subject_id:023-06-0051;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.845Z,2015-03-16T03:17:09.594Z
1448517_3,Mycobacterium tuberculosis TKK_05MA_0052,Mycobacterium tuberculosis TKK_05MA_0052,1448517.0,WGS,TKK_05MA_0052,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235522,SAMN02586012,GCA_000653255.1,JJWJ00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,82.0,87.0,4378190.0,65.6,4346.0,,3981.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,44,,,,host_subject_id:023-06-0052;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.863Z,2015-03-16T03:17:09.594Z
1448519_3,Mycobacterium tuberculosis TKK_05MA_0055,,1448519.0,WGS,TKK_05MA_0055,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA235524,SAMN02586014,GCA_000705745.1,JJWI00000000,-,Broad Institute,,Illumina,85.0x,allpaths v. R48559,,,68.0,71.0,4424410.0,65.6,4312.0,,4024.0,,sputum,,2013,South Africa,South Africa: King Dinuzulu Hospital,,,,,,"Human, Homo sapiens",Male,35,,,,host_subject_id:023-06-0055;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T23:07:00.013Z,2015-03-16T03:17:09.594Z
1448522_3,Mycobacterium tuberculosis TKK_05MA_2005,Mycobacterium tuberculosis TKK_05MA_2005,1448522.0,WGS,TKK_05MA_2005,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235527,SAMN02586017,GCA_000653315.1,JJWF00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,4.0,4.0,4400930.0,65.6,4339.0,,4001.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,29,,,,host_subject_id:023-06-2005;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;microscopy ziehl-neelsen:Positive;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.894Z,2015-03-16T03:17:09.594Z
1448523_3,Mycobacterium tuberculosis TKK_05MA_2008,Mycobacterium tuberculosis TKK_05MA_2008,1448523.0,WGS,TKK_05MA_2008,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235528,SAMN02586018,GCA_000653335.1,JJWE00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,4.0,5.0,4399452.0,65.6,4340.0,,4001.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,43,,,,host_subject_id:023-06-2008;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:Positive;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.911Z,2015-03-16T03:17:09.594Z
1448524_3,Mycobacterium tuberculosis TKK_05MA_2015,Mycobacterium tuberculosis TKK_05MA_2015,1448524.0,WGS,TKK_05MA_2015,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235529,SAMN02586019,GCA_000653355.1,JJWD00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,66.0,71.0,4379939.0,65.6,4348.0,,3999.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,43,,,,host_subject_id:023-06-2015;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.921Z,2015-03-16T03:17:09.594Z
1448526_3,Mycobacterium tuberculosis TKK_05SA_0010,Mycobacterium tuberculosis TKK_05SA_0010,1448526.0,WGS,TKK_05SA_0010,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235531,SAMN02586021,GCA_000653375.1,JJWC00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,77.0,79.0,4443530.0,65.6,4395.0,,4014.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,47,,,,host_subject_id:023-06-0010;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.933Z,2015-03-16T03:17:09.594Z
1448527_3,Mycobacterium tuberculosis TKK_05SA_0011,Mycobacterium tuberculosis TKK_05SA_0011,1448527.0,WGS,TKK_05SA_0011,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235532,SAMN02586022,GCA_000658635.1,JJWB00000000,-,Broad Institute,WGS,Illumina,76.0x,allpaths v. R48559,,,59.0,63.0,4412964.0,65.62,4355.0,,4012.0,,sputum,,2013,South Africa,South Africa: King Dinuzulu Hospital,,,,,,"Human, Homo sapiens",Male,27,,,,host_subject_id:023-06-0011;treatment course:enrollment;co-morbidity:Negative;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible;Intermediate,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.943Z,2015-03-16T03:17:09.594Z
1448529_3,Mycobacterium tuberculosis TKK_05SA_0014,Mycobacterium tuberculosis TKK_05SA_0014,1448529.0,WGS,TKK_05SA_0014,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235534,SAMN02586024,GCA_000653415.1,JJVZ00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,71.0,80.0,4341933.0,65.6,4322.0,,3982.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,39,,,,host_subject_id:023-06-0014;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.961Z,2015-03-16T03:17:09.594Z
1448530_3,Mycobacterium tuberculosis TKK_05SA_0016,Mycobacterium tuberculosis TKK_05SA_0016,1448530.0,WGS,TKK_05SA_0016,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235535,SAMN02586025,GCA_000653435.1,JJVY00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,73.0,79.0,4388824.0,65.6,4362.0,,4021.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,40,,,,host_subject_id:023-06-0016;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.971Z,2015-03-16T03:17:09.594Z
1448532_3,Mycobacterium tuberculosis TKK_05SA_0018,Mycobacterium tuberculosis TKK_05SA_0018,1448532.0,WGS,TKK_05SA_0018,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235537,SAMN02586027,GCA_000653475.1,JJVW00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,67.0,73.0,4387250.0,65.6,4350.0,,3987.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,49,,,,host_subject_id:023-06-0018;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.990Z,2015-03-16T03:17:09.594Z
1448533_3,Mycobacterium tuberculosis TKK_05SA_0019,Mycobacterium tuberculosis TKK_05SA_0019,1448533.0,WGS,TKK_05SA_0019,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235538,SAMN02586028,GCA_000653495.1,JJVV00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,83.0,87.0,4378276.0,65.6,4353.0,,3979.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,31,,,,host_subject_id:023-06-0019;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:21Z,2015-03-16T03:17:09.594Z
1448535_3,Mycobacterium tuberculosis TKK_05SA_0021,Mycobacterium tuberculosis TKK_05SA_0021,1448535.0,WGS,TKK_05SA_0021,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235540,SAMN02586030,GCA_000653515.1,JJVT00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,67.0,70.0,4393683.0,65.6,4345.0,,3989.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,30,,,,host_subject_id:023-06-0021;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:21.009Z,2015-03-16T03:17:09.594Z
1448537_3,Mycobacterium tuberculosis TKK_05SA_0024,,1448537.0,WGS,TKK_05SA_0024,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA235542,SAMN02586032,GCA_000705725.1,JJVR00000000,-,Broad Institute,,Illumina,89.0x,allpaths v. R48559,,,86.0,87.0,4423260.0,65.6,4311.0,,4018.0,,sputum,,2013,South Africa,South Africa: King Dinuzulu Hospital,,,,,,"Human, Homo sapiens",Male,36,,,,host_subject_id:023-06-0024;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T23:07:00.548Z,2015-03-16T03:17:09.594Z
1448538_3,Mycobacterium tuberculosis TKK_05SA_0025,Mycobacterium tuberculosis TKK_05SA_0025,1448538.0,WGS,TKK_05SA_0025,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235543,SAMN02586033,GCA_000653555.1,JJVQ00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,70.0,74.0,4434398.0,65.6,4386.0,,4028.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,42,,,,host_subject_id:023-06-0025;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:21.028Z,2015-03-16T03:17:09.594Z
1448544_3,Mycobacterium tuberculosis TKK_05SA_0041,Mycobacterium tuberculosis TKK_05SA_0041,1448544.0,WGS,TKK_05SA_0041,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235549,SAMN02586039,GCA_000653615.1,JJVM00000000,-,Broad Institute,WGS,Illumina,73.0x,allpaths v. R48559,,,67.0,72.0,4398179.0,65.6,4353.0,,4012.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:023-06-0041;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:21.065Z,2015-03-16T03:17:09.594Z
1448545_3,Mycobacterium tuberculosis TKK_05SA_0042,Mycobacterium tuberculosis TKK_05SA_0042,1448545.0,WGS,TKK_05SA_0042,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235550,SAMN02586040,GCA_000653635.1,JJVL00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,68.0,73.0,4388637.0,65.6,4346.0,,4000.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,38,,,,host_subject_id:023-06-0042;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Pre-XDR TB (KAN Susceptible);microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:21.075Z,2015-03-16T03:17:09.594Z
1448546_3,Mycobacterium tuberculosis TKK_05SA_0043,Mycobacterium tuberculosis TKK_05SA_0043,1448546.0,WGS,TKK_05SA_0043,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235551,SAMN02586041,GCA_000653655.1,JJVK00000000,-,Broad Institute,WGS,Illumina,65.0x,allpaths v. R48559,,,2.0,2.0,4399244.0,65.6,4353.0,,4001.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,38,,,,host_subject_id:023-06-0043;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:21.084Z,2015-03-16T03:17:09.594Z
1448547_3,Mycobacterium tuberculosis TKK_05SA_0044,Mycobacterium tuberculosis TKK_05SA_0044,1448547.0,WGS,TKK_05SA_0044,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235552,SAMN02586042,GCA_000653675.1,JJVJ00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,68.0,73.0,4407176.0,65.6,4370.0,,4016.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,32,,,,host_subject_id:023-06-0044;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:21.094Z,2015-03-16T03:17:09.594Z
1448548_3,Mycobacterium tuberculosis TKK_05SA_0046,Mycobacterium tuberculosis TKK_05SA_0046,1448548.0,WGS,TKK_05SA_0046,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235553,SAMN02586043,GCA_000653695.1,JJVI00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,81.0,86.0,4372836.0,65.6,4359.0,,3983.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,31,,,,host_subject_id:023-06-0046;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:21.104Z,2015-03-16T03:17:09.594Z
1448550_3,Mycobacterium tuberculosis TKK_05SA_0048,Mycobacterium tuberculosis TKK_05SA_0048,1448550.0,WGS,TKK_05SA_0048,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235555,SAMN02586045,GCA_000653735.1,JJVG00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R48559,,,72.0,76.0,4390775.0,65.6,4360.0,,3997.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,52,,,,host_subject_id:023-06-0048;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:21.121Z,2015-03-16T03:17:09.594Z
1448551_3,Mycobacterium tuberculosis TKK_05SA_0050,Mycobacterium tuberculosis TKK_05SA_0050,1448551.0,WGS,TKK_05SA_0050,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235556,SAMN02586046,GCA_000653755.1,JJVF00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,80.0,87.0,4395479.0,65.6,4370.0,,4007.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,44,,,,host_subject_id:023-06-0050;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:21.131Z,2015-03-16T03:17:09.594Z
1448552_3,Mycobacterium tuberculosis TKK_05SA_0052,Mycobacterium tuberculosis TKK_05SA_0052,1448552.0,WGS,TKK_05SA_0052,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235557,SAMN02586047,GCA_000653775.1,JJVE00000000,-,Broad Institute,WGS,Illumina,65.0x,allpaths v. R48559,,,82.0,87.0,4374326.0,65.6,4360.0,,3980.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,44,,,,host_subject_id:023-06-0052;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:21.140Z,2015-03-16T03:17:09.594Z
1448554_3,Mycobacterium tuberculosis TKK_05SA_0054,Mycobacterium tuberculosis TKK_05SA_0054,1448554.0,WGS,TKK_05SA_0054,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235559,SAMN02586049,GCA_000653795.1,JJVD00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,70.0,77.0,4393037.0,65.6,4369.0,,4016.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,36,,,,host_subject_id:023-06-0054;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:Yes;previous mdr-tx:Yes;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:21.149Z,2015-03-16T03:17:09.594Z
1448555_3,Mycobacterium tuberculosis TKK_05SA_0055,Mycobacterium tuberculosis TKK_05SA_0055,1448555.0,WGS,TKK_05SA_0055,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235560,SAMN02586050,GCA_000653815.1,JJVC00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,69.0,70.0,4429814.0,65.6,4369.0,,4011.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,35,,,,host_subject_id:023-06-0055;treatment course:enrollment;co-morbidity:Positive;previous tb treatment:No;previous mdr-tx:n/a;previous drug susceptible tb tx:No,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:21.159Z,2015-03-16T03:17:09.594Z
1448559_3,Mycobacterium tuberculosis TKK_04_0074,Mycobacterium tuberculosis TKK_04_0074,1448559.0,WGS,TKK_04_0074,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235564,SAMN02586054,GCA_000653855.1,JJVA00000000,-,Broad Institute,WGS,Illumina,69.0x,allpaths v. R48559,,,71.0,75.0,4396073.0,65.6,4344.0,,4018.0,,sputum,,2013,South Africa,,,,,,,"Human, Homo sapiens",Female,29,,,,host_subject_id:NL_074;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.146Z,2015-03-16T03:17:09.594Z
1448560_3,Mycobacterium tuberculosis TKK_04_0085,Mycobacterium tuberculosis TKK_04_0085,1448560.0,WGS,TKK_04_0085,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235565,SAMN02586055,GCA_000653875.1,JJUZ00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,74.0,82.0,4394295.0,65.6,4353.0,,3979.0,,sputum,,2013,,,,,,,,"Human, Homo sapiens",Female,22,,,,host_subject_id:NL_085;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:2+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:S;rifampicin hain result:R,2014-12-08T22:12:20.230Z,2015-03-16T03:17:09.594Z
1448561_3,Mycobacterium tuberculosis TKK_04_0089,Mycobacterium tuberculosis TKK_04_0089,1448561.0,WGS,TKK_04_0089,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235566,SAMN02586056,GCA_000653895.1,JJUY00000000,-,Broad Institute,WGS,Illumina,70.0x,allpaths v. R48559,,,84.0,88.0,4376248.0,65.6,4344.0,,3983.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,43,,,,host_subject_id:NL_089;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:S;rifampicin hain result:R,2014-12-08T22:12:20.250Z,2015-03-16T03:17:09.594Z
1448562_3,Mycobacterium tuberculosis TKK_04_0090,Mycobacterium tuberculosis TKK_04_0090,1448562.0,WGS,TKK_04_0090,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235567,SAMN02586057,GCA_000653915.1,JJUX00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,64.0,67.0,4413652.0,65.6,4358.0,,4017.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,32,,,,host_subject_id:NL_090;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.259Z,2015-03-16T03:17:09.594Z
1448563_3,Mycobacterium tuberculosis TKK_04_0094,Mycobacterium tuberculosis TKK_04_0094,1448563.0,WGS,TKK_04_0094,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235568,SAMN02586058,GCA_000653935.1,JJUW00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,67.0,68.0,4448258.0,65.6,4387.0,,4017.0,,sputum,,2013,Scotland,Scotland: Dundee,,,,,,"Human, Homo sapiens",Female,15,,,,host_subject_id:NL_094;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:S;rifampicin hain result:R,2014-12-08T22:12:20.269Z,2015-03-16T03:17:09.594Z
1448564_3,Mycobacterium tuberculosis TKK_04_0095,Mycobacterium tuberculosis TKK_04_0095,1448564.0,WGS,TKK_04_0095,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235569,SAMN02586059,GCA_000658695.1,JJUV00000000,-,Broad Institute,WGS,Illumina,65.0x,allpaths v. R48559,,,61.0,61.0,4444263.0,65.6,4418.0,,4022.0,,sputum,,2013,South Africa,South Africa: Edendale Hospital,,,,,,"Human, Homo sapiens",Female,34,,,,host_subject_id:NL_095;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.278Z,2015-03-16T03:17:09.594Z
1448565_3,Mycobacterium tuberculosis TKK_04_0096,Mycobacterium tuberculosis TKK_04_0096,1448565.0,WGS,TKK_04_0096,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235570,SAMN02586060,GCA_000653955.1,JJUU00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,66.0,69.0,4409910.0,65.6,4361.0,,4027.0,,sputum,,2013,South Africa,,,,,,,"Human, Homo sapiens",Female,43,,,,host_subject_id:NL_096;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.287Z,2015-03-16T03:17:09.594Z
1448567_3,Mycobacterium tuberculosis TKK_04_0098,Mycobacterium tuberculosis TKK_04_0098,1448567.0,WGS,TKK_04_0098,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235572,SAMN02586062,GCA_000653975.1,JJUS00000000,-,Broad Institute,WGS,Illumina,63.0x,allpaths v. R48559,,,86.0,92.0,4371298.0,65.6,4342.0,,3976.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,32,,,,host_subject_id:NL_098;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:S;rifampicin hain result:R,2014-12-08T22:12:20.297Z,2015-03-16T03:17:09.594Z
1448568_3,Mycobacterium tuberculosis TKK_04_0099,Mycobacterium tuberculosis TKK_04_0099,1448568.0,WGS,TKK_04_0099,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235573,SAMN02586063,GCA_000653995.1,JJUR00000000,-,Broad Institute,WGS,Illumina,72.0x,allpaths v. R48559,,,6.0,6.0,4400332.0,65.6,4344.0,,4010.0,,sputum,,2013,South Africa,,,,,,,"Human, Homo sapiens",Female,8,,,,host_subject_id:NL_099;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.305Z,2015-03-16T03:17:09.594Z
1448569_3,Mycobacterium tuberculosis TKK_04_0103,Mycobacterium tuberculosis TKK_04_0103,1448569.0,WGS,TKK_04_0103,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235574,SAMN02586064,GCA_000654015.1,JJUQ00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,66.0,71.0,4386603.0,65.6,4358.0,,3987.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,36,,,,host_subject_id:NL_103;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.313Z,2015-03-16T03:17:09.594Z
1448570_3,Mycobacterium tuberculosis TKK_04_0105,Mycobacterium tuberculosis TKK_04_0105,1448570.0,WGS,TKK_04_0105,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235575,SAMN02586065,GCA_000654035.1,JJUP00000000,-,Broad Institute,WGS,Illumina,76.0x,allpaths v. R48559,,,7.0,7.0,4395378.0,65.6,4333.0,,3997.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:NL_105;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.330Z,2015-03-16T03:17:09.594Z
1448571_3,Mycobacterium tuberculosis TKK_04_0106,Mycobacterium tuberculosis TKK_04_0106,1448571.0,WGS,TKK_04_0106,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235576,SAMN02586066,GCA_000654055.1,JJUO00000000,-,Broad Institute,WGS,Illumina,73.0x,allpaths v. R48559,,,5.0,6.0,4398799.0,65.6,4338.0,,4002.0,,sputum,,2013,,,,,,,,"Human, Homo sapiens",Male,33,,,,host_subject_id:NL_106;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.338Z,2015-03-16T03:17:09.594Z
1448572_3,Mycobacterium tuberculosis TKK_04_0107,Mycobacterium tuberculosis TKK_04_0107,1448572.0,WGS,TKK_04_0107,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235577,SAMN02586067,GCA_000654075.1,JJUN00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R48559,,,76.0,81.0,4371956.0,65.6,4346.0,,3972.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,38,,,,host_subject_id:NL_107;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.346Z,2015-03-16T03:17:09.594Z
1448573_3,Mycobacterium tuberculosis TKK_04_0108,Mycobacterium tuberculosis TKK_04_0108,1448573.0,WGS,TKK_04_0108,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235578,SAMN02586068,GCA_000658735.1,JJUM00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,61.0,61.0,4421391.0,65.61,4387.0,,4014.0,,sputum,,2013,South Africa,South Africa: Chwezi Clinic,,,,,,"Human, Homo sapiens",Female,30,,,,host_subject_id:NL_108;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.354Z,2015-03-16T03:17:09.594Z
1448574_3,Mycobacterium tuberculosis TKK_04_0109,Mycobacterium tuberculosis TKK_04_0109,1448574.0,WGS,TKK_04_0109,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235579,SAMN02586069,GCA_000654095.1,JJUL00000000,-,Broad Institute,WGS,Illumina,69.0x,allpaths v. R48559,,,3.0,3.0,4400052.0,65.6,4349.0,,4001.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,"Human, Homo sapiens",,,"Human, Homo sapiens",Male,38,,,,host_subject_id:NL_109;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.363Z,2015-03-16T03:17:09.594Z
1448575_3,Mycobacterium tuberculosis TKK_04_0112,Mycobacterium tuberculosis TKK_04_0112,1448575.0,WGS,TKK_04_0112,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235580,SAMN02586070,GCA_000658755.1,JJUK00000000,-,Broad Institute,WGS,Illumina,69.0x,allpaths v. R48559,,,56.0,56.0,4425475.0,65.61,4355.0,,4004.0,,sputum,,2013,South Africa,South Africa: King Dinuzulu Hospital,,,,,,"Human, Homo sapiens",Male,unknown,,,,host_subject_id:NL_112;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.372Z,2015-03-16T03:17:09.594Z
1448576_3,Mycobacterium tuberculosis TKK_04_0113,Mycobacterium tuberculosis TKK_04_0113,1448576.0,WGS,TKK_04_0113,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235581,SAMN02586071,GCA_000654115.1,JJUJ00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,68.0,74.0,4384917.0,65.6,4334.0,,3985.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,"Human, Homo sapiens",,,"Human, Homo sapiens",Male,36,,,,host_subject_id:NL_113;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.381Z,2015-03-16T03:17:09.594Z
1448577_3,Mycobacterium tuberculosis TKK_04_0114,Mycobacterium tuberculosis TKK_04_0114,1448577.0,WGS,TKK_04_0114,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235582,SAMN02586072,GCA_000654135.1,JJUI00000000,-,Broad Institute,WGS,Illumina,78.0x,allpaths v. R48559,,,75.0,81.0,4366289.0,65.6,4341.0,,3978.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,34,,,,host_subject_id:NL_114;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:1+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.390Z,2015-03-16T03:17:09.594Z
1448579_3,Mycobacterium tuberculosis TKK_04_0117,Mycobacterium tuberculosis TKK_04_0117,1448579.0,WGS,TKK_04_0117,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235584,SAMN02586074,GCA_000654155.1,JJUH00000000,-,Broad Institute,WGS,Illumina,59.0x,allpaths v. R48559,,,3.0,3.0,4398181.0,65.6,4345.0,,4001.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,27,,,,host_subject_id:NL_117;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.399Z,2015-03-16T03:17:09.594Z
1448580_3,Mycobacterium tuberculosis TKK_04_0118,Mycobacterium tuberculosis TKK_04_0118,1448580.0,WGS,TKK_04_0118,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235585,SAMN02586075,GCA_000658775.1,JJUG00000000,-,Broad Institute,WGS,Illumina,57.0x,allpaths v. R48559,,,51.0,51.0,4422221.0,65.61,4357.0,,4023.0,,sputum,,2013,South Africa,South Africa: Christ The King Hospital,,,,,,"Human, Homo sapiens",Male,44,,,,host_subject_id:NL_118;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.409Z,2015-03-16T03:17:09.594Z
1448582_3,Mycobacterium tuberculosis TKK_04_0120,Mycobacterium tuberculosis TKK_04_0120,1448582.0,WGS,TKK_04_0120,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235587,SAMN02586077,GCA_000654175.1,JJUF00000000,-,Broad Institute,WGS,Illumina,95.0x,allpaths v. R48559,,,57.0,60.0,4400143.0,65.6,4363.0,,3975.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,56,,,,host_subject_id:NL_120;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.420Z,2015-03-16T03:17:09.594Z
1448584_3,Mycobacterium tuberculosis TKK_04_0122,Mycobacterium tuberculosis TKK_04_0122,1448584.0,WGS,TKK_04_0122,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235589,SAMN02586079,GCA_000654195.1,JJUE00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,5.0,5.0,4405980.0,65.6,4339.0,,4000.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,32,,,,host_subject_id:NL_122;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.431Z,2015-03-16T03:17:09.594Z
1448585_3,Mycobacterium tuberculosis TKK_04_0123,Mycobacterium tuberculosis TKK_04_0123,1448585.0,WGS,TKK_04_0123,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235590,SAMN02586080,GCA_000654215.1,JJUD00000000,-,Broad Institute,WGS,Illumina,132.0x,allpaths v. R48559,,,3.0,3.0,4399511.0,65.6,4352.0,,4001.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,40,,,,host_subject_id:NL_123;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.441Z,2015-03-16T03:17:09.594Z
1448586_3,Mycobacterium tuberculosis TKK_04_0124,,1448586.0,WGS,TKK_04_0124,,,,,,,,2014-06-13T00:00:00Z,-,PRJNA235591,SAMN02586081,GCA_000706565.1,JJUC00000000,-,Broad Institute,,Illumina,135.0x,allpaths v. R48559,,,1.0,1.0,4409530.0,65.6,4295.0,,4002.0,,sputum,,,,,,,,,,,Female,unknown,,,,host_subject_id:NL_124;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T23:07:01.102Z,2015-03-16T03:17:09.594Z
1448587_3,Mycobacterium tuberculosis TKK_04_0125,Mycobacterium tuberculosis TKK_04_0125,1448587.0,WGS,TKK_04_0125,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235592,SAMN02586082,GCA_000656695.1,JJUB00000000,-,Broad Institute,WGS,Illumina,135.0x,allpaths v. R48559,,,16.0,16.0,4389212.0,65.6,4327.0,,4004.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,22,,,,host_subject_id:NL_125;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (Oflox Susceptible);microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.450Z,2015-03-16T03:17:09.594Z
1448588_3,Mycobacterium tuberculosis TKK_04_0126,Mycobacterium tuberculosis TKK_04_0126,1448588.0,WGS,TKK_04_0126,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235593,SAMN02586083,GCA_000656715.1,JJUA00000000,-,Broad Institute,WGS,Illumina,134.0x,allpaths v. R48559,,,20.0,20.0,4394989.0,65.6,4376.0,,3990.0,,Sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,28,,,,host_subject_id:NL_126;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (Oflox Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.460Z,2015-03-16T03:17:09.594Z
1448589_3,Mycobacterium tuberculosis TKK_04_0129,Mycobacterium tuberculosis TKK_04_0129,1448589.0,WGS,TKK_04_0129,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235594,SAMN02586084,GCA_000656735.1,JJTZ00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,2.0,2.0,4411212.0,65.7,4359.0,,4002.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,41,,,,host_subject_id:NL_129;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.469Z,2015-03-16T03:17:09.594Z
1448590_3,Mycobacterium tuberculosis TKK_04_0130,Mycobacterium tuberculosis TKK_04_0130,1448590.0,WGS,TKK_04_0130,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235595,SAMN02586085,GCA_000656755.1,JJTY00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,3.0,3.0,4399881.0,65.6,4338.0,,3998.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,36,,,,host_subject_id:NL_130;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.479Z,2015-03-16T03:17:09.594Z
1448591_3,Mycobacterium tuberculosis TKK_04_0131,Mycobacterium tuberculosis TKK_04_0131,1448591.0,WGS,TKK_04_0131,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235596,SAMN02586086,GCA_000656775.1,JJTX00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,75.0,82.0,4368889.0,65.6,4334.0,,3979.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,26,,,,host_subject_id:NL_131;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (KAN Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.489Z,2015-03-16T03:17:09.594Z
1448592_3,Mycobacterium tuberculosis TKK_04_0132,Mycobacterium tuberculosis TKK_04_0132,1448592.0,WGS,TKK_04_0132,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235597,SAMN02586087,GCA_000656795.1,JJTW00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,3.0,3.0,4400261.0,65.6,4355.0,,4002.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,41,,,,host_subject_id:NL_132;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.498Z,2015-03-16T03:17:09.594Z
1448593_3,Mycobacterium tuberculosis TKK_04_0134,Mycobacterium tuberculosis TKK_04_0134,1448593.0,WGS,TKK_04_0134,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235598,SAMN02586088,GCA_000656815.1,JJTV00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,89.0,95.0,4371100.0,65.6,4336.0,,3976.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,28,,,,host_subject_id:NL_134;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.508Z,2015-03-16T03:17:09.594Z
1448594_3,Mycobacterium tuberculosis TKK_04_0136,Mycobacterium tuberculosis TKK_04_0136,1448594.0,WGS,TKK_04_0136,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235599,SAMN02586089,GCA_000656835.1,JJTU00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,89.0,95.0,4375601.0,65.6,4336.0,,3974.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,41,,,,host_subject_id:NL_136;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.517Z,2015-03-16T03:17:09.594Z
1448595_3,Mycobacterium tuberculosis TKK_04_0137,Mycobacterium tuberculosis TKK_04_0137,1448595.0,WGS,TKK_04_0137,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235600,SAMN02586090,GCA_000656855.1,JJTT00000000,-,Broad Institute,WGS,Illumina,67.0x,allpaths v. R48559,,,5.0,5.0,4401631.0,65.6,4344.0,,4002.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,61,,,,host_subject_id:NL_137;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.527Z,2015-03-16T03:17:09.594Z
1448596_3,Mycobacterium tuberculosis TKK_04_0139,Mycobacterium tuberculosis TKK_04_0139,1448596.0,WGS,TKK_04_0139,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235601,SAMN02586091,GCA_000656875.1,JJTS00000000,-,Broad Institute,WGS,Illumina,65.0x,allpaths v. R48559,,,89.0,92.0,4410213.0,65.6,4376.0,,4007.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,30,,,,host_subject_id:NL_139;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.537Z,2015-03-16T03:17:09.594Z
1448597_3,Mycobacterium tuberculosis TKK_04_0140,Mycobacterium tuberculosis TKK_04_0140,1448597.0,WGS,TKK_04_0140,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235602,SAMN02586092,GCA_000656895.1,JJTR00000000,-,Broad Institute,WGS,Illumina,70.0x,allpaths v. R48559,,,70.0,74.0,4437138.0,65.6,4382.0,,4021.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,18,,,,host_subject_id:NL_140;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:pre-XDR (Oflox Susceptible);microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:S;rifampicin hain result:R,2014-12-08T22:12:20.546Z,2015-03-16T03:17:09.594Z
1448598_3,Mycobacterium tuberculosis TKK_04_0141,Mycobacterium tuberculosis TKK_04_0141,1448598.0,WGS,TKK_04_0141,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235603,SAMN02586093,GCA_000658795.1,JJTQ00000000,-,Broad Institute,WGS,Illumina,72.0x,allpaths v. R48559,,,66.0,66.0,4448770.0,65.61,4382.0,,4022.0,,sputum,,2013,South Africa,South Africa: Doris Goodwin Hospital,,,,,,"Human, Homo sapiens",Male,40,,,,host_subject_id:NL_141;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:ND;rifampicin hain result:ND,2014-12-08T22:12:20.556Z,2015-03-16T03:17:09.594Z
1448599_3,Mycobacterium tuberculosis TKK_04_0145,Mycobacterium tuberculosis TKK_04_0145,1448599.0,WGS,TKK_04_0145,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235604,SAMN02586094,GCA_000656915.1,JJTP00000000,-,Broad Institute,WGS,Illumina,56.0x,allpaths v. R48559,,,55.0,56.0,4416824.0,65.6,4372.0,,3998.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,36,,,,host_subject_id:NL_145;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.565Z,2015-03-16T03:17:09.594Z
1448600_3,Mycobacterium tuberculosis TKK_04_0148,Mycobacterium tuberculosis TKK_04_0148,1448600.0,WGS,TKK_04_0148,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235605,SAMN02586095,GCA_000656935.1,JJTO00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,77.0,81.0,4405268.0,65.6,4383.0,,3998.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,41,,,,host_subject_id:NL_148;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:S;rifampicin hain result:R,2014-12-08T22:12:20.575Z,2015-03-16T03:17:09.594Z
1448601_3,Mycobacterium tuberculosis TKK_04_0149,Mycobacterium tuberculosis TKK_04_0149,1448601.0,WGS,TKK_04_0149,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235606,SAMN02586096,GCA_000656955.1,JJTN00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,79.0,84.0,4378414.0,65.6,4337.0,,3971.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Female,56,,,,host_subject_id:NL_149;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Susceptible;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:S;rifampicin hain result:R,2014-12-08T22:12:20.584Z,2015-03-16T03:17:09.594Z
1448602_3,Mycobacterium tuberculosis TKK_04_0150,Mycobacterium tuberculosis TKK_04_0150,1448602.0,WGS,TKK_04_0150,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235607,SAMN02586097,GCA_000656975.1,JJTM00000000,-,Broad Institute,WGS,Illumina,64.0x,allpaths v. R48559,,,63.0,66.0,4433367.0,65.6,4385.0,,4034.0,,sputum,,2013,South Africa,,,,,,,"Human, Homo sapiens",Male,unknown,,,,host_subject_id:NL_150;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:INC;rifampicin hain result:S,2014-12-08T22:12:20.594Z,2015-03-16T03:17:09.594Z
1448604_3,Mycobacterium tuberculosis TKK_04_0153,Mycobacterium tuberculosis TKK_04_0153,1448604.0,WGS,TKK_04_0153,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235609,SAMN02586099,GCA_000656995.1,JJTL00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,77.0,83.0,4344383.0,65.6,4327.0,,3979.0,,sputum,,2013,,,,,,,,"Human, Homo sapiens",Female,unknown,,,,host_subject_id:NL_153;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Poly-drug resistant TB;microscopy ziehl-neelsen:Negative;microscopy auramine:ND;microscopy smear status:Negative;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.604Z,2015-03-16T03:17:09.594Z
1448605_3,Mycobacterium tuberculosis TKK_04_0155,Mycobacterium tuberculosis TKK_04_0155,1448605.0,WGS,TKK_04_0155,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235610,SAMN02586100,GCA_000657015.1,JJTK00000000,-,Broad Institute,WGS,Illumina,69.0x,allpaths v. R48559,,,88.0,94.0,4402917.0,65.6,4378.0,,4020.0,,sputum,,2013,,,,,,,,"Human, Homo sapiens",Female,39,,,,host_subject_id:NL_155;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:S;rifampicin hain result:R,2014-12-08T22:12:20.613Z,2015-03-16T03:17:09.594Z
1448606_3,Mycobacterium tuberculosis TKK_04_0157,Mycobacterium tuberculosis TKK_04_0157,1448606.0,WGS,TKK_04_0157,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235611,SAMN02586101,GCA_000658815.1,JJTJ00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,58.0,61.0,4406333.0,65.61,4343.0,,4015.0,,sputum,,2013,South Africa,South Africa: Manguzi Hospital,,,,,,"Human, Homo sapiens",Male,36,,,,host_subject_id:NL_157;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:1+/3+;microscopy auramine:ND;microscopy smear status:Positive;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.623Z,2015-03-16T03:17:09.594Z
1448607_3,Mycobacterium tuberculosis TKK_04_0158,Mycobacterium tuberculosis TKK_04_0158,1448607.0,WGS,TKK_04_0158,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235612,SAMN02586102,GCA_000657035.1,JJTI00000000,-,Broad Institute,WGS,Illumina,71.0x,allpaths v. R48559,,,64.0,68.0,4413889.0,65.6,4361.0,,4022.0,,CSF,,2013,India,India: Warangal,,,,,,"Human, Homo sapiens",Male,unknown,,,,host_subject_id:NL_158;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:MDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:S,2014-12-08T22:12:20.633Z,2015-03-16T03:17:09.594Z
1448608_3,Mycobacterium tuberculosis TKK_04_0159,Mycobacterium tuberculosis TKK_04_0159,1448608.0,WGS,TKK_04_0159,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235613,SAMN02586103,GCA_000657055.1,JJTH00000000,-,Broad Institute,WGS,Illumina,111.0x,allpaths v. R48559,,,17.0,17.0,4389462.0,65.6,4356.0,,3986.0,,sputum,,2013,,,,,,,,"Human, Homo sapiens",Male,52,,,,host_subject_id:NL_159;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:Mono-drug resistant TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.642Z,2015-03-16T03:17:09.594Z
1448609_3,Mycobacterium tuberculosis TKK_04_0104,Mycobacterium tuberculosis TKK_04_0104,1448609.0,WGS,TKK_04_0104,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235614,SAMN02586104,GCA_000657075.1,JJTG00000000,-,Broad Institute,WGS,Illumina,78.0x,allpaths v. R48559,,,3.0,3.0,4400239.0,65.6,4345.0,,4002.0,,sputum,,2013,South Africa,South Africa: Kwazulu Natal,,,,,,"Human, Homo sapiens",Male,51,,,,host_subject_id:NL_104;treatment course:n/a;co-morbidity:unknown;previous tb treatment:unknown;previous mdr-tx:unknown;previous drug susceptible tb tx:unknown,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - KRITH 2,tb culture:TB culture;tb culture mgit:MTB isolated;tb culture 7h11:MTB isolated;phenotype:XDR-TB;microscopy ziehl-neelsen:ND;microscopy auramine:ND;microscopy smear status:n/a;lineage:Not tested;isoniazid hain result:R;rifampicin hain result:R,2014-12-08T22:12:20.321Z,2015-03-16T03:17:09.594Z
1448610_3,Mycobacterium tuberculosis M984,Mycobacterium tuberculosis M984,1448610.0,WGS,M984,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235620,SAMN02598956,GCA_000654235.1,JKQE00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,16.0,19.0,4421014.0,65.6,4368.0,,3995.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:9;pattern:V,2014-12-08T22:12:12.828Z,2015-03-16T03:17:09.594Z
1448611_3,Mycobacterium tuberculosis M987,Mycobacterium tuberculosis M987,1448611.0,WGS,M987,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235621,SAMN02598957,GCA_000654255.1,JKQD00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,24.0,28.0,4416584.0,65.6,4346.0,,3988.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:9;pattern:AN,2014-12-08T22:12:12.837Z,2015-03-16T03:17:09.594Z
1448612_3,Mycobacterium tuberculosis M990,Mycobacterium tuberculosis M990,1448612.0,WGS,M990,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235623,SAMN02598958,GCA_000654275.1,JKQC00000000,-,Broad Institute,WGS,Illumina,116.0x,allpaths v. R48559,,,20.0,20.0,4415264.0,65.6,4368.0,,3981.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:4;pattern:B,2014-12-08T22:12:12.847Z,2015-03-16T03:17:09.594Z
1448613_3,Mycobacterium tuberculosis M991,Mycobacterium tuberculosis M991,1448613.0,WGS,M991,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235624,SAMN02598959,GCA_000654295.1,JKQB00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,44.0,49.0,4390870.0,65.6,4349.0,,3974.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:12.857Z,2015-03-16T03:17:09.594Z
1448614_3,Mycobacterium tuberculosis M1004,Mycobacterium tuberculosis M1004,1448614.0,WGS,M1004,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235625,SAMN02598960,GCA_000654315.1,JKQA00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48559,,,12.0,13.0,4417124.0,65.6,4353.0,,3977.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.164Z,2015-03-16T03:17:09.594Z
1448615_3,Mycobacterium tuberculosis M992,Mycobacterium tuberculosis M992,1448615.0,WGS,M992,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235626,SAMN02598961,GCA_000654335.1,JKPZ00000000,-,Broad Institute,WGS,Illumina,55.0x,allpaths v. R48559,,,70.0,76.0,4410631.0,65.6,4379.0,,3985.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:3;pattern:G,2014-12-08T22:12:12.865Z,2015-03-16T03:17:09.594Z
1448616_3,Mycobacterium tuberculosis M995,Mycobacterium tuberculosis M995,1448616.0,WGS,M995,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235627,SAMN02598962,GCA_000654355.1,JKPY00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48559,,,15.0,17.0,4403492.0,65.6,4335.0,,3972.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:12.874Z,2015-03-16T03:17:09.594Z
1448617_3,Mycobacterium tuberculosis M1007,Mycobacterium tuberculosis M1007,1448617.0,WGS,M1007,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235628,SAMN02598963,GCA_000654375.1,JKPX00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,16.0,18.0,4406662.0,65.6,4361.0,,3972.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.174Z,2015-03-16T03:17:09.594Z
1448618_3,Mycobacterium tuberculosis M1008,Mycobacterium tuberculosis M1008,1448618.0,WGS,M1008,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235629,SAMN02598964,GCA_000654395.1,JKPW00000000,-,Broad Institute,WGS,Illumina,109.0x,allpaths v. R48559,,,32.0,34.0,4411440.0,65.6,4371.0,,3981.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:4;pattern:G,2014-12-08T22:12:11.184Z,2015-03-16T03:17:09.594Z
1448619_3,Mycobacterium tuberculosis M1009,Mycobacterium tuberculosis M1009,1448619.0,WGS,M1009,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235630,SAMN02598965,GCA_000654415.1,JKPV00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,17.0,18.0,4414393.0,65.6,4352.0,,3979.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:2;pattern:C,2014-12-08T22:12:11.193Z,2015-03-16T03:17:09.594Z
1448620_3,Mycobacterium tuberculosis M1010,Mycobacterium tuberculosis M1010,1448620.0,WGS,M1010,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235631,SAMN02598966,GCA_000654435.1,JKPU00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,17.0,20.0,4407456.0,65.6,4352.0,,3980.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.201Z,2015-03-16T03:17:09.594Z
1448621_3,Mycobacterium tuberculosis M1012,Mycobacterium tuberculosis M1012,1448621.0,WGS,M1012,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235632,SAMN02598967,GCA_000654455.1,JKPT00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,17.0,18.0,4412615.0,65.6,4357.0,,3976.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:2;pattern:C,2014-12-08T22:12:11.218Z,2015-03-16T03:17:09.594Z
1448622_3,Mycobacterium tuberculosis M1011,Mycobacterium tuberculosis M1011,1448622.0,WGS,M1011,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235633,SAMN02598968,GCA_000654475.1,JKPS00000000,-,Broad Institute,WGS,Illumina,72.0x,allpaths v. R48559,,,73.0,80.0,4427769.0,65.6,4395.0,,3998.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:1;pattern:A,2014-12-08T22:12:11.210Z,2015-03-16T03:17:09.594Z
1448623_3,Mycobacterium tuberculosis M1017,Mycobacterium tuberculosis M1017,1448623.0,WGS,M1017,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235634,SAMN02598969,GCA_000654495.1,JKPR00000000,-,Broad Institute,WGS,Illumina,64.0x,allpaths v. R48559,,,84.0,92.0,4389383.0,65.6,4370.0,,4000.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777400000771;spol db4:CAS;st no:599;is6110 copy:11;pattern:AK,2014-12-08T22:12:11.226Z,2015-03-16T03:17:09.594Z
1448624_3,Mycobacterium tuberculosis M1021,Mycobacterium tuberculosis M1021,1448624.0,WGS,M1021,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235635,SAMN02598970,GCA_000654515.1,JKPQ00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,15.0,19.0,4419359.0,65.6,4345.0,,3977.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:3;pattern:G,2014-12-08T22:12:11.236Z,2015-03-16T03:17:09.594Z
1448625_3,Mycobacterium tuberculosis M1023,Mycobacterium tuberculosis M1023,1448625.0,WGS,M1023,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235636,SAMN02598971,GCA_000654535.1,JKPP00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,13.0,16.0,4416903.0,65.6,4336.0,,3983.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:2;pattern:C,2014-12-08T22:12:11.256Z,2015-03-16T03:17:09.594Z
1448626_3,Mycobacterium tuberculosis M1022,Mycobacterium tuberculosis M1022,1448626.0,WGS,M1022,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235637,SAMN02598972,GCA_000654555.1,JKPO00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,21.0,21.0,4416404.0,65.6,4352.0,,3979.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:4;pattern:B,2014-12-08T22:12:11.245Z,2015-03-16T03:17:09.594Z
1448627_3,Mycobacterium tuberculosis M1024,Mycobacterium tuberculosis M1024,1448627.0,WGS,M1024,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235638,SAMN02598973,GCA_000654575.1,JKPN00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,26.0,26.0,4411180.0,65.6,4366.0,,3966.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.265Z,2015-03-16T03:17:09.594Z
1448628_3,Mycobacterium tuberculosis M1025,Mycobacterium tuberculosis M1025,1448628.0,WGS,M1025,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235639,SAMN02598974,GCA_000654595.1,JKPM00000000,-,Broad Institute,WGS,Illumina,56.0x,allpaths v. R48559,,,73.0,78.0,4391112.0,65.6,4357.0,,3966.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.275Z,2015-03-16T03:17:09.594Z
1448629_3,Mycobacterium tuberculosis M1026,Mycobacterium tuberculosis M1026,1448629.0,WGS,M1026,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235640,SAMN02598975,GCA_000654615.1,JKPL00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,22.0,24.0,4402490.0,65.6,4346.0,,3967.0,,Sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:475777777413771;spol db4:Orphan;st no:EAI 5;is6110 copy:3;pattern:E,2014-12-08T22:12:11.284Z,2015-03-16T03:17:09.594Z
1448630_3,Mycobacterium tuberculosis M1029,Mycobacterium tuberculosis M1029,1448630.0,WGS,M1029,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235641,SAMN02598976,GCA_000658335.1,JKPK00000000,-,Broad Institute,WGS,Illumina,49.0x,allpaths v. R48559,,,74.0,79.0,4401735.0,65.58,4377.0,,3984.0,,sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:1;pattern:A,2014-12-08T22:12:11.292Z,2015-03-16T03:17:09.594Z
1448631_3,Mycobacterium tuberculosis M1030,Mycobacterium tuberculosis M1030,1448631.0,WGS,M1030,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235642,SAMN02598977,GCA_000658355.1,JKPJ00000000,-,Broad Institute,WGS,Illumina,58.0x,allpaths v. R48559,,,66.0,72.0,4405329.0,65.6,4398.0,,3976.0,,sputum,,2001,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.300Z,2015-03-16T03:17:09.594Z
1448632_3,Mycobacterium tuberculosis M1034,Mycobacterium tuberculosis M1034,1448632.0,WGS,M1034,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235643,SAMN02598978,GCA_000654635.1,JKPI00000000,-,Broad Institute,WGS,Illumina,49.0x,allpaths v. R48559,,,72.0,77.0,4409857.0,65.6,4362.0,,2817.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:NO COPY,2014-12-08T22:12:11.309Z,2015-03-16T03:17:09.594Z
1448633_3,Mycobacterium tuberculosis M1210,Mycobacterium tuberculosis M1210,1448633.0,WGS,M1210,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235644,SAMN02598979,GCA_000654655.1,JKPH00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,18.0,19.0,4417766.0,65.6,4372.0,,3990.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:1;pattern:A,2014-12-08T22:12:11.318Z,2015-03-16T03:17:09.594Z
1448634_3,Mycobacterium tuberculosis M1212,Mycobacterium tuberculosis M1212,1448634.0,WGS,M1212,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235645,SAMN02598980,GCA_000654675.1,JKPG00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,23.0,27.0,4405718.0,65.6,4362.0,,3979.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.326Z,2015-03-16T03:17:09.594Z
1448635_3,Mycobacterium tuberculosis M1213,Mycobacterium tuberculosis M1213,1448635.0,WGS,M1213,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235646,SAMN02598981,GCA_000654695.1,JKPF00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,15.0,16.0,4411237.0,65.6,4352.0,,3972.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.335Z,2015-03-16T03:17:09.594Z
1448636_3,Mycobacterium tuberculosis M1215,Mycobacterium tuberculosis M1215,1448636.0,WGS,M1215,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235647,SAMN02598982,GCA_000654715.1,JKPE00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,17.0,22.0,4407196.0,65.6,4349.0,,3985.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.344Z,2015-03-16T03:17:09.594Z
1448638_3,Mycobacterium tuberculosis M1232,Mycobacterium tuberculosis M1232,1448638.0,WGS,M1232,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235649,SAMN02598984,GCA_000654755.1,JKPC00000000,-,Broad Institute,WGS,Illumina,128.0x,allpaths v. R48559,,,20.0,20.0,4419511.0,65.6,4356.0,,3984.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:6;pattern:E,2014-12-08T22:12:11.352Z,2015-03-16T03:17:09.594Z
1448639_3,Mycobacterium tuberculosis M1233,Mycobacterium tuberculosis M1233,1448639.0,WGS,M1233,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235650,SAMN02598985,GCA_000654775.1,JKPB00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48559,,,67.0,70.0,4408441.0,65.6,4383.0,,3988.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:7;pattern:AR,2014-12-08T22:12:11.361Z,2015-03-16T03:17:09.594Z
1448640_3,Mycobacterium tuberculosis M1236,Mycobacterium tuberculosis M1236,1448640.0,WGS,M1236,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235651,SAMN02598986,GCA_000654795.1,JKPA00000000,-,Broad Institute,WGS,Illumina,54.0x,allpaths v. R48559,,,71.0,77.0,4399636.0,65.6,4383.0,,3980.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:4;pattern:AG,2014-12-08T22:12:11.370Z,2015-03-16T03:17:09.594Z
1448641_3,Mycobacterium tuberculosis M1253,Mycobacterium tuberculosis M1253,1448641.0,WGS,M1253,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235652,SAMN02598987,GCA_000654815.1,JKOZ00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,18.0,21.0,4413887.0,65.6,4356.0,,3984.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:5;pattern:D,2014-12-08T22:12:11.378Z,2015-03-16T03:17:09.594Z
1448642_3,Mycobacterium tuberculosis M1270,Mycobacterium tuberculosis M1270,1448642.0,WGS,M1270,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235653,SAMN02598988,GCA_000654835.1,JKOY00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48559,,,24.0,24.0,4414287.0,65.6,4387.0,,4012.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:4;pattern:B,2014-12-08T22:12:11.387Z,2015-03-16T03:17:09.594Z
1448643_3,Mycobacterium tuberculosis M1271,Mycobacterium tuberculosis M1271,1448643.0,WGS,M1271,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235654,SAMN02598989,GCA_000654855.1,JKOX00000000,-,Broad Institute,WGS,Illumina,114.0x,allpaths v. R48559,,,24.0,27.0,4415442.0,65.6,4373.0,,3992.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:4;pattern:B,2014-12-08T22:12:11.397Z,2015-03-16T03:17:09.594Z
1448644_3,Mycobacterium tuberculosis M1273,Mycobacterium tuberculosis M1273,1448644.0,WGS,M1273,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235655,SAMN02598990,GCA_000654875.1,JKOW00000000,-,Broad Institute,WGS,Illumina,99.0x,allpaths v. R48559,,,33.0,35.0,4395134.0,65.6,4366.0,,3972.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.417Z,2015-03-16T03:17:09.594Z
1448645_3,Mycobacterium tuberculosis M1274,Mycobacterium tuberculosis M1274,1448645.0,WGS,M1274,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235656,SAMN02598991,GCA_000654895.1,JKOV00000000,-,Broad Institute,WGS,Illumina,60.0x,allpaths v. R48559,,,84.0,92.0,4393431.0,65.6,4374.0,,4007.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:10;pattern:AN,2014-12-08T22:12:11.425Z,2015-03-16T03:17:09.594Z
1448646_3,Mycobacterium tuberculosis M1283,Mycobacterium tuberculosis M1283,1448646.0,WGS,M1283,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235657,SAMN02598992,GCA_000654915.1,JKOU00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,19.0,21.0,4420944.0,65.6,4374.0,,3986.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:5;pattern:D,2014-12-08T22:12:11.434Z,2015-03-16T03:17:09.594Z
1448647_3,Mycobacterium tuberculosis M1272,Mycobacterium tuberculosis M1272,1448647.0,WGS,M1272,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235658,SAMN02598993,GCA_000654935.1,JKOT00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48559,,,11.0,13.0,4415915.0,65.6,4342.0,,3977.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.408Z,2015-03-16T03:17:09.594Z
1448648_3,Mycobacterium tuberculosis M1287,Mycobacterium tuberculosis M1287,1448648.0,WGS,M1287,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235659,SAMN02598994,GCA_000654955.1,JKOS00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,17.0,18.0,4401607.0,65.6,4331.0,,3966.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.443Z,2015-03-16T03:17:09.594Z
1448649_3,Mycobacterium tuberculosis M1288,Mycobacterium tuberculosis M1288,1448649.0,WGS,M1288,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235660,SAMN02598995,GCA_000654975.1,JKOR00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,21.0,23.0,4411268.0,65.6,4358.0,,3983.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:5;pattern:D,2014-12-08T22:12:11.452Z,2015-03-16T03:17:09.594Z
1448650_3,Mycobacterium tuberculosis M1292,Mycobacterium tuberculosis M1292,1448650.0,WGS,M1292,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235661,SAMN02598996,GCA_000654995.1,JKOQ00000000,-,Broad Institute,WGS,Illumina,94.0x,allpaths v. R48559,,,75.0,80.0,4404338.0,65.6,4382.0,,4004.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003171;spol db4:CAS1_DELHI;st no:25;is6110 copy:12;pattern:BS,2014-12-08T22:12:11.460Z,2015-03-16T03:17:09.594Z
1448651_3,Mycobacterium tuberculosis M1294,Mycobacterium tuberculosis M1294,1448651.0,WGS,M1294,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235662,SAMN02598997,GCA_000655015.1,JKOP00000000,-,Broad Institute,WGS,Illumina,71.0x,allpaths v. R48559,,,87.0,93.0,4396704.0,65.6,4354.0,,3995.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:12;pattern:AB,2014-12-08T22:12:11.468Z,2015-03-16T03:17:09.594Z
1448652_3,Mycobacterium tuberculosis M1295,Mycobacterium tuberculosis M1295,1448652.0,WGS,M1295,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235663,SAMN02598998,GCA_000655035.1,JKOO00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,23.0,26.0,4403580.0,65.6,4348.0,,3977.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.477Z,2015-03-16T03:17:09.594Z
1448653_3,Mycobacterium tuberculosis M1300,Mycobacterium tuberculosis M1300,1448653.0,WGS,M1300,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235664,SAMN02598999,GCA_000655055.1,JKON00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48559,,,22.0,23.0,4416797.0,65.6,4362.0,,3979.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:5;pattern:Y,2014-12-08T22:12:11.493Z,2015-03-16T03:17:09.594Z
1448654_3,Mycobacterium tuberculosis M1304,Mycobacterium tuberculosis M1304,1448654.0,WGS,M1304,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235665,SAMN02599000,GCA_000655075.1,JKOM00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,22.0,25.0,4413932.0,65.6,4371.0,,3982.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:9;pattern:AQ,2014-12-08T22:12:11.503Z,2015-03-16T03:17:09.594Z
1448655_3,Mycobacterium tuberculosis M1307,,1448655.0,WGS,M1307,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA235666,SAMN02599001,GCA_000706145.1,JKOL00000000,-,Broad Institute,,Illumina,126.0x,allpaths v. R48559,,,7.0,23.0,4421950.0,65.6,4296.0,,3978.0,,sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:5;pattern:C,2014-12-08T23:07:01.659Z,2015-03-16T03:17:09.594Z
1448656_3,Mycobacterium tuberculosis M1309,Mycobacterium tuberculosis M1309,1448656.0,WGS,M1309,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235667,SAMN02599002,GCA_000662465.1,JKOK00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,21.0,21.0,4417336.0,65.6,4384.0,,4016.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:14;pattern:Q,2014-12-08T22:12:11.512Z,2015-03-16T03:17:09.594Z
1448657_3,Mycobacterium tuberculosis M1310,Mycobacterium tuberculosis M1310,1448657.0,WGS,M1310,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235668,SAMN02599003,GCA_000662485.1,JKOJ00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,20.0,21.0,4417488.0,65.6,4361.0,,3977.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:5;pattern:Y,2014-12-08T22:12:11.520Z,2015-03-16T03:17:09.594Z
1448659_3,Mycobacterium tuberculosis M1317,Mycobacterium tuberculosis M1317,1448659.0,WGS,M1317,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235670,SAMN02599005,GCA_000662525.1,JKOH00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,18.0,21.0,4402957.0,65.6,4337.0,,3967.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:NO COPY,2014-12-08T22:12:11.539Z,2015-03-16T03:17:09.594Z
1448660_3,Mycobacterium tuberculosis M1319,Mycobacterium tuberculosis M1319,1448660.0,WGS,M1319,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235671,SAMN02599006,GCA_000662545.1,JKOG00000000,-,Broad Institute,WGS,Illumina,99.0x,allpaths v. R48559,,,15.0,15.0,4415617.0,65.6,4353.0,,3973.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:757777777413731;spol db4:EAI1_SOM;st no:806;is6110 copy:1;pattern:A,2014-12-08T22:12:11.548Z,2015-03-16T03:17:09.594Z
1448661_3,Mycobacterium tuberculosis M1324,Mycobacterium tuberculosis M1324,1448661.0,WGS,M1324,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235672,SAMN02599007,GCA_000662565.1,JKOF00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,20.0,23.0,4416565.0,65.6,4376.0,,3988.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:1;pattern:A,2014-12-08T22:12:11.557Z,2015-03-16T03:17:09.594Z
1448662_3,Mycobacterium tuberculosis M1325,Mycobacterium tuberculosis M1325,1448662.0,WGS,M1325,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235673,SAMN02599008,GCA_000662585.1,JKOE00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48559,,,22.0,23.0,4426630.0,65.6,4375.0,,3996.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:1;pattern:A,2014-12-08T22:12:11.567Z,2015-03-16T03:17:09.594Z
1448663_3,Mycobacterium tuberculosis M1340,Mycobacterium tuberculosis M1340,1448663.0,WGS,M1340,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235674,SAMN02599009,GCA_000662605.1,JKOD00000000,-,Broad Institute,WGS,Illumina,131.0x,allpaths v. R48559,,,14.0,15.0,4401741.0,65.6,4347.0,,3968.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:2;pattern:L,2014-12-08T22:12:11.576Z,2015-03-16T03:17:09.594Z
1448664_3,Mycobacterium tuberculosis M1373,Mycobacterium tuberculosis M1373,1448664.0,WGS,M1373,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235675,SAMN02599010,GCA_000662625.1,JKOC00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48559,,,20.0,21.0,4431168.0,65.6,4393.0,,4008.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:1;pattern:A,2014-12-08T22:12:11.585Z,2015-03-16T03:17:09.594Z
1448665_3,Mycobacterium tuberculosis M1374,Mycobacterium tuberculosis M1374,1448665.0,WGS,M1374,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235676,SAMN02599011,GCA_000662645.1,JKOB00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48559,,,20.0,20.0,4405063.0,65.6,4374.0,,3998.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:13;pattern:AK,2014-12-08T22:12:11.595Z,2015-03-16T03:17:09.594Z
1448666_3,Mycobacterium tuberculosis M1381,Mycobacterium tuberculosis M1381,1448666.0,WGS,M1381,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235677,SAMN02599012,GCA_000662665.1,JKOA00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,12.0,16.0,4408664.0,65.6,4353.0,,3971.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.604Z,2015-03-16T03:17:09.594Z
1448667_3,Mycobacterium tuberculosis M1384,Mycobacterium tuberculosis M1384,1448667.0,WGS,M1384,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235678,SAMN02599013,GCA_000662685.1,JKNZ00000000,-,Broad Institute,WGS,Illumina,67.0x,allpaths v. R48559,,,74.0,80.0,4405158.0,65.6,4380.0,,3980.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.613Z,2015-03-16T03:17:09.594Z
1448668_3,Mycobacterium tuberculosis M1389,Mycobacterium tuberculosis M1389,1448668.0,WGS,M1389,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235679,SAMN02599014,GCA_000662705.1,JKNY00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,18.0,22.0,4423240.0,65.6,4350.0,,3986.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:2;pattern:N,2014-12-08T22:12:11.622Z,2015-03-16T03:17:09.594Z
1448669_3,Mycobacterium tuberculosis M1392,Mycobacterium tuberculosis M1392,1448669.0,WGS,M1392,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235680,SAMN02599015,GCA_000662725.1,JKNX00000000,-,Broad Institute,WGS,Illumina,115.0x,allpaths v. R48559,,,18.0,20.0,4418292.0,65.6,4379.0,,3990.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:7;pattern:B,2014-12-08T22:12:11.632Z,2015-03-16T03:17:09.594Z
1448670_3,Mycobacterium tuberculosis M1393,Mycobacterium tuberculosis M1393,1448670.0,WGS,M1393,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235681,SAMN02599016,GCA_000662745.1,JKNW00000000,-,Broad Institute,WGS,Illumina,133.0x,allpaths v. R48559,,,20.0,21.0,4411437.0,65.6,4362.0,,4005.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:700377740003771;spol db4:CAS2;st no:288;is6110 copy:7;pattern:X,2014-12-08T22:12:11.641Z,2015-03-16T03:17:09.594Z
1448671_3,Mycobacterium tuberculosis M1397,Mycobacterium tuberculosis M1397,1448671.0,WGS,M1397,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235682,SAMN02599017,GCA_000662765.1,JKNV00000000,-,Broad Institute,WGS,Illumina,45.0x,allpaths v. R48559,,,80.0,87.0,4363432.0,65.6,4335.0,,3971.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1,2014-12-08T22:12:11.649Z,2015-03-16T03:17:09.594Z
1448672_3,Mycobacterium tuberculosis M1400,Mycobacterium tuberculosis M1400,1448672.0,WGS,M1400,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235683,SAMN02599018,GCA_000662785.1,JKNU00000000,-,Broad Institute,WGS,Illumina,116.0x,allpaths v. R48559,,,20.0,23.0,4406781.0,65.6,4348.0,,3971.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.658Z,2015-03-16T03:17:09.594Z
1448673_3,Mycobacterium tuberculosis M1402,Mycobacterium tuberculosis M1402,1448673.0,WGS,M1402,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235684,SAMN02599019,GCA_000662805.1,JKNT00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48559,,,13.0,14.0,4419754.0,65.6,4379.0,,3978.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.667Z,2015-03-16T03:17:09.594Z
1448674_3,Mycobacterium tuberculosis M1404,Mycobacterium tuberculosis M1404,1448674.0,WGS,M1404,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235685,SAMN02599020,GCA_000662825.1,JKNS00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,19.0,21.0,4407630.0,65.6,4349.0,,3978.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.676Z,2015-03-16T03:17:09.594Z
1448675_3,Mycobacterium tuberculosis M1410,Mycobacterium tuberculosis M1410,1448675.0,WGS,M1410,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235686,SAMN02599021,GCA_000662845.1,JKNR00000000,-,Broad Institute,WGS,Illumina,107.0x,allpaths v. R48559,,,17.0,18.0,4416746.0,65.6,4370.0,,3978.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777577777003731;spol db4:EAI undefined;st no:72;is6110 copy:1;pattern:B,2014-12-08T22:12:11.685Z,2015-03-16T03:17:09.594Z
1448676_3,Mycobacterium tuberculosis M1415,Mycobacterium tuberculosis M1415,1448676.0,WGS,M1415,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235687,SAMN02599022,GCA_000662865.1,JKNQ00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,24.0,25.0,4418062.0,65.6,4362.0,,3988.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.694Z,2015-03-16T03:17:09.594Z
1448677_3,Mycobacterium tuberculosis M1416,Mycobacterium tuberculosis M1416,1448677.0,WGS,M1416,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235688,SAMN02599023,GCA_000662885.1,JKNP00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,17.0,18.0,4413275.0,65.6,4362.0,,3984.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:5;pattern:N,2014-12-08T22:12:11.704Z,2015-03-16T03:17:09.594Z
1448678_3,Mycobacterium tuberculosis M1417,Mycobacterium tuberculosis M1417,1448678.0,WGS,M1417,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235689,SAMN02599024,GCA_000662905.1,JKNO00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48559,,,19.0,19.0,4418572.0,65.6,4374.0,,3978.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.713Z,2015-03-16T03:17:09.594Z
1448679_3,Mycobacterium tuberculosis M1418,Mycobacterium tuberculosis M1418,1448679.0,WGS,M1418,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235690,SAMN02599025,GCA_000662925.1,JKNN00000000,-,Broad Institute,WGS,Illumina,126.0x,allpaths v. R48559,,,24.0,24.0,4408050.0,65.6,4350.0,,3973.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:757777777413731;spol db4:EAI1_SOM;st no:806;is6110 copy:4;pattern:B,2014-12-08T22:12:11.722Z,2015-03-16T03:17:09.594Z
1448680_3,Mycobacterium tuberculosis M1422,Mycobacterium tuberculosis M1422,1448680.0,WGS,M1422,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235691,SAMN02599026,GCA_000662945.1,JKNM00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,19.0,21.0,4411028.0,65.6,4350.0,,3977.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.732Z,2015-03-16T03:17:09.594Z
1448681_3,Mycobacterium tuberculosis M1424,Mycobacterium tuberculosis M1424,1448681.0,WGS,M1424,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235692,SAMN02599027,GCA_000662965.1,JKNL00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,19.0,21.0,4411812.0,65.6,4353.0,,3979.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:6;pattern:AI,2014-12-08T22:12:11.742Z,2015-03-16T03:17:09.594Z
1448682_3,Mycobacterium tuberculosis M1425,Mycobacterium tuberculosis M1425,1448682.0,WGS,M1425,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235693,SAMN02599028,GCA_000662985.1,JKNK00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,33.0,35.0,4398031.0,65.6,4348.0,,3970.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.753Z,2015-03-16T03:17:09.594Z
1448683_3,Mycobacterium tuberculosis M1429,Mycobacterium tuberculosis M1429,1448683.0,WGS,M1429,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235694,SAMN02599029,GCA_000663005.1,JKNJ00000000,-,Broad Institute,WGS,Illumina,65.0x,allpaths v. R48559,,,71.0,77.0,4411911.0,65.6,4391.0,,3982.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:7;pattern:A,2014-12-08T22:12:11.761Z,2015-03-16T03:17:09.594Z
1448684_3,Mycobacterium tuberculosis M1431,Mycobacterium tuberculosis M1431,1448684.0,WGS,M1431,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235695,SAMN02599030,GCA_000663025.1,JKNI00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,18.0,19.0,4409527.0,65.6,4367.0,,3986.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:1;pattern:A,2014-12-08T22:12:11.770Z,2015-03-16T03:17:09.594Z
1448685_3,Mycobacterium tuberculosis M1438,Mycobacterium tuberculosis M1438,1448685.0,WGS,M1438,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235696,SAMN02599031,GCA_000663045.1,JKNH00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,16.0,20.0,4413825.0,65.6,4365.0,,3985.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:5;pattern:D,2014-12-08T22:12:11.778Z,2015-03-16T03:17:09.594Z
1448686_3,Mycobacterium tuberculosis M1439,Mycobacterium tuberculosis M1439,1448686.0,WGS,M1439,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235697,SAMN02599032,GCA_000663065.1,JKNG00000000,-,Broad Institute,WGS,Illumina,129.0x,allpaths v. R48559,,,17.0,18.0,4412305.0,65.6,4344.0,,3981.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:5;pattern:D,2014-12-08T22:12:11.786Z,2015-03-16T03:17:09.594Z
1448687_3,Mycobacterium tuberculosis M1441,Mycobacterium tuberculosis M1441,1448687.0,WGS,M1441,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235698,SAMN02599033,GCA_000663085.1,JKNF00000000,-,Broad Institute,WGS,Illumina,124.0x,allpaths v. R48559,,,26.0,27.0,4420430.0,65.6,4381.0,,3997.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:6;pattern:W,2014-12-08T22:12:11.796Z,2015-03-16T03:17:09.594Z
1448688_3,Mycobacterium tuberculosis M1444,Mycobacterium tuberculosis M1444,1448688.0,WGS,M1444,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235699,SAMN02599034,GCA_000663105.1,JKNE00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,17.0,21.0,4410096.0,65.6,4347.0,,3973.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.804Z,2015-03-16T03:17:09.594Z
1448689_3,Mycobacterium tuberculosis M1448,Mycobacterium tuberculosis M1448,1448689.0,WGS,M1448,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235700,SAMN02599035,GCA_000663125.1,JKND00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,19.0,21.0,4409338.0,65.6,4355.0,,3978.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.815Z,2015-03-16T03:17:09.594Z
1448690_3,Mycobacterium tuberculosis M1449,Mycobacterium tuberculosis M1449,1448690.0,WGS,M1449,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235701,SAMN02599036,GCA_000663145.1,JKNC00000000,-,Broad Institute,WGS,Illumina,119.0x,allpaths v. R48559,,,27.0,28.0,4416576.0,65.6,4358.0,,3982.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:5;pattern:E,2014-12-08T22:12:11.824Z,2015-03-16T03:17:09.594Z
1448691_3,Mycobacterium tuberculosis M1700,Mycobacterium tuberculosis M1700,1448691.0,WGS,M1700,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235702,SAMN02599037,GCA_000663165.1,JKNB00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,29.0,29.0,4386433.0,65.6,4346.0,,3983.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:13;pattern:AT,2014-12-08T22:12:11.979Z,2015-03-16T03:17:09.594Z
1448692_3,Mycobacterium tuberculosis M1452,Mycobacterium tuberculosis M1452,1448692.0,WGS,M1452,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235703,SAMN02599038,GCA_000663185.1,JKNA00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,20.0,20.0,4405488.0,65.6,4355.0,,3976.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.833Z,2015-03-16T03:17:09.594Z
1448693_3,Mycobacterium tuberculosis M1456,Mycobacterium tuberculosis M1456,1448693.0,WGS,M1456,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235704,SAMN02599039,GCA_000663205.1,JKMZ00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,18.0,18.0,4403939.0,65.6,4360.0,,3962.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.843Z,2015-03-16T03:17:09.594Z
1448694_3,Mycobacterium tuberculosis M1458,Mycobacterium tuberculosis M1458,1448694.0,WGS,M1458,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235705,SAMN02599040,GCA_000663225.1,JKMY00000000,-,Broad Institute,WGS,Illumina,130.0x,allpaths v. R48559,,,31.0,32.0,4414569.0,65.6,4361.0,,3985.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:4;pattern:B,2014-12-08T22:12:11.853Z,2015-03-16T03:17:09.594Z
1448695_3,Mycobacterium tuberculosis M1459,Mycobacterium tuberculosis M1459,1448695.0,WGS,M1459,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235706,SAMN02599041,GCA_000663245.1,JKMX00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,17.0,17.0,4422565.0,65.6,4388.0,,4013.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:13;pattern:AD,2014-12-08T22:12:11.863Z,2015-03-16T03:17:09.594Z
1448696_3,Mycobacterium tuberculosis M1461,Mycobacterium tuberculosis M1461,1448696.0,WGS,M1461,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235707,SAMN02599042,GCA_000663265.1,JKMW00000000,-,Broad Institute,WGS,Illumina,104.0x,allpaths v. R48559,,,30.0,32.0,4410239.0,65.6,4360.0,,3980.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:6;pattern:A,2014-12-08T22:12:11.872Z,2015-03-16T03:17:09.594Z
1448697_3,Mycobacterium tuberculosis M1475,Mycobacterium tuberculosis M1475,1448697.0,WGS,M1475,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235708,SAMN02599043,GCA_000663285.1,JKMV00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,24.0,24.0,4415521.0,65.6,4364.0,,3977.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:5;pattern:Y,2014-12-08T22:12:11.880Z,2015-03-16T03:17:09.594Z
1448698_3,Mycobacterium tuberculosis M1481,Mycobacterium tuberculosis M1481,1448698.0,WGS,M1481,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235709,SAMN02599044,GCA_000663305.1,JKMU00000000,-,Broad Institute,WGS,Illumina,121.0x,allpaths v. R48559,,,18.0,19.0,4402773.0,65.6,4334.0,,3962.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3_IND;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:11.889Z,2015-03-16T03:17:09.594Z
1448699_3,Mycobacterium tuberculosis M1488,Mycobacterium tuberculosis M1488,1448699.0,WGS,M1488,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235710,SAMN02599045,GCA_000663325.1,JKMT00000000,-,Broad Institute,WGS,Illumina,120.0x,allpaths v. R48559,,,23.0,24.0,4418480.0,65.6,4381.0,,4010.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:10;pattern:J,2014-12-08T22:12:11.898Z,2015-03-16T03:17:09.594Z
1448700_3,Mycobacterium tuberculosis M1520,Mycobacterium tuberculosis M1520,1448700.0,WGS,M1520,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235711,SAMN02599046,GCA_000663345.1,JKMS00000000,-,Broad Institute,WGS,Illumina,105.0x,allpaths v. R48559,,,30.0,32.0,4411846.0,65.6,4377.0,,3980.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:1;pattern:B,2014-12-08T22:12:11.908Z,2015-03-16T03:17:09.594Z
1448701_3,Mycobacterium tuberculosis M1533,Mycobacterium tuberculosis M1533,1448701.0,WGS,M1533,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235712,SAMN02599047,GCA_000663365.1,JKMR00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,20.0,21.0,4412225.0,65.6,4358.0,,3976.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740000000;spol db4:CAS;st no:1264;is6110 copy:12;pattern:AU,2014-12-08T22:12:11.917Z,2015-03-16T03:17:09.594Z
1448702_3,Mycobacterium tuberculosis M1545,Mycobacterium tuberculosis M1545,1448702.0,WGS,M1545,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235713,SAMN02599048,GCA_000663385.1,JKMQ00000000,-,Broad Institute,WGS,Illumina,127.0x,allpaths v. R48559,,,16.0,17.0,4416786.0,65.6,4385.0,,4005.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:16;pattern:L,2014-12-08T22:12:11.926Z,2015-03-16T03:17:09.594Z
1448703_3,Mycobacterium tuberculosis M1559,Mycobacterium tuberculosis M1559,1448703.0,WGS,M1559,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235714,SAMN02599049,GCA_000663405.1,JKMP00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,78.0,82.0,4406307.0,65.6,4371.0,,4007.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:700377740003771;spol db4:CAS2;st no:288;is6110 copy:10;pattern:J,2014-12-08T22:12:11.934Z,2015-03-16T03:17:09.594Z
1448704_3,Mycobacterium tuberculosis M1560,Mycobacterium tuberculosis M1560,1448704.0,WGS,M1560,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235715,SAMN02599050,GCA_000663425.1,JKMO00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,82.0,87.0,4415848.0,65.6,4382.0,,3991.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:4;pattern:U,2014-12-08T22:12:11.943Z,2015-03-16T03:17:09.594Z
1448705_3,Mycobacterium tuberculosis M1570,Mycobacterium tuberculosis M1570,1448705.0,WGS,M1570,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235716,SAMN02599051,GCA_000663445.1,JKMN00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,71.0,75.0,4426702.0,65.6,4400.0,,3994.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:1;pattern:A,2014-12-08T22:12:11.952Z,2015-03-16T03:17:09.594Z
1448706_3,Mycobacterium tuberculosis M1615,Mycobacterium tuberculosis M1615,1448706.0,WGS,M1615,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235717,SAMN02599052,GCA_000663465.1,JKMM00000000,-,Broad Institute,WGS,Illumina,71.0x,allpaths v. R48559,,,81.0,87.0,4373519.0,65.6,4342.0,,3988.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:15;pattern:AA,2014-12-08T22:12:11.960Z,2015-03-16T03:17:09.594Z
1448707_3,Mycobacterium tuberculosis M1638,Mycobacterium tuberculosis M1638,1448707.0,WGS,M1638,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235718,SAMN02599053,GCA_000663485.1,JKML00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,82.0,89.0,4398851.0,65.6,4362.0,,3993.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:12;pattern:AT,2014-12-08T22:12:11.969Z,2015-03-16T03:17:09.594Z
1448708_3,Mycobacterium tuberculosis M1702,Mycobacterium tuberculosis M1702,1448708.0,WGS,M1702,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235719,SAMN02599054,GCA_000663505.1,JKMK00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,80.0,85.0,4395561.0,65.6,4362.0,,3991.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:15;pattern:AK,2014-12-08T22:12:11.988Z,2015-03-16T03:17:09.594Z
1448709_3,Mycobacterium tuberculosis M1703,Mycobacterium tuberculosis M1703,1448709.0,WGS,M1703,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235720,SAMN02599055,GCA_000663525.1,JKMJ00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,76.0,82.0,4418973.0,65.6,4401.0,,3998.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:677777477413751;spol db4:EAI2_MANILLA;st no:287;is6110 copy:15;pattern:AL,2014-12-08T22:12:11.997Z,2015-03-16T03:17:09.594Z
1448710_3,Mycobacterium tuberculosis M1704,Mycobacterium tuberculosis M1704,1448710.0,WGS,M1704,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235721,SAMN02599056,GCA_000663545.1,JKMI00000000,-,Broad Institute,WGS,Illumina,76.0x,allpaths v. R48559,,,82.0,86.0,4388663.0,65.6,4363.0,,3996.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:12;pattern:AJ,2014-12-08T22:12:12.007Z,2015-03-16T03:17:09.594Z
1448711_3,Mycobacterium tuberculosis M1726,Mycobacterium tuberculosis M1726,1448711.0,WGS,M1726,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235722,SAMN02599057,GCA_000663565.1,JKMH00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,69.0,77.0,4406305.0,65.6,4370.0,,3982.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:757777777413731;spol db4:EAI1_SOM;st no:806;is6110 copy:1;pattern:A,2014-12-08T22:12:12.017Z,2015-03-16T03:17:09.594Z
1448712_3,Mycobacterium tuberculosis M1728,Mycobacterium tuberculosis M1728,1448712.0,WGS,M1728,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235723,SAMN02599058,GCA_000663585.1,JKMG00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,84.0,90.0,4365245.0,65.6,4320.0,,3977.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:NO COPY,2014-12-08T22:12:12.026Z,2015-03-16T03:17:09.594Z
1448713_3,Mycobacterium tuberculosis M1734,Mycobacterium tuberculosis M1734,1448713.0,WGS,M1734,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235724,SAMN02599059,GCA_000663605.1,JKMF00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,71.0,77.0,4407009.0,65.6,4377.0,,3984.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:757777777413731;spol db4:EAI1_SOM;st no:806;is6110 copy:1;pattern:A,2014-12-08T22:12:12.035Z,2015-03-16T03:17:09.594Z
1448714_3,Mycobacterium tuberculosis M1759,,1448714.0,WGS,M1759,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA235725,SAMN02599060,GCA_000706125.1,JKME00000000,-,Broad Institute,,Illumina,86.0x,allpaths v. R48559,,,80.0,87.0,4430740.0,65.6,4335.0,,4009.0,,sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703737740003171;spol db4:CAS1_DELHI;st no:1198;is6110 copy:12;pattern:BC,2014-12-08T23:07:02.333Z,2015-03-16T03:17:09.594Z
1448715_3,Mycobacterium tuberculosis M1762,Mycobacterium tuberculosis M1762,1448715.0,WGS,M1762,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235726,SAMN02599061,GCA_000663625.1,JKMD00000000,-,Broad Institute,WGS,Illumina,46.0x,allpaths v. R48559,,,82.0,87.0,4369884.0,65.5,4356.0,,4000.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:13;pattern:U,2014-12-08T22:12:12.043Z,2015-03-16T03:17:09.594Z
1448716_3,Mycobacterium tuberculosis M1780,Mycobacterium tuberculosis M1780,1448716.0,WGS,M1780,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235727,SAMN02599062,GCA_000663645.1,JKMC00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R48559,,,81.0,87.0,4402970.0,65.6,4374.0,,4000.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:700377740003771;spol db4:CAS2;st no:288;is6110 copy:11;pattern:AR,2014-12-08T22:12:12.052Z,2015-03-16T03:17:09.594Z
1448717_3,Mycobacterium tuberculosis M1787,Mycobacterium tuberculosis M1787,1448717.0,WGS,M1787,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235728,SAMN02599063,GCA_000663665.1,JKMB00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,77.0,82.0,4398075.0,65.6,4381.0,,4002.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003171;spol db4:CAS1_DELHI;st no:25;is6110 copy:12;pattern:D,2014-12-08T22:12:12.071Z,2015-03-16T03:17:09.594Z
1448718_3,Mycobacterium tuberculosis M1782,Mycobacterium tuberculosis M1782,1448718.0,WGS,M1782,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235729,SAMN02599064,GCA_000663685.1,JKMA00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R48559,,,74.0,80.0,4371135.0,65.6,4329.0,,3983.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:15;pattern:G,2014-12-08T22:12:12.061Z,2015-03-16T03:17:09.594Z
1448719_3,Mycobacterium tuberculosis M1816,Mycobacterium tuberculosis M1816,1448719.0,WGS,M1816,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235730,SAMN02599065,GCA_000663705.1,JKLZ00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,75.0,79.0,4411511.0,65.6,4387.0,,3982.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:3;pattern:AE,2014-12-08T22:12:12.080Z,2015-03-16T03:17:09.594Z
1448720_3,Mycobacterium tuberculosis M1822,Mycobacterium tuberculosis M1822,1448720.0,WGS,M1822,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235731,SAMN02599066,GCA_000663725.1,JKLY00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,79.0,83.0,4374029.0,65.6,4357.0,,3979.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:15;pattern:G,2014-12-08T22:12:12.088Z,2015-03-16T03:17:09.594Z
1448721_3,Mycobacterium tuberculosis M1848,Mycobacterium tuberculosis M1848,1448721.0,WGS,M1848,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235732,SAMN02599067,GCA_000663745.1,JKLX00000000,-,Broad Institute,WGS,Illumina,72.0x,allpaths v. R48559,,,83.0,92.0,4372425.0,65.6,4343.0,,3985.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:14;pattern:N,2014-12-08T22:12:12.097Z,2015-03-16T03:17:09.594Z
1448722_3,Mycobacterium tuberculosis M1893,Mycobacterium tuberculosis M1893,1448722.0,WGS,M1893,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235733,SAMN02599068,GCA_000663765.1,JKLW00000000,-,Broad Institute,WGS,Illumina,50.0x,allpaths v. R48559,,,109.0,119.0,4388848.0,65.6,4355.0,,3991.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:6;pattern:B,2014-12-08T22:12:12.106Z,2015-03-16T03:17:09.594Z
1448723_3,Mycobacterium tuberculosis M1895,Mycobacterium tuberculosis M1895,1448723.0,WGS,M1895,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235734,SAMN02599069,GCA_000663785.1,JKLV00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,80.0,85.0,4371461.0,65.6,4337.0,,3979.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:12;pattern:J,2014-12-08T22:12:12.115Z,2015-03-16T03:17:09.594Z
1448724_3,Mycobacterium tuberculosis M1906,Mycobacterium tuberculosis M1906,1448724.0,WGS,M1906,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235735,SAMN02599070,GCA_000663805.1,JKLU00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,77.0,81.0,4400131.0,65.6,4383.0,,3987.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:077777777413731;spol db4:EAI1_SOM;st no:6;is6110 copy:1;pattern:A,2014-12-08T22:12:12.124Z,2015-03-16T03:17:09.594Z
1448725_3,Mycobacterium tuberculosis M1913,Mycobacterium tuberculosis M1913,1448725.0,WGS,M1913,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235736,SAMN02599071,GCA_000663825.1,JKLT00000000,-,Broad Institute,WGS,Illumina,64.0x,allpaths v. R48559,,,72.0,77.0,4395719.0,65.6,4371.0,,4005.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:11;pattern:AT,2014-12-08T22:12:12.133Z,2015-03-16T03:17:09.594Z
1448726_3,Mycobacterium tuberculosis M1914,Mycobacterium tuberculosis M1914,1448726.0,WGS,M1914,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235737,SAMN02599072,GCA_000663845.1,JKLS00000000,-,Broad Institute,WGS,Illumina,68.0x,allpaths v. R48559,,,84.0,91.0,4371976.0,65.6,4328.0,,3981.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:13;pattern:AU,2014-12-08T22:12:12.142Z,2015-03-16T03:17:09.594Z
1448727_3,Mycobacterium tuberculosis M1926,Mycobacterium tuberculosis M1926,1448727.0,WGS,M1926,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235738,SAMN02599073,GCA_000658375.1,JKLR00000000,-,Broad Institute,WGS,Illumina,63.0x,allpaths v. R48559,,,73.0,79.0,4377769.0,65.61,4330.0,,3978.0,,sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:9;pattern:AH,2014-12-08T22:12:12.151Z,2015-03-16T03:17:09.594Z
1448728_3,Mycobacterium tuberculosis M1928,Mycobacterium tuberculosis M1928,1448728.0,WGS,M1928,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235739,SAMN02599074,GCA_000663865.1,JKLQ00000000,-,Broad Institute,WGS,Illumina,75.0x,allpaths v. R48559,,,82.0,92.0,4405791.0,65.6,4383.0,,3998.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:674000003413771;spol db4:EAI2_NTB;st no:89;is6110 copy:10;pattern:BB,2014-12-08T22:12:12.160Z,2015-03-16T03:17:09.594Z
1448729_3,Mycobacterium tuberculosis M1929,Mycobacterium tuberculosis M1929,1448729.0,WGS,M1929,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235740,SAMN02599075,GCA_000663885.1,JKLP00000000,-,Broad Institute,WGS,Illumina,69.0x,allpaths v. R48559,,,70.0,75.0,4403167.0,65.6,4366.0,,3982.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:077777777413771;spol db4:EAI1_SOM;st no:6;is6110 copy:1;pattern:A,2014-12-08T22:12:12.169Z,2015-03-16T03:17:09.594Z
1448730_3,Mycobacterium tuberculosis M1932,Mycobacterium tuberculosis M1932,1448730.0,WGS,M1932,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235741,SAMN02599076,GCA_000663905.1,JKLO00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,83.0,88.0,4382169.0,65.6,4341.0,,3976.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:17;pattern:B,2014-12-08T22:12:12.178Z,2015-03-16T03:17:09.594Z
1448731_3,Mycobacterium tuberculosis M1948,Mycobacterium tuberculosis M1948,1448731.0,WGS,M1948,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235742,SAMN02599077,GCA_000663925.1,JKLN00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,78.0,85.0,4410970.0,65.6,4382.0,,3994.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777577777003731;spol db4:EAI undefined;st no:177;is6110 copy:1;pattern:A,2014-12-08T22:12:12.188Z,2015-03-16T03:17:09.594Z
1448732_3,Mycobacterium tuberculosis M1955,Mycobacterium tuberculosis M1955,1448732.0,WGS,M1955,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235743,SAMN02599078,GCA_000663945.1,JKLM00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,85.0,92.0,4391611.0,65.6,4366.0,,4002.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:11;pattern:AT,2014-12-08T22:12:12.197Z,2015-03-16T03:17:09.594Z
1448733_3,Mycobacterium tuberculosis M1956,Mycobacterium tuberculosis M1956,1448733.0,WGS,M1956,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235744,SAMN02599079,GCA_000663965.1,JKLL00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,77.0,82.0,4368407.0,65.6,4346.0,,3978.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:17;pattern:D,2014-12-08T22:12:12.205Z,2015-03-16T03:17:09.594Z
1448734_3,Mycobacterium tuberculosis M1959,Mycobacterium tuberculosis M1959,1448734.0,WGS,M1959,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235746,SAMN02599080,GCA_000663985.1,JKLK00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,60.0,65.0,4410102.0,65.6,4376.0,,3988.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:1;pattern:A,2014-12-08T22:12:12.215Z,2015-03-16T03:17:09.594Z
1448735_3,Mycobacterium tuberculosis M1961,Mycobacterium tuberculosis M1961,1448735.0,WGS,M1961,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235747,SAMN02599081,GCA_000664005.1,JKLJ00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,71.0,77.0,4428881.0,65.6,4402.0,,4016.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:10;pattern:BN,2014-12-08T22:12:12.224Z,2015-03-16T03:17:09.594Z
1448736_3,Mycobacterium tuberculosis M1967,Mycobacterium tuberculosis M1967,1448736.0,WGS,M1967,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235748,SAMN02599082,GCA_000664025.1,JKLI00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,71.0,77.0,4403435.0,65.6,4384.0,,3979.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:1;pattern:A,2014-12-08T22:12:12.233Z,2015-03-16T03:17:09.594Z
1448737_3,Mycobacterium tuberculosis M1973,Mycobacterium tuberculosis M1973,1448737.0,WGS,M1973,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235749,SAMN02599083,GCA_000664045.1,JKLH00000000,-,Broad Institute,WGS,Illumina,59.0x,allpaths v. R48559,,,85.0,91.0,4369758.0,65.6,4342.0,,3973.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:14;pattern:X,2014-12-08T22:12:12.242Z,2015-03-16T03:17:09.594Z
1448738_3,Mycobacterium tuberculosis M1976,Mycobacterium tuberculosis M1976,1448738.0,WGS,M1976,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235750,SAMN02599084,GCA_000664065.1,JKLG00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,81.0,87.0,4429909.0,65.6,4404.0,,3990.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:677777477413771;spol db4:EAI2_MANILLA;st no:19;is6110 copy:12;pattern:AH,2014-12-08T22:12:12.251Z,2015-03-16T03:17:09.594Z
1448739_3,Mycobacterium tuberculosis M1978,Mycobacterium tuberculosis M1978,1448739.0,WGS,M1978,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235751,SAMN02599085,GCA_000664085.1,JKLF00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,79.0,84.0,4403250.0,65.6,4372.0,,3995.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:11;pattern:AM,2014-12-08T22:12:12.259Z,2015-03-16T03:17:09.594Z
1448740_3,Mycobacterium tuberculosis M1979,Mycobacterium tuberculosis M1979,1448740.0,WGS,M1979,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235752,SAMN02599086,GCA_000664105.1,JKLE00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,80.0,88.0,4404070.0,65.6,4377.0,,3982.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:1;pattern:A,2014-12-08T22:12:12.268Z,2015-03-16T03:17:09.594Z
1448742_3,Mycobacterium tuberculosis M2003,Mycobacterium tuberculosis M2003,1448742.0,WGS,M2003,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235754,SAMN02599088,GCA_000664125.1,JKLD00000000,-,Broad Institute,WGS,Illumina,70.0x,allpaths v. R48559,,,77.0,85.0,4407920.0,65.6,4364.0,,3985.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:1;pattern:A,2014-12-08T22:12:12.277Z,2015-03-16T03:17:09.594Z
1448743_3,Mycobacterium tuberculosis M2006,Mycobacterium tuberculosis M2006,1448743.0,WGS,M2006,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235755,SAMN02599089,GCA_000664145.1,JKLC00000000,-,Broad Institute,WGS,Illumina,52.0x,allpaths v. R48559,,,112.0,123.0,4373779.0,65.6,4366.0,,4003.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777700003771;spol db4:CAS;st no:142;is6110 copy:13;pattern:AV,2014-12-08T22:12:12.286Z,2015-03-16T03:17:09.594Z
1448744_3,Mycobacterium tuberculosis M2007,Mycobacterium tuberculosis M2007,1448744.0,WGS,M2007,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235756,SAMN02599090,GCA_000664165.1,JKLB00000000,-,Broad Institute,WGS,Illumina,44.0x,allpaths v. R48559,,,83.0,88.0,4395746.0,65.6,4370.0,,3996.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777700003771;spol db4:CAS;st no:142;is6110 copy:13;pattern:AV,2014-12-08T22:12:12.295Z,2015-03-16T03:17:09.594Z
1448745_3,Mycobacterium tuberculosis M2010,Mycobacterium tuberculosis M2010,1448745.0,WGS,M2010,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235757,SAMN02599091,GCA_000664185.1,JKLA00000000,-,Broad Institute,WGS,Illumina,75.0x,allpaths v. R48559,,,83.0,91.0,4410433.0,65.6,4374.0,,3994.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:3;pattern:A,2014-12-08T22:12:12.304Z,2015-03-16T03:17:09.594Z
1448746_3,Mycobacterium tuberculosis M2020,Mycobacterium tuberculosis M2020,1448746.0,WGS,M2020,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235758,SAMN02599092,GCA_000664205.1,JKKZ00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,62.0,67.0,4411041.0,65.6,4352.0,,4004.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777770771;spol db4:CAS;st no:1378;is6110 copy:4;pattern:F,2014-12-08T22:12:12.313Z,2015-03-16T03:17:09.594Z
1448747_3,Mycobacterium tuberculosis M2021,Mycobacterium tuberculosis M2021,1448747.0,WGS,M2021,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235759,SAMN02599093,GCA_000664225.1,JKKY00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,73.0,77.0,4407626.0,65.6,4378.0,,3979.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:1;pattern:A,2014-12-08T22:12:12.322Z,2015-03-16T03:17:09.594Z
1448748_3,Mycobacterium tuberculosis M2032,Mycobacterium tuberculosis M2032,1448748.0,WGS,M2032,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235760,SAMN02599094,GCA_000664245.1,JKKX00000000,-,Broad Institute,WGS,Illumina,76.0x,allpaths v. R48559,,,72.0,77.0,4410205.0,65.6,4383.0,,3980.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:1;pattern:A,2014-12-08T22:12:12.331Z,2015-03-16T03:17:09.594Z
1448749_3,Mycobacterium tuberculosis M2084,,1448749.0,WGS,M2084,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA235761,SAMN02599095,GCA_000706105.1,JKKW00000000,-,Broad Institute,,Illumina,87.0x,allpaths v. R48559,,,79.0,85.0,4396030.0,65.6,4290.0,,3973.0,,sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:17;pattern:F,2014-12-08T23:07:02.837Z,2015-03-16T03:17:09.594Z
1448750_3,Mycobacterium tuberculosis M2085,Mycobacterium tuberculosis M2085,1448750.0,WGS,M2085,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235762,SAMN02599096,GCA_000664265.1,JKKV00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,82.0,88.0,4377420.0,65.6,4358.0,,3978.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:17;pattern:F,2014-12-08T22:12:12.340Z,2015-03-16T03:17:09.594Z
1448751_3,Mycobacterium tuberculosis M2086,Mycobacterium tuberculosis M2086,1448751.0,WGS,M2086,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235763,SAMN02599097,GCA_000664285.1,JKKU00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,82.0,88.0,4380814.0,65.6,4370.0,,3981.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:14;pattern:X,2014-12-08T22:12:12.349Z,2015-03-16T03:17:09.594Z
1448752_3,Mycobacterium tuberculosis M2113,Mycobacterium tuberculosis M2113,1448752.0,WGS,M2113,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235764,SAMN02599098,GCA_000664305.1,JKKT00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,64.0,67.0,4402783.0,65.6,4366.0,,4016.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777770771;spol db4:CAS;st no:1378;is6110 copy:8;pattern:I,2014-12-08T22:12:12.358Z,2015-03-16T03:17:09.594Z
1448753_3,Mycobacterium tuberculosis M2116,Mycobacterium tuberculosis M2116,1448753.0,WGS,M2116,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235765,SAMN02599099,GCA_000664325.1,JKKS00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,72.0,79.0,4404336.0,65.6,4350.0,,3979.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:1;pattern:A,2014-12-08T22:12:12.367Z,2015-03-16T03:17:09.594Z
1448754_3,Mycobacterium tuberculosis M2128,Mycobacterium tuberculosis M2128,1448754.0,WGS,M2128,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235766,SAMN02599100,GCA_000664345.1,JKKR00000000,-,Broad Institute,WGS,Illumina,77.0x,allpaths v. R48559,,,70.0,75.0,4408968.0,65.6,4389.0,,3985.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777776413771;spol db4:Orphan;st no:EAI 5;is6110 copy:1;pattern:B,2014-12-08T22:12:12.376Z,2015-03-16T03:17:09.594Z
1448755_3,Mycobacterium tuberculosis M2129,Mycobacterium tuberculosis M2129,1448755.0,WGS,M2129,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235767,SAMN02599101,GCA_000664365.1,JKKQ00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,72.0,76.0,4412450.0,65.6,4367.0,,3982.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777776413771;spol db4:Orphan;st no:EAI 5;is6110 copy:1;pattern:B,2014-12-08T22:12:12.386Z,2015-03-16T03:17:09.594Z
1448756_3,Mycobacterium tuberculosis M2131,Mycobacterium tuberculosis M2131,1448756.0,WGS,M2131,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235768,SAMN02599102,GCA_000664385.1,JKKP00000000,-,Broad Institute,WGS,Illumina,63.0x,allpaths v. R48559,,,81.0,86.0,4374130.0,65.6,4360.0,,3982.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:002000100003771;spol db4:Orphan;st no:Beijing;is6110 copy:14;pattern:I,2014-12-08T22:12:12.406Z,2015-03-16T03:17:09.594Z
1448757_3,Mycobacterium tuberculosis M2130,Mycobacterium tuberculosis M2130,1448757.0,WGS,M2130,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235769,SAMN02599103,GCA_000664405.1,JKKO00000000,-,Broad Institute,WGS,Illumina,54.0x,allpaths v. R48559,,,71.0,75.0,4378959.0,65.6,4344.0,,3983.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:002000100003771;spol db4:Orphan;st no:Beijing;is6110 copy:10;pattern:A,2014-12-08T22:12:12.395Z,2015-03-16T03:17:09.594Z
1448758_3,Mycobacterium tuberculosis M2132,Mycobacterium tuberculosis M2132,1448758.0,WGS,M2132,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235770,SAMN02599104,GCA_000664425.1,JKKN00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,66.0,72.0,4382151.0,65.6,4346.0,,3986.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777767737714771;spol db4:Orphan;st no:Family 33;is6110 copy:9;pattern:O,2014-12-08T22:12:12.417Z,2015-03-16T03:17:09.594Z
1448759_3,Mycobacterium tuberculosis M2134,Mycobacterium tuberculosis M2134,1448759.0,WGS,M2134,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235771,SAMN02599105,GCA_000664445.1,JKKM00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,71.0,76.0,4417649.0,65.6,4399.0,,3999.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:702276137513731;spol db4:Orphan;st no:Family33;is6110 copy:1;pattern:A,2014-12-08T22:12:12.426Z,2015-03-16T03:17:09.594Z
1448760_3,Mycobacterium tuberculosis M2136,Mycobacterium tuberculosis M2136,1448760.0,WGS,M2136,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235772,SAMN02599106,GCA_000664465.1,JKKL00000000,-,Broad Institute,WGS,Illumina,65.0x,allpaths v. R48559,,,77.0,82.0,4408293.0,65.6,4368.0,,3983.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777774413011;spol db4:Orphan;st no:EAI3;is6110 copy:NO COPY,2014-12-08T22:12:12.434Z,2015-03-16T03:17:09.594Z
1448761_3,Mycobacterium tuberculosis M2137,Mycobacterium tuberculosis M2137,1448761.0,WGS,M2137,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235773,SAMN02599107,GCA_000664485.1,JKKK00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R48559,,,75.0,80.0,4405166.0,65.6,4377.0,,3991.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777517731;spol db4:Orphan;st no:Family33;is6110 copy:NO COPY,2014-12-08T22:12:12.443Z,2015-03-16T03:17:09.594Z
1448762_3,Mycobacterium tuberculosis M2139,Mycobacterium tuberculosis M2139,1448762.0,WGS,M2139,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235774,SAMN02599108,GCA_000664505.1,JKKJ00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,73.0,79.0,4394639.0,65.6,4342.0,,3966.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777567537417071;spol db4:Orphan;st no:Family 33;is6110 copy:1;pattern:A,2014-12-08T22:12:12.459Z,2015-03-16T03:17:09.594Z
1448763_3,Mycobacterium tuberculosis M2138,Mycobacterium tuberculosis M2138,1448763.0,WGS,M2138,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235775,SAMN02599109,GCA_000664525.1,JKKI00000000,-,Broad Institute,WGS,Illumina,75.0x,allpaths v. R48559,,,75.0,81.0,4389135.0,65.6,4377.0,,3984.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777574107413771;spol db4:Orphan;st no:Orphan;is6110 copy:13;pattern:AX,2014-12-08T22:12:12.451Z,2015-03-16T03:17:09.594Z
1448764_3,Mycobacterium tuberculosis M2140,Mycobacterium tuberculosis M2140,1448764.0,WGS,M2140,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235776,SAMN02599110,GCA_000664545.1,JKKH00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,76.0,80.0,4403593.0,65.6,4372.0,,3993.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:1;pattern:A,2014-12-08T22:12:12.468Z,2015-03-16T03:17:09.594Z
1448765_3,Mycobacterium tuberculosis M2248,Mycobacterium tuberculosis M2248,1448765.0,WGS,M2248,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235777,SAMN02599111,GCA_000664565.1,JKKG00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,79.0,84.0,4405516.0,65.6,4373.0,,4007.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:13;pattern:W,2014-12-08T22:12:12.591Z,2015-03-16T03:17:09.594Z
1448766_3,Mycobacterium tuberculosis M2218,Mycobacterium tuberculosis M2218,1448766.0,WGS,M2218,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235778,SAMN02599112,GCA_000664585.1,JKKF00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,71.0,76.0,4410842.0,65.6,4374.0,,3982.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:467777777413071;spol db4:Orphan;st no:EAI3;is6110 copy:1;pattern:A,2014-12-08T22:12:12.582Z,2015-03-16T03:17:09.594Z
1448767_3,Mycobacterium tuberculosis M2211,Mycobacterium tuberculosis M2211,1448767.0,WGS,M2211,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235779,SAMN02599113,GCA_000664605.1,JKKE00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,78.0,84.0,4414197.0,65.6,4403.0,,3997.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777774007413771;spol db4:Orphan;st no:Orphan;is6110 copy:8;pattern:AQ,2014-12-08T22:12:12.573Z,2015-03-16T03:17:09.594Z
1448768_3,Mycobacterium tuberculosis M2206,Mycobacterium tuberculosis M2206,1448768.0,WGS,M2206,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235780,SAMN02599114,GCA_000664625.1,JKKD00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,71.0,80.0,4396986.0,65.6,4375.0,,3978.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:475767637402070;spol db4:Orphan;st no:EAI3;is6110 copy:3;pattern:B,2014-12-08T22:12:12.565Z,2015-03-16T03:17:09.594Z
1448769_3,Mycobacterium tuberculosis M2204,Mycobacterium tuberculosis M2204,1448769.0,WGS,M2204,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235781,SAMN02599115,GCA_000664645.1,JKKC00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,81.0,86.0,4374930.0,65.6,4344.0,,3977.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:13;pattern:AU,2014-12-08T22:12:12.556Z,2015-03-16T03:17:09.594Z
1448770_3,Mycobacterium tuberculosis M2203,Mycobacterium tuberculosis M2203,1448770.0,WGS,M2203,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235782,SAMN02599116,GCA_000664665.1,JKKB00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,74.0,79.0,4419644.0,65.6,4372.0,,3997.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777747777413731;spol db4:Orphan;st no:EAI 5;is6110 copy:1;pattern:A,2014-12-08T22:12:12.547Z,2015-03-16T03:17:09.594Z
1448771_3,Mycobacterium tuberculosis M2199,Mycobacterium tuberculosis M2199,1448771.0,WGS,M2199,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235783,SAMN02599117,GCA_000664685.1,JKKA00000000,-,Broad Institute,WGS,Illumina,74.0x,allpaths v. R48559,,,70.0,77.0,4393543.0,65.6,4356.0,,4016.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:776377777770771;spol db4:Orphan;st no:T1;is6110 copy:7;pattern:S,2014-12-08T22:12:12.538Z,2015-03-16T03:17:09.594Z
1448772_3,Mycobacterium tuberculosis M2198,Mycobacterium tuberculosis M2198,1448772.0,WGS,M2198,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235784,SAMN02599118,GCA_000664705.1,JKJZ00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,73.0,79.0,4400873.0,65.6,4385.0,,3985.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:401777777413071;spol db4:Orphan;st no:EAI3;is6110 copy:2;pattern:A,2014-12-08T22:12:12.529Z,2015-03-16T03:17:09.594Z
1448773_3,Mycobacterium tuberculosis M2193,,1448773.0,WGS,M2193,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA235785,SAMN02599119,GCA_000706085.1,JKJY00000000,-,Broad Institute,,Illumina,61.0x,allpaths v. R48559,,,77.0,82.0,4419020.0,65.6,4312.0,,4003.0,,sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:603777740003771;spol db4:CAS;st no:952;is6110 copy:13;pattern:N,2014-12-08T23:07:03.413Z,2015-03-16T03:17:09.594Z
1448774_3,Mycobacterium tuberculosis M2192,Mycobacterium tuberculosis M2192,1448774.0,WGS,M2192,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235786,SAMN02599120,GCA_000664725.1,JKJX00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,67.0,72.0,4411859.0,65.6,4361.0,,3978.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477747777413031;spol db4:Orphan;st no:EAI3;is6110 copy:1;pattern:A,2014-12-08T22:12:12.521Z,2015-03-16T03:17:09.594Z
1448775_3,Mycobacterium tuberculosis M2191,Mycobacterium tuberculosis M2191,1448775.0,WGS,M2191,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235787,SAMN02599121,GCA_000664745.1,JKJW00000000,-,Broad Institute,WGS,Illumina,92.0x,allpaths v. R48559,,,78.0,83.0,4393127.0,65.6,4360.0,,3989.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:12;pattern:BI,2014-12-08T22:12:12.512Z,2015-03-16T03:17:09.594Z
1448776_3,Mycobacterium tuberculosis M2141,Mycobacterium tuberculosis M2141,1448776.0,WGS,M2141,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235788,SAMN02599122,GCA_000664765.1,JKJV00000000,-,Broad Institute,WGS,Illumina,67.0x,allpaths v. R48559,,,89.0,96.0,4406213.0,65.6,4373.0,,3992.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:377600107417371;spol db4:Orphan;st no:Family 33;is6110 copy:10;pattern:BE,2014-12-08T22:12:12.476Z,2015-03-16T03:17:09.594Z
1448777_3,Mycobacterium tuberculosis M2352,Mycobacterium tuberculosis M2352,1448777.0,WGS,M2352,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235789,SAMN02599123,GCA_000658395.1,JKJU00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,78.0,86.0,4412165.0,65.59,4415.0,,4009.0,,sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:1;pattern:A,2014-12-08T22:12:12.703Z,2015-03-16T03:17:09.594Z
1448778_3,Mycobacterium tuberculosis M2343,Mycobacterium tuberculosis M2343,1448778.0,WGS,M2343,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235790,SAMN02599124,GCA_000664785.1,JKJT00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,74.0,79.0,4410021.0,65.6,4375.0,,3979.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:1;pattern:A,2014-12-08T22:12:12.673Z,2015-03-16T03:17:09.594Z
1448779_3,Mycobacterium tuberculosis M2342,Mycobacterium tuberculosis M2342,1448779.0,WGS,M2342,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235791,SAMN02599125,GCA_000664805.1,JKJS00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,67.0,70.0,4418233.0,65.6,4377.0,,3979.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:1;pattern:A,2014-12-08T22:12:12.664Z,2015-03-16T03:17:09.594Z
1448780_3,Mycobacterium tuberculosis M2324,Mycobacterium tuberculosis M2324,1448780.0,WGS,M2324,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235792,SAMN02599126,GCA_000664825.1,JKJR00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,77.0,82.0,4405552.0,65.6,4349.0,,4001.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:700377740003771;spol db4:CAS2;st no:288;is6110 copy:10;pattern:G,2014-12-08T22:12:12.654Z,2015-03-16T03:17:09.594Z
1448781_3,Mycobacterium tuberculosis M2323,Mycobacterium tuberculosis M2323,1448781.0,WGS,M2323,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235793,SAMN02599127,GCA_000664845.1,JKJQ00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,81.0,85.0,4400436.0,65.6,4354.0,,3999.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:700377740003771;spol db4:CAS2;st no:288;is6110 copy:10;pattern:G,2014-12-08T22:12:12.645Z,2015-03-16T03:17:09.594Z
1448783_3,Mycobacterium tuberculosis M2278,Mycobacterium tuberculosis M2278,1448783.0,WGS,M2278,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235795,SAMN02599129,GCA_000664865.1,JKJP00000000,-,Broad Institute,WGS,Illumina,89.0x,allpaths v. R48559,,,72.0,76.0,4397305.0,65.6,4379.0,,3972.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:1;pattern:A,2014-12-08T22:12:12.636Z,2015-03-16T03:17:09.594Z
1448784_3,Mycobacterium tuberculosis M2277,Mycobacterium tuberculosis M2277,1448784.0,WGS,M2277,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235796,SAMN02599130,GCA_000664885.1,JKJO00000000,-,Broad Institute,WGS,Illumina,77.0x,allpaths v. R48559,,,79.0,83.0,4394658.0,65.6,4347.0,,3991.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:10;pattern:J,2014-12-08T22:12:12.627Z,2015-03-16T03:17:09.594Z
1448785_3,Mycobacterium tuberculosis M2276,Mycobacterium tuberculosis M2276,1448785.0,WGS,M2276,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235797,SAMN02599131,GCA_000664905.1,JKJN00000000,-,Broad Institute,WGS,Illumina,80.0x,allpaths v. R48559,,,81.0,87.0,4391211.0,65.6,4351.0,,3993.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:10;pattern:J,2014-12-08T22:12:12.618Z,2015-03-16T03:17:09.594Z
1448786_3,Mycobacterium tuberculosis M2259,Mycobacterium tuberculosis M2259,1448786.0,WGS,M2259,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235798,SAMN02599132,GCA_000664925.1,JKJM00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,74.0,79.0,4417218.0,65.6,4412.0,,3993.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413731;spol db4:EAI1_SOM;st no:48;is6110 copy:1;pattern:B,2014-12-08T22:12:12.609Z,2015-03-16T03:17:09.594Z
1448787_3,Mycobacterium tuberculosis M2249,Mycobacterium tuberculosis M2249,1448787.0,WGS,M2249,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235799,SAMN02599133,GCA_000664945.1,JKJL00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,73.0,78.0,4394740.0,65.6,4353.0,,3998.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703400000000000;spol db4:CAS;st no:873;is6110 copy:6;pattern:BB,2014-12-08T22:12:12.600Z,2015-03-16T03:17:09.594Z
1448788_3,Mycobacterium tuberculosis M2142,Mycobacterium tuberculosis M2142,1448788.0,WGS,M2142,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235800,SAMN02599134,GCA_000664965.1,JKJK00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,76.0,84.0,4403898.0,65.6,4369.0,,3980.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777517771;spol db4:Orphan;st no:Family 33;is6110 copy:1;pattern:A,2014-12-08T22:12:12.485Z,2015-03-16T03:17:09.594Z
1448789_3,Mycobacterium tuberculosis M2459,Mycobacterium tuberculosis M2459,1448789.0,WGS,M2459,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235801,SAMN02599135,GCA_000664985.1,JKJJ00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,83.0,86.0,4379332.0,65.6,4329.0,,3984.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:16;pattern:M,2014-12-08T22:12:12.790Z,2015-03-16T03:17:09.594Z
1448790_3,Mycobacterium tuberculosis M2442,Mycobacterium tuberculosis M2442,1448790.0,WGS,M2442,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235802,SAMN02599136,GCA_000665005.1,JKJI00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,85.0,93.0,4420924.0,65.6,4407.0,,4018.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:7;pattern:AW,2014-12-08T22:12:12.781Z,2015-03-16T03:17:09.594Z
1448791_3,Mycobacterium tuberculosis M2440,Mycobacterium tuberculosis M2440,1448791.0,WGS,M2440,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235803,SAMN02599137,GCA_000665025.1,JKJH00000000,-,Broad Institute,WGS,Illumina,70.0x,allpaths v. R48559,,,81.0,85.0,4403083.0,65.6,4340.0,,3992.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:13;pattern:AV,2014-12-08T22:12:12.773Z,2015-03-16T03:17:09.594Z
1448792_3,Mycobacterium tuberculosis M2435,Mycobacterium tuberculosis M2435,1448792.0,WGS,M2435,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235804,SAMN02599138,GCA_000665045.1,JKJG00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,72.0,77.0,4408191.0,65.6,4355.0,,3973.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:11;pattern:AY,2014-12-08T22:12:12.765Z,2015-03-16T03:17:09.594Z
1448794_3,Mycobacterium tuberculosis M2416,Mycobacterium tuberculosis M2416,1448794.0,WGS,M2416,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235806,SAMN02599140,GCA_000665065.1,JKJF00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,76.0,83.0,4402667.0,65.6,4366.0,,3982.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:1;pattern:A,2014-12-08T22:12:12.756Z,2015-03-16T03:17:09.594Z
1448795_3,Mycobacterium tuberculosis M2402,Mycobacterium tuberculosis M2402,1448795.0,WGS,M2402,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235807,SAMN02599141,GCA_000665085.1,JKJE00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,79.0,81.0,4415852.0,65.6,4388.0,,4007.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703777740003771;spol db4:CAS1_DELHI;st no:26;is6110 copy:12;pattern:P,2014-12-08T22:12:12.748Z,2015-03-16T03:17:09.594Z
1448796_3,Mycobacterium tuberculosis M2376,Mycobacterium tuberculosis M2376,1448796.0,WGS,M2376,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235808,SAMN02599142,GCA_000665105.1,JKJD00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,82.0,85.0,4402257.0,65.6,4376.0,,4002.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:700377740003771;spol db4:CAS2;st no:288;is6110 copy:13;pattern:BG,2014-12-08T22:12:12.730Z,2015-03-16T03:17:09.594Z
1448797_3,Mycobacterium tuberculosis M2361,Mycobacterium tuberculosis M2361,1448797.0,WGS,M2361,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235809,SAMN02599143,GCA_000665125.1,JKJC00000000,-,Broad Institute,WGS,Illumina,90.0x,allpaths v. R48559,,,84.0,89.0,4375362.0,65.6,4329.0,,3983.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:17;pattern:H,2014-12-08T22:12:12.721Z,2015-03-16T03:17:09.594Z
1448798_3,Mycobacterium tuberculosis M2360,Mycobacterium tuberculosis M2360,1448798.0,WGS,M2360,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235810,SAMN02599144,GCA_000665145.1,JKJB00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,82.0,86.0,4377134.0,65.6,4342.0,,3982.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:BEIJING;st no:1;is6110 copy:17;pattern:H,2014-12-08T22:12:12.713Z,2015-03-16T03:17:09.594Z
1448799_3,Mycobacterium tuberculosis M2145,Mycobacterium tuberculosis M2145,1448799.0,WGS,M2145,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235811,SAMN02599145,GCA_000665165.1,JKJA00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,70.0,76.0,4408900.0,65.6,4375.0,,3983.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477767777412071;spol db4:Orphan;st no:EAI3;is6110 copy:1;pattern:D,2014-12-08T22:12:12.503Z,2015-03-16T03:17:09.594Z
1448800_3,Mycobacterium tuberculosis M2144,Mycobacterium tuberculosis M2144,1448800.0,WGS,M2144,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235812,SAMN02599146,GCA_000665185.1,JKIZ00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,69.0,74.0,4407404.0,65.6,4377.0,,3973.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:NO COPY,2014-12-08T22:12:12.494Z,2015-03-16T03:17:09.594Z
1448801_3,Mycobacterium tuberculosis M2479,Mycobacterium tuberculosis M2479,1448801.0,WGS,M2479,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235813,SAMN02599147,GCA_000665205.1,JKIY00000000,-,Broad Institute,WGS,Illumina,80.0x,allpaths v. R48559,,,88.0,92.0,4407780.0,65.6,4381.0,,4016.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:700377740003771;spol db4:CAS2;st no:288;is6110 copy:13;pattern:AY,2014-12-08T22:12:12.799Z,2015-03-16T03:17:09.594Z
1448802_3,Mycobacterium tuberculosis M2384,Mycobacterium tuberculosis M2384,1448802.0,WGS,M2384,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235814,SAMN02599148,GCA_000665225.1,JKIX00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,66.0,67.0,4417155.0,65.6,4375.0,,3976.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:1;pattern:B,2014-12-08T22:12:12.739Z,2015-03-16T03:17:09.594Z
1448803_3,Mycobacterium tuberculosis M2508,Mycobacterium tuberculosis M2508,1448803.0,WGS,M2508,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235815,SAMN02599149,GCA_000665245.1,JKIW00000000,-,Broad Institute,WGS,Illumina,88.0x,allpaths v. R48559,,,68.0,72.0,4390426.0,65.6,4340.0,,3990.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:703400000000000;spol db4:CAS;st no:873;is6110 copy:6;pattern:BB,2014-12-08T22:12:12.807Z,2015-03-16T03:17:09.594Z
1448804_3,Mycobacterium tuberculosis H1329,Mycobacterium tuberculosis H1329,1448804.0,WGS,H1329,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235816,SAMN02599150,GCA_000665265.1,JKIV00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,74.0,79.0,4360040.0,65.6,4339.0,,3968.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:Beijing;st no:1;is6110 copy:11;pattern:S,2014-12-08T22:12:10.074Z,2015-03-16T03:17:09.594Z
1448806_3,Mycobacterium tuberculosis H1580,Mycobacterium tuberculosis H1580,1448806.0,WGS,H1580,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235818,SAMN02599152,GCA_000665305.1,JKIT00000000,-,Broad Institute,WGS,Illumina,81.0x,allpaths v. R48559,,,74.0,79.0,4403713.0,65.6,4381.0,,3980.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413771;spol db4:EAI5;st no:126;is6110 copy:1;pattern:A,2014-12-08T22:12:10.084Z,2015-03-16T03:17:09.594Z
1448807_3,Mycobacterium tuberculosis H1589,Mycobacterium tuberculosis H1589,1448807.0,WGS,H1589,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235819,SAMN02599153,GCA_000665325.1,JKIS00000000,-,Broad Institute,WGS,Illumina,80.0x,allpaths v. R48559,,,72.0,78.0,4397154.0,65.6,4370.0,,3975.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:10.093Z,2015-03-16T03:17:09.594Z
1448808_3,Mycobacterium tuberculosis H1856,Mycobacterium tuberculosis H1856,1448808.0,WGS,H1856,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235820,SAMN02599154,GCA_000665345.1,JKIR00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,81.0,88.0,4368541.0,65.6,4342.0,,3980.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:Beijing;st no:1;is6110 copy:16;pattern:G,2014-12-08T22:12:10.102Z,2015-03-16T03:17:09.594Z
1448810_3,Mycobacterium tuberculosis H2101,Mycobacterium tuberculosis H2101,1448810.0,WGS,H2101,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235822,SAMN02599156,GCA_000665365.1,JKIQ00000000,-,Broad Institute,WGS,Illumina,44.0x,allpaths v. R48559,,,73.0,79.0,4389561.0,65.6,4342.0,,3989.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:700377740003771;spol db4:CAS;st no:288;is6110 copy:14;pattern:I,2014-12-08T22:12:10.121Z,2015-03-16T03:17:09.594Z
1448811_3,Mycobacterium tuberculosis H2102,Mycobacterium tuberculosis H2102,1448811.0,WGS,H2102,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235823,SAMN02599157,GCA_000665385.1,JKIP00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,85.0,95.0,4383054.0,65.6,4352.0,,3974.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:757777757413771;spol db4:EAI6_BGD1;st no:889;is6110 copy:12;pattern:AD,2014-12-08T22:12:10.129Z,2015-03-16T03:17:09.594Z
1448812_3,Mycobacterium tuberculosis H2300,Mycobacterium tuberculosis H2300,1448812.0,WGS,H2300,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235824,SAMN02599158,GCA_000665405.1,JKIO00000000,-,Broad Institute,WGS,Illumina,59.0x,allpaths v. R48559,,,82.0,86.0,4368769.0,65.6,4337.0,,3979.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:Beijing;st no:1;is6110 copy:15;pattern:U,2014-12-08T22:12:10.147Z,2015-03-16T03:17:09.594Z
1448813_3,Mycobacterium tuberculosis H2438,Mycobacterium tuberculosis H2438,1448813.0,WGS,H2438,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235825,SAMN02599159,GCA_000665425.1,JKIN00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,79.0,84.0,4394774.0,65.6,4359.0,,3965.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413031;spol db4:EAI5;st no:355;is6110 copy:2;pattern:H,2014-12-08T22:12:10.165Z,2015-03-16T03:17:09.594Z
1448814_3,Mycobacterium tuberculosis H2760,Mycobacterium tuberculosis H2760,1448814.0,WGS,H2760,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235826,SAMN02599160,GCA_000665445.1,JKIM00000000,-,Broad Institute,WGS,Illumina,84.0x,allpaths v. R48559,,,74.0,77.0,4429893.0,65.6,4401.0,,3985.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI5;st no:355;is6110 copy:1;pattern:A,2014-12-08T22:12:10.201Z,2015-03-16T03:17:09.594Z
1448815_3,Mycobacterium tuberculosis H3004,Mycobacterium tuberculosis H3004,1448815.0,WGS,H3004,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235827,SAMN02599161,GCA_000665465.1,JKIL00000000,-,Broad Institute,WGS,Illumina,56.0x,allpaths v. R48559,,,82.0,84.0,4401269.0,65.6,4358.0,,3966.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:775377717413771;spol db4:EAI5;st no:Orphan;is6110 copy:10;pattern:AG,2014-12-08T22:12:10.210Z,2015-03-16T03:17:09.594Z
1448816_3,Mycobacterium tuberculosis H3005,Mycobacterium tuberculosis H3005,1448816.0,WGS,H3005,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235828,SAMN02599162,GCA_000665485.1,JKIK00000000,-,Broad Institute,WGS,Illumina,79.0x,allpaths v. R48559,,,68.0,71.0,4417897.0,65.6,4372.0,,3976.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3;st no:11;is6110 copy:1;pattern:A,2014-12-08T22:12:10.220Z,2015-03-16T03:17:09.594Z
1448817_3,Mycobacterium tuberculosis H3033,Mycobacterium tuberculosis H3033,1448817.0,WGS,H3033,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235829,SAMN02599163,GCA_000665505.1,JKIJ00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,79.0,85.0,4407571.0,65.6,4380.0,,3985.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3;st no:11;is6110 copy:4;pattern:V,2014-12-08T22:12:10.228Z,2015-03-16T03:17:09.594Z
1448818_3,Mycobacterium tuberculosis H3360,Mycobacterium tuberculosis H3360,1448818.0,WGS,H3360,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235830,SAMN02599164,GCA_000665525.1,JKII00000000,-,Broad Institute,WGS,Illumina,73.0x,allpaths v. R48559,,,82.0,89.0,4370282.0,65.6,4333.0,,3981.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:Beijing;st no:1;is6110 copy:16;pattern:A,2014-12-08T22:12:10.246Z,2015-03-16T03:17:09.594Z
1448819_3,Mycobacterium tuberculosis H3361,Mycobacterium tuberculosis H3361,1448819.0,WGS,H3361,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235831,SAMN02599165,GCA_000665545.1,JKIH00000000,-,Broad Institute,WGS,Illumina,66.0x,allpaths v. R48559,,,69.0,72.0,4436651.0,65.6,4389.0,,3989.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777410031;spol db4:Orphan;st no:Orphan;is6110 copy:1;pattern:E,2014-12-08T22:12:10.256Z,2015-03-16T03:17:09.594Z
1448821_3,Mycobacterium tuberculosis H2463,Mycobacterium tuberculosis H2463,1448821.0,WGS,H2463,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235833,SAMN02599167,GCA_000665565.1,JKIG00000000,-,Broad Institute,WGS,Illumina,85.0x,allpaths v. R48559,,,72.0,76.0,4396311.0,65.6,4365.0,,3964.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3;st no:11;is6110 copy:3;pattern:G,2014-12-08T22:12:10.174Z,2015-03-16T03:17:09.594Z
1448822_3,Mycobacterium tuberculosis H2754,Mycobacterium tuberculosis H2754,1448822.0,WGS,H2754,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235834,SAMN02599168,GCA_000665585.1,JKIF00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,76.0,80.0,4405031.0,65.6,4367.0,,3967.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:474377777413771;spol db4:EAI5;st no:340;is6110 copy:1;pattern:A,2014-12-08T22:12:10.192Z,2015-03-16T03:17:09.594Z
1448823_3,Mycobacterium tuberculosis H3094,Mycobacterium tuberculosis H3094,1448823.0,WGS,H3094,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235835,SAMN02599169,GCA_000665605.1,JKIE00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,72.0,82.0,4402714.0,65.6,4353.0,,3984.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777413700;spol db4:EAI5;st no:138;is6110 copy:3;pattern:AI,2014-12-08T22:12:10.237Z,2015-03-16T03:17:09.594Z
1448824_3,Mycobacterium tuberculosis H3986,Mycobacterium tuberculosis H3986,1448824.0,WGS,H3986,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235836,SAMN02599170,GCA_000665625.1,JKID00000000,-,Broad Institute,WGS,Illumina,71.0x,allpaths v. R48559,,,71.0,77.0,4410003.0,65.6,4382.0,,3988.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:401777777410071;spol db4:U;st no:1488;is6110 copy:1;pattern:A,2014-12-08T22:12:10.346Z,2015-03-16T03:17:09.594Z
1448825_3,Mycobacterium tuberculosis H1249,Mycobacterium tuberculosis H1249,1448825.0,WGS,H1249,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235837,SAMN02599171,GCA_000665645.1,JKIC00000000,-,Broad Institute,WGS,Illumina,65.0x,allpaths v. R48559,,,64.0,68.0,4422815.0,65.6,4391.0,,3992.0,,Sputum,,2002,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777003731;spol db4:EAI5;st no:Orphan;is6110 copy:1;pattern:B,2014-12-08T22:12:10.065Z,2015-03-16T03:17:09.594Z
1448826_3,Mycobacterium tuberculosis H1996,Mycobacterium tuberculosis H1996,1448826.0,WGS,H1996,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235838,SAMN02599172,GCA_000665665.1,JKIB00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,75.0,75.0,4420153.0,65.6,4378.0,,3985.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3;st no:11;is6110 copy:6;pattern:AB,2014-12-08T22:12:10.111Z,2015-03-16T03:17:09.594Z
1448827_3,Mycobacterium tuberculosis H2375,,1448827.0,WGS,H2375,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA235839,SAMN02599173,GCA_000706065.1,JKIA00000000,-,Broad Institute,,Illumina,85.0x,allpaths v. R48559,,,69.0,74.0,4423530.0,65.6,4308.0,,3965.0,,sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3;st no:11;is6110 copy:3;pattern:G,2014-12-08T23:07:04.812Z,2015-03-16T03:17:09.594Z
1448828_3,Mycobacterium tuberculosis H2581,Mycobacterium tuberculosis H2581,1448828.0,WGS,H2581,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235840,SAMN02599174,GCA_000665685.1,JKHZ00000000,-,Broad Institute,WGS,Illumina,76.0x,allpaths v. R48559,,,84.0,88.0,4379064.0,65.6,4337.0,,3983.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:000000000003771;spol db4:Beijing;st no:1;is6110 copy:15;pattern:R,2014-12-08T22:12:10.183Z,2015-03-16T03:17:09.594Z
1448829_3,Mycobacterium tuberculosis H2264,Mycobacterium tuberculosis H2264,1448829.0,WGS,H2264,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235841,SAMN02599175,GCA_000665705.1,JKHY00000000,-,Broad Institute,WGS,Illumina,87.0x,allpaths v. R48559,,,74.0,79.0,4402091.0,65.6,4372.0,,3987.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777413071;spol db4:EAI3;st no:11;is6110 copy:6;pattern:P,2014-12-08T22:12:10.138Z,2015-03-16T03:17:09.594Z
1448830_3,Mycobacterium tuberculosis H2398,Mycobacterium tuberculosis H2398,1448830.0,WGS,H2398,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235842,SAMN02599176,GCA_000665725.1,JKHX00000000,-,Broad Institute,WGS,Illumina,54.0x,allpaths v. R48559,,,64.0,65.0,4425648.0,65.6,4391.0,,3984.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:700377700003771;spol db4:CAS;st no:Orphan;is6110 copy:10;pattern:BS,2014-12-08T22:12:10.157Z,2015-03-16T03:17:09.594Z
1448831_3,Mycobacterium tuberculosis H1964,,1448831.0,WGS,H1964,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA235843,SAMN02599177,GCA_000706045.1,JKHW00000000,-,Broad Institute,,Illumina,69.0x,allpaths v. R48559,,,93.0,97.0,4421160.0,65.6,4326.0,,4010.0,,sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:503707600003771;spol db4:CAS;st no:Orphan;is6110 copy:12;pattern:X,2014-12-08T23:07:05.265Z,2015-03-16T03:17:09.594Z
1448833_3,Mycobacterium tuberculosis H3367,Mycobacterium tuberculosis H3367,1448833.0,WGS,H3367,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235845,SAMN02599179,GCA_000665745.1,JKHV00000000,-,Broad Institute,WGS,Illumina,56.0x,allpaths v. R48559,,,98.0,108.0,4386575.0,65.6,4351.0,,3978.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,comorbidity:HIV Positive,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:475777737413771;spol db4:EAI5;st no:Orphan;is6110 copy:1;pattern:A,2014-12-08T22:12:10.265Z,2015-03-16T03:17:09.594Z
1448834_3,Mycobacterium tuberculosis M2828,Mycobacterium tuberculosis M2828,1448834.0,WGS,M2828,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235846,SAMN02599180,GCA_000665765.1,JKHU00000000,-,Broad Institute,WGS,Illumina,69.0x,allpaths v. R48559,,,128.0,138.0,4374075.0,65.6,4350.0,,4001.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:717777777413771;spol db4:Orphan;st no:EAI5;is6110 copy:11;pattern:Z,2014-12-08T22:12:12.818Z,2015-03-16T03:17:09.594Z
1448835_3,Mycobacterium tuberculosis M2898,,1448835.0,WGS,M2898,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA235847,SAMN02599181,GCA_000706025.1,JKHT00000000,-,Broad Institute,,Illumina,85.0x,allpaths v. R48559,,,73.0,74.0,4406460.0,65.6,4307.0,,3990.0,,sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777777777700771;spol db4:U;st no:124;is6110 copy:4;pattern:AQ,2014-12-08T23:07:05.728Z,2015-03-16T03:17:09.594Z
1448836_3,Mycobacterium tuberculosis M2346,Mycobacterium tuberculosis M2346,1448836.0,WGS,M2346,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235848,SAMN02599182,GCA_000665785.1,JKHS00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,77.0,82.0,4412600.0,65.6,4381.0,,3993.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:477777777412071;spol db4:EAI5;st no:625;is6110 copy:2;pattern:F,2014-12-08T22:12:12.683Z,2015-03-16T03:17:09.594Z
1448837_3,Mycobacterium tuberculosis M2350,Mycobacterium tuberculosis M2350,1448837.0,WGS,M2350,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235849,SAMN02599183,GCA_000665805.1,JKHR00000000,-,Broad Institute,WGS,Illumina,82.0x,allpaths v. R48559,,,70.0,77.0,4394093.0,65.6,4357.0,,3992.0,,Sputum,,2003,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:777776777760601;spol db4:X2;st no:137;is6110 copy:2;pattern:K,2014-12-08T22:12:12.693Z,2015-03-16T03:17:09.594Z
1448838_3,Mycobacterium tuberculosis M13,Mycobacterium tuberculosis M13,1448838.0,WGS,M13,,,,,,,,2014-04-29T00:00:00Z,,PRJNA235850,SAMN02599184,GCA_000665825.1,JKHQ00000000,-,Broad Institute,WGS,Illumina,86.0x,allpaths v. R48559,,,76.0,81.0,4417338.0,65.6,4369.0,,3978.0,,Sputum,,2000,India,India: Tiruvallur,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - India,octal code:403777777413731;spol db4:Orphan;st no:EAI 5;is6110 copy:2;pattern:A,2014-12-08T22:12:11.485Z,2015-03-16T03:17:09.594Z
1455263_3,Mycobacterium tuberculosis NRITLD44,Mycobacterium tuberculosis NRITLD44,1455263.0,WGS,NRITLD44,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237385,SAMN02628478,GCA_000657095.1,JJTF00000000,-,Broad Institute,WGS,Illumina,35.0x,allpaths v. R48559,,,203.0,215.0,4299747.0,65.4,4358.0,,4006.0,,,,2012,Iran,Iran,,,,,,"Human, Homo sapiens",M,34,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran44;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 24;microscopy ziehl-neelsen:Positive 2+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.388Z,2015-03-16T03:17:09.594Z
1455264_3,Mycobacterium tuberculosis NRITLD45,Mycobacterium tuberculosis NRITLD45,1455264.0,WGS,NRITLD45,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237386,SAMN02628479,GCA_000657115.1,JJTE00000000,-,Broad Institute,WGS,Illumina,91.0x,allpaths v. R48559,,,69.0,71.0,4419912.0,65.6,4393.0,,4027.0,,,,2013,Iran,Iran,,,,,,"Human, Homo sapiens",M,37,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran45;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 25;lineage:H4;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.397Z,2015-03-16T03:17:09.594Z
1455266_3,Mycobacterium tuberculosis NRITLD47,Mycobacterium tuberculosis NRITLD47,1455266.0,WGS,NRITLD47,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237388,SAMN02628481,GCA_000657135.1,JJTD00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,41.0,41.0,4388073.0,65.6,4344.0,,3988.0,,,,2009,Iran,Iran,,,,,,"Human, Homo sapiens",F,15,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran47;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 27;lineage:Beijing;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 500 colonies/tube,2014-12-08T22:12:14.407Z,2015-03-16T03:17:09.594Z
1455268_3,Mycobacterium tuberculosis NRITLD49,Mycobacterium tuberculosis NRITLD49,1455268.0,WGS,NRITLD49,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237390,SAMN02628483,GCA_000657155.1,JJTC00000000,-,Broad Institute,WGS,Illumina,67.0x,allpaths v. R48559,,,84.0,89.0,4377078.0,65.6,4344.0,,3978.0,,,,2013,Iran,Iran,,,,,,"Human, Homo sapiens",M,21,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran49;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 28;lineage:Beijing;microscopy ziehl-neelsen:Positive 2+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.416Z,2015-03-16T03:17:09.594Z
1455269_3,Mycobacterium tuberculosis NRITLD50,Mycobacterium tuberculosis NRITLD50,1455269.0,WGS,NRITLD50,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237391,SAMN02628484,GCA_000657175.1,JJTB00000000,-,Broad Institute,WGS,Illumina,66.0x,allpaths v. R48559,,,81.0,88.0,4370465.0,65.6,4341.0,,3977.0,,,,2013,Iran,Iran,,,,,,"Human, Homo sapiens",M,21,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran50;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 28;lineage:Beijing;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.425Z,2015-03-16T03:17:09.594Z
1455270_3,Mycobacterium tuberculosis NRITLD51,Mycobacterium tuberculosis NRITLD51,1455270.0,WGS,NRITLD51,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237392,SAMN02628485,GCA_000657195.1,JJTA00000000,-,Broad Institute,WGS,Illumina,117.0x,allpaths v. R48559,,,71.0,75.0,4363583.0,65.5,4342.0,,3982.0,,,,2012,Iran,Iran,,,,,,"Human, Homo sapiens",M,21,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran51;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 28;lineage:Beijing;microscopy ziehl-neelsen:Positive 2+;tb culture lowenstein-jensen:Positive More than 500 colonies/tube,2014-12-08T22:12:14.434Z,2015-03-16T03:17:09.594Z
1455272_3,Mycobacterium tuberculosis NRITLD53,Mycobacterium tuberculosis NRITLD53,1455272.0,WGS,NRITLD53,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237394,SAMN02628487,GCA_000657215.1,JJSZ00000000,-,Broad Institute,WGS,Illumina,26.0x,allpaths v. R48559,,,88.0,91.0,4373737.0,65.6,4335.0,,3968.0,,,,2013,Iran,Iran,,,,,,"Human, Homo sapiens",M,45,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran53;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 30;lineage:Beijing;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.444Z,2015-03-16T03:17:09.594Z
1455273_3,Mycobacterium tuberculosis NRITLD54,Mycobacterium tuberculosis NRITLD54,1455273.0,WGS,NRITLD54,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237395,SAMN02628488,GCA_000657235.1,JJSY00000000,-,Broad Institute,WGS,Illumina,47.0x,allpaths v. R48559,,,168.0,174.0,4324187.0,65.4,4379.0,,3996.0,,,,2012,Iran,Iran,,,,,,"Human, Homo sapiens",M,44,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran54;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 31;lineage:Beijing;microscopy ziehl-neelsen:Positive 1+;tb culture lowenstein-jensen:Positive More than 100 colonies/tube,2014-12-08T22:12:14.455Z,2015-03-16T03:17:09.594Z
1455274_3,Mycobacterium tuberculosis NRITLD55,Mycobacterium tuberculosis NRITLD55,1455274.0,WGS,NRITLD55,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237396,SAMN02628489,GCA_000657255.1,JJSX00000000,-,Broad Institute,WGS,Illumina,52.0x,allpaths v. R48559,,,86.0,90.0,4354471.0,65.5,4356.0,,3978.0,,,,2013,Iran,Iran,,,,,,"Human, Homo sapiens",F,43,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran55;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 32;lineage:Beijing;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.465Z,2015-03-16T03:17:09.594Z
1455275_3,Mycobacterium tuberculosis NRITLD56,Mycobacterium tuberculosis NRITLD56,1455275.0,WGS,NRITLD56,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237397,SAMN02628490,GCA_000657275.1,JJSW00000000,-,Broad Institute,WGS,Illumina,44.0x,allpaths v. R48559,,,97.0,107.0,4327378.0,65.5,4352.0,,3979.0,,,,2013,Iran,Iran,,,,,,"Human, Homo sapiens",M,40,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran56;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 33;lineage:Beijing;microscopy ziehl-neelsen:Positive 1+;tb culture lowenstein-jensen:Positive More than100 colonies/tube,2014-12-08T22:12:14.477Z,2015-03-16T03:17:09.594Z
1455276_3,Mycobacterium tuberculosis NRITLD57,Mycobacterium tuberculosis NRITLD57,1455276.0,WGS,NRITLD57,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237398,SAMN02628491,GCA_000657295.1,JJSV00000000,-,Broad Institute,WGS,Illumina,125.0x,allpaths v. R48559,,,46.0,48.0,4379439.0,65.6,4349.0,,3988.0,,,,2013,Iran,Iran,,,,,,"Human, Homo sapiens",M,27,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran57;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 34;lineage:T1;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 500 colonies/tube,2014-12-08T22:12:14.485Z,2015-03-16T03:17:09.594Z
1455278_3,Mycobacterium tuberculosis NRITLD59,Mycobacterium tuberculosis NRITLD59,1455278.0,WGS,NRITLD59,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237400,SAMN02628493,GCA_000657315.1,JJSU00000000,-,Broad Institute,WGS,Illumina,107.0x,allpaths v. R48559,,,74.0,75.0,4402646.0,65.6,4377.0,,4006.0,,,,2009,Iran,Iran,,,,,,"Human, Homo sapiens",M,25,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran59;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 36;lineage:Beijing;microscopy ziehl-neelsen:Positive 1+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.495Z,2015-03-16T03:17:09.594Z
1455283_3,Mycobacterium tuberculosis NRITLD09,Mycobacterium tuberculosis NRITLD09,1455283.0,WGS,NRITLD09,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237405,SAMN02628498,GCA_000657355.1,JJSS00000000,-,Broad Institute,WGS,Illumina,83.0x,allpaths v. R48559,,,176.0,192.0,4326771.0,65.5,4342.0,,3961.0,,,,2011,Iran,Iran,,,,,,"Human, Homo sapiens",M,20,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran09;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 5;lineage:Beijing;microscopy ziehl-neelsen:Positive 2+;tb culture lowenstein-jensen:Positive More than 100 colonies/tube,2014-12-08T22:12:14.232Z,2015-03-16T03:17:09.594Z
1455284_3,Mycobacterium tuberculosis NRITLD10,Mycobacterium tuberculosis NRITLD10,1455284.0,WGS,NRITLD10,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237406,SAMN02628499,GCA_000657375.1,JJSR00000000,-,Broad Institute,WGS,Illumina,73.0x,allpaths v. R48559,,,86.0,92.0,4372789.0,65.6,4321.0,,3972.0,,,,2010,Iran,Iran,,,,,,"Human, Homo sapiens",M,20,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran10;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 5;lineage:Beijing;microscopy ziehl-neelsen:Positive 2+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.241Z,2015-03-16T03:17:09.594Z
1455285_3,Mycobacterium tuberculosis NRITLD11,Mycobacterium tuberculosis NRITLD11,1455285.0,WGS,NRITLD11,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237407,SAMN02628500,GCA_000657395.1,JJSQ00000000,-,Broad Institute,WGS,Illumina,73.0x,allpaths v. R48559,,,82.0,88.0,4362401.0,65.6,4335.0,,3971.0,,,,2010,Iran,Iran,,,,,,"Human, Homo sapiens",M,20,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran11;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 5;lineage:Beijing;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.252Z,2015-03-16T03:17:09.594Z
1455286_3,Mycobacterium tuberculosis NRITLD12,Mycobacterium tuberculosis NRITLD12,1455286.0,WGS,NRITLD12,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237408,SAMN02628501,GCA_000657415.1,JJSP00000000,-,Broad Institute,WGS,Illumina,55.0x,allpaths v. R48559,,,255.0,259.0,4297201.0,65.4,4331.0,,3964.0,,,,2011,Iran,Iran,,,,,,"Human, Homo sapiens",M,20,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran12;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 5;lineage:Beijing;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.261Z,2015-03-16T03:17:09.594Z
1455287_3,Mycobacterium tuberculosis NRITLD13,Mycobacterium tuberculosis NRITLD13,1455287.0,WGS,NRITLD13,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237409,SAMN02628502,GCA_000657435.1,JJSO00000000,-,Broad Institute,WGS,Illumina,70.0x,allpaths v. R48559,,,87.0,90.0,4385787.0,65.6,4334.0,,3982.0,,,,2010,Iran,Iran,,,,,,"Human, Homo sapiens",M,20,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran13;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 5;lineage:Beijing;microscopy ziehl-neelsen:Positive 1+;tb culture lowenstein-jensen:Positive More than 100 colonies/tube,2014-12-08T22:12:14.270Z,2015-03-16T03:17:09.594Z
1455288_3,Mycobacterium tuberculosis NRITLD14,Mycobacterium tuberculosis NRITLD14,1455288.0,WGS,NRITLD14,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237410,SAMN02628503,GCA_000657455.1,JJSN00000000,-,Broad Institute,WGS,Illumina,59.0x,allpaths v. R48559,,,66.0,70.0,4399496.0,65.6,4356.0,,4019.0,,,,2013,Iran,Iran,,,,,,"Human, Homo sapiens",M,35,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran14;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 6;lineage:T1;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 100 colonies/tube,2014-12-08T22:12:14.278Z,2015-03-16T03:17:09.594Z
1455289_3,Mycobacterium tuberculosis NRITLD15,Mycobacterium tuberculosis NRITLD15,1455289.0,WGS,NRITLD15,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237411,SAMN02628504,GCA_000657475.1,JJSM00000000,-,Broad Institute,WGS,Illumina,70.0x,allpaths v. R48559,,,81.0,85.0,4372581.0,65.6,4341.0,,3976.0,,,,2012,Iran,Iran,,,,,,"Human, Homo sapiens",M,48,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran15;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 7;lineage:Beijing;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.287Z,2015-03-16T03:17:09.594Z
1455290_3,Mycobacterium tuberculosis NRITLD16,Mycobacterium tuberculosis NRITLD16,1455290.0,WGS,NRITLD16,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237412,SAMN02628505,GCA_000657495.1,JJSL00000000,-,Broad Institute,WGS,Illumina,73.0x,allpaths v. R48559,,,83.0,88.0,4375832.0,65.6,4346.0,,3978.0,,,,2010,Iran,Iran,,,,,,"Human, Homo sapiens",M,48,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran16;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 7;lineage:Beijing;microscopy ziehl-neelsen:Positive 1+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.296Z,2015-03-16T03:17:09.594Z
1455291_3,Mycobacterium tuberculosis NRITLD17,Mycobacterium tuberculosis NRITLD17,1455291.0,WGS,NRITLD17,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237413,SAMN02628506,GCA_000657515.1,JJSK00000000,-,Broad Institute,WGS,Illumina,39.0x,allpaths v. R48559,,,77.0,78.0,4409418.0,65.6,4358.0,,3998.0,,,,2011,Iran,Iran,,,,,,"Human, Homo sapiens",F,31,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran17;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 8;lineage:CAS1-DEL;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 100 colonies/tube,2014-12-08T22:12:14.304Z,2015-03-16T03:17:09.594Z
1455292_3,Mycobacterium tuberculosis NRITLD18,,1455292.0,WGS,NRITLD18,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA237414,SAMN02628507,GCA_000711645.1,JJSJ00000000,-,Broad Institute,,Illumina,29.0x,allpaths v. R48559,,,94.0,94.0,4400600.0,65.6,4302.0,,4005.0,,,,2012,Iran,Iran,,,,,,"Human, Homo sapiens",M,90,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran18;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 9;lineage:Beijing;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T23:08:04.394Z,2015-03-16T03:17:09.594Z
1455294_3,Mycobacterium tuberculosis NRITLD20,Mycobacterium tuberculosis NRITLD20,1455294.0,WGS,NRITLD20,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237416,SAMN02628509,GCA_000657555.1,JJSH00000000,-,Broad Institute,WGS,Illumina,48.0x,allpaths v. R48559,,,87.0,90.0,4399483.0,65.5,4389.0,,4023.0,,,,2009,Iran,Iran,,,,,,"Human, Homo sapiens",F,31,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran20;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 11;lineage:H4;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 100 colonies/tube,2014-12-08T22:12:14.322Z,2015-03-16T03:17:09.594Z
1455295_3,Mycobacterium tuberculosis NRITLD21,Mycobacterium tuberculosis NRITLD21,1455295.0,WGS,NRITLD21,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237417,SAMN02628510,GCA_000657575.1,JJSG00000000,-,Broad Institute,WGS,Illumina,55.0x,allpaths v. R48559,,,86.0,93.0,4358500.0,65.6,4354.0,,3977.0,,,,2012,Iran,Iran,,,,,,"Human, Homo sapiens",M,45,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran21;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 12;lineage:Beijing;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 500 colonies/tube,2014-12-08T22:12:14.332Z,2015-03-16T03:17:09.594Z
1455302_3,Mycobacterium tuberculosis NRITLD28,,1455302.0,WGS,NRITLD28,,,,,,,,2014-06-12T00:00:00Z,-,PRJNA237424,SAMN02628517,GCA_000705705.1,JJSF00000000,-,Broad Institute,,Illumina,68.0x,allpaths v. R48559,,,95.0,96.0,4417440.0,65.6,4332.0,,4006.0,,,,2012,Iran,Iran,,,,,,"Human, Homo sapiens",M,39,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran28;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 37;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 500 colonies/tube,2014-12-08T23:08:04.888Z,2015-03-16T03:17:09.594Z
1455305_3,Mycobacterium tuberculosis NRITLD31,Mycobacterium tuberculosis NRITLD31,1455305.0,WGS,NRITLD31,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237427,SAMN02628520,GCA_000657595.1,JJSE00000000,-,Broad Institute,WGS,Illumina,58.0x,allpaths v. R48559,,,67.0,71.0,4380811.0,65.6,4329.0,,3987.0,,,,2013,Iran,Iran,,,,,,"Human, Homo sapiens",M,44,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran31;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 18;lineage:T1;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.340Z,2015-03-16T03:17:09.594Z
1455307_3,Mycobacterium tuberculosis NRITLD33,Mycobacterium tuberculosis NRITLD33,1455307.0,WGS,NRITLD33,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237429,SAMN02628522,GCA_000657615.1,JJSD00000000,-,Broad Institute,WGS,Illumina,114.0x,allpaths v. R48559,,,42.0,45.0,4412381.0,65.6,4383.0,,4021.0,,,,2012,Iran,Iran,,,,,,"Human, Homo sapiens",M,54,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran33;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 19;lineage:CAS1-DEL;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.350Z,2015-03-16T03:17:09.594Z
1455308_3,Mycobacterium tuberculosis NRITLD34,Mycobacterium tuberculosis NRITLD34,1455308.0,WGS,NRITLD34,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237430,SAMN02628523,GCA_000657635.1,JJSC00000000,-,Broad Institute,WGS,Illumina,122.0x,allpaths v. R48559,,,42.0,44.0,4402244.0,65.6,4359.0,,4023.0,,,,2013,Iran,Iran,,,,,,"Human, Homo sapiens",M,25,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran34;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 20;lineage:T1;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.360Z,2015-03-16T03:17:09.594Z
1455311_3,Mycobacterium tuberculosis NRITLD37,Mycobacterium tuberculosis NRITLD37,1455311.0,WGS,NRITLD37,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237433,SAMN02628526,GCA_000657655.1,JJSB00000000,-,Broad Institute,WGS,Illumina,113.0x,allpaths v. R48559,,,109.0,130.0,4369809.0,65.6,4371.0,,4013.0,,,,2011,Iran,Iran,,,,,,"Human, Homo sapiens",M,50,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran37;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 22;lineage:Beijing;microscopy ziehl-neelsen:Positive 1+;tb culture lowenstein-jensen:Positive More than 50 colonies/tube,2014-12-08T22:12:14.370Z,2015-03-16T03:17:09.594Z
1455312_3,Mycobacterium tuberculosis NRITLD38,Mycobacterium tuberculosis NRITLD38,1455312.0,WGS,NRITLD38,,,,,,,,2014-04-29T00:00:00Z,,PRJNA237434,SAMN02628527,GCA_000657675.1,JJSA00000000,-,Broad Institute,WGS,Illumina,123.0x,allpaths v. R48559,,,32.0,34.0,4392045.0,65.6,4352.0,,3990.0,,,,2011,Iran,Iran,,,,,,"Human, Homo sapiens",F,28,,,,,Resistant,AMR Panel,,,,,,,,,,,TB-ARC - Iran,specimen id:Iran38;genotyping method:Drug-susceptibility testing for antibiotic resistance;specimen source id:Patient 23;lineage:Beijing;microscopy ziehl-neelsen:Positive 3+;tb culture lowenstein-jensen:Positive More than 500 colonies/tube,2014-12-08T22:12:14.379Z,2015-03-16T03:17:09.594Z
1773_169,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1773_170,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1773_171,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1773_172,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1773_173,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1773_174,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
1773_265,Mycobacterium tuberculosis 4276-09,,1773.0,WGS,4276-09,,,,,mlva:1905-122,,,,25599400,,SAMEA2535307,,,,,,,,,,,119.0,119.0,4346054.0,65.53,4262.0,,,,,,,Swaziland,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:Africa2;phenotype:fully susceptible,2015-03-05T20:13:28.997Z,2015-03-16T03:17:09.594Z
1773_266,Mycobacterium tuberculosis 10507-09,,1773.0,WGS,10507-09,,,,,mlva:342-122,,,,25599400,,SAMEA2535298,,,,,,,,,,,147.0,147.0,4418522.0,65.45,4394.0,,,,,,,Swaziland,,,,,,,"Human, Homo sapiens",,,,,,,Resistant,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:Africa2;phenotype:MDR,2015-03-05T20:13:34.905Z,2015-03-16T03:17:09.594Z
1773_267,Mycobacterium tuberculosis 8073-07,,1773.0,WGS,8073-07,,,,,mlva:1084-33,,,,25599400,,SAMEA2535290,,,,,,,,,,,159.0,159.0,4512167.0,65.42,4470.0,,,,,,,Burma,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:RD150;phenotype:MDR,2015-03-05T20:13:40.093Z,2015-03-16T03:17:09.594Z
1773_268,Mycobacterium tuberculosis 1314-04,,1773.0,WGS,1314-04,,,,,mlva:1048-32,,,,25599400,,SAMEA2535280,,,,,,,,,,,176.0,176.0,4340165.0,65.43,4303.0,,,,,,,China,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:undefined;phenotype:fully susceptible,2015-03-05T20:13:45.298Z,2015-03-16T03:17:09.594Z
1773_269,Mycobacterium tuberculosis 4203-01,,1773.0,WGS,4203-01,,,,,mlva:1310-189,,,,25599400,,SAMEA2535268,,,,,,,,,,,169.0,169.0,4531990.0,65.43,4456.0,,,,,,,Vietnam,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:Africa1;phenotype:fully susceptible,2015-03-05T20:13:51.320Z,2015-03-16T03:17:09.594Z
1773_271,Mycobacterium tuberculosis 9686-04,,1773.0,WGS,9686-04,,,,,mlva:94-32,,,,25599400,,SAMEA2535248,,,,,,,,,,,208.0,208.0,4349301.0,65.55,4254.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:14:02.242Z,2015-03-16T03:17:09.594Z
1773_272,Mycobacterium tuberculosis 474-05,,1773.0,WGS,474-05,,,,,mlva:9375-32,,,,25599400,,SAMEA2535236,,,,,,,,,,,157.0,157.0,4331064.0,65.4,4276.0,,,,,,,Abkhazia,,,,,,,"Human, Homo sapiens",,,,,,,Resistant,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:MDR,2015-03-05T20:14:09.127Z,2015-03-16T03:17:09.594Z
1773_273,Mycobacterium tuberculosis 7194-05,,1773.0,WGS,7194-05,,,,,mlva:1048-32,,,,25599400,,SAMEA2535188,,,,,,,,,,,213.0,213.0,4363553.0,65.51,4308.0,,,,,,,Nepal,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:undefined;phenotype:fully susceptible,2015-03-05T20:14:13.943Z,2015-03-16T03:17:09.594Z
1773_274,Mycobacterium tuberculosis 5569-09,,1773.0,WGS,5569-09,,,,,mlva:3819-32,,,,25599400,,SAMEA2535180,,,,,,,,,,,165.0,165.0,4330547.0,65.43,4298.0,,,,,,,Swaziland,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:Africa2;phenotype:fully susceptible,2015-03-05T20:14:20.142Z,2015-03-16T03:17:09.594Z
1773_275,Mycobacterium tuberculosis 10734-04,,1773.0,WGS,10734-04,,,,,mlva:9137-32,,,,25599400,,SAMEA2535166,,,,,,,,,,,185.0,185.0,4339569.0,65.46,4276.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CA;phenotype:MDR,2015-03-05T20:14:25.340Z,2015-03-16T03:17:09.594Z
1773_276,Mycobacterium tuberculosis 8304-09,,1773.0,WGS,8304-09,,,,,mlva:5143-32,,,,25599400,,SAMEA2535152,,,,,,,,,,,152.0,152.0,4337208.0,65.44,4288.0,,,,,,,Swaziland,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:Africa2;phenotype:DR,2015-03-05T20:14:30.143Z,2015-03-16T03:17:09.594Z
1773_277,Mycobacterium tuberculosis 7424-07,,1773.0,WGS,7424-07,,,,,mlva:1087-32,,,,25599400,,SAMEA2535142,,,,,,,,,,,142.0,142.0,4358732.0,65.54,4267.0,,,,,,,India,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral2;phenotype:MDR,2015-03-05T20:14:35.982Z,2015-03-16T03:17:09.594Z
1773_278,Mycobacterium tuberculosis 4546-04,,1773.0,WGS,4546-04,,,,,mlva:94-32,,,,25599400,,SAMEA2535134,,,,,,,,,,,160.0,160.0,4345641.0,65.48,4279.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CA;phenotype:MDR,2015-03-05T20:14:41.707Z,2015-03-16T03:17:09.594Z
1773_279,Mycobacterium tuberculosis 8654-06,,1773.0,WGS,8654-06,,,,,mlva:9417-189,,,,25599400,,SAMEA2535126,,,,,,,,,,,148.0,148.0,4351201.0,65.54,4262.0,,,,,,,Kenya,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:Africa1;phenotype:fully susceptible,2015-03-05T20:14:46.428Z,2015-03-16T03:17:09.594Z
1773_280,Mycobacterium tuberculosis 1500-03,,1773.0,WGS,1500-03,,,,,mlva:1047-189,,,,25599400,,SAMEA2535125,,,,,,,,,,,140.0,140.0,4343312.0,65.46,4289.0,,,,,,,Iran,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CA;phenotype:fully susceptible,2015-03-05T20:14:52.021Z,2015-03-16T03:17:09.594Z
1773_281,Mycobacterium tuberculosis 683-05,,1773.0,WGS,683-05,,,,,mlva:100-32,,,,25599400,,SAMEA2535113,,,,,,,,,,,147.0,147.0,4319100.0,65.39,4277.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:MDR,2015-03-05T20:14:57.676Z,2015-03-16T03:17:09.594Z
1773_282,Mycobacterium tuberculosis 8038-95,,1773.0,WGS,8038-95,,,,,mlva:9335-32,,,,25599400,,SAMEA2535029,,,,,,,,,,,170.0,170.0,4338454.0,65.44,4278.0,,,,,,,Germany,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral3;phenotype:MDR,2015-03-05T20:15:03.885Z,2015-03-16T03:17:09.594Z
1773_283,Mycobacterium tuberculosis 11458-02,,1773.0,WGS,11458-02,,,,,mlva:4199-175,,,,25599400,,SAMEA2535025,,,,,,,,,,,181.0,181.0,4307307.0,65.38,4282.0,,,,,,,Germany,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:undefined;phenotype:DR,2015-03-05T20:15:08.744Z,2015-03-16T03:17:09.594Z
1773_284,Mycobacterium tuberculosis 685-05,,1773.0,WGS,685-05,,,,,mlva:9129-32,,,,25599400,,SAMEA2535016,,,,,,,,,,,124.0,124.0,4351687.0,65.54,4256.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:15:14.680Z,2015-03-16T03:17:09.594Z
1773_285,Mycobacterium tuberculosis 5331-05,,1773.0,WGS,5331-05,,,,,mlva:9510-32,,,,25599400,,SAMEA2534994,,,,,,,,,,,155.0,155.0,4344012.0,65.53,4273.0,,,,,,,Vietnam,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral1;phenotype:fully susceptible,2015-03-05T20:15:27.021Z,2015-03-16T03:17:09.594Z
1773_286,Mycobacterium tuberculosis 9827-01,,1773.0,WGS,9827-01,,,,,mlva:1066-32,,,,25599400,,SAMEA2534993,,,,,,,,,,,115.0,115.0,4352152.0,65.51,4272.0,,,,,,,Turkmenistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:undefined;phenotype:DR,2015-03-05T20:15:32.116Z,2015-03-16T03:17:09.594Z
1773_287,Mycobacterium tuberculosis 10530-05,,1773.0,WGS,10530-05,,,,,mlva:94-32,,,,25599400,,SAMEA2534992,,,,,,,,,,,158.0,158.0,4329798.0,65.45,4278.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:15:37.973Z,2015-03-16T03:17:09.594Z
1773_289,Mycobacterium tuberculosis 7253-02,,1773.0,WGS,7253-02,,,,,mlva:5284-32,,,,25599400,,SAMEA2534942,,,,,,,,,,,158.0,158.0,4340902.0,65.5,4277.0,,,,,,,China,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral1;phenotype:fully susceptible,2015-03-05T20:15:48.744Z,2015-03-16T03:17:09.594Z
1773_290,Mycobacterium tuberculosis R06-0174,,1773.0,WGS,R06-0174,,,,,mlva:100-32,,,,25599400,,SAMEA2534935,,,,,,,,,,,159.0,159.0,4319384.0,65.38,4289.0,,,,,,,Denmark,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:undefined;phenotype:fully susceptible,2015-03-05T20:15:59.581Z,2015-03-16T03:17:09.594Z
1773_292,Mycobacterium tuberculosis 57-02,,1773.0,WGS,57-02,,,,,mlva:4694-32,,,,25599400,,SAMEA2534884,,,,,,,,,,,164.0,164.0,4417819.0,65.46,4361.0,,,,,,,Turkmenistan,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral1;phenotype:fully susceptible,2015-03-05T20:16:09.220Z,2015-03-16T03:17:09.594Z
1773_293,Mycobacterium tuberculosis 1691-01,,1773.0,WGS,1691-01,,,,,mlva:9510-32,,,,25599400,,SAMEA2534880,,,,,,,,,,,157.0,157.0,4332063.0,65.42,4293.0,,,,,,,Vietnam,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral1;phenotype:fully susceptible,2015-03-05T20:16:15.100Z,2015-03-16T03:17:09.594Z
1773_294,Mycobacterium tuberculosis 6265-09,,1773.0,WGS,6265-09,,,,,mlva:1547-88,,,,25599400,,SAMEA2534866,,,,,,,,,,,178.0,178.0,4320792.0,65.4,4281.0,,,,,,,Swaziland,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:Africa2;phenotype:fully susceptible,2015-03-05T20:16:25.361Z,2015-03-16T03:17:09.594Z
1773_295,Mycobacterium tuberculosis 178-03,,1773.0,WGS,178-03,,,,,mlva:204-33,,,,25599400,,SAMEA2534823,,,,,,,,,,,161.0,161.0,4366847.0,65.42,4338.0,,,,,,,Thailand,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:RD150;phenotype:fully susceptible,2015-03-05T20:16:31.640Z,2015-03-16T03:17:09.594Z
1773_296,Mycobacterium tuberculosis 12448-03,,1773.0,WGS,12448-03,,,,,mlva:100-32,,,,25599400,,SAMEA2534809,,,,,,,,,,,117.0,117.0,4343544.0,65.46,4302.0,,,,,,,Germany,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:MDR,2015-03-05T20:16:38.439Z,2015-03-16T03:17:09.594Z
1773_297,Mycobacterium tuberculosis 9700-04,,1773.0,WGS,9700-04,,,,,mlva:100-32,,,,25599400,,SAMEA2534744,,,,,,,,,,,143.0,143.0,4356979.0,65.52,4279.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:MDR,2015-03-05T20:16:43.931Z,2015-03-16T03:17:09.594Z
1773_298,Mycobacterium tuberculosis 8372-95,,1773.0,WGS,8372-95,,,,,mlva:9340-32,,,,25599400,,SAMEA2534730,,,,,,,,,,,167.0,167.0,4353019.0,65.47,4298.0,,,,,,,Germany,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:undefined;phenotype:DR,2015-03-05T20:16:50.066Z,2015-03-16T03:17:09.594Z
1773_300,Mycobacterium tuberculosis 8888-01,,1773.0,WGS,8888-01,,,,,mlva:94-32,,,,25599400,,SAMEA2534687,,,,,,,,,,,95.0,95.0,4369768.0,65.54,4271.0,,,,,,,Turkmenistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:DR,2015-03-05T20:17:08.407Z,2015-03-16T03:17:09.594Z
1773_301,Mycobacterium tuberculosis 10721-03,,1773.0,WGS,10721-03,,,,,mlva:3828-32,,,,25599400,,SAMEA2534677,,,,,,,,,,,178.0,178.0,4353007.0,65.51,4282.0,,,,,,,Abkhazia,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:DR,2015-03-05T20:17:13.142Z,2015-03-16T03:17:09.594Z
1773_302,Mycobacterium tuberculosis 4419-02,,1773.0,WGS,4419-02,,,,,mlva:94-32,,,,25599400,,SAMEA2534676,,,,,,,,,,,186.0,186.0,4346354.0,65.55,4253.0,,,,,,,Kazakhstan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:17:18.240Z,2015-03-16T03:17:09.594Z
1773_304,Mycobacterium tuberculosis 3684-08,,1773.0,WGS,3684-08,,,,,mlva:100-32,,,,25599400,,SAMEA2534642,,,,,,,,,,,140.0,140.0,4352914.0,65.5,4276.0,,,,,,,Russia,,,,,,,"Human, Homo sapiens",,,,,,,Resistant,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:XDR,2015-03-05T20:17:37.138Z,2015-03-16T03:17:09.594Z
1773_305,Mycobacterium tuberculosis 9048-05,,1773.0,WGS,9048-05,,,,,mlva:94-32,,,,25599400,,SAMEA2534593,,,,,,,,,,,160.0,160.0,4339960.0,65.48,4290.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:17:42.817Z,2015-03-16T03:17:09.594Z
1773_307,Mycobacterium tuberculosis 10812-03,,1773.0,WGS,10812-03,,,,,mlva:1071-32,,,,25599400,,SAMEA2534492,,,,,,,,,,,140.0,140.0,4316993.0,65.39,4268.0,,,,,,,Abkhazia,,,,,,,"Human, Homo sapiens",,,,,,,Resistant,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral2;phenotype:MDR,2015-03-05T20:17:59.292Z,2015-03-16T03:17:09.594Z
1773_308,Mycobacterium tuberculosis 7454-06,,1773.0,WGS,7454-06,,,,,mlva:1065-32,,,,25599400,,SAMEA2534477,,,,,,,,,,,190.0,190.0,4349545.0,65.5,4279.0,,,,,,,Azerbaijan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CA;phenotype:MDR,2015-03-05T20:18:10.485Z,2015-03-16T03:17:09.594Z
1773_309,Mycobacterium tuberculosis 8662-05,,1773.0,WGS,8662-05,,,,,mlva:898-32,,,,25599400,,SAMEA2534474,,,,,,,,,,,175.0,175.0,4341828.0,65.49,4285.0,,,,,,,Thailand,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:undefined;phenotype:DR,2015-03-05T20:18:17.293Z,2015-03-16T03:17:09.594Z
1773_31,Mycobacterium tuberculosis UT205,Mycobacterium tuberculosis UT205,1097669.0,Complete,,,,,,,,,2012-02-24T00:00:00Z,22404577,PRJNA162183,SAMEA2272432,GCA_000304555.1,HE608151.1,,,,,,,1.0,,,1.0,4418088.0,63.3,4212.0,,3804.0,,sputum,,,Colombia,,,,,,,"Human, Homo sapiens",male,33,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,Tuberculosis,-,,2014-12-08T22:12:21.985Z,2015-03-16T03:17:09.594Z
1773_311,Mycobacterium tuberculosis 966-95,,1773.0,WGS,966-95,,,,,mlva:100-32,,,,25599400,,SAMEA2534441,,,,,,,,,,,159.0,159.0,4351050.0,65.43,4300.0,,,,,,,Russia,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:MDR,2015-03-05T20:18:28.467Z,2015-03-16T03:17:09.594Z
1773_312,Mycobacterium tuberculosis 12615-95,,1773.0,WGS,12615-95,,,,,mlva:100-32,,,,25599400,,SAMEA2534438,,,,,,,,,,,171.0,171.0,4382085.0,65.48,4302.0,,,,,,,Russia,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:MDR,2015-03-05T20:18:34.824Z,2015-03-16T03:17:09.594Z
1773_313,Mycobacterium tuberculosis 2280-07,,1773.0,WGS,2280-07,,,,,mlva:407-32,,,,25599400,,SAMEA2534433,,,,,,,,,,,132.0,132.0,4352679.0,65.54,4259.0,,,,,,,Afghanistan,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CA;phenotype:fully susceptible,2015-03-05T20:18:39.879Z,2015-03-16T03:17:09.594Z
1773_314,Mycobacterium tuberculosis 10836-09,,1773.0,WGS,10836-09,,,,,mlva:100-32,,,,25599400,,SAMEA2534405,,,,,,,,,,,156.0,156.0,4375084.0,65.54,4297.0,,,,,,,Germany,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:MDR,2015-03-05T20:18:49.520Z,2015-03-16T03:17:09.594Z
1773_315,Mycobacterium tuberculosis 3015-05,,1773.0,WGS,3015-05,,,,,mlva:897-32,,,,25599400,,SAMEA2534335,,,,,,,,,,,160.0,160.0,4360369.0,65.52,4294.0,,,,,,,Germany,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:Africa2;phenotype:fully susceptible,2015-03-05T20:18:54.927Z,2015-03-16T03:17:09.594Z
1773_316,Mycobacterium tuberculosis 7187-09,,1773.0,WGS,7187-09,,,,,mlva:3828-85,,,,25599400,,SAMEA2534330,,,,,,,,,,,167.0,167.0,4333050.0,65.41,4284.0,,,,,,,Swaziland,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:undefined;phenotype:fully susceptible,2015-03-05T20:19:01.474Z,2015-03-16T03:17:09.594Z
1773_317,Mycobacterium tuberculosis 1934-03,,1773.0,WGS,1934-03,,,,,mlva:1048-133,,,,25599400,,SAMEA2534329,,,,,,,,,,,165.0,165.0,4331939.0,65.46,4287.0,,,,,,,China,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:undefined;phenotype:fully susceptible,2015-03-05T20:19:06.909Z,2015-03-16T03:17:09.594Z
1773_318,Mycobacterium tuberculosis 6844-06,,1773.0,WGS,6844-06,,,,,mlva:1071-32,,,,25599400,,SAMEA2534314,,,,,,,,,,,102.0,102.0,4353109.0,65.56,4267.0,,,,,,,Russia,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral2;phenotype:MDR,2015-03-05T20:19:14.814Z,2015-03-16T03:17:09.594Z
1773_319,Mycobacterium tuberculosis 9052-05,,1773.0,WGS,9052-05,,,,,mlva:94-32,,,,25599400,,SAMEA2534307,,,,,,,,,,,111.0,111.0,4355717.0,65.48,4298.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:19:22.045Z,2015-03-16T03:17:09.594Z
1773_320,Mycobacterium tuberculosis 1339-07,,1773.0,WGS,1339-07,,,,,mlva:9417-189,,,,25599400,,SAMEA2534301,,,,,,,,,,,161.0,161.0,4384114.0,65.55,4310.0,,,,,,,Nigeria,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:Africa1;phenotype:fully susceptible,2015-03-05T20:19:29.131Z,2015-03-16T03:17:09.594Z
1773_322,Mycobacterium tuberculosis 10737-02,,1773.0,WGS,10737-02,,,,,mlva:6345-33,,,,25599400,,SAMEA2534295,,,,,,,,,,,158.0,158.0,4336894.0,65.44,4309.0,,,,,,,Indonesia,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:RD150;phenotype:fully susceptible,2015-03-05T20:19:39.986Z,2015-03-16T03:17:09.594Z
1773_323,Mycobacterium tuberculosis 1232-02,,1773.0,WGS,1232-02,,,,,mlva:94-32,,,,25599400,,SAMEA2534262,,,,,,,,,,,166.0,166.0,4341926.0,65.44,4288.0,,,,,,,Turkmenistan,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CA;phenotype:fully susceptible,2015-03-05T20:19:48.545Z,2015-03-16T03:17:09.594Z
1773_324,Mycobacterium tuberculosis 4296-09,,1773.0,WGS,4296-09,,,,,mlva:1922-88,,,,25599400,,SAMEA2534241,,,,,,,,,,,158.0,158.0,4340824.0,65.45,4305.0,,,,,,,Swaziland,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:Africa2;phenotype:fully susceptible,2015-03-05T20:19:55.335Z,2015-03-16T03:17:09.594Z
1773_325,Mycobacterium tuberculosis 711-05,,1773.0,WGS,711-05,,,,,mlva:94-32,,,,25599400,,SAMEA2534216,,,,,,,,,,,112.0,112.0,4362233.0,65.55,4271.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:20:00.433Z,2015-03-16T03:17:09.594Z
1773_326,Mycobacterium tuberculosis 7942-05,,1773.0,WGS,7942-05,,,,,mlva:94-32,,,,25599400,,SAMEA2534205,,,,,,,,,,,110.0,110.0,4339658.0,65.45,4275.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:20:11.283Z,2015-03-16T03:17:09.594Z
1773_327,Mycobacterium tuberculosis 4461-02,,1773.0,WGS,4461-02,,,,,mlva:94-32,,,,25599400,,SAMEA2534182,,,,,,,,,,,208.0,208.0,4348693.0,65.55,4248.0,,,,,,,Kazakhstan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:20:17.162Z,2015-03-16T03:17:09.594Z
1773_328,Mycobacterium tuberculosis 1511-02,,1773.0,WGS,1511-02,,,,,mlva:1465-33,,,,25599400,,SAMEA2534126,,,,,,,,,,,149.0,149.0,4335587.0,65.46,4294.0,,,,,,,Vietnam,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:RD150;phenotype:fully susceptible,2015-03-05T20:20:23.290Z,2015-03-16T03:17:09.594Z
1773_331,Mycobacterium tuberculosis 10735-04,,1773.0,WGS,10735-04,,,,,mlva:94-32,,,,25599400,,SAMEA2534086,,,,,,,,,,,168.0,168.0,4336950.0,65.46,4285.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:20:42.904Z,2015-03-16T03:17:09.594Z
1773_332,Mycobacterium tuberculosis 7750-01,,1773.0,WGS,7750-01,,,,,mlva:9536-32,,,,25599400,,SAMEA2534085,,,,,,,,,,,143.0,143.0,4408674.0,65.44,4367.0,,,,,,,Turkmenistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral1;phenotype:DR,2015-03-05T20:20:50.622Z,2015-03-16T03:17:09.594Z
1773_334,Mycobacterium tuberculosis 3936-02,,1773.0,WGS,3936-02,,,,,mlva:4839-32,,,,25599400,,SAMEA2534036,,,,,,,,,,,161.0,161.0,4471594.0,65.42,4404.0,,,,,,,Germany,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral3;phenotype:fully susceptible,2015-03-05T20:20:58.217Z,2015-03-16T03:17:09.594Z
1773_335,Mycobacterium tuberculosis 2389-05,,1773.0,WGS,2389-05,,,,,mlva:94-32,,,,25599400,,SAMEA2534025,,,,,,,,,,,115.0,115.0,4333977.0,65.42,4283.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:21:04.555Z,2015-03-16T03:17:09.594Z
1773_336,Mycobacterium tuberculosis 4769-05,,1773.0,WGS,4769-05,,,,,mlva:1075-32,,,,25599400,,SAMEA2534023,,,,,,,,,,,131.0,131.0,4351225.0,65.5,4273.0,,,,,,,Abkhazia,,,,,,,"Human, Homo sapiens",,,,,,,Resistant,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:MDR,2015-03-05T20:21:09.401Z,2015-03-16T03:17:09.594Z
1773_337,Mycobacterium tuberculosis 5250-07,,1773.0,WGS,5250-07,,,,,mlva:1083-33,,,,25599400,,SAMEA2534018,,,,,,,,,,,564.0,564.0,4414275.0,65.54,4346.0,,,,,,,Germany,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:RD150;phenotype:MDR,2015-03-05T20:21:15.487Z,2015-03-16T03:17:09.594Z
1773_338,Mycobacterium tuberculosis 4484-07,,1773.0,WGS,4484-07,,,,,mlva:1048-32,,,,25599400,,SAMEA2533997,,,,,,,,,,,136.0,136.0,4367734.0,65.54,4292.0,,,,,,,Nepal,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:undefined;phenotype:fully susceptible,2015-03-05T20:21:21.119Z,2015-03-16T03:17:09.594Z
1773_339,Mycobacterium tuberculosis 2488-02,,1773.0,WGS,2488-02,,,,,mlva:100-32,,,,25599400,,SAMEA2533982,,,,,,,,,,,158.0,158.0,4343152.0,65.44,4281.0,,,,,,,Turkmenistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:MDR,2015-03-05T20:21:25.957Z,2015-03-16T03:17:09.594Z
1773_340,Mycobacterium tuberculosis 4730-03,,1773.0,WGS,4730-03,,,,,mlva:3445-32,,,,25599400,,SAMEA2533923,,,,,,,,,,,144.0,144.0,4320270.0,65.44,4274.0,,,,,,,Sierra Leone,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral3;phenotype:MDR,2015-03-05T20:21:31.511Z,2015-03-16T03:17:09.594Z
1773_341,Mycobacterium tuberculosis R04-0039,,1773.0,WGS,R04-0039,,,,,mlva:100-32,,,,25599400,,SAMEA2533893,,,,,,,,,,,139.0,139.0,4361632.0,65.5,4315.0,,,,,,,Denmark,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:undefined;phenotype:fully susceptible,2015-03-05T20:21:37.027Z,2015-03-16T03:17:09.594Z
1773_342,Mycobacterium tuberculosis 3811-05,,1773.0,WGS,3811-05,,,,,mlva:94-32,,,,25599400,,SAMEA2533887,,,,,,,,,,,107.0,107.0,4345338.0,65.47,4260.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:21:42.193Z,2015-03-16T03:17:09.594Z
1773_343,Mycobacterium tuberculosis 5712-95,,1773.0,WGS,5712-95,,,,,mlva:100-32,,,,25599400,,SAMEA2533850,,,,,,,,,,,156.0,156.0,4540427.0,65.47,4464.0,,,,,,,Russia,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:MDR,2015-03-05T20:21:48.082Z,2015-03-16T03:17:09.594Z
1773_344,Mycobacterium tuberculosis 1312-05,,1773.0,WGS,1312-05,,,,,mlva:94-32,,,,25599400,,SAMEA2533849,,,,,,,,,,,163.0,163.0,4320550.0,65.44,4281.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:21:54.203Z,2015-03-16T03:17:09.594Z
1773_345,Mycobacterium tuberculosis 9829-08,,1773.0,WGS,9829-08,,,,,mlva:9381-332,,,,25599400,,SAMEA2533840,,,,,,,,,,,157.0,157.0,4351629.0,65.53,4282.0,,,,,,,Kazakhstan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CA;phenotype:DR,2015-03-05T20:21:58.884Z,2015-03-16T03:17:09.594Z
1773_346,Mycobacterium tuberculosis 3435-06,,1773.0,WGS,3435-06,,,,,mlva:1631-32,,,,25599400,,SAMEA2533789,,,,,,,,,,,165.0,165.0,4337044.0,65.52,4263.0,,,,,,,Thailand,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral3;phenotype:fully susceptible,2015-03-05T20:22:04.806Z,2015-03-16T03:17:09.594Z
1773_348,Mycobacterium tuberculosis 9847-95,,1773.0,WGS,9847-95,,,,,mlva:100-32,,,,25599400,,SAMEA2533777,,,,,,,,,,,171.0,171.0,4330943.0,65.42,4281.0,,,,,,,Russia,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:MDR,2015-03-05T20:22:12.340Z,2015-03-16T03:17:09.594Z
1773_349,Mycobacterium tuberculosis 49-02,,1773.0,Complete,49-02,,,,,mlva:801-32,,,2014-11-03T00:00:00Z,25599400,PRJEB4916,SAMEA2533772,GCA_000786505.1,HG813240.1,NZ_HG813240.1,JLU,,,,,1.0,,146.0,146.0,4342408.0,65.47,4270.0,,,,,,,Turkmenistan,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CA;phenotype:fully susceptible,2015-03-05T20:22:17.988Z,2015-03-16T03:17:09.594Z
1773_351,Mycobacterium tuberculosis 8886-01,,1773.0,WGS,8886-01,,,,,mlva:94-32,,,,25599400,,SAMEA2533751,,,,,,,,,,,125.0,125.0,4338177.0,65.47,4257.0,,,,,,,Turkmenistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:DR,2015-03-05T20:22:29.658Z,2015-03-16T03:17:09.594Z
1773_352,Mycobacterium tuberculosis 679-04,,1773.0,WGS,679-04,,,,,mlva:99-32,,,,25599400,,SAMEA2533743,,,,,,,,,,,123.0,123.0,4357454.0,65.52,4271.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CA;phenotype:MDR,2015-03-05T20:22:34.832Z,2015-03-16T03:17:09.594Z
1773_354,Mycobacterium tuberculosis 3297-06,,1773.0,WGS,3297-06,,,,,mlva:1070-32,,,,25599400,,SAMEA2533692,,,,,,,,,,,178.0,178.0,4451981.0,65.4,4408.0,,,,,,,Russia,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:W148;phenotype:MDR,2015-03-05T20:22:46.623Z,2015-03-16T03:17:09.594Z
1773_355,Mycobacterium tuberculosis 575-03,,1773.0,WGS,575-03,,,,,mlva:9510-32,,,,25599400,,SAMEA2533688,,,,,,,,,,,147.0,147.0,4405123.0,65.48,4366.0,,,,,,,Vietnam,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral1;phenotype:fully susceptible,2015-03-05T20:22:51.554Z,2015-03-16T03:17:09.594Z
1773_356,Mycobacterium tuberculosis 4688-09,,1773.0,WGS,4688-09,,,,,mlva:342-122,,,,25599400,,SAMEA2533682,,,,,,,,,,,169.0,169.0,4328215.0,65.43,4280.0,,,,,,,Swaziland,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:Africa2;phenotype:fully susceptible,2015-03-05T20:22:57.956Z,2015-03-16T03:17:09.594Z
1773_357,Mycobacterium tuberculosis 4703-09,,1773.0,WGS,4703-09,,,,,mlva:1465-33,,,,25599400,,SAMEA2533675,,,,,,,,,,,178.0,178.0,4352445.0,65.47,4273.0,,,,,,,Swaziland,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:RD150;phenotype:fully susceptible,2015-03-05T20:23:03.633Z,2015-03-16T03:17:09.594Z
1773_358,Mycobacterium tuberculosis 8195-08,,1773.0,WGS,8195-08,,,,,mlva:342-32,,,,25599400,,SAMEA2533628,,,,,,,,,,,151.0,151.0,4339318.0,65.53,4261.0,,,,,,,Poland,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:Africa2;phenotype:fully susceptible,2015-03-05T20:23:09.392Z,2015-03-16T03:17:09.594Z
1773_359,Mycobacterium tuberculosis 8889-01,,1773.0,WGS,8889-01,,,,,mlva:94-32,,,,25599400,,SAMEA2533609,,,,,,,,,,,133.0,133.0,4356157.0,65.52,4261.0,,,,,,,Turkmenistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:DR,2015-03-05T20:23:14.680Z,2015-03-16T03:17:09.594Z
1773_360,Mycobacterium tuberculosis 3454-10,,1773.0,WGS,3454-10,,,,,mlva:8251-15,,,,25599400,,SAMEA2533593,,,,,,,,,,,299.0,299.0,4361592.0,65.54,4276.0,,,,,,,Simbabwe,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:RD150;phenotype:fully susceptible,2015-03-05T20:23:19.612Z,2015-03-16T03:17:09.594Z
1773_361,Mycobacterium tuberculosis 4403-05,,1773.0,WGS,4403-05,,,,,mlva:2083-32,,,,25599400,,SAMEA2533583,,,,,,,,,,,102.0,102.0,4374547.0,65.55,4291.0,,,,,,,New Guinea,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral3;phenotype:DR,2015-03-05T20:23:24.434Z,2015-03-16T03:17:09.594Z
1773_363,Mycobacterium tuberculosis 4950-04,,1773.0,WGS,4950-04,,,,,mlva:9552-799,,,,25599400,,SAMEA2533569,,,,,,,,,,,171.0,171.0,4372692.0,65.48,4305.0,,,,,,,China,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral3;phenotype:fully susceptible,2015-03-05T20:23:37.470Z,2015-03-16T03:17:09.594Z
1773_364,Mycobacterium tuberculosis 9589-07,,1773.0,WGS,9589-07,,,,,mlva:342-32,,,,25599400,,SAMEA2533555,,,,,,,,,,,160.0,160.0,4372019.0,65.55,4286.0,,,,,,,China,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:Africa2;phenotype:fully susceptible,2015-03-05T20:23:42.593Z,2015-03-16T03:17:09.594Z
1773_365,Mycobacterium tuberculosis 10529-05,,1773.0,WGS,10529-05,,,,,mlva:94-32,,,,25599400,,SAMEA2533542,,,,,,,,,,,157.0,157.0,4360636.0,65.43,4322.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:23:48.490Z,2015-03-16T03:17:09.594Z
1773_366,Mycobacterium tuberculosis 10107-01,,1773.0,WGS,10107-01,,,,,mlva:94-32,,,,25599400,,SAMEA2533465,,,,,,,,,,,102.0,102.0,4374166.0,65.55,4273.0,,,,,,,Turkmenistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:DR,2015-03-05T20:23:53.765Z,2015-03-16T03:17:09.594Z
1773_367,Mycobacterium tuberculosis 8455-05,,1773.0,WGS,8455-05,,,,,mlva:9126-32,,,,25599400,,SAMEA2533463,,,,,,,,,,,106.0,106.0,4338855.0,65.45,4262.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:24:00.170Z,2015-03-16T03:17:09.594Z
1773_368,Mycobacterium tuberculosis 5790-04,,1773.0,WGS,5790-04,,,,,mlva:1923-311,,,,25599400,,SAMEA2533435,,,,,,,,,,,119.0,119.0,4363464.0,65.54,4257.0,,,,,,,South Africa,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:undefined;phenotype:fully susceptible,2015-03-05T20:24:07.965Z,2015-03-16T03:17:09.594Z
1773_369,Mycobacterium tuberculosis R10-0225,,1773.0,WGS,R10-0225,,,,,mlva:100-32,,,,25599400,,SAMEA2533434,,,,,,,,,,,150.0,150.0,4316719.0,65.43,4287.0,,,,,,,Denmark,,,,,,,"Human, Homo sapiens",,,,,,,Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:undefined;phenotype:fully susceptible,2015-03-05T20:24:14.086Z,2015-03-16T03:17:09.594Z
1773_370,Mycobacterium tuberculosis 694-05,,1773.0,WGS,694-05,,,,,mlva:94-32,,,,25599400,,SAMEA2533423,,,,,,,,,,,195.0,195.0,4353218.0,65.54,4263.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:MDR,2015-03-05T20:24:18.754Z,2015-03-16T03:17:09.594Z
1773_371,Mycobacterium tuberculosis 9406-05,,1773.0,WGS,9406-05,,,,,mlva:1071-32,,,,25599400,,SAMEA2533380,,,,,,,,,,,241.0,241.0,4306895.0,65.47,4292.0,,,,,,,Abkhazia,,,,,,,"Human, Homo sapiens",,,,,,,Resistant,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:ancestral2;phenotype:MDR,2015-03-05T20:24:24.840Z,2015-03-16T03:17:09.594Z
1773_372,Mycobacterium tuberculosis 709-05,,1773.0,WGS,709-05,,,,,mlva:94-32,,,,25599400,,SAMEA2533372,,,,,,,,,,,106.0,106.0,4356226.0,65.53,4253.0,,,,,,,Uzbekistan,,,,,,,"Human, Homo sapiens",,,,,,,Resistant;Susceptible,AMR Panel,,,,,,,,,,,Global diversity of the Mycobacterium tuberculosis Beijing genotype,subgroup:CAO;phenotype:DR,2015-03-05T20:24:30.492Z,2015-03-16T03:17:09.594Z
652616_4,Mycobacterium tuberculosis str. Erdman = ATCC 35801 [PRJNA221521],,652616.0,WGS,Erdman,,,,,,,,,,PRJNA221521,SAMN02364096,GCA_000668235.1,JLBG00000000,,,,,,,,,10.0,10.0,4417384.0,65.65,4372.0,,4006.0,,,,,,,,,,,,,,,TB,,,treatment course:Unknown,Susceptible,AMR Panel,,,,,,,,,,,,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:23.449Z,2015-03-16T03:17:09.594Z
83331_31,Mycobacterium tuberculosis CDC1551 [PRJNA227750],,83331.0,WGS,cdc1551,,,,,,,,,,PRJNA227750,SAMN02402661,GCA_000669715.1,JLBH00000000,,,,,,,,,5.0,5.0,4405815.0,65.62,4346.0,,4000.0,,,,,,,,,,,,,,,TB,,,,Susceptible,AMR Panel,,,,,,,,,,,,organism detection method:MGIT;phenotype:Fully Susceptible,2014-12-08T22:12:09.955Z,2015-03-16T03:17:09.594Z
83332_12,Mycobacterium tuberculosis H37Rv,Mycobacterium tuberculosis H37Rv,83332.0,Complete,H37Rv,,,,,,,,1998-06-20T00:00:00Z,"9634230,12368430",PRJNA224,,GCA_000195955.2,AL123456,NC_000962,Wellcome Trust Sanger Institute,complete,,,,1.0,,,1.0,4411532.0,65.6,4367.0,,3989.0,,derived from the original human-lung H37 isolate,"derived from the original human-lung H37 isolate in 1934, and has been used extensively worldwide in biomedical research",,,,,,,,,"Human, Homo sapiens",,,,,,,,,+,Rod,No,No,Mesophilic,37,,Aerobic,Host-associated,Tuberculosis,"Mycobacterium tuberculosis strain H37RV. This strain has been derived from the original human-lung H37 isolate in 1934, and has been used extensively worldwide in biomedical research. Unlike some clinical isolates, it retains full virulence in animal models of tuberculosis and is susceptible to drugs and receptive to genetic manipulation.",,2014-12-08T22:12:10.274Z,2015-03-16T03:17:09.594Z
